Study ID	Patient ID	Sample ID	Diagnosis Age	Diagnosis Age (days)	Alternative Therapy Given	Other Alternative Therapy Given	Analysis Cohort	BCR ABL1 Status	Bone Marrow Blasts Day 15	Bone Marrow Blasts Day 29	Bone Marrow Blasts Day 43	Bone Marrow Blasts Day 8	Bone Marrow Site of Relapse	Cancer Type	Cancer Type Detailed	Cell of tumor origin	CNS Site of Relapse	CNS Status	Congenital Abnormality	Death from Initial Pathologic Diagnosis Date	Time To Event (days)	DNA Index	Ethnicity Category	ETV6-RUNX1 Fusion Status	First Event	Fraction Genome Altered	Karyotype	MLL Status	Molecular Subtype	MRD Percentage at end of Consolidation	MRD Percentage at end of Consolidation Sensitivity	MRD Percentage Day 29	MRD Percentage Day 29 Sensitivity	MRD Percentage Day 43	MRD Percentage Day 43 Sensitivity	MRD Percentage Day 8	MRD Percentage Day 8 Sensitivity	Mutation Count	Oncotree Code	Overall Survival Days	Overall Survival (Months)	Overall Survival Status	Other Site of Relapse	Protocol	Race Category	Number of Samples Per Patient	Sex	Somatic Status	TCF3-PBX1 Status	Testes Site of Relapse	Testicular Involvement	TMB (nonsynonymous)	Trisomy 4_10	WBC
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.1	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.10	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.12	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.16	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.18	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.2	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.3	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.4	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.5	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.6	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABC	TARGET-10-CAAABC-60.7	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	11	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABD	TARGET-10-CAAABD-60.1	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	5	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABD	TARGET-10-CAAABD-60.2	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	5	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABD	TARGET-10-CAAABD-60.3	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	5	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABD	TARGET-10-CAAABD-60.4	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	5	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABD	TARGET-10-CAAABD-60.6	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	5	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.1	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.11	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.13	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.15	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.16	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.18	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.19	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.3	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.5	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-CAAABF	TARGET-10-CAAABF-60.9	NA	NA	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	10	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-03	14.0	5081.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-09	14.0	5081.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	0.0846	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.1	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.11	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.13	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.15	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.16	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.2	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.3	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.4	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.5	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.7	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKHZT	TARGET-10-PAKHZT-60.9	14.0	5081.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	355.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.127972466	NA	1.123899797	NA	NA	NA	0.1	0.01	NA	BLL	605.0	20.0	1:DECEASED	No	9906	White	13	Male	Matched	Negative	No	No	NA	Negative	307.0
all_phase2_target_2018_pub	TARGET-10-PAKKCA	TARGET-10-PAKKCA-03	12.0	4253.0	NA	NA	DISCOVERY	Negative	NA	17.0	4.0	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	733.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(6)(Q13Q23),DEL(9)(P22)[20]	Negative	None of above	NA	NA	17.98857868	NA	NA	NA	16.22	0.01	NA	BLL	1110.0	37.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	No	No	NA	Negative	236.4
all_phase2_target_2018_pub	TARGET-10-PAKKCA	TARGET-10-PAKKCA-09	12.0	4253.0	NA	NA	DISCOVERY	Negative	NA	17.0	4.0	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	733.0	1	Hispanic or Latino	Negative	Relapse	0.0226	46,XY,DEL(6)(Q13Q23),DEL(9)(P22)[20]	Negative	None of above	NA	NA	17.98857868	NA	NA	NA	16.22	0.01	NA	BLL	1110.0	37.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	No	No	NA	Negative	236.4
all_phase2_target_2018_pub	TARGET-10-PAKKCA	TARGET-10-PAKKCA-60.1	12.0	4253.0	NA	NA	XENOGRAFT	Negative	NA	17.0	4.0	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	733.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(6)(Q13Q23),DEL(9)(P22)[20]	Negative	None of above	NA	NA	17.98857868	NA	NA	NA	16.22	0.01	NA	BLL	1110.0	37.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	No	No	NA	Negative	236.4
all_phase2_target_2018_pub	TARGET-10-PAKKCA	TARGET-10-PAKKCA-60.2	12.0	4253.0	NA	NA	XENOGRAFT	Negative	NA	17.0	4.0	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	733.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(6)(Q13Q23),DEL(9)(P22)[20]	Negative	None of above	NA	NA	17.98857868	NA	NA	NA	16.22	0.01	NA	BLL	1110.0	37.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	No	No	NA	Negative	236.4
all_phase2_target_2018_pub	TARGET-10-PAKKCA	TARGET-10-PAKKCA-60.3	12.0	4253.0	NA	NA	XENOGRAFT	Negative	NA	17.0	4.0	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	733.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(6)(Q13Q23),DEL(9)(P22)[20]	Negative	None of above	NA	NA	17.98857868	NA	NA	NA	16.22	0.01	NA	BLL	1110.0	37.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	No	No	NA	Negative	236.4
all_phase2_target_2018_pub	TARGET-10-PAKKXB	TARGET-10-PAKKXB-03	15.0	5310.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	No	NA	2097.0	1	Hispanic or Latino	Negative	None	NA	46,XX[21]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.67	0.01	NA	BLL	2097.0	69.0	0:LIVING	No	9906	White	4	Female	Matched	Negative	No	NA	NA	Negative	92.7
all_phase2_target_2018_pub	TARGET-10-PAKKXB	TARGET-10-PAKKXB-09	15.0	5310.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	No	NA	2097.0	1	Hispanic or Latino	Negative	None	0.0015	46,XX[21]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.67	0.01	NA	BLL	2097.0	69.0	0:LIVING	No	9906	White	4	Female	Matched	Negative	No	NA	NA	Negative	92.7
all_phase2_target_2018_pub	TARGET-10-PAKKXB	TARGET-10-PAKKXB-60.1	15.0	5310.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	No	NA	2097.0	1	Hispanic or Latino	Negative	None	NA	46,XX[21]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.67	0.01	NA	BLL	2097.0	69.0	0:LIVING	No	9906	White	4	Female	Matched	Negative	No	NA	NA	Negative	92.7
all_phase2_target_2018_pub	TARGET-10-PAKKXB	TARGET-10-PAKKXB-60.2	15.0	5310.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	No	NA	2097.0	1	Hispanic or Latino	Negative	None	NA	46,XX[21]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.67	0.01	NA	BLL	2097.0	69.0	0:LIVING	No	9906	White	4	Female	Matched	Negative	No	NA	NA	Negative	92.7
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-09	2.0	523.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	0.0421	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-60.1	2.0	523.0	NA	NA	XENOGRAFT	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-60.2	2.0	523.0	NA	NA	XENOGRAFT	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-60.3	2.0	523.0	NA	NA	XENOGRAFT	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-60.4	2.0	523.0	NA	NA	XENOGRAFT	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-60.5	2.0	523.0	NA	NA	XENOGRAFT	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMVD	TARGET-10-PAKMVD-60.6	2.0	523.0	NA	NA	XENOGRAFT	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	3328.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	1.03	0.01	NA	BLL	3328.0	110.0	0:LIVING	No	9906	Black or African American	7	Male	Matched	Negative	No	No	NA	Negative	82.9
all_phase2_target_2018_pub	TARGET-10-PAKMZM	TARGET-10-PAKMZM-03	19.0	6666.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1229.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.01	0.559292035	NA	NA	NA	24.69	0.01	NA	BLL	1914.0	63.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	Yes	No	NA	Negative	114.6
all_phase2_target_2018_pub	TARGET-10-PAKMZM	TARGET-10-PAKMZM-09	19.0	6666.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1229.0	1	Hispanic or Latino	Negative	Relapse	0.0019	46,XY[20]	Negative	None of above	0.0	0.01	0.559292035	NA	NA	NA	24.69	0.01	NA	BLL	1914.0	63.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	Yes	No	NA	Negative	114.6
all_phase2_target_2018_pub	TARGET-10-PAKMZM	TARGET-10-PAKMZM-60.1	19.0	6666.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1229.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.01	0.559292035	NA	NA	NA	24.69	0.01	NA	BLL	1914.0	63.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	Yes	No	NA	Negative	114.6
all_phase2_target_2018_pub	TARGET-10-PAKMZM	TARGET-10-PAKMZM-60.2	19.0	6666.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1229.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.01	0.559292035	NA	NA	NA	24.69	0.01	NA	BLL	1914.0	63.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	Yes	No	NA	Negative	114.6
all_phase2_target_2018_pub	TARGET-10-PAKMZM	TARGET-10-PAKMZM-60.3	19.0	6666.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1229.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.01	0.559292035	NA	NA	NA	24.69	0.01	NA	BLL	1914.0	63.0	1:DECEASED	No	9906	White	5	Male	Matched	Negative	Yes	No	NA	Negative	114.6
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-03	14.0	5008.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-09	14.0	5008.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	0.0535	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.1	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.11	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.13	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.14	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.15	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.16	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.17	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.18	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.19	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.2	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.3	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.4	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.5	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.6	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.7	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKRSL	TARGET-10-PAKRSL-60.9	14.0	5008.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	670.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,+21C[4]/48,IDEM,+X[11]	Negative	None of above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	9906	White	18	Female	Matched	Negative	No	NA	NA	Negative	321.2
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-03	16.0	5516.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	9	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	0.3	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-04	16.0	5516.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	0.0010	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-09	16.0	5516.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	0.0130	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	9	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	0.3	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.1	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.10	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.12	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.14	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.15	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.16	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.17	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.18	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.19	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.2	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.20	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.3	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.4	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.5	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKSWW	TARGET-10-PAKSWW-60.7	16.0	5516.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	532.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,DEL(8)(P21)[4]/46,IDEM,I(7)(Q10)[3]/46,IDEM,DEL(17)(P11.1)[2]/45,IDEM,ADD(7)(P11.2),-17[12]	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	0.73	0.01	NA	BLL	1592.0	53.0	1:DECEASED	No	9906	White	19	Male	Matched	Negative	No	No	NA	Negative	202.4
all_phase2_target_2018_pub	TARGET-10-PAKTAL	TARGET-10-PAKTAL-09	13.0	4469.0	NA	NA	DISCOVERY	Negative	NA	14.0	1.0	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	No	NA	1043.0	1	Hispanic or Latino	Negative	Relapse	0.0015	NA	Negative	None of above	1.199195171	NA	4.021384356	NA	NA	NA	2.75	0.01	NA	BLL	1061.0	35.0	1:DECEASED	No	9906	White	2	Female	Matched	Negative	No	NA	NA	Negative	478.0
all_phase2_target_2018_pub	TARGET-10-PAKTAL	TARGET-10-PAKTAL-60.1	13.0	4469.0	NA	NA	XENOGRAFT	Negative	NA	14.0	1.0	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	No	NA	1043.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	1.199195171	NA	4.021384356	NA	NA	NA	2.75	0.01	NA	BLL	1061.0	35.0	1:DECEASED	No	9906	White	2	Female	Matched	Negative	No	NA	NA	Negative	478.0
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-03	15.0	5250.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-09	15.0	5250.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	0.0206	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-60.1	15.0	5250.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-60.2	15.0	5250.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-60.3	15.0	5250.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-60.4	15.0	5250.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-60.5	15.0	5250.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKVKK	TARGET-10-PAKVKK-60.6	15.0	5250.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	48.50993377	NA	46.0032591	NA	NA	NA	0.95	0.01	NA	BLL	4193.0	138.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	220.7
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-09	3.0	988.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	0.0830	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.1	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.2	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.3	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.4	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.5	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.6	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PAKYEP	TARGET-10-PAKYEP-60.7	3.0	988.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	464.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+2,DEL(2)(P23),T(3;22;9)(P12;Q11.2;P24)[10]/46,XY[2]	Negative	None of above	0.32281553399999996	NA	0.0	0.01	NA	NA	3.14	0.01	NA	BLL	2463.0	81.0	0:LIVING	No	9906	White	8	Male	Matched	Negative	No	No	NA	Negative	958.8
all_phase2_target_2018_pub	TARGET-10-PALJCF	TARGET-10-PALJCF-09	4.0	1275.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	4672.0	1.1	Hispanic or Latino	Negative	None	0.1510	51,XX,+X,+8,+8,+14,+21[14]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	4.53	0.01	NA	BLL	4671.0	154.0	0:LIVING	No	9906	White	6	Female	Matched	Negative	No	NA	NA	Negative	214.0
all_phase2_target_2018_pub	TARGET-10-PALJCF	TARGET-10-PALJCF-60.1	4.0	1275.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	4672.0	1.1	Hispanic or Latino	Negative	None	NA	51,XX,+X,+8,+8,+14,+21[14]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	4.53	0.01	NA	BLL	4671.0	154.0	0:LIVING	No	9906	White	6	Female	Matched	Negative	No	NA	NA	Negative	214.0
all_phase2_target_2018_pub	TARGET-10-PALJCF	TARGET-10-PALJCF-60.2	4.0	1275.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	4672.0	1.1	Hispanic or Latino	Negative	None	NA	51,XX,+X,+8,+8,+14,+21[14]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	4.53	0.01	NA	BLL	4671.0	154.0	0:LIVING	No	9906	White	6	Female	Matched	Negative	No	NA	NA	Negative	214.0
all_phase2_target_2018_pub	TARGET-10-PALJCF	TARGET-10-PALJCF-60.3	4.0	1275.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	4672.0	1.1	Hispanic or Latino	Negative	None	NA	51,XX,+X,+8,+8,+14,+21[14]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	4.53	0.01	NA	BLL	4671.0	154.0	0:LIVING	No	9906	White	6	Female	Matched	Negative	No	NA	NA	Negative	214.0
all_phase2_target_2018_pub	TARGET-10-PALJCF	TARGET-10-PALJCF-60.4	4.0	1275.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	4672.0	1.1	Hispanic or Latino	Negative	None	NA	51,XX,+X,+8,+8,+14,+21[14]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	4.53	0.01	NA	BLL	4671.0	154.0	0:LIVING	No	9906	White	6	Female	Matched	Negative	No	NA	NA	Negative	214.0
all_phase2_target_2018_pub	TARGET-10-PALJCF	TARGET-10-PALJCF-60.5	4.0	1275.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	4672.0	1.1	Hispanic or Latino	Negative	None	NA	51,XX,+X,+8,+8,+14,+21[14]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	4.53	0.01	NA	BLL	4671.0	154.0	0:LIVING	No	9906	White	6	Female	Matched	Negative	No	NA	NA	Negative	214.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-09	4.0	1167.0	NA	NA	DISCOVERY	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	0.0389	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.1	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.10	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.11	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.12	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.2	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.3	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.4	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.6	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.7	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.8	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALJDL	TARGET-10-PALJDL-60.9	4.0	1167.0	NA	NA	XENOGRAFT	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4752.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	4750.0	157.0	0:LIVING	No	9906	White	12	Male	Matched	Negative	No	No	NA	Negative	156.0
all_phase2_target_2018_pub	TARGET-10-PALKTY	TARGET-10-PALKTY-03	7.0	2223.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	Yes	NA	1310.0	1	Hispanic or Latino	Negative	Relapse	NA	48,XX,+8,DER(14;21)(Q10;Q10)C,+21C,+21[5]/46,XX,DER(14;21)(Q10;Q10)C,+21C[10]	Negative	None of above	0.0	0.01	0.059293044	NA	NA	NA	NA	NA	NA	BLL	1507.0	50.0	1:DECEASED	No	9906	Unknown	6	Female	Matched	Negative	No	NA	NA	Negative	202.0
all_phase2_target_2018_pub	TARGET-10-PALKTY	TARGET-10-PALKTY-09	7.0	2223.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	Yes	NA	1310.0	1	Hispanic or Latino	Negative	Relapse	0.0027	48,XX,+8,DER(14;21)(Q10;Q10)C,+21C,+21[5]/46,XX,DER(14;21)(Q10;Q10)C,+21C[10]	Negative	None of above	0.0	0.01	0.059293044	NA	NA	NA	NA	NA	NA	BLL	1507.0	50.0	1:DECEASED	No	9906	Unknown	6	Female	Matched	Negative	No	NA	NA	Negative	202.0
all_phase2_target_2018_pub	TARGET-10-PALKTY	TARGET-10-PALKTY-60.1	7.0	2223.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	Yes	NA	1310.0	1	Hispanic or Latino	Negative	Relapse	NA	48,XX,+8,DER(14;21)(Q10;Q10)C,+21C,+21[5]/46,XX,DER(14;21)(Q10;Q10)C,+21C[10]	Negative	None of above	0.0	0.01	0.059293044	NA	NA	NA	NA	NA	NA	BLL	1507.0	50.0	1:DECEASED	No	9906	Unknown	6	Female	Matched	Negative	No	NA	NA	Negative	202.0
all_phase2_target_2018_pub	TARGET-10-PALKTY	TARGET-10-PALKTY-60.2	7.0	2223.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	Yes	NA	1310.0	1	Hispanic or Latino	Negative	Relapse	NA	48,XX,+8,DER(14;21)(Q10;Q10)C,+21C,+21[5]/46,XX,DER(14;21)(Q10;Q10)C,+21C[10]	Negative	None of above	0.0	0.01	0.059293044	NA	NA	NA	NA	NA	NA	BLL	1507.0	50.0	1:DECEASED	No	9906	Unknown	6	Female	Matched	Negative	No	NA	NA	Negative	202.0
all_phase2_target_2018_pub	TARGET-10-PALKTY	TARGET-10-PALKTY-60.3	7.0	2223.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	Yes	NA	1310.0	1	Hispanic or Latino	Negative	Relapse	NA	48,XX,+8,DER(14;21)(Q10;Q10)C,+21C,+21[5]/46,XX,DER(14;21)(Q10;Q10)C,+21C[10]	Negative	None of above	0.0	0.01	0.059293044	NA	NA	NA	NA	NA	NA	BLL	1507.0	50.0	1:DECEASED	No	9906	Unknown	6	Female	Matched	Negative	No	NA	NA	Negative	202.0
all_phase2_target_2018_pub	TARGET-10-PALKTY	TARGET-10-PALKTY-60.4	7.0	2223.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	Yes	NA	1310.0	1	Hispanic or Latino	Negative	Relapse	NA	48,XX,+8,DER(14;21)(Q10;Q10)C,+21C,+21[5]/46,XX,DER(14;21)(Q10;Q10)C,+21C[10]	Negative	None of above	0.0	0.01	0.059293044	NA	NA	NA	NA	NA	NA	BLL	1507.0	50.0	1:DECEASED	No	9906	Unknown	6	Female	Matched	Negative	No	NA	NA	Negative	202.0
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-03	15.0	5177.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-09	15.0	5177.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	0.0173	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.1	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.10	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.12	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.13	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.15	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.17	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.18	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.2	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.3	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.4	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.5	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALLSD	TARGET-10-PALLSD-60.8	15.0	5177.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	No	NA	687.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of above	0.0	0.01	0.0	0.01	NA	NA	1.22	0.01	NA	BLL	3060.0	101.0	1:DECEASED	No	9906	White	14	Male	Matched	Negative	No	No	NA	Unknown	166.5
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-09	9.0	3179.0	Chemotherapy	NA	DISCOVERY	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	0.0545	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.1	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.10	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.11	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.12	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.2	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.3	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.4	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.5	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.6	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.7	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.8	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALNTB	TARGET-10-PALNTB-60.9	9.0	3179.0	Chemotherapy	NA	XENOGRAFT	Negative	NA	2.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2	Unknown	NA	1023.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+X[20]/46,XX[6]	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	3.19	0.01	NA	BLL	1415.0	47.0	1:DECEASED	No	9906	White	13	Female	Matched	Negative	No	NA	NA	Negative	314.8
all_phase2_target_2018_pub	TARGET-10-PALTWS	TARGET-10-PALTWS-09	15.0	5194.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	2703.0	1	Hispanic or Latino	Negative	None	0.0020	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	9906	Unknown	6	Male	Matched	Negative	No	No	NA	Negative	96.5
all_phase2_target_2018_pub	TARGET-10-PALTWS	TARGET-10-PALTWS-60.1	15.0	5194.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	2703.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	9906	Unknown	6	Male	Matched	Negative	No	No	NA	Negative	96.5
all_phase2_target_2018_pub	TARGET-10-PALTWS	TARGET-10-PALTWS-60.2	15.0	5194.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	2703.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	9906	Unknown	6	Male	Matched	Negative	No	No	NA	Negative	96.5
all_phase2_target_2018_pub	TARGET-10-PALTWS	TARGET-10-PALTWS-60.3	15.0	5194.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	2703.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	9906	Unknown	6	Male	Matched	Negative	No	No	NA	Negative	96.5
all_phase2_target_2018_pub	TARGET-10-PALTWS	TARGET-10-PALTWS-60.4	15.0	5194.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	2703.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	9906	Unknown	6	Male	Matched	Negative	No	No	NA	Negative	96.5
all_phase2_target_2018_pub	TARGET-10-PALTWS	TARGET-10-PALTWS-60.5	15.0	5194.0	NA	NA	XENOGRAFT	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3	No	NA	2703.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	None of above	0.0	0.1	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	9906	Unknown	6	Male	Matched	Negative	No	No	NA	Negative	96.5
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-09	14.0	4861.0	NA	NA	DISCOVERY	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	0.0005	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.1	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.10	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.2	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.3	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.4	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.5	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.6	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.7	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.8	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDKS	TARGET-10-PAMDKS-60.9	14.0	4861.0	NA	NA	XENOGRAFT	Negative	NA	0.0	0.0	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Unknown	NA	69.0	1	Hispanic or Latino	Negative	Death	NA	46,XX[20]	Negative	None of above	NA	NA	0.180550459	NA	NA	NA	0.83	0.01	NA	BLL	69.0	3.0	1:DECEASED	No	9906	White	11	Female	Matched	Negative	No	NA	NA	Negative	592.6
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-09	8.0	2875.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	0.0018	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.1	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.11	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.12	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.13	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.14	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.15	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.16	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.17	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.18	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.2	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.3	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.4	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.5	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.6	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.7	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.8	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMDRM	TARGET-10-PAMDRM-60.9	8.0	2875.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2	Unknown	NA	994.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of above	0.0	0.1	0.022339027999999997	NA	NA	NA	9.94	0.01	NA	BLL	1213.0	40.0	1:DECEASED	No	9906	Asian	18	Male	Matched	Negative	No	No	NA	Negative	351.3
all_phase2_target_2018_pub	TARGET-10-PAMKZB	TARGET-10-PAMKZB-60.1	15.0	5430.0	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	Yes	NA	NA	NA	236.0	NA	Not Hispanic or Latino	NA	Relapse	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	327.0	11.0	1:DECEASED	No	AALL0031	White	6	Male	Matched	NA	No	NA	NA	NA	107.0
all_phase2_target_2018_pub	TARGET-10-PAMKZB	TARGET-10-PAMKZB-60.11	15.0	5430.0	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	Yes	NA	NA	NA	236.0	NA	Not Hispanic or Latino	NA	Relapse	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	327.0	11.0	1:DECEASED	No	AALL0031	White	6	Male	Matched	NA	No	NA	NA	NA	107.0
all_phase2_target_2018_pub	TARGET-10-PAMKZB	TARGET-10-PAMKZB-60.14	15.0	5430.0	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	Yes	NA	NA	NA	236.0	NA	Not Hispanic or Latino	NA	Relapse	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	327.0	11.0	1:DECEASED	No	AALL0031	White	6	Male	Matched	NA	No	NA	NA	NA	107.0
all_phase2_target_2018_pub	TARGET-10-PAMKZB	TARGET-10-PAMKZB-60.2	15.0	5430.0	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	Yes	NA	NA	NA	236.0	NA	Not Hispanic or Latino	NA	Relapse	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	327.0	11.0	1:DECEASED	No	AALL0031	White	6	Male	Matched	NA	No	NA	NA	NA	107.0
all_phase2_target_2018_pub	TARGET-10-PAMKZB	TARGET-10-PAMKZB-60.6	15.0	5430.0	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	Yes	NA	NA	NA	236.0	NA	Not Hispanic or Latino	NA	Relapse	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	327.0	11.0	1:DECEASED	No	AALL0031	White	6	Male	Matched	NA	No	NA	NA	NA	107.0
all_phase2_target_2018_pub	TARGET-10-PAMKZB	TARGET-10-PAMKZB-60.8	15.0	5430.0	NA	NA	XENOGRAFT	NA	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	Yes	NA	NA	NA	236.0	NA	Not Hispanic or Latino	NA	Relapse	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	327.0	11.0	1:DECEASED	No	AALL0031	White	6	Male	Matched	NA	No	NA	NA	NA	107.0
all_phase2_target_2018_pub	TARGET-10-PAMVYK	TARGET-10-PAMVYK-09	12.0	4291.0	NA	NA	DISCOVERY	Negative	29.0	16.0	0.0	83.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2636.0	1.225	Not Hispanic or Latino	Unknown	None	0.9146	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	0.0	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	2636.0	87.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.3
all_phase2_target_2018_pub	TARGET-10-PAMXGS	TARGET-10-PAMXGS-09	4.0	1386.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4425.0	1	Hispanic or Latino	Positive	None	0.0590	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4425.0	146.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Unknown	91.6
all_phase2_target_2018_pub	TARGET-10-PAMXHJ	TARGET-10-PAMXHJ-09	7.0	2219.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	55.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4089.0	1.34	Hispanic or Latino	Negative	None	0.6899	60,XY,+Y,dup(1)(q21q42),+4,+5,+6,+10,+14,+14,+15,+17,+18,+18,-20,+21,+22,+2mar[cp10]/46,XY[2]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	4089.0	135.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.0666666666667	Positive	200.0
all_phase2_target_2018_pub	TARGET-10-PAMXSP	TARGET-10-PAMXSP-09	4.0	1223.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	4383.0	1.12	Hispanic or Latino	Negative	None	NA	54,XY,+X,+Y,+10,add(10)(q22),+14,+15,-16m+18,+21,+r,+mar[7]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	4383.0	145.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.2	Negative	74.0
all_phase2_target_2018_pub	TARGET-10-PAMXXP	TARGET-10-PAMXXP-03	5.0	1611.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3114.0	1.142	Not Hispanic or Latino	Unknown	None	0.0320	46,XY,del(6)(q15q23),add(12)(p13)[10]/47,idem,+21[4]/46,XY[3]	Negative	None of the above	NA	NA	0.057999999999999996	0.001	NA	NA	NA	NA	NA	BLL	3114.0	103.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	283.0
all_phase2_target_2018_pub	TARGET-10-PAMYCC	TARGET-10-PAMYCC-09	12.0	4206.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3556.0	1.04	Not Hispanic or Latino	Negative	None	0.0595	47,XX,t(1;9)(p13;p13),+8[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3556.0	117.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	50.4
all_phase2_target_2018_pub	TARGET-10-PAMYDV	TARGET-10-PAMYDV-09	2.0	444.0	NA	NA	DISCOVERY	Negative	2.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4123.0	1	Hispanic or Latino	Negative	None	0.0198	46,XX,t(1;19)(q23;p13.3),+mar[2]/46,idem,del(6)(q21q25),i(9)(q10)[7]/46,XX[6]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4123.0	136.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	182.0
all_phase2_target_2018_pub	TARGET-10-PAMYEJ	TARGET-10-PAMYEJ-09	14.0	5011.0	NA	NA	DISCOVERY	Negative	32.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2402.0	1	Hispanic or Latino	Unknown	None	0.0022	46,XY,t(12;17)(p13;q22)[3]/46,XY[3]	Negative	None of the above	0.02	0.01	0.38	0.01	NA	NA	NA	NA	NA	BLL	2402.0	79.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	65.23
all_phase2_target_2018_pub	TARGET-10-PAMYLL	TARGET-10-PAMYLL-03	2.0	649.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4129.0	1	Hispanic or Latino	Unknown	None	0.0305	NA	Unknown	None of the above	NA	NA	0.009000000000000001	0.001	NA	NA	NA	NA	NA	BLL	4129.0	136.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	138.0
all_phase2_target_2018_pub	TARGET-10-PAMYNW	TARGET-10-PAMYNW-09	16.0	5609.0	NA	NA	DISCOVERY	Negative	42.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4260.0	1	Not Hispanic or Latino	Negative	None	0.0490	46,XY	Negative	None of the above	0.008	0.001	0.0	0.01	NA	NA	NA	NA	NA	BLL	4260.0	141.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	18.7
all_phase2_target_2018_pub	TARGET-10-PAMYSA	TARGET-10-PAMYSA-09	7.0	2292.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4465.0	1	Not Hispanic or Latino	Unknown	None	0.0227	46,XX,t(1;19)(q42;q13.3),t(2;22)q13;p12)[1]/46,idem,add(15)(p12)[8]/46,XX[13]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4465.0	147.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	64.4
all_phase2_target_2018_pub	TARGET-10-PAMYTW	TARGET-10-PAMYTW-09	13.0	4524.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2703.0	1	Hispanic or Latino	Positive	None	0.0492	NA	Unknown	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2703.0	89.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	41.1
all_phase2_target_2018_pub	TARGET-10-PAMYVH	TARGET-10-PAMYVH-09	16.0	5522.0	NA	NA	DISCOVERY	Positive	1.0	0.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2962.0	1	Not Hispanic or Latino	Negative	None	0.0135	46,XX,trp(21)(q21q22)[3]/46,idem,t(9;22)(q34;q11.2)[7]/46,XX[10]	Negative	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2962.0	98.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	12.7
all_phase2_target_2018_pub	TARGET-10-PAMYWB	TARGET-10-PAMYWB-09	18.0	6446.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2325.0	1	Not Hispanic or Latino	Unknown	None	0.0002	46,XX,t(4;11)(q21;q23)[20]	Positive	MLL-Rearranged	0.012	0.001	0.066	0.001	NA	NA	NA	NA	NA	BLL	2325.0	77.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	452.1
all_phase2_target_2018_pub	TARGET-10-PAMYWC	TARGET-10-PAMYWC-09	2.0	534.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1826.0	1	Not Hispanic or Latino	Unknown	None	0.0760	46,XY,i(9)(q10),der(19)t(1;19)(q23;p13)[9]/46,XY[11]	Negative	TCF3-PBX1	NA	NA	0.0047	NA	NA	NA	NA	NA	NA	BLL	1826.0	61.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	145.0
all_phase2_target_2018_pub	TARGET-10-PAMYWX	TARGET-10-PAMYWX-09	14.0	5029.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2603.0	1	Hispanic or Latino	Negative	None	0.0109	47,XX,+2,i(8)(q10),del(12)(p13([2]/46,XX[18]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2603.0	86.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	321.0
all_phase2_target_2018_pub	TARGET-10-PAMYYP	TARGET-10-PAMYYP-09	3.0	769.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	NA	4139.0	1	Not Hispanic or Latino	Positive	None	0.0213	NA	Unknown	ETV6-RUNX1	NA	NA	0.12	0.01	NA	NA	NA	NA	NA	BLL	4139.0	137.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	58.7
all_phase2_target_2018_pub	TARGET-10-PAMZDX	TARGET-10-PAMZDX-03	13.0	4631.0	NA	NA	DISCOVERY	Positive	2.0	0.0	NA	11.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2910.0	1.104	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,+1,dic(1;21)(p11;p11.2),-3,del(6)(q25q27),-7,der(9)add(9)(p22)t(9;22)(q34;q11.2),add(19)(p13.3),der(22)t(9;22)(q34;q11.2)[17]/46,XY[11]/Nonclonal[1]	Negative	BCR-ABL1	NA	NA	0.084	0.001	NA	NA	NA	NA	NA	BLL	3677.0	121.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	Yes	No	NA	Negative	8.1
all_phase2_target_2018_pub	TARGET-10-PAMZHB	TARGET-10-PAMZHB-09	3.0	978.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1201.0	1.17	Not Hispanic or Latino	Negative	Censored	0.1962	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.01	0.01	NA	NA	NA	NA	NA	BLL	1201.0	40.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	61.7
all_phase2_target_2018_pub	TARGET-10-PAMZKV	TARGET-10-PAMZKV-09	12.0	4368.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4327.0	1.179	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4327.0	143.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	800.0
all_phase2_target_2018_pub	TARGET-10-PAMZLK	TARGET-10-PAMZLK-03	3.0	826.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3373.0	1	Not Hispanic or Latino	Unknown	None	0.0908	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3373.0	111.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	59.1
all_phase2_target_2018_pub	TARGET-10-PAMZLS	TARGET-10-PAMZLS-09	5.0	1557.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2662.0	1	Not Hispanic or Latino	Unknown	None	0.0006	46,XY[21]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2662.0	88.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	57.0
all_phase2_target_2018_pub	TARGET-10-PAMZTU	TARGET-10-PAMZTU-09	11.0	3811.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3154.0	1	Not Hispanic or Latino	Unknown	None	0.0009	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3154.0	104.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	4.5
all_phase2_target_2018_pub	TARGET-10-PANAEN	TARGET-10-PANAEN-09	3.0	1093.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4355.0	1	Not Hispanic or Latino	Unknown	None	0.0370	NA	Unknown	None of the above	0.0	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	4355.0	144.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	334.3
all_phase2_target_2018_pub	TARGET-10-PANAKF	TARGET-10-PANAKF-09	12.0	4048.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3725.0	1	Hispanic or Latino	Negative	None	0.0108	46,XY[20]	Unknown	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3725.0	123.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Positive	No	No	NA	Unknown	11.9
all_phase2_target_2018_pub	TARGET-10-PANAKL	TARGET-10-PANAKL-03	18.0	6248.0	Chemotherapy	NA	DISCOVERY	Positive	4.0	0.0	NA	58.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2821.0	1.156	Not Hispanic or Latino	Unknown	None	0.1980	54,XY,+2,+6,t(9;22)(q34;q11.2),+13,+14,+21,+21,+2mar[cp3]/46,XY[8]	Negative	BCR-ABL1	NA	NA	0.93645	NA	NA	NA	NA	NA	NA	BLL	2821.0	93.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	200.0
all_phase2_target_2018_pub	TARGET-10-PANALD	TARGET-10-PANALD-09	3.0	951.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3609.0	1.189	Not Hispanic or Latino	Unknown	None	0.2874	54,XY,dup(1)(q21q?32),+4,+6,+10,+14,+17,+18,+21,+21[cp13]/46,XY,[7]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3609.0	119.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	193.0
all_phase2_target_2018_pub	TARGET-10-PANANL	TARGET-10-PANANL-09	11.0	3932.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	1630.0	1.116	Not Hispanic or Latino	Unknown	None	0.0924	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1630.0	54.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	44.4
all_phase2_target_2018_pub	TARGET-10-PANATY	TARGET-10-PANATY-03	5.0	1542.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4077.0	1	Not Hispanic or Latino	Unknown	None	NA	45,XX,dic(9;20)(p11;q11.2)[19]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4077.0	135.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	197.0
all_phase2_target_2018_pub	TARGET-10-PANAVL	TARGET-10-PANAVL-09	2.0	652.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3938.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3938.0	130.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	60.5
all_phase2_target_2018_pub	TARGET-10-PANAWL	TARGET-10-PANAWL-09	20.0	6943.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	43.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4313.0	1	Not Hispanic or Latino	Negative	None	0.0561	45,XX,-7[15]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4313.0	142.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.8
all_phase2_target_2018_pub	TARGET-10-PANAWU	TARGET-10-PANAWU-09	9.0	3068.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4045.0	1	Not Hispanic or Latino	Unknown	None	0.0081	46,XY,del(12)(p11.2)[12]/46,XY[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4045.0	133.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	83.6
all_phase2_target_2018_pub	TARGET-10-PANAYM	TARGET-10-PANAYM-09	6.0	2122.0	NA	NA	DISCOVERY	Negative	4.0	4.0	NA	42.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2177.0	1	Unknown	Negative	None	0.0096	46,Y,t(X;20;5)(p22.3;q13.1;q33)[17]/46,XY[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2177.0	72.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	249.0
all_phase2_target_2018_pub	TARGET-10-PANAYT	TARGET-10-PANAYT-09	12.0	4068.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2546.0	1	Not Hispanic or Latino	Negative	None	0.0126	46,XX,-21,+mar[10]/46,XX[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2546.0	84.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.7
all_phase2_target_2018_pub	TARGET-10-PANBDJ	TARGET-10-PANBDJ-09	16.0	5738.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4104.0	1	Not Hispanic or Latino	Unknown	None	0.0083	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4104.0	135.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	37.0
all_phase2_target_2018_pub	TARGET-10-PANBGW	TARGET-10-PANBGW-09	6.0	1974.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4339.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XX,+21[7]/47,idem,del(12)(p11.2)[4]/48,idem,add(12)(p13),+21,+22[6]/46,XX[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4339.0	143.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	52.3
all_phase2_target_2018_pub	TARGET-10-PANBHA	TARGET-10-PANBHA-03	3.0	958.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4149.0	1	Not Hispanic or Latino	Unknown	None	0.0651	46,XY,t(7;9)(p15;q21.1),der(11)t(1;11)(q32;q21)[17]/46,XY[2]/46,XY,t(7;9)(p13;q21.1)[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4149.0	137.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	111.0
all_phase2_target_2018_pub	TARGET-10-PANBIK	TARGET-10-PANBIK-09	17.0	5939.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	683.0	1	Hispanic or Latino	Unknown	Censored	0.0760	NA	Unknown	None of the above	NA	NA	0.0118	NA	NA	NA	NA	NA	NA	BLL	683.0	23.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	16.8
all_phase2_target_2018_pub	TARGET-10-PANBIU	TARGET-10-PANBIU-03	2.0	724.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	958.0	1	Hispanic or Latino	Unknown	None	0.0035	46,XX[69]/nonclonal[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	958.0	32.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	108.0
all_phase2_target_2018_pub	TARGET-10-PANBMP	TARGET-10-PANBMP-09	17.0	6148.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2975.0	1	Not Hispanic or Latino	Unknown	None	0.0295	46,XY,der(19)t(1;19)(q23;p13.3)[9]/46,XY[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2975.0	98.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	19.43
all_phase2_target_2018_pub	TARGET-10-PANBPG	TARGET-10-PANBPG-09	15.0	5215.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2720.0	1	Hispanic or Latino	Negative	None	0.0015	46,XY,der(9)t(X;9)(q24;q34)[6]/46,XY,der(4)t(X;4)(q24;p16)[3]/46,XY[7]	Negative	None of the above	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	2720.0	90.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	47.5
all_phase2_target_2018_pub	TARGET-10-PANBVU	TARGET-10-PANBVU-03	3.0	843.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4244.0	1	Hispanic or Latino	Unknown	None	0.0249	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4244.0	140.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	53.8
all_phase2_target_2018_pub	TARGET-10-PANBWB	TARGET-10-PANBWB-09	13.0	4535.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1904.0	1	Hispanic or Latino	Negative	None	0.0001	46,XX[26]	Unknown	None of the above	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	1904.0	63.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	1.1
all_phase2_target_2018_pub	TARGET-10-PANBXW	TARGET-10-PANBXW-09	8.0	2872.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1764.0	1	Not Hispanic or Latino	Positive	Relapse	0.1200	46,XX,t(1;17)(q42;q25),-2,add(16)(q22),+r[3]/46,XX[27]	Negative	ETV6-RUNX1	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	3464.0	114.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	117.0
all_phase2_target_2018_pub	TARGET-10-PANCVR	TARGET-10-PANCVR-03	7.0	2329.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	96.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	473.0	285.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,t(5;9)(q21;q34)[16]	Negative	None of the above	NA	NA	0.03	0.01	NA	NA	NA	NA	3	BLL	473.0	16.0	1:DECEASED	Yes	AALL0232	White	3	Male	Matched	Negative	No	No	0.1	Negative	209.2
all_phase2_target_2018_pub	TARGET-10-PANCVR	TARGET-10-PANCVR-04	7.0	2329.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	96.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	473.0	285.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,t(5;9)(q21;q34)[16]	Negative	None of the above	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	473.0	16.0	1:DECEASED	Yes	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	209.2
all_phase2_target_2018_pub	TARGET-10-PANCVR	TARGET-10-PANCVR-09	7.0	2329.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	96.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	473.0	285.0	1	Hispanic or Latino	Negative	Relapse	0.0091	46,XY,t(5;9)(q21;q34)[16]	Negative	None of the above	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	473.0	16.0	1:DECEASED	Yes	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	209.2
all_phase2_target_2018_pub	TARGET-10-PANCZY	TARGET-10-PANCZY-09	16.0	5789.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3554.0	1	Not Hispanic or Latino	Positive	None	0.1840	47,XY,t(9;12)(p13;q24.1),del(19)(q13.1),+mar[3]/46,XY[7]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3554.0	117.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	3.2
all_phase2_target_2018_pub	TARGET-10-PANDBV	TARGET-10-PANDBV-09	18.0	6412.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1371.0	1	Hispanic or Latino	Negative	Relapse	0.0130	NA	Unknown	None of the above	NA	NA	0.0311	NA	NA	NA	NA	NA	NA	BLL	1626.0	54.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	13.4
all_phase2_target_2018_pub	TARGET-10-PANDBX	TARGET-10-PANDBX-09	4.0	1398.0	NA	NA	DISCOVERY	Negative	2.0	NA	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	801.0	1	Not Hispanic or Latino	Negative	Relapse	0.0369	46,XX,dic(9;20)(p11;q11),+21[cp2]	Negative	None of the above	NA	NA	0.35	0.01	NA	NA	NA	NA	NA	BLL	1719.0	57.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	75.9
all_phase2_target_2018_pub	TARGET-10-PANDCF	TARGET-10-PANDCF-03	8.0	2683.0	NA	NA	DISCOVERY	Negative	80.0	0.0	NA	78.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1069.0	908.0	1.16	Hispanic or Latino	Negative	Relapse	NA	52,XY,+X,+5,+6,+11,+13,+22[25]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1069.0	36.0	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	250.7
all_phase2_target_2018_pub	TARGET-10-PANDCF	TARGET-10-PANDCF-04	8.0	2683.0	NA	NA	DISCOVERY	Negative	80.0	0.0	NA	78.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1069.0	908.0	1.16	Hispanic or Latino	Negative	Relapse	NA	52,XY,+X,+5,+6,+11,+13,+22[25]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1069.0	36.0	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	250.7
all_phase2_target_2018_pub	TARGET-10-PANDCF	TARGET-10-PANDCF-09	8.0	2683.0	NA	NA	DISCOVERY	Negative	80.0	0.0	NA	78.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1069.0	908.0	1.16	Hispanic or Latino	Negative	Relapse	0.2282	52,XY,+X,+5,+6,+11,+13,+22[25]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1069.0	36.0	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	250.7
all_phase2_target_2018_pub	TARGET-10-PANDJJ	TARGET-10-PANDJJ-09	2.0	703.0	NA	NA	DISCOVERY	Negative	23.0	0.0	NA	78.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4087.0	1	Not Hispanic or Latino	Positive	None	0.0165	NA	Unknown	ETV6-RUNX1	0.0	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	4087.0	135.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	243.0
all_phase2_target_2018_pub	TARGET-10-PANDPX	TARGET-10-PANDPX-03	4.0	1393.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1961.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0428	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3982.0	131.0	0:LIVING	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	65.3
all_phase2_target_2018_pub	TARGET-10-PANDPX	TARGET-10-PANDPX-04	4.0	1393.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1961.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3982.0	131.0	0:LIVING	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	65.3
all_phase2_target_2018_pub	TARGET-10-PANDRS	TARGET-10-PANDRS-09	19.0	6673.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	81.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1063.0	978.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.0019	NA	NA	NA	NA	NA	NA	BLL	1063.0	35.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	400.0
all_phase2_target_2018_pub	TARGET-10-PANDSH	TARGET-10-PANDSH-09	4.0	1155.0	NA	NA	DISCOVERY	Positive	14.0	3.0	NA	91.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	758.0	1	Not Hispanic or Latino	Unknown	Death	0.0016	46,XX,t(9;22)(q34;q11.2[3]/47,idem,+der(22)t(9;22)[1]/46,XX[2]	Negative	BCR-ABL1	NA	NA	3.9760000000000004	0.001	NA	NA	NA	NA	NA	BLL	758.0	25.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	89.3
all_phase2_target_2018_pub	TARGET-10-PANDUK	TARGET-10-PANDUK-03	4.0	1389.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4158.0	1	Not Hispanic or Latino	Unknown	None	0.0626	47,XY,del(6)(q15q23),+16[11]/46,XY[9]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4158.0	137.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	84.0
all_phase2_target_2018_pub	TARGET-10-PANDVD	TARGET-10-PANDVD-09	4.0	1396.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1372.0	1.1	Hispanic or Latino	Positive	Relapse	0.1098	46,XY[20]	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3741.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	108.08
all_phase2_target_2018_pub	TARGET-10-PANDWE	TARGET-10-PANDWE-03	15.0	5213.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	86.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1571.0	1137.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	None of the above	1.5	0.01	0.382	0.001	NA	NA	NA	NA	2	BLL	1571.0	52.0	1:DECEASED	No	AALL0232	White	3	Female	Matched	Unknown	No	NA	0.0666666666667	Unknown	64.9
all_phase2_target_2018_pub	TARGET-10-PANDWE	TARGET-10-PANDWE-04	15.0	5213.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	86.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1571.0	1137.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	None of the above	1.5	0.01	0.382	0.001	NA	NA	NA	NA	NA	BLL	1571.0	52.0	1:DECEASED	No	AALL0232	White	3	Female	Matched	Unknown	No	NA	NA	Unknown	64.9
all_phase2_target_2018_pub	TARGET-10-PANDWE	TARGET-10-PANDWE-09	15.0	5213.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	86.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1571.0	1137.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	None of the above	1.5	0.01	0.382	0.001	NA	NA	NA	NA	NA	BLL	1571.0	52.0	1:DECEASED	No	AALL0232	White	3	Female	Matched	Unknown	No	NA	NA	Unknown	64.9
all_phase2_target_2018_pub	TARGET-10-PANDYD	TARGET-10-PANDYD-09	17.0	5953.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	345.0	209.0	1	Not Hispanic or Latino	Negative	Relapse	0.0588	46,XY,t(1;19)(q23;p13.3)[9]/46,XY[11]	Negative	TCF3-PBX1	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	345.0	12.0	1:DECEASED	No	AALL0232	American Indian or Alaska Native	1	Male	Matched	Positive	No	No	NA	Negative	37.3
all_phase2_target_2018_pub	TARGET-10-PANEBL	TARGET-10-PANEBL-03	2.0	488.0	NA	NA	DISCOVERY	Negative	60.0	50.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	30.0	1	Hispanic or Latino	Negative	Induction failure	NA	46,XX,der(11)inv(11)(p13p15)inv(11)(q12q23)del(11)(q14q23)[7]/46,XX[2]	Positive	MLL-Rearranged	NA	NA	41.2	0.01	NA	NA	NA	NA	NA	BLL	4052.0	134.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	79.8
all_phase2_target_2018_pub	TARGET-10-PANEJT	TARGET-10-PANEJT-09	12.0	4171.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4239.0	1	Not Hispanic or Latino	Negative	None	0.0010	46,XY,y(1;19)(q23;p13.3)[15]/46,XY[5]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4239.0	140.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	22.5
all_phase2_target_2018_pub	TARGET-10-PANELP	TARGET-10-PANELP-03	13.0	4741.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1966.0	1.068	Hispanic or Latino	Unknown	None	0.0448	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1966.0	65.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	41.3
all_phase2_target_2018_pub	TARGET-10-PANEPB	TARGET-10-PANEPB-09	2.0	717.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3982.0	1	Not Hispanic or Latino	Negative	None	0.0023	46,XY,t(9;15)(p13;q24)[14]/46,XY[64]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3982.0	131.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	142.4
all_phase2_target_2018_pub	TARGET-10-PANEPX	TARGET-10-PANEPX-03	19.0	6785.0	Chemotherapy	NA	DISCOVERY	Negative	10.0	23.0	15.0	83.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	350.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[18]	Unknown	None of the above	NA	NA	46.6	0.01	NA	NA	NA	NA	NA	BLL	546.0	18.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Unknown	87.5
all_phase2_target_2018_pub	TARGET-10-PANEPX	TARGET-10-PANEPX-09	19.0	6785.0	Chemotherapy	NA	DISCOVERY	Negative	10.0	23.0	15.0	83.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	350.0	1	Not Hispanic or Latino	Negative	Relapse	0.0030	46,XY[18]	Unknown	None of the above	NA	NA	46.6	0.01	NA	NA	NA	NA	NA	BLL	546.0	18.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Unknown	87.5
all_phase2_target_2018_pub	TARGET-10-PANERJ	TARGET-10-PANERJ-09	3.0	1008.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2609.0	1	Not Hispanic or Latino	Negative	None	0.0020	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2609.0	86.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	250.0
all_phase2_target_2018_pub	TARGET-10-PANEUH	TARGET-10-PANEUH-09	2.0	648.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4132.0	1.2	Not Hispanic or Latino	Unknown	None	0.2642	55,XY,+X,+4,+6,+10,+14,+17,+18,+21,+21[11]/46,XY[3]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	NA	NA	NA	NA	NA	2	BLL	4132.0	136.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.0666666666667	Positive	137.0
all_phase2_target_2018_pub	TARGET-10-PANEVA	TARGET-10-PANEVA-09	5.0	1527.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3067.0	1	Not Hispanic or Latino	Negative	None	0.0125	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3067.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	158.2
all_phase2_target_2018_pub	TARGET-10-PANEYX	TARGET-10-PANEYX-03	6.0	1988.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3960.0	1	Not Hispanic or Latino	Unknown	None	0.0541	47,XY,add(5)(p13),+6,add(6)(q21)x2,der(8)t(8;12)(q22;q24),der(12)add(12)(p11.2)t(8;12)(q22;q24)[10]/46,XY[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3960.0	131.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	58.3
all_phase2_target_2018_pub	TARGET-10-PANEZJ	TARGET-10-PANEZJ-09	13.0	4399.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3971.0	1	Hispanic or Latino	Negative	None	0.0232	46,XX,t(1;12)(q21;p13),del(4)(p14p16),del(9)(p22p24),?add(22)(q13)[9]/46,XX[11]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3971.0	131.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	39.6
all_phase2_target_2018_pub	TARGET-10-PANEZV	TARGET-10-PANEZV-09	3.0	850.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4237.0	1	Hispanic or Latino	Positive	None	0.0341	46,XY,add(3)(q25),add(9)(p13),add(12)(p11.2)[2]/46,XY[9]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4237.0	140.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	65.1
all_phase2_target_2018_pub	TARGET-10-PANEZY	TARGET-10-PANEZY-09	12.0	4186.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3948.0	1.074	Not Hispanic or Latino	Unknown	None	0.0500	NA	Unknown	None of the above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	3948.0	130.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	1.6
all_phase2_target_2018_pub	TARGET-10-PANFAE	TARGET-10-PANFAE-09	4.0	1130.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2677.0	1	Not Hispanic or Latino	Unknown	None	0.0252	46,XY,del(12)(p12),i(21)(p12)[cp12]/46,idem,del(7)(q?31)[3]/46,idem,?del(1)(p13p22),del(7)(q11.2)[2]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2677.0	89.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	121.3
all_phase2_target_2018_pub	TARGET-10-PANFCE	TARGET-10-PANFCE-09	13.0	4455.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4142.0	1	Not Hispanic or Latino	Unknown	None	0.0986	NA	Unknown	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	4142.0	137.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	9.8
all_phase2_target_2018_pub	TARGET-10-PANFGV	TARGET-10-PANFGV-09	14.0	4836.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	22.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1309.0	1.224	Not Hispanic or Latino	Unknown	Relapse	NA	57,XX,+X,add(1)(q44),+4,+5,+6,+10,+12,+14,+17,+21,+21,+mar[cp7]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1851.0	61.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	7.9
all_phase2_target_2018_pub	TARGET-10-PANFNZ	TARGET-10-PANFNZ-03	5.0	1470.0	NA	NA	DISCOVERY	Negative	33.0	1.0	0.0	88.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2357.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XX[20]	Negative	None of the above	0.0	0.1	1.02	0.01	NA	NA	NA	NA	NA	BLL	2778.0	92.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	143.7
all_phase2_target_2018_pub	TARGET-10-PANFNZ	TARGET-10-PANFNZ-09	5.0	1470.0	NA	NA	DISCOVERY	Negative	33.0	1.0	0.0	88.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2357.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0006	46,XX[20]	Negative	None of the above	0.0	0.1	1.02	0.01	NA	NA	NA	NA	1	BLL	2778.0	92.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.0333333333333	Negative	143.7
all_phase2_target_2018_pub	TARGET-10-PANFPD	TARGET-10-PANFPD-09	5.0	1566.0	NA	NA	DISCOVERY	Negative	NA	0.0	0.0	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1307.0	1	Not Hispanic or Latino	Unknown	None	0.0147	47,XX,+21[6]/46,XX[8]	Negative	None of the above	0.0	0.1	5.02	0.01	NA	NA	NA	NA	NA	BLL	1307.0	43.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	92.7
all_phase2_target_2018_pub	TARGET-10-PANFRW	TARGET-10-PANFRW-09	7.0	2465.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	849.0	1.21	Hispanic or Latino	Negative	Censored	0.4671	57,XX,+X,t(2;9)(p12;p21),+4,+6,+8,+14,+17,+18,+21,+21,+21,+mar[20]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	849.0	28.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	79.1
all_phase2_target_2018_pub	TARGET-10-PANFSE	TARGET-10-PANFSE-09	3.0	946.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	31.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3936.0	1.21	Not Hispanic or Latino	Negative	None	0.2862	56,XY,+X,+4,+5,+6,+10,+14,+17,+18,+21,+21[cp6]/46,XY[14]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3936.0	130.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	83.5
all_phase2_target_2018_pub	TARGET-10-PANFUM	TARGET-10-PANFUM-03	4.0	1201.0	NA	NA	DISCOVERY	Negative	2.0	2.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3034.0	1	Not Hispanic or Latino	Unknown	None	0.0127	NA	Unknown	None of the above	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3034.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	132.0
all_phase2_target_2018_pub	TARGET-10-PANGAW	TARGET-10-PANGAW-09	13.0	4435.0	Chemotherapy	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	134.0	1	Hispanic or Latino	Negative	Censored	0.0372	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	134.0	5.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Unknown	13.5
all_phase2_target_2018_pub	TARGET-10-PANGBH	TARGET-10-PANGBH-03	6.0	1886.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4228.0	1	Not Hispanic or Latino	Positive	None	0.0469	46,X,-X,t(10;12;21)(q23;p13;q22),?dup(21)(q22q22)[12]/45,idem,del(13)(q14q32),-14,+mar[3]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4228.0	140.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	67.9
all_phase2_target_2018_pub	TARGET-10-PANGFS	TARGET-10-PANGFS-09	16.0	5816.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3950.0	1	Not Hispanic or Latino	Unknown	None	0.0005	46,XY[100]	Negative	None of the above	NA	NA	0.022000000000000002	0.001	NA	NA	NA	NA	NA	BLL	3950.0	130.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	29.3
all_phase2_target_2018_pub	TARGET-10-PANGIF	TARGET-10-PANGIF-03	12.0	4087.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	428.0	368.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	TCF3-PBX1	NA	NA	0.26	0.01	NA	NA	NA	NA	NA	BLL	428.0	15.0	1:DECEASED	No	AALL0232	Unknown	2	Female	Matched	Positive	No	NA	NA	Unknown	24.6
all_phase2_target_2018_pub	TARGET-10-PANGIF	TARGET-10-PANGIF-09	12.0	4087.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	428.0	368.0	1	Hispanic or Latino	Negative	Relapse	0.2002	NA	Unknown	TCF3-PBX1	NA	NA	0.26	0.01	NA	NA	NA	NA	1	BLL	428.0	15.0	1:DECEASED	No	AALL0232	Unknown	2	Female	Matched	Positive	No	NA	0.0333333333333	Unknown	24.6
all_phase2_target_2018_pub	TARGET-10-PANGJC	TARGET-10-PANGJC-09	14.0	4928.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3652.0	1.183	Not Hispanic or Latino	Unknown	None	0.2611	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3652.0	121.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	7.9
all_phase2_target_2018_pub	TARGET-10-PANGKN	TARGET-10-PANGKN-03	14.0	4849.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3487.0	1	Hispanic or Latino	Unknown	None	0.0710	47,XY,+5,del(9)(p22)[13]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3487.0	115.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	13.0
all_phase2_target_2018_pub	TARGET-10-PANGRZ	TARGET-10-PANGRZ-09	14.0	4783.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	77.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4182.0	1.16	Not Hispanic or Latino	Negative	None	0.2252	51,XY,+6,+8,+10,+12,+21[16]/46,XY[5]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4182.0	138.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.8
all_phase2_target_2018_pub	TARGET-10-PANGVW	TARGET-10-PANGVW-09	15.0	5198.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	684.0	1	Not Hispanic or Latino	Unknown	None	0.0296	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	684.0	23.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	68.0
all_phase2_target_2018_pub	TARGET-10-PANGZM	TARGET-10-PANGZM-09	25.0	8833.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3918.0	1.079	Not Hispanic or Latino	Unknown	None	0.0371	46,XX[20]	Negative	None of the above	NA	NA	0.018000000000000002	0.001	NA	NA	NA	NA	NA	BLL	3918.0	129.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.6
all_phase2_target_2018_pub	TARGET-10-PANHLV	TARGET-10-PANHLV-09	5.0	1580.0	NA	NA	DISCOVERY	Negative	6.0	0.0	NA	48.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3874.0	1	Not Hispanic or Latino	Negative	None	0.0469	NA	Unknown	None of the above	NA	NA	0.005	0.001	NA	NA	NA	NA	NA	BLL	3874.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	232.7
all_phase2_target_2018_pub	TARGET-10-PANHPA	TARGET-10-PANHPA-09	3.0	1093.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4152.0	1	Not Hispanic or Latino	Positive	None	0.0554	45,XX,dic(18;22)(p11.1;p11.1)[cp3]/46,XX[13]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4152.0	137.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	147.7
all_phase2_target_2018_pub	TARGET-10-PANHRW	TARGET-10-PANHRW-09	20.0	7249.0	NA	NA	DISCOVERY	Positive	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	336.0	1.05	Not Hispanic or Latino	Unknown	None	0.0929	NA	Unknown	BCR-ABL1	0.019	0.001	2.3	0.01	NA	NA	NA	NA	NA	BLL	336.0	12.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	24.0
all_phase2_target_2018_pub	TARGET-10-PANHTV	TARGET-10-PANHTV-09	16.0	5650.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2712.0	1	Not Hispanic or Latino	Unknown	None	0.0007	46,XY,del(6)(q15q21)[3]/46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2712.0	90.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PANICK	TARGET-10-PANICK-09	15.0	5147.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3719.0	1	Not Hispanic or Latino	Unknown	None	0.0410	46,XY,i(9)(q10)[18]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3719.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	22.0
all_phase2_target_2018_pub	TARGET-10-PANIDC	TARGET-10-PANIDC-03	13.0	4724.0	NA	NA	DISCOVERY	Negative	4.0	2.0	4.0	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3973.0	1	Not Hispanic or Latino	Unknown	None	0.0011	46,XY,t(4;11)(q21;q23)[15]/46,XY[5]	Positive	MLL-Rearranged	NA	NA	1.1	0.01	NA	NA	NA	NA	NA	BLL	3973.0	131.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	241.0
all_phase2_target_2018_pub	TARGET-10-PANIEB	TARGET-10-PANIEB-09	13.0	4443.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3930.0	1	Not Hispanic or Latino	Negative	None	0.1096	NA	Unknown	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3930.0	130.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Unknown	29.8
all_phase2_target_2018_pub	TARGET-10-PANIEU	TARGET-10-PANIEU-03	8.0	2823.0	NA	NA	DISCOVERY	Positive	0.0	1.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	526.0	526.0	1	Not Hispanic or Latino	Negative	Death	NA	46,X,der(Y)dup(Y)(q11.2q12)t(Y;8)(q12;q13),der(9)t(9;22)(q34;q11.2)add(9)(p11),der(22)t(9;22)[12]/46,XY,der(9)t(9;22)(q34;q11.2)add(9)(p11),del(9)(q13q34),der(22)t(9;22)[3]/46,XY[5]	Negative	BCR-ABL1	NA	NA	2.1	0.01	NA	NA	NA	NA	NA	BLL	526.0	18.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	144.0
all_phase2_target_2018_pub	TARGET-10-PANIEU	TARGET-10-PANIEU-09	8.0	2823.0	NA	NA	DISCOVERY	Positive	0.0	1.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	526.0	526.0	1	Not Hispanic or Latino	Negative	Death	0.0766	46,X,der(Y)dup(Y)(q11.2q12)t(Y;8)(q12;q13),der(9)t(9;22)(q34;q11.2)add(9)(p11),der(22)t(9;22)[12]/46,XY,der(9)t(9;22)(q34;q11.2)add(9)(p11),del(9)(q13q34),der(22)t(9;22)[3]/46,XY[5]	Negative	BCR-ABL1	NA	NA	2.1	0.01	NA	NA	NA	NA	3	BLL	526.0	18.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.1	Negative	144.0
all_phase2_target_2018_pub	TARGET-10-PANIIY	TARGET-10-PANIIY-09	2.0	593.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3105.0	1	Hispanic or Latino	Unknown	None	0.0873	47,XY,+5,r(9)(p?21q?21),del(13)(q12q14)[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3105.0	103.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	110.5
all_phase2_target_2018_pub	TARGET-10-PANIKK	TARGET-10-PANIKK-09	7.0	2488.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2329.0	1.08	Not Hispanic or Latino	Negative	None	0.4938	46,XX[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2329.0	77.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	175.2
all_phase2_target_2018_pub	TARGET-10-PANIPE	TARGET-10-PANIPE-09	3.0	1055.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2849.0	1.17	Hispanic or Latino	Negative	None	NA	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2849.0	94.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Unknown	154.0
all_phase2_target_2018_pub	TARGET-10-PANITD	TARGET-10-PANITD-09	7.0	2386.0	NA	NA	DISCOVERY	Negative	5.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3281.0	1	Hispanic or Latino	Unknown	None	0.0312	46,XY,der(1)t(1;5)(q42;q15),del(5)(q12q33),inv(5)(q13q15),del(6)(q13q15),add(12)(p13)[20]	Negative	None of the above	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	3281.0	108.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	102.3
all_phase2_target_2018_pub	TARGET-10-PANIUJ	TARGET-10-PANIUJ-09	16.0	5653.0	NA	NA	DISCOVERY	Negative	6.0	2.0	1.0	55.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	636.0	1	Unknown	Negative	Relapse	0.1428	46,XY,der(9)inv(9)(p13q32)del(9)(p13p24),inv(22)(q11.1q11.2)[13]/46,XY[7]	Negative	None of the above	0.05	0.01	1.2	0.01	NA	NA	NA	NA	NA	BLL	677.0	23.0	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	114.3
all_phase2_target_2018_pub	TARGET-10-PANIXZ	TARGET-10-PANIXZ-03	11.0	3817.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2092.0	1	Not Hispanic or Latino	Unknown	None	0.0016	46,XY[24]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	2092.0	69.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	78.0
all_phase2_target_2018_pub	TARGET-10-PANJDT	TARGET-10-PANJDT-09	2.0	639.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	1.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3476.0	1.05	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	None of the above	NA	NA	0.19	0.01	NA	NA	NA	NA	NA	BLL	3476.0	115.0	0:LIVING	No	AALL0232	Native Hawaiian or other Pacific Islander	1	Male	Matched	Negative	No	No	NA	Unknown	119.6
all_phase2_target_2018_pub	TARGET-10-PANJJE	TARGET-10-PANJJE-09	16.0	5543.0	Chemotherapy	NA	DISCOVERY	Negative	80.0	0.0	NA	87.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	839.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0063	NA	Unknown	None of the above	2.2	0.01	6.2	0.01	NA	NA	NA	NA	NA	BLL	1001.0	33.0	1:DECEASED	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	272.0
all_phase2_target_2018_pub	TARGET-10-PANJKW	TARGET-10-PANJKW-09	3.0	781.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3850.0	1	Unknown	Negative	None	0.1058	44,XX,der(1)dup(1)(q31q23)inv(1)(q21q25),add(4)(q21q33),der(7)t(7;20)(q11.2;q11.2),add(9)(p22),dic,(9;20)(p21;q11.2),add(15)(q24),-16,add(17)(p11.2),-19,+mar[6]/46,XX[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3850.0	127.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	61.8
all_phase2_target_2018_pub	TARGET-10-PANJLJ	TARGET-10-PANJLJ-09	16.0	5666.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3552.0	1	Not Hispanic or Latino	Negative	None	0.0248	46,XY,del(9)(p22p24)[18]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3552.0	117.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	19.2
all_phase2_target_2018_pub	TARGET-10-PANJPG	TARGET-10-PANJPG-03	14.0	4810.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4072.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX[20]	Negative	None of the above	NA	NA	0.011000000000000001	0.001	NA	NA	NA	NA	2	BLL	4072.0	134.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.0666666666667	Negative	4.7
all_phase2_target_2018_pub	TARGET-10-PANJPG	TARGET-10-PANJPG-09	14.0	4810.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4072.0	1	Not Hispanic or Latino	Unknown	None	0.0008	46,XX[20]	Negative	None of the above	NA	NA	0.011000000000000001	0.001	NA	NA	NA	NA	NA	BLL	4072.0	134.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	4.7
all_phase2_target_2018_pub	TARGET-10-PANJRD	TARGET-10-PANJRD-09	17.0	6086.0	NA	NA	DISCOVERY	Negative	12.0	0.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2140.0	1	Not Hispanic or Latino	Unknown	None	0.0106	46,XX,del(12)(p13)[6]/46,XX[19]	Negative	None of the above	0.17	0.01	0.96	0.01	NA	NA	NA	NA	NA	BLL	2140.0	71.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.0
all_phase2_target_2018_pub	TARGET-10-PANJVN	TARGET-10-PANJVN-09	18.0	6210.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1385.0	1	Hispanic or Latino	Unknown	None	0.0036	46,XY,t(3;11)(p25;q13)]20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1385.0	46.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	5.14
all_phase2_target_2018_pub	TARGET-10-PANJWJ	TARGET-10-PANJWJ-09	12.0	4018.0	NA	NA	DISCOVERY	Positive	11.0	7.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	689.0	1.335	Not Hispanic or Latino	Unknown	Relapse	0.0014	46,XY,t(9;22)(q34;q11.2)[20]	Negative	BCR-ABL1	NA	NA	19.02	0.01	NA	NA	NA	NA	1	BLL	3684.0	122.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.0333333333333	Negative	401.4
all_phase2_target_2018_pub	TARGET-10-PANJXI	TARGET-10-PANJXI-09	14.0	4942.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4017.0	1	Not Hispanic or Latino	Negative	None	0.0256	46,XX,del(6)(q21q23),t(17;21)(p11.2;p11.2)[18]/46,XX[2]	Negative	None of the above	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	4017.0	133.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	15.7
all_phase2_target_2018_pub	TARGET-10-PANJZA	TARGET-10-PANJZA-09	16.0	5699.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	22.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2151.0	1	Hispanic or Latino	Unknown	Relapse	0.0266	46,XY,i(9)(q10),t(11;14)(q23.3;q32)[12]/46,XY[8]	Negative	None of the above	NA	NA	0.54	0.01	NA	NA	NA	NA	NA	BLL	2803.0	93.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	1.5
all_phase2_target_2018_pub	TARGET-10-PANKAK	TARGET-10-PANKAK-04	7.0	2342.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1095.0	950.0	1.48	Not Hispanic or Latino	Negative	Relapse	NA	67<3n>,XXY,-3,+8,-9,-16,-17,+20/66,idem,del(X)(p22.1),-8,del(10)(q22q26),-20,+mar	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1095.0	36.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Positive	74.9
all_phase2_target_2018_pub	TARGET-10-PANKAK	TARGET-10-PANKAK-09	7.0	2342.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1095.0	950.0	1.48	Not Hispanic or Latino	Negative	Relapse	NA	67<3n>,XXY,-3,+8,-9,-16,-17,+20/66,idem,del(X)(p22.1),-8,del(10)(q22q26),-20,+mar	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	1095.0	36.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.0666666666667	Positive	74.9
all_phase2_target_2018_pub	TARGET-10-PANKBV	TARGET-10-PANKBV-09	17.0	6099.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2920.0	1	Not Hispanic or Latino	Unknown	None	0.0397	46,XY,del(13)(q12q14),der(19)t(1;19)(q23;p13.3)[18]/46,XY[2]	Negative	TCF3-PBX1	NA	NA	0.021	0.001	NA	NA	NA	NA	NA	BLL	2920.0	96.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	2.6
all_phase2_target_2018_pub	TARGET-10-PANKCZ	TARGET-10-PANKCZ-09	16.0	5789.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	NA	2371.0	1	Not Hispanic or Latino	Negative	None	0.0018	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2371.0	78.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	4.1
all_phase2_target_2018_pub	TARGET-10-PANKDT	TARGET-10-PANKDT-03	11.0	3679.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3859.0	1	Unknown	Unknown	None	0.0141	46,XX,t(12;17)(p13;q21),idic(21)(p11.2)[14]/46,XX[6]	Negative	None of the above	0.13	0.01	0.102	0.001	NA	NA	NA	NA	NA	BLL	3859.0	127.0	0:LIVING	No	AALL0232	Unknown	2	Female	Matched	Negative	No	NA	NA	Negative	24.1
all_phase2_target_2018_pub	TARGET-10-PANKDT	TARGET-10-PANKDT-09	11.0	3679.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3859.0	1	Unknown	Unknown	None	NA	46,XX,t(12;17)(p13;q21),idic(21)(p11.2)[14]/46,XX[6]	Negative	None of the above	0.13	0.01	0.102	0.001	NA	NA	NA	NA	6	BLL	3859.0	127.0	0:LIVING	No	AALL0232	Unknown	2	Female	Matched	Negative	No	NA	0.2	Negative	24.1
all_phase2_target_2018_pub	TARGET-10-PANKFU	TARGET-10-PANKFU-09	8.0	2675.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2285.0	1	Not Hispanic or Latino	Unknown	None	0.0115	46,XY,der(9)t(1;9)(p36.1;p2?3)[35]/46,XY[4]	Negative	None of the above	NA	NA	0.059000000000000004	0.1	NA	NA	NA	NA	NA	BLL	2285.0	76.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	97.9
all_phase2_target_2018_pub	TARGET-10-PANKGB	TARGET-10-PANKGB-09	16.0	5519.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3967.0	1	Not Hispanic or Latino	Negative	None	0.0049	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3967.0	131.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	6.87
all_phase2_target_2018_pub	TARGET-10-PANKGK	TARGET-10-PANKGK-09	13.0	4655.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2034.0	1.132	Not Hispanic or Latino	Unknown	None	0.0033	46,XY,der(1)t(1;12)(p36.1;p13),der dic(6;12)(q13;p11.1)t(1;12)(p36.1;q13),der(12)t(6;12)(q21;p12)[6]/46,XY[16]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	2034.0	67.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.1	Negative	15.9
all_phase2_target_2018_pub	TARGET-10-PANKKU	TARGET-10-PANKKU-03	2.0	454.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	563.0	546.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0011	46,XX,t(11;19)(q23;p13.3)[20]	Positive	MLL-Rearranged	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	563.0	19.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	168.0
all_phase2_target_2018_pub	TARGET-10-PANKMB	TARGET-10-PANKMB-09	9.0	3000.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	64.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4175.0	1	Not Hispanic or Latino	Unknown	None	0.0477	47,XX,del(3)(p21),del(5)(q13q22),del(7)(q32),del(9)(p21),del(10)(q23),del(12)(p12),del(14)(q11.2),der(16)t(10;16)(q23;p13)t(14;16)(q11.2;q24),dup(21)(q?),+dup(21)(q?)[10]/46,XX[10]	Negative	None of the above	NA	NA	0.024	0.001	NA	NA	NA	NA	4	BLL	4175.0	138.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	0.133333333333	Negative	110.0
all_phase2_target_2018_pub	TARGET-10-PANKNK	TARGET-10-PANKNK-09	16.0	5539.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3501.0	0.69	Not Hispanic or Latino	Negative	None	0.9728	NA	Unknown	Hypodiploid	NA	NA	0.93	0.01	NA	NA	NA	NA	NA	BLL	3501.0	116.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	46.47
all_phase2_target_2018_pub	TARGET-10-PANKRG	TARGET-10-PANKRG-03	2.0	431.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3932.0	1.13	Not Hispanic or Latino	Unknown	None	0.1717	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	3932.0	130.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	0.1	Unknown	119.3
all_phase2_target_2018_pub	TARGET-10-PANKTJ	TARGET-10-PANKTJ-09	18.0	6418.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	328.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0192	46,XX,del(7)(p11.2)[20]/46,XX[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3850.0	127.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	41.3
all_phase2_target_2018_pub	TARGET-10-PANKVL	TARGET-10-PANKVL-09	14.0	4822.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4067.0	1	Not Hispanic or Latino	Negative	None	0.0338	46,XX,der(7)t(1;7)(q23;p15),der(19)t(1;19)(q23;p13.3)[6]/46,XX[14]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4067.0	134.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Positive	No	NA	NA	Negative	90.51
all_phase2_target_2018_pub	TARGET-10-PANKYV	TARGET-10-PANKYV-03	3.0	924.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	NA	4197.0	1	Not Hispanic or Latino	Negative	None	0.0006	NA	Unknown	None of the above	NA	NA	0.13	0.01	NA	NA	NA	NA	NA	BLL	4197.0	138.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	217.0
all_phase2_target_2018_pub	TARGET-10-PANKZE	TARGET-10-PANKZE-09	11.0	3716.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3220.0	1	Hispanic or Latino	Negative	None	0.0579	NA	Unknown	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3220.0	106.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Positive	No	NA	NA	Unknown	47.9
all_phase2_target_2018_pub	TARGET-10-PANLGM	TARGET-10-PANLGM-09	5.0	1628.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	2214.0	1	Not Hispanic or Latino	Positive	Relapse	0.0622	49,XY,-10,der(12)t(10;12)(q11.2;p11.2),+16,+22,+2mar[cp6]/46,XY[7]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3833.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	51.0
all_phase2_target_2018_pub	TARGET-10-PANLGV	TARGET-10-PANLGV-09	8.0	2885.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4078.0	1	Hispanic or Latino	Negative	None	0.0131	46,XY,der(11)t(11;22)(q14;q12),der(22)t(11;22)(q23;q22)[3]/46,XY[15]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4078.0	135.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	80.7
all_phase2_target_2018_pub	TARGET-10-PANLIC	TARGET-10-PANLIC-09	15.0	5421.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	81.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4015.0	1	Not Hispanic or Latino	Negative	None	0.0807	47,XX,del(8)(p11.2p23),-15,del(16)(q12.1q22),-20,+21,add(21)(q22)x2,+2mar[14]/47,idem,del(17)(p11.2)[3]/47,XX,add(11)(q21),-13,+r,+mar[2]/46,XX[1]	Negative	None of the above	NA	NA	0.07	0.01	NA	NA	NA	NA	5	BLL	4015.0	132.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	0.166666666667	Negative	2.3
all_phase2_target_2018_pub	TARGET-10-PANLKU	TARGET-10-PANLKU-03	12.0	4310.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3681.0	1	Not Hispanic or Latino	Unknown	None	0.0512	44,XX,del(6)(q12),del(9)(p21),der(15;22)(q10;q10),dic(19;22)(p13;p11.1),add(21)(q22)[12]/46,XX[8]	Negative	None of the above	NA	NA	0.0011	0.01	NA	NA	NA	NA	NA	BLL	3681.0	122.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	27.7
all_phase2_target_2018_pub	TARGET-10-PANLLB	TARGET-10-PANLLB-09	12.0	4296.0	NA	NA	DISCOVERY	Negative	8.0	2.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4153.0	1	Hispanic or Latino	Negative	None	0.0578	NA	Unknown	None of the above	0.01	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	4153.0	137.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	13.0
all_phase2_target_2018_pub	TARGET-10-PANLRD	TARGET-10-PANLRD-03	3.0	957.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3949.0	1	Not Hispanic or Latino	Unknown	None	0.0471	46,XX,der(19)t(1;19)(q23;p13.3)[8]/46,XX[12]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3949.0	130.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	105.0
all_phase2_target_2018_pub	TARGET-10-PANLTI	TARGET-10-PANLTI-03	3.0	897.0	NA	NA	DISCOVERY	Negative	1.0	3.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3853.0	1	Not Hispanic or Latino	Unknown	None	0.0353	46,XY,der(2)t(1;2)(q2?1;p12)t(2;16)(q37;p11.2),der(16)t(2;16)(p12;p11.2)[18]/46,XY[2]	Negative	None of the above	NA	NA	0.0025	NA	NA	NA	NA	NA	NA	BLL	3853.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	83.5
all_phase2_target_2018_pub	TARGET-10-PANLWD	TARGET-10-PANLWD-09	17.0	5948.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1299.0	1	Not Hispanic or Latino	Positive	None	0.0313	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1299.0	43.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	27.7
all_phase2_target_2018_pub	TARGET-10-PANLWU	TARGET-10-PANLWU-09	4.0	1377.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1466.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0239	NA	Unknown	None of the above	NA	NA	0.00063	NA	NA	NA	NA	NA	NA	BLL	3521.0	116.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	Yes	No	NA	Unknown	106.3
all_phase2_target_2018_pub	TARGET-10-PANLYC	TARGET-10-PANLYC-09	2.0	528.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3843.0	1	Not Hispanic or Latino	Unknown	None	0.0198	45,XX,del(1)(q42),dic(12;12)(p11.2;p11.2)[5]/44,idem,-X[5]/46,XX[34]	Negative	None of the above	NA	NA	0.00043	NA	NA	NA	NA	NA	NA	BLL	3843.0	127.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	123.0
all_phase2_target_2018_pub	TARGET-10-PANMCB	TARGET-10-PANMCB-09	4.0	1162.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	97.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3987.0	1.09	Not Hispanic or Latino	Negative	None	0.1987	50,XX,+X,+2,+4,-7,+21,+21[20]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3987.0	132.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	110.3
all_phase2_target_2018_pub	TARGET-10-PANMEN	TARGET-10-PANMEN-09	3.0	976.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	46.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1226.0	1.163	Not Hispanic or Latino	Unknown	None	0.2278	56,XX,+X,+6,+14,+17,+18,+21,+21,+mar[12]/46,XX[8]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0037	NA	NA	NA	NA	NA	NA	BLL	1226.0	41.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	52.5
all_phase2_target_2018_pub	TARGET-10-PANMGD	TARGET-10-PANMGD-09	16.0	5685.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4160.0	1	Not Hispanic or Latino	Negative	None	0.0028	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4160.0	137.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Unknown	12.3
all_phase2_target_2018_pub	TARGET-10-PANMHB	TARGET-10-PANMHB-09	7.0	2446.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3844.0	1	Not Hispanic or Latino	Negative	None	0.0028	46,XX[28]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3844.0	127.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	64.9
all_phase2_target_2018_pub	TARGET-10-PANMMK	TARGET-10-PANMMK-03	4.0	1229.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3922.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(4;11)(q21;q23)[15]/46,XX[5]	Positive	MLL-Rearranged	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3922.0	129.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	512.0
all_phase2_target_2018_pub	TARGET-10-PANMSM	TARGET-10-PANMSM-09	14.0	4852.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2751.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2751.0	91.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	60.8
all_phase2_target_2018_pub	TARGET-10-PANMVV	TARGET-10-PANMVV-09	12.0	4146.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1244.0	1.09	Not Hispanic or Latino	Negative	Censored	0.2233	51,XY,del(3)(q13.2q23),+6,del(7)(p13p22),+10,+11,der(12)del(12)(p11.2p13)del(12)(q15q24.1),+21,+mar[9]/46,XY[11]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1244.0	41.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	14.0
all_phase2_target_2018_pub	TARGET-10-PANMVY	TARGET-10-PANMVY-09	9.0	3119.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	51.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3884.0	1	Not Hispanic or Latino	Positive	None	0.0694	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3884.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	93.2
all_phase2_target_2018_pub	TARGET-10-PANMWD	TARGET-10-PANMWD-09	15.0	5153.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2143.0	1	Not Hispanic or Latino	Negative	None	0.0379	46,XY,der(9*)t(9*;9)(p12;q21.2)[7]/46,XY[13]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2143.0	71.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	2.3
all_phase2_target_2018_pub	TARGET-10-PANMZB	TARGET-10-PANMZB-09	2.0	708.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3849.0	1	Not Hispanic or Latino	Unknown	None	0.0336	46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3849.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	74.6
all_phase2_target_2018_pub	TARGET-10-PANNGL	TARGET-10-PANNGL-09	13.0	4694.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2514.0	1	Not Hispanic or Latino	Negative	None	0.0693	47,XX,r(7)(p12q31),+9[14]/46,XX[6]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2514.0	83.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	15.8
all_phase2_target_2018_pub	TARGET-10-PANNKX	TARGET-10-PANNKX-03	13.0	4407.0	NA	NA	DISCOVERY	Negative	92.0	38.0	NA	82.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	29.0	1	Not Hispanic or Latino	Unknown	Induction failure	0.0024	NA	Unknown	None of the above	NA	NA	21.8	0.01	NA	NA	NA	NA	NA	BLL	1578.0	52.0	1:DECEASED	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	247.0
all_phase2_target_2018_pub	TARGET-10-PANNMG	TARGET-10-PANNMG-03	14.0	5095.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	189.0	0.841	Hispanic or Latino	Unknown	Relapse	0.0071	36,X,+X,+1,+5,+6,+8,+10,+11,+14,+15,+18,+19,+21,+22[9]/46,XX[12]	Negative	Hypodiploid	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	252.0	9.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	43.1
all_phase2_target_2018_pub	TARGET-10-PANNPI	TARGET-10-PANNPI-09	9.0	2949.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3768.0	1	Not Hispanic or Latino	Positive	None	0.0789	45,X,-X,der(6)add(6)(p25)del(6)(q13q24),del(9)(p22)[19]/46,XX[1]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3768.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	67.3
all_phase2_target_2018_pub	TARGET-10-PANNSV	TARGET-10-PANNSV-09	4.0	1384.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1831.0	1	Not Hispanic or Latino	Unknown	None	0.0249	47,XX,+21[1]/46,XX[46]	Negative	None of the above	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	1831.0	61.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	78.0
all_phase2_target_2018_pub	TARGET-10-PANNUY	TARGET-10-PANNUY-09	16.0	5679.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2475.0	1	Hispanic or Latino	Negative	None	0.1810	47,XY,add(4)(q21),+5,der(9)t(9;16)(p13;p11.2),+14,-16[7]/48,idem,+del(9)(p13),-der(9)t(9;16),+16,-20,+mar[cp3]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2475.0	82.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	16.1
all_phase2_target_2018_pub	TARGET-10-PANNWH	TARGET-10-PANNWH-09	13.0	4645.0	NA	NA	DISCOVERY	Positive	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4011.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4011.0	132.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	6.91
all_phase2_target_2018_pub	TARGET-10-PANNYE	TARGET-10-PANNYE-09	7.0	2305.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	909.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0360	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3916.0	129.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	208.1
all_phase2_target_2018_pub	TARGET-10-PANPAC	TARGET-10-PANPAC-09	16.0	5646.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3216.0	1	Not Hispanic or Latino	Unknown	None	0.0014	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3216.0	106.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	11.7
all_phase2_target_2018_pub	TARGET-10-PANPDG	TARGET-10-PANPDG-09	6.0	1900.0	NA	NA	DISCOVERY	Negative	8.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3720.0	1	Not Hispanic or Latino	Negative	None	0.0966	45,XY,der(6)t(6;9)(q13;q12),-9,der(19)t(1;19)(q23;p13.3)[6]/46,XY[14]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3720.0	123.0	0:LIVING	No	AALL0232	American Indian or Alaska Native	1	Male	Matched	Positive	No	No	NA	Negative	266.4
all_phase2_target_2018_pub	TARGET-10-PANPDM	TARGET-10-PANPDM-03	15.0	5136.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1946.0	1.081	Not Hispanic or Latino	Unknown	None	0.0639	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1946.0	64.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	94.7
all_phase2_target_2018_pub	TARGET-10-PANPEW	TARGET-10-PANPEW-09	2.0	527.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1613.0	1	Not Hispanic or Latino	Negative	None	0.0006	46,XY[20]	Unknown	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1613.0	54.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Unknown	110.3
all_phase2_target_2018_pub	TARGET-10-PANPJI	TARGET-10-PANPJI-09	18.0	6270.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4081.0	1.06	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	None of the above	NA	NA	0.0031	NA	NA	NA	NA	NA	1	BLL	4081.0	135.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	0.0333333333333	Unknown	3.6
all_phase2_target_2018_pub	TARGET-10-PANPJW	TARGET-10-PANPJW-04	13.0	4579.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	424.0	0.75	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Unknown	None of the above	NA	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	882.0	29.0	0:LIVING	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Unknown	16.7
all_phase2_target_2018_pub	TARGET-10-PANPJW	TARGET-10-PANPJW-09	13.0	4579.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	424.0	0.75	Not Hispanic or Latino	Negative	Relapse	0.9403	46,XY[20]	Unknown	None of the above	NA	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	882.0	29.0	0:LIVING	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Unknown	16.7
all_phase2_target_2018_pub	TARGET-10-PANPNJ	TARGET-10-PANPNJ-09	18.0	6535.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	38.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1239.0	1	Not Hispanic or Latino	Unknown	Censored	0.0022	NA	Unknown	None of the above	NA	NA	0.54	0.01	NA	NA	NA	NA	NA	BLL	1239.0	41.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.7
all_phase2_target_2018_pub	TARGET-10-PANPNM	TARGET-10-PANPNM-09	8.0	2717.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1234.0	1	Hispanic or Latino	Unknown	None	0.0373	46,XX,t(4;9)(q21;p24),der(19)t(1;19)(q23;p13.3)[19]/46,XX[2]	Negative	TCF3-PBX1	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1234.0	41.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	59.95
all_phase2_target_2018_pub	TARGET-10-PANPRP	TARGET-10-PANPRP-09	18.0	6378.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1147.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0334	NA	Unknown	None of the above	NA	NA	0.77	0.01	NA	NA	NA	NA	NA	BLL	2625.0	87.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	19.0
all_phase2_target_2018_pub	TARGET-10-PANPSS	TARGET-10-PANPSS-09	18.0	6305.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3774.0	1	Not Hispanic or Latino	Unknown	None	0.0046	46,XY,der(9)del(9)(p13)inv(9)(p13q32),t(9;18)(p22;q23),der(10)t(9;10)(p13;p13)[15]/46,XY[7]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3774.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	36.0
all_phase2_target_2018_pub	TARGET-10-PANPUY	TARGET-10-PANPUY-09	19.0	6791.0	NA	NA	DISCOVERY	Negative	4.0	4.0	1.0	61.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1601.0	1	Not Hispanic or Latino	Unknown	SMN	NA	46,XY[39]/nonclonal[1]	Negative	None of the above	NA	NA	2.1	0.01	NA	NA	NA	NA	NA	BLL	2438.0	81.0	1:DECEASED	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	1.3
all_phase2_target_2018_pub	TARGET-10-PANPVG	TARGET-10-PANPVG-09	15.0	5236.0	NA	NA	DISCOVERY	Negative	0.0	3.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3143.0	1	Not Hispanic or Latino	Unknown	None	0.0663	47,XY,del(6)(q21),del(7)(q22q32),-15,add(17)(q23),-18,add(19)(q13.3),+21,+2mar[18]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3143.0	104.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	3.0
all_phase2_target_2018_pub	TARGET-10-PANPVL	TARGET-10-PANPVL-09	17.0	6022.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3865.0	1	Hispanic or Latino	Negative	None	0.0010	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3865.0	128.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Unknown	28.1
all_phase2_target_2018_pub	TARGET-10-PANPYK	TARGET-10-PANPYK-03	9.0	3132.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3507.0	1.082	Not Hispanic or Latino	Unknown	None	0.0081	46,XX,add(12)(p11)[9]/46,XX[3]	Negative	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3507.0	116.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	52.8
all_phase2_target_2018_pub	TARGET-10-PANRAL	TARGET-10-PANRAL-03	3.0	771.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2979.0	1	Hispanic or Latino	Unknown	None	0.0013	46,XY,del(22)(q13)[2]/46,XY[3]	Negative	None of the above	NA	NA	0.11	0.01	NA	NA	NA	NA	NA	BLL	2979.0	98.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	54.17
all_phase2_target_2018_pub	TARGET-10-PANRBJ	TARGET-10-PANRBJ-09	4.0	1174.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4028.0	1	Hispanic or Latino	Positive	None	0.0020	46,XY[20]	Unknown	ETV6-RUNX1	NA	NA	0.0028	NA	NA	NA	NA	NA	NA	BLL	4028.0	133.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Unknown	92.0
all_phase2_target_2018_pub	TARGET-10-PANRDC	TARGET-10-PANRDC-03	2.0	539.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3832.0	1	Not Hispanic or Latino	Unknown	None	0.0012	NA	Unknown	None of the above	NA	NA	0.01	0.01	NA	NA	NA	NA	6	BLL	3832.0	126.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	0.166666666667	Unknown	76.5
all_phase2_target_2018_pub	TARGET-10-PANRER	TARGET-10-PANRER-09	13.0	4690.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2782.0	1	Hispanic or Latino	Negative	None	0.1201	NA	Unknown	None of the above	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	2782.0	92.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Unknown	16.0
all_phase2_target_2018_pub	TARGET-10-PANRET	TARGET-10-PANRET-09	12.0	4087.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3046.0	1	Not Hispanic or Latino	Negative	None	0.0132	46,XY,add(9)(p22)[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3046.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	17.45
all_phase2_target_2018_pub	TARGET-10-PANRFG	TARGET-10-PANRFG-09	14.0	4768.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4086.0	1	Not Hispanic or Latino	Negative	SMN	0.0227	46,XX,add(8)(p21),add(9)(p22)[2]/46,idem,t(8;22)(q24.1;q11.2)[11]/46,XX,der(8)add(8)(p21)add(8)(q24.1),t(8;22)(q24.1;q11.2),add(9)(p22)[11]/46,XX[6]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4086.0	135.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	164.0
all_phase2_target_2018_pub	TARGET-10-PANRGS	TARGET-10-PANRGS-09	3.0	1053.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3754.0	1.13	Not Hispanic or Latino	Unknown	None	0.2463	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3754.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	74.6
all_phase2_target_2018_pub	TARGET-10-PANRHE	TARGET-10-PANRHE-09	12.0	4382.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3062.0	1	Not Hispanic or Latino	Unknown	None	0.0219	45,XX,dic(9;12)(p13;p13)[6]/46,XX[14]	Negative	None of the above	NA	NA	0.0015	NA	NA	NA	NA	NA	NA	BLL	3062.0	101.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.8
all_phase2_target_2018_pub	TARGET-10-PANRIM	TARGET-10-PANRIM-03	2.0	643.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3776.0	1	Not Hispanic or Latino	Unknown	None	0.0223	46,XX,t(9;10)(q34;q22)[4]/45,idem,dic(12;20)(p11.2;q11.2)[11]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3776.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	356.4
all_phase2_target_2018_pub	TARGET-10-PANRJL	TARGET-10-PANRJL-09	3.0	1086.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3772.0	1	Not Hispanic or Latino	Negative	None	0.4230	NA	Unknown	None of the above	NA	NA	0.0017	NA	NA	NA	NA	NA	NA	BLL	3772.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Unknown	106.0
all_phase2_target_2018_pub	TARGET-10-PANRNE	TARGET-10-PANRNE-03	3.0	1059.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3769.0	1.056	Not Hispanic or Latino	Unknown	None	0.0562	46,XX,t(9;11)(p13;q25)[7]/47,idem,+8[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3769.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	365.0
all_phase2_target_2018_pub	TARGET-10-PANRNL	TARGET-10-PANRNL-09	9.0	3106.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	78.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1126.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0143	NA	Unknown	None of the above	0.017	0.001	0.2	0.01	NA	NA	NA	NA	NA	BLL	3425.0	113.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	51.0
all_phase2_target_2018_pub	TARGET-10-PANRPL	TARGET-10-PANRPL-09	13.0	4447.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2385.0	1	Unknown	Unknown	None	0.0024	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2385.0	79.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.8
all_phase2_target_2018_pub	TARGET-10-PANRPM	TARGET-10-PANRPM-09	19.0	6778.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	Yes	NA	3885.0	1	Not Hispanic or Latino	Negative	None	0.0149	47,XY,t(9;19)(q34;q12),del(12)(p12),+21c[10]/47,XY,+21c[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3885.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	8.6
all_phase2_target_2018_pub	TARGET-10-PANRSI	TARGET-10-PANRSI-09	3.0	811.0	NA	NA	DISCOVERY	Negative	2.0	4.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3924.0	1	Not Hispanic or Latino	Positive	None	0.0242	47,XX,+10[7]/46,XX[13]	Negative	ETV6-RUNX1	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3924.0	130.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	65.9
all_phase2_target_2018_pub	TARGET-10-PANRSM	TARGET-10-PANRSM-09	14.0	4906.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1664.0	1.27	Hispanic or Latino	Negative	None	0.1978	58,XY,+X,+X,+Y,+4,+6,+9,+10,+12,+14,+17,+21,+21[7]/46,XY[13]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1664.0	55.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	2.63
all_phase2_target_2018_pub	TARGET-10-PANRSR	TARGET-10-PANRSR-09	17.0	5998.0	NA	NA	DISCOVERY	Negative	0.0	0.0	0.0	63.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2164.0	1	Not Hispanic or Latino	Negative	Relapse	0.0017	NA	Unknown	None of the above	0.004	0.001	1.5	0.01	NA	NA	NA	NA	NA	BLL	3974.0	131.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PANRSU	TARGET-10-PANRSU-09	11.0	3886.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1512.0	1.181	Not Hispanic or Latino	Unknown	None	0.2262	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.037000000000000005	0.001	NA	NA	NA	NA	NA	BLL	1512.0	50.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.6
all_phase2_target_2018_pub	TARGET-10-PANRUP	TARGET-10-PANRUP-03	9.0	3176.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	35.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1984.0	1.215	Not Hispanic or Latino	Unknown	Relapse	0.4495	57,XY,+X,+Y,+4,+del(5)(q15q33),+6,+14,+17,+18,+21,+21,+mar[9]/46,XY[11]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.024	0.001	NA	NA	NA	NA	NA	BLL	3982.0	131.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	90.1
all_phase2_target_2018_pub	TARGET-10-PANRVB	TARGET-10-PANRVB-09	13.0	4577.0	NA	NA	DISCOVERY	Negative	0.0	1.0	1.0	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	2188.0	1442.0	1	Unknown	Negative	Relapse	0.0021	NA	Unknown	None of the above	0.0034	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	2188.0	72.0	1:DECEASED	Yes	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	71.13
all_phase2_target_2018_pub	TARGET-10-PANRWG	TARGET-10-PANRWG-09	3.0	978.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3769.0	1.14	Not Hispanic or Latino	Negative	None	0.1454	47,XY,der(2)t(1;2)(q23;q33),der(2)del(2)(p21)del(2)(q32),+10,t(11;12)(q12;p12),der(16)(16pter->q24::?->?::1q31->1qter),der(19)t(2;19)(?q;p13.3),-20,+21[7]/49,idem,der(11)(11qter->11p15::2?->2?::1q31->1qter),+20,+22[8]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	4	BLL	3769.0	124.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.133333333333	Negative	97.4
all_phase2_target_2018_pub	TARGET-10-PANRWW	TARGET-10-PANRWW-09	2.0	513.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3830.0	1.18	Not Hispanic or Latino	Negative	None	0.3517	53,XY,+X,+4,+6,+10,+14,+18,+21[7]/46,XY[13]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3830.0	126.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Positive	103.8
all_phase2_target_2018_pub	TARGET-10-PANRWZ	TARGET-10-PANRWZ-09	6.0	1876.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2327.0	1	Not Hispanic or Latino	Positive	None	0.0207	46,XX[20]	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2327.0	77.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	63.2
all_phase2_target_2018_pub	TARGET-10-PANRXJ	TARGET-10-PANRXJ-09	4.0	1340.0	NA	NA	DISCOVERY	Positive	2.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4019.0	1.17	Not Hispanic or Latino	Negative	None	0.0092	46,XX,t(9;22)(q34;q11.2)[19]/54,idem,+X,+2,+4,+6,+17,+18,+21,+der(22)t(9;22)[9]/46,XX[2]	Negative	BCR-ABL1	NA	NA	0.063	0.001	NA	NA	NA	NA	NA	BLL	4019.0	133.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	147.4
all_phase2_target_2018_pub	TARGET-10-PANRXM	TARGET-10-PANRXM-09	4.0	1350.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3927.0	1	Hispanic or Latino	Negative	None	0.0467	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3927.0	130.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	75.4
all_phase2_target_2018_pub	TARGET-10-PANRYM	TARGET-10-PANRYM-09	3.0	852.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1675.0	1.181	Not Hispanic or Latino	Unknown	None	0.3551	55,XX,+X,dup(1)(q21q42),+4,+6,+10,+14,+17,+18,+21,+22[18]/46,XX[2]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	1675.0	56.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	0.1	Positive	91.7
all_phase2_target_2018_pub	TARGET-10-PANRYX	TARGET-10-PANRYX-09	27.0	9556.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	603.0	404.0	1	Not Hispanic or Latino	Negative	Relapse	0.0882	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	603.0	20.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	33.9
all_phase2_target_2018_pub	TARGET-10-PANRYX	TARGET-10-PANRYX-40	27.0	9556.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	603.0	404.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	603.0	20.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	33.9
all_phase2_target_2018_pub	TARGET-10-PANSBC	TARGET-10-PANSBC-09	13.0	4418.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	885.0	1	Not Hispanic or Latino	Unknown	Censored	0.0379	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	885.0	30.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	5.0
all_phase2_target_2018_pub	TARGET-10-PANSBK	TARGET-10-PANSBK-09	6.0	1884.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1179.0	1	Hispanic or Latino	Negative	None	0.0392	46,XX,dic(9;20)(p11;q11.2),+21[4]/46,XX[19]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1179.0	39.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	86.36
all_phase2_target_2018_pub	TARGET-10-PANSBR	TARGET-10-PANSBR-09	21.0	7519.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	2.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1688.0	728.0	1	Not Hispanic or Latino	Negative	Relapse	0.0027	NA	Unknown	None of the above	0.013000000000000001	0.001	0.56	0.01	NA	NA	NA	NA	4	BLL	1688.0	56.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	0.133333333333	Unknown	10.9
all_phase2_target_2018_pub	TARGET-10-PANSCX	TARGET-10-PANSCX-09	18.0	6435.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3890.0	1	Not Hispanic or Latino	Unknown	None	0.0313	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3890.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.1
all_phase2_target_2018_pub	TARGET-10-PANSDA	TARGET-10-PANSDA-04	13.0	4616.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1141.0	863.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XX[30]	Negative	None of the above	NA	NA	0.16	0.01	NA	NA	NA	NA	NA	BLL	1141.0	38.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	40.6
all_phase2_target_2018_pub	TARGET-10-PANSDA	TARGET-10-PANSDA-09	13.0	4616.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1141.0	863.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0021	46,XX[30]	Negative	None of the above	NA	NA	0.16	0.01	NA	NA	NA	NA	3	BLL	1141.0	38.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.1	Negative	40.6
all_phase2_target_2018_pub	TARGET-10-PANSDV	TARGET-10-PANSDV-09	16.0	5621.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2157.0	1.205	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2157.0	71.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.06
all_phase2_target_2018_pub	TARGET-10-PANSFD	TARGET-10-PANSFD-03	6.0	1987.0	CHEMOTHERAPY	NA	DISCOVERY	Negative	0.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	341.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,ins(12;9)(p13;q34q34)[?20]	Negative	None of the above	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	561.0	19.0	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	83.0
all_phase2_target_2018_pub	TARGET-10-PANSFD	TARGET-10-PANSFD-09	6.0	1987.0	CHEMOTHERAPY	NA	DISCOVERY	Negative	0.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	341.0	1	Not Hispanic or Latino	Negative	Relapse	0.0017	46,XY,ins(12;9)(p13;q34q34)[?20]	Negative	None of the above	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	561.0	19.0	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	83.0
all_phase2_target_2018_pub	TARGET-10-PANSFD	TARGET-10-PANSFD-60.1	6.0	1987.0	CHEMOTHERAPY	NA	XENOGRAFT	Negative	0.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	341.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,ins(12;9)(p13;q34q34)[?20]	Negative	None of the above	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	561.0	19.0	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	83.0
all_phase2_target_2018_pub	TARGET-10-PANSFD	TARGET-10-PANSFD-60.2	6.0	1987.0	CHEMOTHERAPY	NA	XENOGRAFT	Negative	0.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	341.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,ins(12;9)(p13;q34q34)[?20]	Negative	None of the above	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	561.0	19.0	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	83.0
all_phase2_target_2018_pub	TARGET-10-PANSGY	TARGET-10-PANSGY-09	13.0	4694.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4000.0	1.219	Not Hispanic or Latino	Unknown	None	0.9313	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	4000.0	132.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	12.3
all_phase2_target_2018_pub	TARGET-10-PANSHK	TARGET-10-PANSHK-04	3.0	837.0	CHEMOTHERAPY; Transplant	NA	VALIDATION;DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1354.0	1	Not Hispanic or Latino	Negative	Relapse	0.0533	46,XY,t(2;12)(p15;p12),del(7)(p11.2p22),der(12)inv(12)(p13q15)add(12)(q24)[3]/47,idem,+10[15]/48,idem,+10,+21[2]/46,XY[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2447.0	81.0	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	18.5
all_phase2_target_2018_pub	TARGET-10-PANSHK	TARGET-10-PANSHK-09	3.0	837.0	CHEMOTHERAPY; Transplant	NA	VALIDATION;DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1354.0	1	Not Hispanic or Latino	Negative	Relapse	0.0489	46,XY,t(2;12)(p15;p12),del(7)(p11.2p22),der(12)inv(12)(p13q15)add(12)(q24)[3]/47,idem,+10[15]/48,idem,+10,+21[2]/46,XY[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	14	BLL	2447.0	81.0	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	0.466666666667	Negative	18.5
all_phase2_target_2018_pub	TARGET-10-PANSIA	TARGET-10-PANSIA-09	6.0	2041.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	42.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3931.0	1.304	Not Hispanic or Latino	Unknown	None	0.5523	64,XX,+X,+4,+5,+6,+8,+10,+10,+11,+12,+13,+15,+16,+17,+18,+19,+21,+21,+22[cp6]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	7	BLL	3931.0	130.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	0.266666666667	Positive	73.6
all_phase2_target_2018_pub	TARGET-10-PANSIL	TARGET-10-PANSIL-09	22.0	7922.0	Chemotherapy; Transplant	NA	DISCOVERY	Positive	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3801.0	1.149	Not Hispanic or Latino	Unknown	None	0.1916	52,XY,+X,+4,+6,t(9;22)(q34;q11.2),+14,+17,der(22)t(9;22)(q34;q11.2)[3]/46,XY[1]	Negative	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3801.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	7.1
all_phase2_target_2018_pub	TARGET-10-PANSIR	TARGET-10-PANSIR-09	2.0	533.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	620.0	1	Hispanic or Latino	Unknown	Relapse	0.0012	NA	Unknown	None of the above	0.0	0.1	0.28	0.01	NA	NA	NA	NA	NA	BLL	2012.0	67.0	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	118.5
all_phase2_target_2018_pub	TARGET-10-PANSIZ	TARGET-10-PANSIZ-09	5.0	1652.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3612.0	1.174	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3612.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	20.9
all_phase2_target_2018_pub	TARGET-10-PANSKH	TARGET-10-PANSKH-09	17.0	5867.0	NA	NA	DISCOVERY	Negative	3.0	0.0	0.0	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3110.0	1.19	Not Hispanic or Latino	Negative	None	0.4827	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	1.4	0.01	NA	NA	NA	NA	NA	BLL	3110.0	103.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	6.0
all_phase2_target_2018_pub	TARGET-10-PANSKJ	TARGET-10-PANSKJ-09	12.0	4309.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	800.0	1	Hispanic or Latino	Negative	Relapse	0.0137	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3780.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	Yes	No	NA	Unknown	29.7
all_phase2_target_2018_pub	TARGET-10-PANSKK	TARGET-10-PANSKK-09	4.0	1440.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3868.0	1	Hispanic or Latino	Positive	None	0.0478	46,XX,del(9)(p24)[3]/46,XX[17]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3868.0	128.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	55.55
all_phase2_target_2018_pub	TARGET-10-PANSNA	TARGET-10-PANSNA-09	18.0	6317.0	NA	NA	DISCOVERY	Negative	14.0	2.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1624.0	1.233	Not Hispanic or Latino	Unknown	None	0.3546	58,XY,+Y,+4,+6,+8,+9,+10,+13,+14,+17,+21,+21,+22[3]/46,XY[12]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.94	0.01	NA	NA	NA	NA	NA	BLL	1624.0	54.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Negative	No	No	NA	Positive	0.57
all_phase2_target_2018_pub	TARGET-10-PANSNR	TARGET-10-PANSNR-03	18.0	6431.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3440.0	1	Not Hispanic or Latino	Unknown	None	0.0875	46,XY,inv(7)(p15q31),del(11)(q21),add(12)(p12),-13,+del(15)(q11.2)c[14]/47,XY,+del(15)(q11.2)mat[4]/46,XY[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3440.0	114.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	13.4
all_phase2_target_2018_pub	TARGET-10-PANSPW	TARGET-10-PANSPW-09	14.0	4798.0	Chemotherapy	NA	DISCOVERY	Positive	10.0	7.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	870.0	113.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0027	46,XY,t(9;22)(q34q11.2)/47,idem,+der(22)t(9;22)	Negative	BCR-ABL1	NA	NA	24.4	0.01	NA	NA	NA	NA	4	BLL	870.0	29.0	1:DECEASED	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	0.133333333333	Negative	58.9
all_phase2_target_2018_pub	TARGET-10-PANSSH	TARGET-10-PANSSH-09	18.0	6260.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3797.0	1	Not Hispanic or Latino	Negative	None	0.0004	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3797.0	125.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	27.3
all_phase2_target_2018_pub	TARGET-10-PANSTA	TARGET-10-PANSTA-09	3.0	884.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3821.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,-1,-13,der(14)t(1;14)(p22;q32.1),+der(?)(?;1)(?;q25),+mar[14]/46,XX[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3821.0	126.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	28.6
all_phase2_target_2018_pub	TARGET-10-PANSTB	TARGET-10-PANSTB-09	4.0	1440.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	848.0	1	Not Hispanic or Latino	Positive	SMN	0.0103	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1063.0	35.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	50.91
all_phase2_target_2018_pub	TARGET-10-PANSTC	TARGET-10-PANSTC-09	6.0	2084.0	NA	NA	DISCOVERY	Negative	8.0	1.0	NA	44.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2094.0	1	Unknown	Unknown	None	0.0127	NA	Unknown	None of the above	0.0	0.01	0.95	0.01	NA	NA	NA	NA	NA	BLL	2094.0	69.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	65.5
all_phase2_target_2018_pub	TARGET-10-PANSUF	TARGET-10-PANSUF-09	5.0	1671.0	NA	NA	DISCOVERY	Negative	4.0	NA	NA	95.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1715.0	1.17	Not Hispanic or Latino	Negative	None	0.2535	53,XX,+X,+X,+4,+6,+14,der(9)t(9;19)(q13.4;q13),+21,+21[cp19]/46,XX[1]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.01	0.65	0.01	NA	NA	NA	NA	NA	BLL	1715.0	57.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	213.6
all_phase2_target_2018_pub	TARGET-10-PANSUL	TARGET-10-PANSUL-09	3.0	886.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1068.0	929.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0422	46,XY,del(12)(p11.2)[3]/46,XY[16]	Negative	None of the above	0.0	0.01	0.13	0.01	NA	NA	NA	NA	3	BLL	1068.0	36.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.1	Negative	51.6
all_phase2_target_2018_pub	TARGET-10-PANSUN	TARGET-10-PANSUN-09	17.0	6123.0	NA	NA	DISCOVERY	Negative	20.0	3.0	NA	84.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	876.0	1	Not Hispanic or Latino	Negative	Relapse	0.0015	46,XY,t(2;14)(q23;q32.3)[12]/46,XY[8]	Negative	None of the above	0.0	0.01	0.42	0.01	NA	NA	NA	NA	NA	BLL	1471.0	49.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	248.0
all_phase2_target_2018_pub	TARGET-10-PANSWH	TARGET-10-PANSWH-09	11.0	3693.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2685.0	1	Hispanic or Latino	Negative	None	0.0015	NA	Unknown	None of the above	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	2685.0	89.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	7.9
all_phase2_target_2018_pub	TARGET-10-PANSXG	TARGET-10-PANSXG-03	8.0	2775.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3830.0	1.15	Not Hispanic or Latino	Negative	None	NA	53,XX,+X,+X,+4,+14,+17,+18,+21[15]/46,XX[5]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	3830.0	126.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.166666666667	Negative	74.2
all_phase2_target_2018_pub	TARGET-10-PANSXG	TARGET-10-PANSXG-09	8.0	2775.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3830.0	1.15	Not Hispanic or Latino	Negative	None	0.2029	53,XX,+X,+X,+4,+14,+17,+18,+21[15]/46,XX[5]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3830.0	126.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	74.2
all_phase2_target_2018_pub	TARGET-10-PANSYA	TARGET-10-PANSYA-09	4.0	1443.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3680.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.005	0.001	NA	NA	NA	NA	NA	BLL	3680.0	121.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	38.5
all_phase2_target_2018_pub	TARGET-10-PANSZD	TARGET-10-PANSZD-09	18.0	6512.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	4060.0	1.13	Not Hispanic or Latino	Negative	None	0.6188	51,XY,+X,+4,i(7)(q10),+14,+17,+21[cp9]/46,XY[11]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.043	0.001	NA	NA	NA	NA	NA	BLL	4060.0	134.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	4.2
all_phase2_target_2018_pub	TARGET-10-PANTBB	TARGET-10-PANTBB-09	4.0	1104.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3668.0	1.109	Unknown	Positive	None	NA	46,XY,add(19)(p13)[6]/46,XY[19]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3668.0	121.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	21.58
all_phase2_target_2018_pub	TARGET-10-PANTCR	TARGET-10-PANTCR-09	6.0	2059.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2403.0	1	Unknown	Positive	None	NA	45-48,add(12)(p13.1),add(14)(q22),-15,-20,+21,+1-2mar[cp12]/46,XY[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2403.0	80.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	2.5
all_phase2_target_2018_pub	TARGET-10-PANTEN	TARGET-10-PANTEN-09	5.0	1546.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3841.0	1	Not Hispanic or Latino	Positive	None	0.0218	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3841.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	77.3
all_phase2_target_2018_pub	TARGET-10-PANTHL	TARGET-10-PANTHL-03	3.0	930.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1873.0	1	Not Hispanic or Latino	Unknown	None	0.0252	46,XY,der(2)t(2;21)(p11.2;q22),der(12)t(2;12)(p11.2;p13),der(12)t(6;12)(p11.2;p12),der(16)t(12;16)(p12;q22)t(12;21)(p13;q22),der(21)t(16;21)(q22;q22)[19]/46,XY[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1873.0	62.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	131.9
all_phase2_target_2018_pub	TARGET-10-PANTHU	TARGET-10-PANTHU-09	14.0	5060.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2678.0	1.06	Not Hispanic or Latino	Negative	None	0.0881	48,XY,+8,del(9)(p22),+16[17]/46,XY[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2678.0	89.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	38.7
all_phase2_target_2018_pub	TARGET-10-PANTKG	TARGET-10-PANTKG-09	12.0	4171.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1248.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0146	46,XY,t(12;15)(q13;q22),add(16)(q24)[3]/47,idem,+10[3]/46,XY[13]/nonclonal[1]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	1457.0	48.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	Yes	No	NA	Negative	0.7
all_phase2_target_2018_pub	TARGET-10-PANTLF	TARGET-10-PANTLF-03	2.0	588.0	NA	NA	VALIDATION	Negative	13.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3781.0	1	Hispanic or Latino	Negative	None	NA	46,XX,ins(10;11)(p12;q13q23)[7]/47,idem,+1,+5,del(12)(p13),psu dic(15;1)(q26;p13)[6]/46,XX[7]	Positive	NA	NA	NA	0.54	0.01	NA	NA	NA	NA	NA	BLL	3781.0	125.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.6
all_phase2_target_2018_pub	TARGET-10-PANTRY	TARGET-10-PANTRY-09	5.0	1656.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3593.0	1	Hispanic or Latino	Positive	None	NA	45,X,-Y,del(10)(p11.2),add(12)(p13)[10]/46,XY[10]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3593.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	14.3
all_phase2_target_2018_pub	TARGET-10-PANTSM	TARGET-10-PANTSM-03	8.0	2591.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1214.0	1087.0	1	Unknown	Negative	Relapse	NA	45,X,-Y,del(9)(p13)[3]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	7	BLL	1214.0	40.0	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	0.233333333333	Negative	22.16
all_phase2_target_2018_pub	TARGET-10-PANTSM	TARGET-10-PANTSM-04	8.0	2591.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1214.0	1087.0	1	Unknown	Negative	Relapse	0.0260	45,X,-Y,del(9)(p13)[3]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1214.0	40.0	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Negative	22.16
all_phase2_target_2018_pub	TARGET-10-PANTSM	TARGET-10-PANTSM-09	8.0	2591.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1214.0	1087.0	1	Unknown	Negative	Relapse	0.0151	45,X,-Y,del(9)(p13)[3]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1214.0	40.0	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Negative	22.16
all_phase2_target_2018_pub	TARGET-10-PANTSN	TARGET-10-PANTSN-09	3.0	971.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3917.0	1	Not Hispanic or Latino	Negative	None	0.0519	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3917.0	129.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	63.2
all_phase2_target_2018_pub	TARGET-10-PANTTB	TARGET-10-PANTTB-09	8.0	2705.0	NA	NA	VALIDATION	Negative	1.0	0.0	3.0	97.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3914.0	1.12	Not Hispanic or Latino	Negative	None	NA	52,XY,+X,+4,+9,+14,+21,+21[19]/46,XY[1]	Negative	NA	NA	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	3914.0	129.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	4.5
all_phase2_target_2018_pub	TARGET-10-PANTTR	TARGET-10-PANTTR-09	15.0	5115.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	4020.0	1	Not Hispanic or Latino	Positive	None	0.0015	46,XY[16]	Unknown	ETV6-RUNX1	NA	NA	0.025	0.001	NA	NA	NA	NA	NA	BLL	4020.0	133.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	44.53
all_phase2_target_2018_pub	TARGET-10-PANTUM	TARGET-10-PANTUM-09	15.0	5364.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2134.0	1	Hispanic or Latino	Unknown	None	0.0093	46,XY[21]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2134.0	71.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	36.0
all_phase2_target_2018_pub	TARGET-10-PANTUZ	TARGET-10-PANTUZ-09	3.0	935.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	37.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	966.0	1.14	Not Hispanic or Latino	Negative	Relapse	NA	53,XY,+X,+Y,+4,+6,+18,+21,+21[17]46,XY[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3972.0	131.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	7.8
all_phase2_target_2018_pub	TARGET-10-PANTVC	TARGET-10-PANTVC-09	2.0	674.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3403.0	1	Hispanic or Latino	Negative	None	NA	46,XY[29]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3403.0	112.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	21.74
all_phase2_target_2018_pub	TARGET-10-PANTVY	TARGET-10-PANTVY-09	13.0	4457.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2486.0	1	Not Hispanic or Latino	Unknown	None	0.0149	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2486.0	82.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	44.8
all_phase2_target_2018_pub	TARGET-10-PANTWC	TARGET-10-PANTWC-09	5.0	1546.0	NA	NA	VALIDATION	Negative	33.0	0.0	NA	65.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	4024.0	1	Hispanic or Latino	Negative	None	NA	47,XY,+7[4]/48,idem,+8[3]/46,XY[23]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4024.0	133.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	22.1
all_phase2_target_2018_pub	TARGET-10-PANTXA	TARGET-10-PANTXA-09	4.0	1357.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3786.0	1.21	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.031	0.001	NA	NA	NA	NA	NA	BLL	3786.0	125.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Unknown	No	NA	NA	Positive	1.1
all_phase2_target_2018_pub	TARGET-10-PANTXE	TARGET-10-PANTXE-09	13.0	4685.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3673.0	1	Hispanic or Latino	Negative	None	0.0653	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3673.0	121.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	74.3
all_phase2_target_2018_pub	TARGET-10-PANTXK	TARGET-10-PANTXK-09	16.0	5680.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2072.0	1	Not Hispanic or Latino	Negative	None	0.0039	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2072.0	69.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	113.3
all_phase2_target_2018_pub	TARGET-10-PANTYM	TARGET-10-PANTYM-09	16.0	5744.0	NA	NA	DISCOVERY	Negative	6.0	2.0	1.0	85.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1514.0	1	Hispanic or Latino	Negative	Death	NA	45,X,-Y,del(9)(p13)[19]/46,XY[1]	Negative	None of the above	NA	NA	1.5	0.01	NA	NA	NA	NA	NA	BLL	1514.0	50.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	79.66
all_phase2_target_2018_pub	TARGET-10-PANTYP	TARGET-10-PANTYP-09	4.0	1138.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3948.0	1.23	Not Hispanic or Latino	Negative	None	NA	57,XX,+X,+X,+4,+8,+9,+10,+14,+17,+18,+21,+21[11]/46,XX[9]	Negative	NA	NA	NA	0.037000000000000005	0.001	NA	NA	NA	NA	NA	BLL	3948.0	130.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	9.3
all_phase2_target_2018_pub	TARGET-10-PANTZD	TARGET-10-PANTZD-09	15.0	5474.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2985.0	1	Not Hispanic or Latino	Negative	None	0.0076	46,XY,t(12;14)(p13;q13),add(16)(p13.3)[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2985.0	99.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	1306.0
all_phase2_target_2018_pub	TARGET-10-PANTZE	TARGET-10-PANTZE-09	4.0	1285.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3833.0	1.051	Not Hispanic or Latino	Positive	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3833.0	127.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	34.2
all_phase2_target_2018_pub	TARGET-10-PANUBA	TARGET-10-PANUBA-03	19.0	6864.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1143.0	1	Hispanic or Latino	Unknown	None	0.0002	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1143.0	38.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.1
all_phase2_target_2018_pub	TARGET-10-PANUEC	TARGET-10-PANUEC-09	12.0	4218.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	36.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1491.0	1.234	Not Hispanic or Latino	Unknown	None	0.4473	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1491.0	50.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.6
all_phase2_target_2018_pub	TARGET-10-PANUHA	TARGET-10-PANUHA-09	4.0	1302.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1294.0	1.062	Hispanic or Latino	Positive	Relapse	0.0042	46,XY[20]	Negative	ETV6-RUNX1	NA	NA	0.0074	NA	NA	NA	NA	NA	3	BLL	4017.0	133.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	Yes	No	0.1	Negative	12.9
all_phase2_target_2018_pub	TARGET-10-PANUIC	TARGET-10-PANUIC-03	18.0	6314.0	Chemotherapy	NA	DISCOVERY	Negative	6.0	0.0	NA	92.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3783.0	1	Hispanic or Latino	Unknown	None	NA	NA	Unknown	None of the above	NA	NA	0.56	0.01	NA	NA	NA	NA	NA	BLL	3783.0	125.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	211.7
all_phase2_target_2018_pub	TARGET-10-PANUIN	TARGET-10-PANUIN-09	10.0	3612.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3921.0	1	Not Hispanic or Latino	Negative	None	0.0348	46,XY,der(19)t(1;19)(q23;p13)[9]/46,idem,del(6)(q21)[cp4]/46,XY[22]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3921.0	129.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	131.67
all_phase2_target_2018_pub	TARGET-10-PANUIW	TARGET-10-PANUIW-09	15.0	5475.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1229.0	1	Not Hispanic or Latino	Negative	None	0.3985	45,XY,dic(1;4)(q44;p16),add(5)(p15)[7]/46,XY,del(1)(q42),-4,add(5)(p15),r(8),+mar[3]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1229.0	41.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.3
all_phase2_target_2018_pub	TARGET-10-PANUJX	TARGET-10-PANUJX-09	18.0	6215.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1345.0	1.059	Unknown	Unknown	None	0.0867	47,XX,+5,t(6;14)(p22;q32),i(9)(q10)[6]/47,idem,del(17)(p11.2)[1]/46,idem,-5,del(17)(p11.2)[7]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1345.0	45.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	1.0
all_phase2_target_2018_pub	TARGET-10-PANUKF	TARGET-10-PANUKF-09	4.0	1351.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	56.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	851.0	1	Not Hispanic or Latino	Positive	Relapse	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2755.0	91.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	41.0
all_phase2_target_2018_pub	TARGET-10-PANUKM	TARGET-10-PANUKM-09	12.0	4129.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3659.0	1	Unknown	Negative	None	0.0121	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3659.0	121.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	110.3
all_phase2_target_2018_pub	TARGET-10-PANUKN	TARGET-10-PANUKN-03	17.0	5957.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	27.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1028.0	1.073	Not Hispanic or Latino	Unknown	Relapse	0.0161	NA	Unknown	None of the above	NA	NA	0.53	0.01	NA	NA	NA	NA	NA	BLL	2693.0	89.0	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Unknown	No	No	NA	Unknown	2.0
all_phase2_target_2018_pub	TARGET-10-PANUKN	TARGET-10-PANUKN-04	17.0	5957.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	27.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1028.0	1.073	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.53	0.01	NA	NA	NA	NA	NA	BLL	2693.0	89.0	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Unknown	No	No	NA	Unknown	2.0
all_phase2_target_2018_pub	TARGET-10-PANUKN	TARGET-10-PANUKN-09	17.0	5957.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	27.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1028.0	1.073	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.53	0.01	NA	NA	NA	NA	NA	BLL	2693.0	89.0	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Unknown	No	No	NA	Unknown	2.0
all_phase2_target_2018_pub	TARGET-10-PANUMV	TARGET-10-PANUMV-03	12.0	4170.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	66.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	NA	3888.0	1.059	Hispanic or Latino	Unknown	None	0.0563	47,XX,i(7)(q10),+21c[6]/47,XX,+21c[14]	Negative	None of the above	NA	NA	0.068	0.001	NA	NA	NA	NA	NA	BLL	3888.0	128.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	58.0
all_phase2_target_2018_pub	TARGET-10-PANUNC	TARGET-10-PANUNC-09	6.0	2011.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2682.0	1	Hispanic or Latino	Unknown	None	0.0273	45,X,-X[12]/45,idem,del(3)(q26.2q29)[9]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2682.0	89.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	58.5
all_phase2_target_2018_pub	TARGET-10-PANUND	TARGET-10-PANUND-09	17.0	5947.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2384.0	1	Not Hispanic or Latino	Unknown	None	0.0772	47,XY,-8,del(9)(p13),der(15;21)(q10;q10)c,add(19)(q13.3),+3mar[5]/45,XY,der(15;21)(q10;q10)c[16]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2384.0	79.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	11.5
all_phase2_target_2018_pub	TARGET-10-PANUNW	TARGET-10-PANUNW-09	15.0	5456.0	NA	NA	DISCOVERY	Positive	0.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1879.0	1.17	Hispanic or Latino	Negative	None	0.2198	53,XY,+X,+2,+4,t(9;22)(q34;q11.2),+10,+14,+21,+der(22)t(9;22)(q34;q11.2)[4]/53,idem,add(10)(q22)[4]/53,idem,+mar[6]/46,XY[5]	Negative	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1879.0	62.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	42.5
all_phase2_target_2018_pub	TARGET-10-PANURR	TARGET-10-PANURR-09	3.0	1083.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	4011.0	1.16	Hispanic or Latino	Negative	None	NA	53,XX,+4,+10,+14,+17,+18,+21,+22[cp4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	4011.0	132.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	2.4
all_phase2_target_2018_pub	TARGET-10-PANURW	TARGET-10-PANURW-09	16.0	5598.0	NA	NA	DISCOVERY	Positive	3.0	70.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1	Hispanic or Latino	Unknown	Induction failure	NA	46,X,inv(Y)(p11.2q11.2)c[20]	Unknown	BCR-ABL1	NA	NA	26.4	0.01	NA	NA	NA	NA	NA	BLL	355.0	12.0	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	4.8
all_phase2_target_2018_pub	TARGET-10-PANUSL	TARGET-10-PANUSL-09	3.0	970.0	NA	NA	VALIDATION	Negative	9.0	0.0	NA	63.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3784.0	1.17	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	0.01	0.0064	0.0064	NA	NA	NA	NA	NA	BLL	3784.0	125.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	8.7
all_phase2_target_2018_pub	TARGET-10-PANUSN	TARGET-10-PANUSN-03	3.0	1043.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	1715.0	1517.0	1.09	Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	1715.0	57.0	1:DECEASED	No	AALL0331	Unknown	3	Male	Matched	Unknown	No	No	NA	Negative	9.9
all_phase2_target_2018_pub	TARGET-10-PANUSN	TARGET-10-PANUSN-04	3.0	1043.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	1715.0	1517.0	1.09	Hispanic or Latino	Negative	Relapse	0.0002	NA	Unknown	None of the above	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	1715.0	57.0	1:DECEASED	No	AALL0331	Unknown	3	Male	Matched	Unknown	No	No	NA	Negative	9.9
all_phase2_target_2018_pub	TARGET-10-PANUSN	TARGET-10-PANUSN-09	3.0	1043.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	1715.0	1517.0	1.09	Hispanic or Latino	Negative	Relapse	0.0005	NA	Unknown	None of the above	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	1715.0	57.0	1:DECEASED	No	AALL0331	Unknown	3	Male	Matched	Unknown	No	No	NA	Negative	9.9
all_phase2_target_2018_pub	TARGET-10-PANUSR	TARGET-10-PANUSR-09	14.0	4950.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	118.0	1	Not Hispanic or Latino	Negative	Relapse	0.0022	46,XY,t(2;8)(p12;q24.1),t(18;22)(q21;q11.2),der(20)t(20;22)(q13.3;q11.2)[26]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1812.0	60.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	22.8
all_phase2_target_2018_pub	TARGET-10-PANUTA	TARGET-10-PANUTA-09	18.0	6348.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3922.0	1	Not Hispanic or Latino	Negative	None	0.0308	46,XX,t(2;14)(p11.2;q32),der(19)t(1;19)(q23;p13.3)[3]/48,idem,+5,+8[5]/46,XX[22]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3922.0	129.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	115.0
all_phase2_target_2018_pub	TARGET-10-PANUUE	TARGET-10-PANUUE-09	11.0	3902.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3620.0	1	Hispanic or Latino	Unknown	None	0.0031	46,XX[30]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3620.0	120.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	305.8
all_phase2_target_2018_pub	TARGET-10-PANUUF	TARGET-10-PANUUF-09	12.0	4029.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	31.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3911.0	1	Not Hispanic or Latino	Unknown	None	0.0014	46,XX[30]	Negative	None of the above	NA	NA	0.057999999999999996	0.001	NA	NA	NA	NA	4	BLL	3911.0	129.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	0.133333333333	Negative	19.8
all_phase2_target_2018_pub	TARGET-10-PANUUW	TARGET-10-PANUUW-03	16.0	5507.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	38.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3832.0	1.055	Not Hispanic or Latino	Unknown	None	0.0216	46,XY,der(1)t(1;13)(p13;q32)ins(2;1)(q35;q23q42),der(2)ins(2;1)(q35;q23q42),der(13)t(1;13)(p13;q32),-14,+mar/46,idem,del(12)(p12)/46,idem,-6,der(9)t(9;12)(p22;q13),?dup(12)(q22q24.3)	Negative	None of the above	NA	NA	0.0022	NA	NA	NA	NA	NA	NA	BLL	3832.0	126.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	56.8
all_phase2_target_2018_pub	TARGET-10-PANUVT	TARGET-10-PANUVT-09	16.0	5738.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2587.0	1	Not Hispanic or Latino	Negative	None	0.0896	48,XX,dic(9;20)(p12;q11.2),+21,+2mar[6]/46,XX[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2587.0	86.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	15.0
all_phase2_target_2018_pub	TARGET-10-PANUWL	TARGET-10-PANUWL-09	24.0	8730.0	NA	NA	DISCOVERY	Negative	20.0	10.0	4.0	58.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2089.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0032	46,XY,t(11;14)(q23.3;q32)[13]/46,XY[7]	Negative	None of the above	0.025	0.01	3.0	0.01	NA	NA	NA	NA	NA	BLL	3741.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PANUWV	TARGET-10-PANUWV-09	6.0	1965.0	NA	NA	DISCOVERY	Negative	10.0	3.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3748.0	1	Hispanic or Latino	Negative	None	0.1179	NA	Unknown	None of the above	NA	NA	0.017	0.001	NA	NA	NA	NA	NA	BLL	3748.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	54.1
all_phase2_target_2018_pub	TARGET-10-PANUXA	TARGET-10-PANUXA-09	2.0	551.0	NA	NA	DISCOVERY	Negative	3.0	2.0	NA	36.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3678.0	1	Not Hispanic or Latino	Unknown	None	0.0791	45,XY,add(1)(q32),add(12)(p11.2),add(12)(p13),-13[3]/46,XY[17]	Negative	None of the above	0.008	0.01	0.28	0.01	NA	NA	NA	NA	NA	BLL	3678.0	121.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	106.4
all_phase2_target_2018_pub	TARGET-10-PANUXS	TARGET-10-PANUXS-09	3.0	789.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	84.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3024.0	1	Hispanic or Latino	Positive	None	NA	46,XX,del(6)(q13q21),del(11)(q21q23)[cp15]/46,XX[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3024.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.5
all_phase2_target_2018_pub	TARGET-10-PANUXU	TARGET-10-PANUXU-09	8.0	2562.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3766.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX[7]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3766.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.06
all_phase2_target_2018_pub	TARGET-10-PANUXV	TARGET-10-PANUXV-03	6.0	2134.0	NA	NA	DISCOVERY	Negative	3.0	3.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	Yes	NA	3717.0	1.07	Hispanic or Latino	Unknown	None	0.0399	47,XX,i(9)(q10),+21c[18]/47,XX,+21c[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3717.0	123.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	174.1
all_phase2_target_2018_pub	TARGET-10-PANUXX	TARGET-10-PANUXX-09	16.0	5555.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3907.0	1.032	Not Hispanic or Latino	Unknown	None	0.1152	47,XY,+10,del(12)(p12p13),-15,+16,-21,add(22)(q13),+mar[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3907.0	129.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	3.3
all_phase2_target_2018_pub	TARGET-10-PANUYZ	TARGET-10-PANUYZ-09	2.0	676.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3767.0	1	Hispanic or Latino	Negative	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3767.0	124.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	16.1
all_phase2_target_2018_pub	TARGET-10-PANVAW	TARGET-10-PANVAW-09	4.0	1358.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	777.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	777.0	26.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	8.0
all_phase2_target_2018_pub	TARGET-10-PANVCM	TARGET-10-PANVCM-09	2.0	588.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3679.0	1.45	Not Hispanic or Latino	Unknown	None	NA	66~69,XY,+X,+Y,+1,add(1)(p13),+2,+3,+4,+5,+6,+7,+8,+10,+10,+11,+12,+13,+14,+17,+18,+21,+21,+22[cp7]/46,XY[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3679.0	121.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	33.8
all_phase2_target_2018_pub	TARGET-10-PANVCN	TARGET-10-PANVCN-09	14.0	4929.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	131.0	1	Not Hispanic or Latino	Negative	Death	0.0284	45,XX,t(1;3)(p36;p21),der(6)t(6;9)(p21;q34),der(9;12)dic(9;12)(p11;p11)t(6;9)(p21;q34)[11]/46,XX[9]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	131.0	5.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	34.0
all_phase2_target_2018_pub	TARGET-10-PANVCR	TARGET-10-PANVCR-09	2.0	558.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	34.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1196.0	1	Not Hispanic or Latino	Negative	Relapse	0.0149	46,XY,del(9)(p12)[4]/46,XY[16]	Negative	None of the above	NA	NA	0.015	0.001	NA	NA	NA	NA	NA	BLL	3735.0	123.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	117.9
all_phase2_target_2018_pub	TARGET-10-PANVCS	TARGET-10-PANVCS-09	16.0	5630.0	NA	NA	DISCOVERY	Negative	48.0	30.0	NA	55.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1	Hispanic or Latino	Negative	Induction failure	0.0011	46,XY,t(5;9)(q11.2;p11)[16]/46,XY[6]	Negative	None of the above	NA	NA	38.6	0.01	NA	NA	NA	NA	NA	BLL	533.0	18.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	34.5
all_phase2_target_2018_pub	TARGET-10-PANVDE	TARGET-10-PANVDE-09	5.0	1802.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3562.0	1	Not Hispanic or Latino	Unknown	None	0.0403	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3562.0	118.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	95.8
all_phase2_target_2018_pub	TARGET-10-PANVDH	TARGET-10-PANVDH-09	6.0	2036.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1909.0	1	Not Hispanic or Latino	Positive	None	NA	45,X,t(X;12)(q13;p13),del(6)(q15),del(12)(p13),-18[4]/46,XX[10]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1909.0	63.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	0.9
all_phase2_target_2018_pub	TARGET-10-PANVDV	TARGET-10-PANVDV-09	8.0	2740.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2687.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2687.0	89.0	0:LIVING	No	AALL0331	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	15.7
all_phase2_target_2018_pub	TARGET-10-PANVEL	TARGET-10-PANVEL-09	13.0	4542.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	907.0	1	Not Hispanic or Latino	Unknown	Censored	0.0679	46,XX,i(9)(q10),der(19)t(1;19)(q23;p13)[9]/46,XX[15]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	907.0	30.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Positive	No	NA	NA	Negative	12.8
all_phase2_target_2018_pub	TARGET-10-PANVFF	TARGET-10-PANVFF-09	5.0	1811.0	NA	NA	VALIDATION	Negative	18.0	0.0	NA	57.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3897.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[42]	Unknown	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3897.0	129.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	12.1
all_phase2_target_2018_pub	TARGET-10-PANVGZ	TARGET-10-PANVGZ-09	2.0	552.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3878.0	1	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3878.0	128.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.5
all_phase2_target_2018_pub	TARGET-10-PANVIB	TARGET-10-PANVIB-09	3.0	1040.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	34.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2954.0	1.19	Not Hispanic or Latino	Negative	None	NA	57,XY,+X,+6,+10,+14,+14,+15,+17,+18,+21,+21,+21[17]/46,XY[3]	Negative	NA	NA	NA	0.26	0.01	NA	NA	NA	NA	NA	BLL	2954.0	98.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	33.1
all_phase2_target_2018_pub	TARGET-10-PANVIC	TARGET-10-PANVIC-03	8.0	2766.0	CHEMOTHERAPY	NA	VALIDATION	Negative	4.0	1.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	1752.0	969.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,+X,add(6)(p21.3),add(7)(q32),-11,add(21)(q22)amp(AML1)[12]/46,XX,+X,add(6)(p21.3),add(5)(q11.2),add(7)(q32),-11,der(14)t(1;14)(q21;q22),add(21)(q22)amp(AML1)[2]/46,XX[16]	Negative	iAMP21	NA	NA	0.14	0.01	NA	NA	NA	NA	NA	BLL	1752.0	58.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	23.9
all_phase2_target_2018_pub	TARGET-10-PANVIC	TARGET-10-PANVIC-09	8.0	2766.0	CHEMOTHERAPY	NA	DISCOVERY	Negative	4.0	1.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	1752.0	969.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,+X,add(6)(p21.3),add(7)(q32),-11,add(21)(q22)amp(AML1)[12]/46,XX,+X,add(6)(p21.3),add(5)(q11.2),add(7)(q32),-11,der(14)t(1;14)(q21;q22),add(21)(q22)amp(AML1)[2]/46,XX[16]	Negative	iAMP21	NA	NA	0.14	0.01	NA	NA	NA	NA	NA	BLL	1752.0	58.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	23.9
all_phase2_target_2018_pub	TARGET-10-PANVIG	TARGET-10-PANVIG-09	7.0	2202.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	521.0	1.038	Not Hispanic or Latino	Unknown	SMN	0.0039	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1588.0	53.0	1:DECEASED	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	62.0
all_phase2_target_2018_pub	TARGET-10-PANVIX	TARGET-10-PANVIX-09	2.0	618.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	51.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	1589.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XX,+21[1]/46,XX[30]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3632.0	120.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.8
all_phase2_target_2018_pub	TARGET-10-PANVJB	TARGET-10-PANVJB-09	3.0	838.0	NA	NA	DISCOVERY	Negative	0.0	3.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2822.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0010	NA	Unknown	None of the above	0.0	0.01	0.88	0.01	NA	NA	NA	NA	NA	BLL	3736.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	106.5
all_phase2_target_2018_pub	TARGET-10-PANVJI	TARGET-10-PANVJI-09	7.0	2257.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3734.0	1	Hispanic or Latino	Negative	None	NA	46,XX[30]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3734.0	123.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.11
all_phase2_target_2018_pub	TARGET-10-PANVJN	TARGET-10-PANVJN-04	3.0	899.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	49.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1713.0	1	Not Hispanic or Latino	Positive	Relapse	NA	48,XY,+10,-17,der(21;21*)(q10;q10)t(12;21*)(p13;q22),+der(21;21*)(q10;q10)t(12;21*)(p13;q22)x2[cp4]/46,XY[12]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3533.0	117.0	0:LIVING	No	AALL0331	Black or African American	2	Male	Matched	Negative	No	No	NA	Negative	11.96
all_phase2_target_2018_pub	TARGET-10-PANVJN	TARGET-10-PANVJN-09	3.0	899.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	49.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1713.0	1	Not Hispanic or Latino	Positive	Relapse	NA	48,XY,+10,-17,der(21;21*)(q10;q10)t(12;21*)(p13;q22),+der(21;21*)(q10;q10)t(12;21*)(p13;q22)x2[cp4]/46,XY[12]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3533.0	117.0	0:LIVING	No	AALL0331	Black or African American	2	Male	Matched	Negative	No	No	NA	Negative	11.96
all_phase2_target_2018_pub	TARGET-10-PANVKF	TARGET-10-PANVKF-09	7.0	2440.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	81.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3442.0	1.138	Not Hispanic or Latino	Positive	None	NA	46,XX,der(12)add(12)(p11.2)add(12)(q13)[6]/46,idem,add(11)(q23)[4]/45,idem,-X[4]/46,idem,-X,del(6)(q13q23),+mar[5]/47,idem,+21[2]	Negative	NA	NA	NA	0.011000000000000001	0.001	NA	NA	NA	NA	NA	BLL	3442.0	114.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.6
all_phase2_target_2018_pub	TARGET-10-PANVKH	TARGET-10-PANVKH-09	5.0	1624.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3749.0	1.38	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3749.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Positive	1.1
all_phase2_target_2018_pub	TARGET-10-PANVKY	TARGET-10-PANVKY-03	2.0	370.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	64.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3928.0	1	Not Hispanic or Latino	Negative	None	0.0499	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3928.0	130.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	307.6
all_phase2_target_2018_pub	TARGET-10-PANVMT	TARGET-10-PANVMT-09	10.0	3359.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3821.0	1.07	Not Hispanic or Latino	Negative	None	NA	48,XX,+4,+8,-14,der(19)t(1;19)(q23;p13),+mar[2]/46,XX[46]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3821.0	126.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Positive	No	NA	NA	Negative	7.2
all_phase2_target_2018_pub	TARGET-10-PANVSI	TARGET-10-PANVSI-09	24.0	8581.0	NA	NA	DISCOVERY	Negative	5.0	5.0	1.0	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3938.0	1	Not Hispanic or Latino	Unknown	None	0.0011	NA	Unknown	None of the above	0.0	0.01	0.028999999999999998	0.001	NA	NA	NA	NA	NA	BLL	3938.0	130.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.8
all_phase2_target_2018_pub	TARGET-10-PANVTB	TARGET-10-PANVTB-09	3.0	868.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	65.0	1	Hispanic or Latino	Negative	None	NA	45,XY,-9,der(18)t(9;18)(q22;q12)[24]/46,XY[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	65.0	3.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PANVUD	TARGET-10-PANVUD-09	10.0	3503.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1904.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,add(2)(p13),del(9)(p21),add(13)(q22),-16,+mar[cp3]/45,idem,-8,der(9)t(8;9)(q13;p22)[cp6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1904.0	63.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	19.2
all_phase2_target_2018_pub	TARGET-10-PANVUU	TARGET-10-PANVUU-09	5.0	1522.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Positive	NA	NA	50,XY,+10,der(10)t(10;19)(p13;p13.1),der(19)t(10;19)(p13;p13.1)add(19)(q13.3),+21,+21,+22[10]/46,XY[5]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	NA	NA	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	39.5
all_phase2_target_2018_pub	TARGET-10-PANVUV	TARGET-10-PANVUV-09	11.0	3969.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	22.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1592.0	1.21	Not Hispanic or Latino	Negative	Relapse	0.8177	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3725.0	123.0	0:LIVING	Yes	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	5.6
all_phase2_target_2018_pub	TARGET-10-PANVVA	TARGET-10-PANVVA-09	14.0	4773.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3836.0	1.152	Not Hispanic or Latino	Unknown	None	0.1027	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3836.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.9
all_phase2_target_2018_pub	TARGET-10-PANVVB	TARGET-10-PANVVB-09	16.0	5660.0	Chemotherapy	NA	DISCOVERY	Negative	15.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1919.0	1.18	Not Hispanic or Latino	Unknown	None	0.8612	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.2	0.01	NA	NA	NA	NA	NA	BLL	1919.0	64.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	6.07
all_phase2_target_2018_pub	TARGET-10-PANVXF	TARGET-10-PANVXF-09	5.0	1507.0	CHEMOTHERAPY	NA	VALIDATION	Negative	2.0	1.0	NA	29.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3506.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,der(19)t(1;19)(q23;p13.3)[13]/46,XX[cp7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3506.0	116.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Positive	No	NA	NA	Negative	30.4
all_phase2_target_2018_pub	TARGET-10-PANVYB	TARGET-10-PANVYB-09	17.0	5886.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3151.0	1	Not Hispanic or Latino	Unknown	None	0.0437	NA	Unknown	None of the above	NA	NA	0.0013	0.01	NA	NA	NA	NA	NA	BLL	3151.0	104.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	15.2
all_phase2_target_2018_pub	TARGET-10-PANVYR	TARGET-10-PANVYR-03	17.0	6140.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	35.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	517.0	288.0	1.067	Hispanic or Latino	Unknown	Relapse	NA	48,XY,+X,+8,+21[8]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	517.0	17.0	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	37.4
all_phase2_target_2018_pub	TARGET-10-PANVYR	TARGET-10-PANVYR-04	17.0	6140.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	35.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	517.0	288.0	1.067	Hispanic or Latino	Unknown	Relapse	NA	48,XY,+X,+8,+21[8]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	517.0	17.0	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	37.4
all_phase2_target_2018_pub	TARGET-10-PANVYR	TARGET-10-PANVYR-09	17.0	6140.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	35.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	517.0	288.0	1.067	Hispanic or Latino	Unknown	Relapse	0.0028	48,XY,+X,+8,+21[8]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	517.0	17.0	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	37.4
all_phase2_target_2018_pub	TARGET-10-PANVZG	TARGET-10-PANVZG-09	16.0	5740.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	963.0	1	Not Hispanic or Latino	Negative	SMN	0.0738	46,XY,der(19)t(1;19)(q23;p13.3)[5]/46,XY[15]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3996.0	132.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	21.72
all_phase2_target_2018_pub	TARGET-10-PANWBR	TARGET-10-PANWBR-09	7.0	2289.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3840.0	1	Hispanic or Latino	Unknown	None	0.0193	46,XY,add(13)(p12),t(13;16)(q12;p13.1)[cp2]/46,XY[3]	Negative	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3840.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	59.5
all_phase2_target_2018_pub	TARGET-10-PANWCH	TARGET-10-PANWCH-09	12.0	4280.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	69.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2684.0	1	Not Hispanic or Latino	Negative	None	0.0023	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2684.0	89.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.3
all_phase2_target_2018_pub	TARGET-10-PANWDL	TARGET-10-PANWDL-09	4.0	1414.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2887.0	1	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2887.0	95.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	35.9
all_phase2_target_2018_pub	TARGET-10-PANWDN	TARGET-10-PANWDN-09	10.0	3479.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3743.0	1	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3743.0	124.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	6.2
all_phase2_target_2018_pub	TARGET-10-PANWDS	TARGET-10-PANWDS-09	6.0	2169.0	NA	NA	VALIDATION	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3622.0	1	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3622.0	120.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	4.9
all_phase2_target_2018_pub	TARGET-10-PANWDU	TARGET-10-PANWDU-09	7.0	2307.0	NA	NA	DISCOVERY	Positive	3.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	200.0	1.12	Hispanic or Latino	Negative	Death	0.0864	47,XX,t(9;22)(q34;q11.2),+21[4]/53,XX,+X,+5,+8,+12,+21,+22[3]/46,XX[25]	Negative	BCR-ABL1	NA	NA	0.17	0.01	NA	NA	NA	NA	NA	BLL	200.0	7.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	100.2
all_phase2_target_2018_pub	TARGET-10-PANWEC	TARGET-10-PANWEC-09	14.0	4934.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3781.0	1	Not Hispanic or Latino	Negative	None	0.0032	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3781.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	3.2
all_phase2_target_2018_pub	TARGET-10-PANWEI	TARGET-10-PANWEI-09	5.0	1604.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3789.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,inv(14)(q11.2q32)[6]/46,XX[17]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3789.0	125.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	10.8
all_phase2_target_2018_pub	TARGET-10-PANWES	TARGET-10-PANWES-09	4.0	1097.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2865.0	1	Hispanic or Latino	Positive	None	NA	47,XX,t(10;12)(q25;p13),t(13;18)(q14;q21),+21[cp15]/46,XX[15]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2865.0	95.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	30.0
all_phase2_target_2018_pub	TARGET-10-PANWEX	TARGET-10-PANWEX-09	7.0	2551.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	2538.0	1.056	Not Hispanic or Latino	Unknown	None	0.0132	46,XX,t(9;19;12)(p22;p12;q22)[14]/46,XX[3]	Negative	None of the above	NA	NA	0.08800000000000001	0.001	NA	NA	NA	NA	NA	BLL	2538.0	84.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	79.7
all_phase2_target_2018_pub	TARGET-10-PANWEZ	TARGET-10-PANWEZ-09	15.0	5236.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	47.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3145.0	1	Not Hispanic or Latino	Positive	None	0.0768	46,XX,del(9)(p22),-15,+16,t(17;22)(q11.2;p11.1)[2]/45,idem,-del(9)(p22),dic(9;12)(p13;p13)[2]/44,idem,-X,-del(9)(p22),dic(9;12)(p13;p13)[2]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3145.0	104.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.7
all_phase2_target_2018_pub	TARGET-10-PANWFA	TARGET-10-PANWFA-09	15.0	5396.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1625.0	1	Hispanic or Latino	Unknown	None	0.0104	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1625.0	54.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	0.88
all_phase2_target_2018_pub	TARGET-10-PANWFB	TARGET-10-PANWFB-09	18.0	6297.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2939.0	1	Not Hispanic or Latino	Unknown	None	0.0031	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2939.0	97.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	21.6
all_phase2_target_2018_pub	TARGET-10-PANWFL	TARGET-10-PANWFL-09	5.0	1495.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	42.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3816.0	1.34	Not Hispanic or Latino	Unknown	None	0.5487	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3816.0	126.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	108.9
all_phase2_target_2018_pub	TARGET-10-PANWGG	TARGET-10-PANWGG-09	4.0	1335.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	6.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1903.0	1	Not Hispanic or Latino	Positive	Relapse	NA	47,XX,-9,+10,del(12)(p12p13),+21,der(22)t(13;22)(q12;p11.2)[6]/46,XX[14]	Negative	NA	NA	NA	0.064	0.001	NA	NA	NA	NA	NA	BLL	3733.0	123.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	10.3
all_phase2_target_2018_pub	TARGET-10-PANWGI	TARGET-10-PANWGI-03	15.0	5304.0	NA	NA	DISCOVERY	Positive	2.0	3.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3762.0	1	Not Hispanic or Latino	Unknown	None	0.0055	46,XY,der(9)(9pter->9q34::14q32.2->14qter),der(14)(14pter->14q32.2::22q11.2->22qter),der(22)(22pter->22q11.2::9q34->9qter)[16]/46,XY[34]	Negative	BCR-ABL1	NA	NA	0.012	0.001	NA	NA	NA	NA	NA	BLL	3762.0	124.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	15.9
all_phase2_target_2018_pub	TARGET-10-PANWGY	TARGET-10-PANWGY-09	17.0	5976.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2711.0	1	Hispanic or Latino	Negative	None	0.0473	46,XY,der(19)t(1;19)(q23;p13.3)[11]/46,idem,-5,+8[2]/46,XY[7]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2711.0	90.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Positive	No	No	NA	Negative	13.0
all_phase2_target_2018_pub	TARGET-10-PANWHJ	TARGET-10-PANWHJ-04	4.0	1131.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1446.0	1.165	Not Hispanic or Latino	Negative	Relapse	0.0587	53,XY,+X,+4,+6,add(8)(p11.2),+14,+18,+21,+21[20]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3770.0	124.0	0:LIVING	Yes	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	2.4
all_phase2_target_2018_pub	TARGET-10-PANWHJ	TARGET-10-PANWHJ-09	4.0	1131.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1446.0	1.165	Not Hispanic or Latino	Negative	Relapse	0.2323	53,XY,+X,+4,+6,add(8)(p11.2),+14,+18,+21,+21[20]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	3770.0	124.0	0:LIVING	Yes	AALL0331	White	2	Male	Matched	Negative	No	No	0.166666666667	Negative	2.4
all_phase2_target_2018_pub	TARGET-10-PANWHM	TARGET-10-PANWHM-09	14.0	4802.0	NA	NA	DISCOVERY	Unknown	66.0	2.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3726.0	1.18	Not Hispanic or Latino	Unknown	None	0.5453	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	0.0	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	3726.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PANWHW	TARGET-10-PANWHW-03	5.0	1468.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1916.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(4;9)(q21;p13),add(5)(q31),del(8)(q22q24.1),del(9)(p11p24),add(16)(q24)[17]/46,XX[3]	Negative	None of the above	NA	NA	NA	NA	NA	NA	NA	NA	5	BLL	1916.0	63.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.2	Negative	96.7
all_phase2_target_2018_pub	TARGET-10-PANWHW	TARGET-10-PANWHW-09	5.0	1468.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1916.0	1	Not Hispanic or Latino	Negative	None	0.0025	46,XX,t(4;9)(q21;p13),add(5)(q31),del(8)(q22q24.1),del(9)(p11p24),add(16)(q24)[17]/46,XX[3]	Negative	None of the above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	1916.0	63.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	96.7
all_phase2_target_2018_pub	TARGET-10-PANWIM	TARGET-10-PANWIM-09	3.0	1004.0	NA	NA	VALIDATION	Negative	2.0	3.0	NA	34.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2952.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2952.0	98.0	0:LIVING	No	AALL0331	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	30.3
all_phase2_target_2018_pub	TARGET-10-PANWJB	TARGET-10-PANWJB-03	15.0	5150.0	NA	NA	DISCOVERY	Negative	40.0	25.0	0.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	382.0	1	Not Hispanic or Latino	Unknown	Death	0.0020	NA	Unknown	None of the above	NA	NA	9.0	0.01	NA	NA	NA	NA	NA	BLL	382.0	13.0	1:DECEASED	No	AALL0232	White	5	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PANWJB	TARGET-10-PANWJB-09	15.0	5150.0	NA	NA	DISCOVERY	Negative	40.0	25.0	0.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	382.0	1	Not Hispanic or Latino	Unknown	Death	NA	NA	Unknown	None of the above	NA	NA	9.0	0.01	NA	NA	NA	NA	NA	BLL	382.0	13.0	1:DECEASED	No	AALL0232	White	5	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PANWJB	TARGET-10-PANWJB-60.1	15.0	5150.0	NA	NA	XENOGRAFT	Negative	40.0	25.0	0.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	382.0	1	Not Hispanic or Latino	Unknown	Death	NA	NA	Unknown	None of the above	NA	NA	9.0	0.01	NA	NA	NA	NA	NA	BLL	382.0	13.0	1:DECEASED	No	AALL0232	White	5	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PANWJB	TARGET-10-PANWJB-60.2	15.0	5150.0	NA	NA	XENOGRAFT	Negative	40.0	25.0	0.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	382.0	1	Not Hispanic or Latino	Unknown	Death	NA	NA	Unknown	None of the above	NA	NA	9.0	0.01	NA	NA	NA	NA	NA	BLL	382.0	13.0	1:DECEASED	No	AALL0232	White	5	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PANWJB	TARGET-10-PANWJB-60.3	15.0	5150.0	NA	NA	XENOGRAFT	Negative	40.0	25.0	0.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	382.0	1	Not Hispanic or Latino	Unknown	Death	NA	NA	Unknown	None of the above	NA	NA	9.0	0.01	NA	NA	NA	NA	NA	BLL	382.0	13.0	1:DECEASED	No	AALL0232	White	5	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PANWJH	TARGET-10-PANWJH-09	8.0	2603.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3834.0	1	Unknown	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3834.0	127.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	28.4
all_phase2_target_2018_pub	TARGET-10-PANWJM	TARGET-10-PANWJM-09	6.0	1896.0	NA	NA	VALIDATION	Negative	80.0	0.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3849.0	1	Hispanic or Latino	Positive	None	NA	47,XX,+21[9]/46,XX[4]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3849.0	127.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.2
all_phase2_target_2018_pub	TARGET-10-PANWJR	TARGET-10-PANWJR-09	6.0	1940.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3742.0	1	Hispanic or Latino	Positive	None	NA	46,XX,del(12)(p13),del(13)(q14q22)[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3742.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.16
all_phase2_target_2018_pub	TARGET-10-PANWJS	TARGET-10-PANWJS-09	6.0	2021.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	35.0	1.17	Not Hispanic or Latino	Negative	Censored	NA	53,XX,+X,+X,+4,+6,+17,+18,+i(21)(q10)[cp2]/46,XX[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	35.0	2.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.04
all_phase2_target_2018_pub	TARGET-10-PANWKM	TARGET-10-PANWKM-09	2.0	684.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	3669.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3669.0	121.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	42.9
all_phase2_target_2018_pub	TARGET-10-PANWKP	TARGET-10-PANWKP-09	4.0	1256.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3611.0	1	Unknown	Positive	None	NA	46,XY[12]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3611.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	22.6
all_phase2_target_2018_pub	TARGET-10-PANWLH	TARGET-10-PANWLH-09	3.0	852.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3870.0	1.2	Not Hispanic or Latino	Negative	None	NA	56,XY,+X,t(3;11)(p25q13),+4,+6,del(6)(q21q25)x2,+8,+10,+14,+17,+18,+21,+21[8]/46,XY[12]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3870.0	128.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	9.9
all_phase2_target_2018_pub	TARGET-10-PANWNG	TARGET-10-PANWNG-09	10.0	3413.0	NA	NA	DISCOVERY	Negative	8.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3741.0	1	Not Hispanic or Latino	Positive	None	0.0068	NA	Unknown	ETV6-RUNX1	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	3741.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	63.2
all_phase2_target_2018_pub	TARGET-10-PANWPI	TARGET-10-PANWPI-09	16.0	5812.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1271.0	1.043	Not Hispanic or Latino	Unknown	None	0.0246	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1271.0	42.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.2
all_phase2_target_2018_pub	TARGET-10-PANWRS	TARGET-10-PANWRS-09	14.0	5088.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2617.0	1	Not Hispanic or Latino	Negative	None	0.0152	46,XX,del(9)(p13)[8]/46,idem,del(6)(q13q21)[cp5]/46,idem,?add(16)(q22)[3]/46,XX[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2617.0	87.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	15.9
all_phase2_target_2018_pub	TARGET-10-PANWSB	TARGET-10-PANWSB-03	4.0	1120.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3901.0	1.4	Not Hispanic or Latino	Negative	None	0.3067	63~65,XX,+X,+2,add(2)(q31),+4,+5,+6,+7,+8,+10,+11,+12,+14,+17,+18,+21,+21,+22,+1~4mar[cp9]/46,XX[6]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3901.0	129.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	78.4
all_phase2_target_2018_pub	TARGET-10-PANWSI	TARGET-10-PANWSI-09	9.0	3161.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2498.0	1	Hispanic or Latino	Negative	None	0.0707	48,XY,t(2;15)(q31;q24),+8,del(9)(p24),+21[cp15]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2498.0	83.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	57.9
all_phase2_target_2018_pub	TARGET-10-PANWSP	TARGET-10-PANWSP-09	4.0	1197.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	2.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	2037.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3668.0	121.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	6.8
all_phase2_target_2018_pub	TARGET-10-PANWUJ	TARGET-10-PANWUJ-09	19.0	6760.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3731.0	1	Not Hispanic or Latino	Unknown	None	0.0018	46,XY,t(4;11)(q21;q23)[3]/46,XY[3]	Positive	MLL-Rearranged	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	3731.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	237.0
all_phase2_target_2018_pub	TARGET-10-PANWUK	TARGET-10-PANWUK-09	15.0	5439.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	27.0	2.0	1.0	62.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2566.0	1	Not Hispanic or Latino	Negative	None	0.0478	46,XY[[20]	Unknown	None of the above	NA	NA	5.5	0.01	NA	NA	NA	NA	NA	BLL	2566.0	85.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	10.88
all_phase2_target_2018_pub	TARGET-10-PANWVI	TARGET-10-PANWVI-09	6.0	2011.0	NA	NA	DISCOVERY	Negative	3.0	3.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 3	No	NA	645.0	1	Hispanic or Latino	Negative	Relapse	0.0036	46,X,t(X;7)(q21;p22)[10]/46,XX[10]	Negative	None of the above	0.09	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	1614.0	54.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	94.6
all_phase2_target_2018_pub	TARGET-10-PANWVW	TARGET-10-PANWVW-09	3.0	1077.0	NA	NA	DISCOVERY	Positive	0.0	0.0	NA	37.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3567.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XY,t(9;22)(q34;q11.2),+der(22)t(9;22)(q34;q11.2)[19]	Negative	BCR-ABL1	NA	NA	0.037000000000000005	0.001	NA	NA	NA	NA	5	BLL	3567.0	118.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.166666666667	Negative	194.2
all_phase2_target_2018_pub	TARGET-10-PANWWG	TARGET-10-PANWWG-09	4.0	1322.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	66.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3903.0	1.23	Not Hispanic or Latino	Negative	None	NA	56,XX,+X,+X,dup(1)(q21q25),+4,+6,+10,+14,+17,+18,+21,+21[4]/46,XX[16]	Negative	NA	0.0	NA	0.82	0.01	NA	NA	NA	NA	NA	BLL	3903.0	129.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	7.3
all_phase2_target_2018_pub	TARGET-10-PANWXT	TARGET-10-PANWXT-03	17.0	5940.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3119.0	1	Hispanic or Latino	Unknown	None	0.0280	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3119.0	103.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	108.8
all_phase2_target_2018_pub	TARGET-10-PANWYB	TARGET-10-PANWYB-09	6.0	2080.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1698.0	1	Not Hispanic or Latino	Negative	Relapse	0.0629	46,XY,+X,-9,del(20)(q13.1)[10]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1720.0	57.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	356.4
all_phase2_target_2018_pub	TARGET-10-PANWYH	TARGET-10-PANWYH-09	5.0	1786.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	0.0	1.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	1418.0	1361.0	1	Hispanic or Latino	Negative	Relapse	0.0479	46,XY,dic(7;9)(p13;p11),del(8)(q22),-9,del(11)(q21q23),+mar[cp8]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	6	BLL	1418.0	47.0	1:DECEASED	No	AALL0331	White	1	Male	Matched	Negative	No	No	0.2	Negative	12.1
all_phase2_target_2018_pub	TARGET-10-PANWYK	TARGET-10-PANWYK-03	16.0	5593.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	3.0	NA	75.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3581.0	1.23	Not Hispanic or Latino	Negative	None	NA	56,XX,+X,+4,+6,+8,del(9)(p21),+14,+17,+18,+21,+21,+mar	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3581.0	118.0	0:LIVING	No	AALL0232	Black or African American	2	Female	Matched	Negative	No	NA	NA	Negative	81.4
all_phase2_target_2018_pub	TARGET-10-PANWYK	TARGET-10-PANWYK-09	16.0	5593.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	3.0	NA	75.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3581.0	1.23	Not Hispanic or Latino	Negative	None	0.5695	56,XX,+X,+4,+6,+8,del(9)(p21),+14,+17,+18,+21,+21,+mar	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3581.0	118.0	0:LIVING	No	AALL0232	Black or African American	2	Female	Matched	Negative	No	NA	NA	Negative	81.4
all_phase2_target_2018_pub	TARGET-10-PANWYL	TARGET-10-PANWYL-09	2.0	537.0	NA	NA	DISCOVERY	Negative	0.0	4.0	NA	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3845.0	1	Not Hispanic or Latino	Positive	None	0.0011	46,XY[29]	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3845.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	89.7
all_phase2_target_2018_pub	TARGET-10-PANWYM	TARGET-10-PANWYM-09	3.0	1056.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3866.0	1.24	Not Hispanic or Latino	Negative	None	NA	57,XY,+X,+5,+6,+8,+10,+14,+17,+18,+21,+21,+22[2]/58,idem,+10[3]/46,XY[15]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3866.0	128.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	22.4
all_phase2_target_2018_pub	TARGET-10-PANWZG	TARGET-10-PANWZG-09	5.0	1585.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3789.0	1	Not Hispanic or Latino	Positive	None	NA	45,XY,psu dic(9;6)(p13;q21),-12,der(13;14)(q10;q10)?c,+2mar[4]/45,der(13;14)(q10;q10)?c[12]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3789.0	125.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	10.5
all_phase2_target_2018_pub	TARGET-10-PANWZU	TARGET-10-PANWZU-09	2.0	680.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1211.0	1	Not Hispanic or Latino	Negative	Censored	0.0408	46,XY,-9,+r[6]/46,XY[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1211.0	40.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	104.4
all_phase2_target_2018_pub	TARGET-10-PANXAA	TARGET-10-PANXAA-09	7.0	2445.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3700.0	1	Unknown	Unknown	None	0.0718	47,XY,+X,dic(9;12)(p13;p11.2),+10[4]/46,XY[16]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3700.0	122.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	55.2
all_phase2_target_2018_pub	TARGET-10-PANXAC	TARGET-10-PANXAC-09	13.0	4528.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3112.0	1.22	Unknown	Unknown	None	0.3603	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3112.0	103.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	4.8
all_phase2_target_2018_pub	TARGET-10-PANXAH	TARGET-10-PANXAH-09	14.0	4816.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3802.0	1.056	Unknown	Unknown	None	0.0029	46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3802.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	32.0
all_phase2_target_2018_pub	TARGET-10-PANXAM	TARGET-10-PANXAM-09	5.0	1741.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3744.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3744.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	27.6
all_phase2_target_2018_pub	TARGET-10-PANXCX	TARGET-10-PANXCX-09	3.0	922.0	NA	NA	VALIDATION	Negative	9.0	1.0	NA	24.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3768.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3768.0	124.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	5.4
all_phase2_target_2018_pub	TARGET-10-PANXDB	TARGET-10-PANXDB-03	8.0	2916.0	NA	NA	DISCOVERY	Negative	30.0	4.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3737.0	1	Not Hispanic or Latino	Negative	None	0.0136	48,XY,t(11;12)(q23;q13),+2mar[5]/48,idem,dup(1)(q23q42)[19]/46,XY[1]	Positive	MLL-Rearranged	NA	NA	1.8	0.01	NA	NA	NA	NA	3	BLL	3737.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.1	Negative	97.87
all_phase2_target_2018_pub	TARGET-10-PANXDP	TARGET-10-PANXDP-09	14.0	4821.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3735.0	1	Not Hispanic or Latino	Negative	None	0.0013	46,X,del(X)(q22)[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3735.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	11.0
all_phase2_target_2018_pub	TARGET-10-PANXDR	TARGET-10-PANXDR-09	4.0	1189.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3801.0	1.265	Not Hispanic or Latino	Unknown	None	0.8201	57,XY,+X,+5,+6,+10,+10,+11,+14,+16,+18,+mar[cp4]/46,XY[16]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	3801.0	125.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	0.0666666666667	Negative	122.5
all_phase2_target_2018_pub	TARGET-10-PANXDS	TARGET-10-PANXDS-09	17.0	6204.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3739.0	1	Hispanic or Latino	Negative	None	0.1021	46,XY,t(4;9)(q31.3;p24),del(6)(q13q25),idic(9)(p12),der(19)t(1;19)(q23;p13.3)[13]/46,XY[17]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3739.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	125.0
all_phase2_target_2018_pub	TARGET-10-PANXDT	TARGET-10-PANXDT-09	14.0	4817.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	855.0	1.9	Not Hispanic or Latino	Positive	Censored	0.1748	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	855.0	29.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.9
all_phase2_target_2018_pub	TARGET-10-PANXDY	TARGET-10-PANXDY-09	7.0	2417.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	966.0	1.041	Not Hispanic or Latino	Unknown	None	0.0017	46,XX,t(1;19)(q23;p13)[9]/46,XX[4]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	966.0	32.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	98.4
all_phase2_target_2018_pub	TARGET-10-PANXEE	TARGET-10-PANXEE-09	3.0	941.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3808.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.006999999999999999	0.001	NA	NA	NA	NA	NA	BLL	3808.0	126.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	11.5
all_phase2_target_2018_pub	TARGET-10-PANXEH	TARGET-10-PANXEH-09	2.0	610.0	NA	NA	DISCOVERY	Negative	44.0	73.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	28.0	1	Not Hispanic or Latino	Unknown	Induction failure	NA	46,XX,t(4;11)(q21;q23)[7]/46,idem,del(17)(p11.2)[8]/53,idem,+X,+1,+3,+8,+17,del(17)(p11.2)x2,+21,+21[2]/46,XY[3]	Positive	MLL-Rearranged	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	235.0	8.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	421.0
all_phase2_target_2018_pub	TARGET-10-PANXFF	TARGET-10-PANXFF-09	16.0	5843.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2413.0	1	Not Hispanic or Latino	Negative	None	0.0013	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2413.0	80.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	4.3
all_phase2_target_2018_pub	TARGET-10-PANXGB	TARGET-10-PANXGB-09	13.0	4425.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3867.0	1.06	Not Hispanic or Latino	Negative	None	0.0384	48,XY,+X,-20,+21,+i(21)(q10),der(21)t(20;21)(p11.2;p12),der(21)t(20;21)(q11.2;p12)[9]/46,XY[6]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3867.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	1.37
all_phase2_target_2018_pub	TARGET-10-PANXGD	TARGET-10-PANXGD-04	9.0	3011.0	NA	NA	DISCOVERY	Negative	3.0	0.0	0.0	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	775.0	775.0	1	Not Hispanic or Latino	Negative	Death	NA	46,XY,inv(1)(p36.1q42),t(4;9)(q12;q12),add(20)(q13),add(21)(q22)[20]	Negative	None of the above	NA	NA	2.8	0.01	NA	NA	NA	NA	NA	BLL	775.0	26.0	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	23.0
all_phase2_target_2018_pub	TARGET-10-PANXGD	TARGET-10-PANXGD-09	9.0	3011.0	NA	NA	VALIDATION;DISCOVERY	Negative	3.0	0.0	0.0	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	775.0	775.0	1	Not Hispanic or Latino	Negative	Death	NA	46,XY,inv(1)(p36.1q42),t(4;9)(q12;q12),add(20)(q13),add(21)(q22)[20]	Negative	None of the above	NA	NA	2.8	0.01	NA	NA	NA	NA	NA	BLL	775.0	26.0	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	23.0
all_phase2_target_2018_pub	TARGET-10-PANXGE	TARGET-10-PANXGE-09	12.0	4142.0	NA	NA	DISCOVERY	Negative	3.0	2.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3835.0	1	Not Hispanic or Latino	Negative	None	0.0689	46,XX,t(2;9)(q31;p22),-7,+21[7]/46,idem,+mar[4]/46,XX[1]	Negative	None of the above	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	3835.0	127.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	14.9
all_phase2_target_2018_pub	TARGET-10-PANXGG	TARGET-10-PANXGG-03	14.0	4925.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3787.0	1	Not Hispanic or Latino	Unknown	None	0.0082	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3787.0	125.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	13.9
all_phase2_target_2018_pub	TARGET-10-PANXGM	TARGET-10-PANXGM-09	10.0	3490.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3055.0	1.13	Unknown	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0033	0.0033	NA	NA	NA	NA	NA	BLL	3055.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	30.9
all_phase2_target_2018_pub	TARGET-10-PANXGT	TARGET-10-PANXGT-09	3.0	1051.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1557.0	1	Not Hispanic or Latino	Negative	None	0.0478	47,XX,+10[8]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1557.0	52.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	82.2
all_phase2_target_2018_pub	TARGET-10-PANXIV	TARGET-10-PANXIV-09	17.0	5848.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3820.0	1	Not Hispanic or Latino	Unknown	None	0.0017	NA	Unknown	None of the above	NA	NA	0.024	0.001	NA	NA	NA	NA	NA	BLL	3820.0	126.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	52.6
all_phase2_target_2018_pub	TARGET-10-PANXLC	TARGET-10-PANXLC-09	3.0	750.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	47.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3752.0	1.16	Not Hispanic or Latino	Negative	None	NA	56,XXXc,+X,+X,+4,+6,+14,+17,+18,+21,+21[7]/47,XXX[5]	Negative	NA	NA	NA	0.005	0.001	NA	NA	NA	NA	NA	BLL	3752.0	124.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	27.8
all_phase2_target_2018_pub	TARGET-10-PANXLP	TARGET-10-PANXLP-09	7.0	2199.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3823.0	1.22	Not Hispanic or Latino	Negative	None	NA	54~58,XY,+X,+4,+5,+6,+10,+13,+17,+21,+21[cp20]/46,XY[3]	Negative	NA	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	3823.0	126.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	2.8
all_phase2_target_2018_pub	TARGET-10-PANXLR	TARGET-10-PANXLR-09	2.0	719.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3362.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX[40]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3362.0	111.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	9.9
all_phase2_target_2018_pub	TARGET-10-PANXMP	TARGET-10-PANXMP-09	11.0	3990.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3792.0	1	Not Hispanic or Latino	Negative	None	0.0232	46,XY,r(9)(p11.2q11.2),der(12)t(9;12)(q12;p11.2)[15]/46,XY[5]	Negative	None of the above	NA	NA	0.06	0.01	NA	NA	NA	NA	NA	BLL	3792.0	125.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	14.9
all_phase2_target_2018_pub	TARGET-10-PANXNA	TARGET-10-PANXNA-09	11.0	3720.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	NA	3619.0	0.92	Not Hispanic or Latino	Negative	None	0.0466	47,XY,i(8)(q10),+21c[2]/47,XY,+21c[18]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3619.0	119.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	12.0
all_phase2_target_2018_pub	TARGET-10-PANXNG	TARGET-10-PANXNG-09	5.0	1729.0	NA	NA	DISCOVERY	Negative	NA	NA	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	858.0	1.073	Not Hispanic or Latino	Unknown	Censored	NA	NA	Unknown	None of the above	NA	NA	0.0032	NA	NA	NA	NA	NA	NA	BLL	858.0	29.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	287.87
all_phase2_target_2018_pub	TARGET-10-PANXPE	TARGET-10-PANXPE-03	4.0	1358.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	1.0	NA	95.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1217.0	1.097	Not Hispanic or Latino	Negative	Relapse	NA	55,XX,+X,+4,+8,+14,+15,+17,+18,+21,+21[15]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	3365.0	111.0	0:LIVING	No	AALL0331	White	3	Female	Matched	Negative	No	NA	0.0666666666667	Negative	24.1
all_phase2_target_2018_pub	TARGET-10-PANXPE	TARGET-10-PANXPE-04	4.0	1358.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	1.0	NA	95.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1217.0	1.097	Not Hispanic or Latino	Negative	Relapse	0.2643	55,XX,+X,+4,+8,+14,+15,+17,+18,+21,+21[15]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3365.0	111.0	0:LIVING	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	24.1
all_phase2_target_2018_pub	TARGET-10-PANXPE	TARGET-10-PANXPE-09	4.0	1358.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	1.0	NA	95.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1217.0	1.097	Not Hispanic or Latino	Negative	Relapse	0.0005	55,XX,+X,+4,+8,+14,+15,+17,+18,+21,+21[15]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3365.0	111.0	0:LIVING	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	24.1
all_phase2_target_2018_pub	TARGET-10-PANXPP	TARGET-10-PANXPP-09	8.0	2832.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	46.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3617.0	1	Not Hispanic or Latino	Unknown	None	0.0187	46,Y,add(X)(p22.1),del(1)(q32q42),r(21)amp(AML1)[14]/46,XY[6]	Negative	iAMP21	NA	NA	0.011000000000000001	0.001	NA	NA	NA	NA	NA	BLL	3617.0	119.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	172.5
all_phase2_target_2018_pub	TARGET-10-PANXPV	TARGET-10-PANXPV-09	19.0	6678.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3964.0	1.245	Not Hispanic or Latino	Unknown	None	0.4566	55,XX,+X,+7,der(7)t(7;14)(p11.2;q11.2),+8,+8,+9,+10,+18,+21,+21[5]/57,idem,+5,+6[cp9]/58,idem,+4,+5,+6,del(6)(q13)[8]/46,XX[6]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.022000000000000002	0.001	NA	NA	NA	NA	NA	BLL	3964.0	131.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	8.5
all_phase2_target_2018_pub	TARGET-10-PANXPX	TARGET-10-PANXPX-09	4.0	1355.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1230.0	1.58	Hispanic or Latino	Unknown	Censored	0.3041	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1230.0	41.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	69.32
all_phase2_target_2018_pub	TARGET-10-PANXSF	TARGET-10-PANXSF-09	3.0	754.0	NA	NA	VALIDATION	Negative	NA	0.0	0.0	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	3870.0	1.2	Hispanic or Latino	Negative	None	NA	56,XY,+X,+4,+6,+9,+10,+14,+17,+18,+21,+21[12]/46,XY[8]	Negative	NA	NA	NA	1.6	0.01	NA	NA	NA	NA	NA	BLL	3870.0	128.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	5.2
all_phase2_target_2018_pub	TARGET-10-PANXTP	TARGET-10-PANXTP-09	3.0	1093.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	4.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3656.0	1.25	Hispanic or Latino	Negative	None	NA	46,XY[30]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3656.0	121.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	11.0
all_phase2_target_2018_pub	TARGET-10-PANXTR	TARGET-10-PANXTR-09	12.0	4122.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	354.0	0.81	Hispanic or Latino	Negative	Death	0.6267	37,X,+X,+1,+4,+5,+6,+8,+9,+10,+11,+18,+19,+20,+21,+22[3]/72,idemx2,-9,-9[5]/46,XX[12]	Negative	Hypodiploid	NA	NA	0.01	0.01	NA	NA	NA	NA	NA	BLL	354.0	12.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.1
all_phase2_target_2018_pub	TARGET-10-PANXUZ	TARGET-10-PANXUZ-03	22.0	7991.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3751.0	1	Not Hispanic or Latino	Negative	None	0.0008	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3751.0	124.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	62.8
all_phase2_target_2018_pub	TARGET-10-PANXVD	TARGET-10-PANXVD-09	15.0	5444.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1382.0	1.056	Not Hispanic or Latino	Unknown	None	0.0124	47,XY,+21[2]/46,XY[18]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1382.0	46.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	13.5
all_phase2_target_2018_pub	TARGET-10-PANXWA	TARGET-10-PANXWA-09	14.0	4916.0	NA	NA	DISCOVERY	Negative	9.0	3.0	1.0	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3833.0	1	Not Hispanic or Latino	Negative	None	0.0095	46,XX,del(9)(q12q32)[10]/92,idemx2,+add(1)(p11),-20[8]/46,XX[20]	Negative	None of the above	NA	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	3833.0	127.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.21
all_phase2_target_2018_pub	TARGET-10-PANXWI	TARGET-10-PANXWI-09	14.0	4830.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3658.0	1	Not Hispanic or Latino	Negative	None	0.0003	47,XXYc,t(1;19)(q23;p13.3)[5]/47,XXYc,der(19)t(1;19)(q23;p13.3)[6]/47,XXYc[69]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3658.0	121.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	49.3
all_phase2_target_2018_pub	TARGET-10-PANXXD	TARGET-10-PANXXD-09	4.0	1362.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3680.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,del(12)(p11.2)[16]/46,XX[13]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3680.0	121.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	13.8
all_phase2_target_2018_pub	TARGET-10-PANXXR	TARGET-10-PANXXR-09	17.0	5994.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	100.0	1.06	Not Hispanic or Latino	Negative	None	0.0006	46,XX,t(4;11)(q21;q23)[39]/46,XX[1]	Positive	MLL-Rearranged	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	100.0	4.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	243.0
all_phase2_target_2018_pub	TARGET-10-PANXXY	TARGET-10-PANXXY-04	8.0	2703.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	61.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1450.0	788.0	1	Not Hispanic or Latino	Positive	Relapse	NA	NA	Unknown	ETV6-RUNX1	NA	NA	0.08800000000000001	0.001	NA	NA	NA	NA	NA	BLL	1450.0	48.0	1:DECEASED	No	AALL0331	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	8.3
all_phase2_target_2018_pub	TARGET-10-PANXYD	TARGET-10-PANXYD-09	16.0	5830.0	Chemotherapy	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3219.0	1	Not Hispanic or Latino	Unknown	None	0.0612	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3219.0	106.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	7.96
all_phase2_target_2018_pub	TARGET-10-PANXZK	TARGET-10-PANXZK-09	5.0	1642.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3886.0	1	Not Hispanic or Latino	Positive	None	NA	47,XX,+21[13]/46,XX[7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3886.0	128.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.66
all_phase2_target_2018_pub	TARGET-10-PANXZX	TARGET-10-PANXZX-09	9.0	3245.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	308.0	1	Not Hispanic or Latino	Negative	Death	NA	46,XX,del(12)(p12),-15,+der(21)t(15;21)(q21;q11.2)[4]/46,XX[11]	Negative	NA	0.002	0.002	0.8	0.01	NA	NA	NA	NA	NA	BLL	308.0	11.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.97
all_phase2_target_2018_pub	TARGET-10-PANYAH	TARGET-10-PANYAH-09	7.0	2272.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3077.0	1	Hispanic or Latino	Negative	None	0.0343	45,XY,t(1;13)(q21;q34),dic(2;12)(q11.2;p11.2),der(6)t(2;6)(q11.2;q13)[8]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3077.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	53.5
all_phase2_target_2018_pub	TARGET-10-PANYAL	TARGET-10-PANYAL-09	5.0	1494.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3578.0	1.2	Not Hispanic or Latino	Negative	None	0.2672	56,XY,+4,+6,+8,+10,+14,+17,+18,+21,+22,+mar[19]/46,XY[1]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.003	0.001	NA	NA	NA	NA	NA	BLL	3578.0	118.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	102.6
all_phase2_target_2018_pub	TARGET-10-PANYDL	TARGET-10-PANYDL-09	3.0	1093.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	149.0	1.08	Unknown	Negative	Death	NA	49,XX,+X,+17,+21c[10]/47,XX,+21c[10]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	149.0	5.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.86
all_phase2_target_2018_pub	TARGET-10-PANYEJ	TARGET-10-PANYEJ-09	2.0	679.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3875.0	1.231	Not Hispanic or Latino	Unknown	None	0.9361	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0023	NA	NA	NA	NA	NA	4	BLL	3875.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	0.133333333333	Unknown	73.6
all_phase2_target_2018_pub	TARGET-10-PANYFV	TARGET-10-PANYFV-09	17.0	6076.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2175.0	1	Hispanic or Latino	Negative	None	0.0899	45,XY,t(2;12)(p11.2;q13),add(7)(q32),-9,-13,add(14)(q32),-15,+21,+mar[cp5]/46,XY[25]	Negative	None of the above	NA	NA	0.003	0.001	NA	NA	NA	NA	NA	BLL	2175.0	72.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	11.5
all_phase2_target_2018_pub	TARGET-10-PANYFY	TARGET-10-PANYFY-03	5.0	1803.0	NA	NA	DISCOVERY	Negative	5.0	0.0	NA	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3630.0	1.17	Hispanic or Latino	Unknown	None	0.2849	56,XX,+X,+4,+6,+8,+10,+14,+17,+18,+21,+21[cp11]/46,XX[9]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.001	0.022000000000000002	0.001	NA	NA	NA	NA	NA	BLL	3630.0	120.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	99.3
all_phase2_target_2018_pub	TARGET-10-PANYGB	TARGET-10-PANYGB-04	8.0	2788.0	NA	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	2110.0	1321.0	1.12	Unknown	Negative	Relapse	0.0091	46,XX,add(7)(q11.2),add(9)(p13)[8]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2110.0	70.0	1:DECEASED	No	AALL0331	Unknown	2	Female	Matched	Negative	No	NA	NA	Negative	21.8
all_phase2_target_2018_pub	TARGET-10-PANYGB	TARGET-10-PANYGB-09	8.0	2788.0	NA	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	2110.0	1321.0	1.12	Unknown	Negative	Relapse	0.0198	46,XX,add(7)(q11.2),add(9)(p13)[8]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	2110.0	70.0	1:DECEASED	No	AALL0331	Unknown	2	Female	Matched	Negative	No	NA	0.0666666666667	Negative	21.8
all_phase2_target_2018_pub	TARGET-10-PANYGV	TARGET-10-PANYGV-09	18.0	6488.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	1563.0	NA	Hispanic or Latino	Negative	Relapse	0.0568	46,XY,i(7)(q10)[6]/46,XY[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1565.0	52.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	6.1
all_phase2_target_2018_pub	TARGET-10-PANYHB	TARGET-10-PANYHB-03	3.0	838.0	NA	NA	VALIDATION	Negative	5.0	1.0	NA	78.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	3582.0	1.16	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+4,+6,+10,+14,+17,+18,+21,+21[12]/46,XY[8]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3582.0	118.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	28.4
all_phase2_target_2018_pub	TARGET-10-PANYHE	TARGET-10-PANYHE-09	3.0	795.0	NA	NA	DISCOVERY	Negative	1.0	3.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3592.0	1.17	Not Hispanic or Latino	Negative	None	0.1772	55,XY,+X,+Y,+6,+10,+14,+14,r(16),+18,+21,+21[14]/46,XY[16]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3592.0	119.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	67.8
all_phase2_target_2018_pub	TARGET-10-PANYHL	TARGET-10-PANYHL-09	7.0	2444.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3766.0	1	Not Hispanic or Latino	Unknown	None	0.0555	46,XX[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3766.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	81.6
all_phase2_target_2018_pub	TARGET-10-PANYHV	TARGET-10-PANYHV-03	15.0	5370.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1563.0	1	Not Hispanic or Latino	Unknown	None	0.0008	NA	Unknown	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	1563.0	52.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	91.6
all_phase2_target_2018_pub	TARGET-10-PANYHW	TARGET-10-PANYHW-09	13.0	4572.0	NA	NA	DISCOVERY	Negative	12.0	2.0	0.0	86.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2269.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0102	NA	Unknown	None of the above	NA	NA	4.9	0.01	NA	NA	NA	NA	NA	BLL	3793.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	17.8
all_phase2_target_2018_pub	TARGET-10-PANYIT	TARGET-10-PANYIT-09	6.0	1938.0	Chemotherapy	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3746.0	1	Not Hispanic or Latino	Unknown	None	0.0014	46,XX[27]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3746.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	134.3
all_phase2_target_2018_pub	TARGET-10-PANYJI	TARGET-10-PANYJI-09	16.0	5759.0	NA	NA	DISCOVERY	Negative	19.0	2.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	NA	3570.0	1.1	Not Hispanic or Latino	Negative	None	0.1742	48~52,XX,+8,+9,+21c,+21,+22,+mar[cp2]/47,XX,+21c[25]	Negative	None of the above	0.0	0.001	0.7	0.01	NA	NA	NA	NA	NA	BLL	3570.0	118.0	0:LIVING	No	AALL0232	American Indian or Alaska Native	1	Female	Matched	Negative	No	NA	NA	Negative	13.6
all_phase2_target_2018_pub	TARGET-10-PANYJJ	TARGET-10-PANYJJ-03	7.0	2454.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	58.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3492.0	1.41	Unknown	Negative	None	0.4133	64,XX,+X,+3,+4,+5,+6,+7,+8,+10,+10,+11,+12,i(12)(q10),add(12)(p11.2),+14,+14,+16,+17,+18,+21,+21[8]/46,XX[39]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3492.0	115.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	72.2
all_phase2_target_2018_pub	TARGET-10-PANYJL	TARGET-10-PANYJL-09	2.0	721.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	179.0	1	Not Hispanic or Latino	Positive	Death	NA	46,XX[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	179.0	6.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	6.7
all_phase2_target_2018_pub	TARGET-10-PANYJV	TARGET-10-PANYJV-09	6.0	2119.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3937.0	1.19	Hispanic or Latino	Negative	None	NA	56,XX,+X,+X,+4,+6,+14,+17,+18,+21,+21,+mar[16]/46,XX[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3937.0	130.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.3
all_phase2_target_2018_pub	TARGET-10-PANYMY	TARGET-10-PANYMY-09	13.0	4595.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3535.0	1	Hispanic or Latino	Negative	None	0.0003	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3535.0	117.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	11.2
all_phase2_target_2018_pub	TARGET-10-PANYNX	TARGET-10-PANYNX-09	2.0	422.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1361.0	1.056	Not Hispanic or Latino	Unknown	None	0.0008	46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1361.0	45.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	52.5
all_phase2_target_2018_pub	TARGET-10-PANYPN	TARGET-10-PANYPN-09	14.0	4824.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	78.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3465.0	1.066	Not Hispanic or Latino	Unknown	None	0.0011	46,XX[20]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	3465.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	81.8
all_phase2_target_2018_pub	TARGET-10-PANYUR	TARGET-10-PANYUR-09	2.0	465.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3714.0	1	Hispanic or Latino	Negative	None	0.0110	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3714.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	54.4
all_phase2_target_2018_pub	TARGET-10-PANYWH	TARGET-10-PANYWH-09	13.0	4536.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3072.0	1	Not Hispanic or Latino	Negative	None	0.0017	46,XX[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3072.0	101.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	5.9
all_phase2_target_2018_pub	TARGET-10-PANYXC	TARGET-10-PANYXC-09	4.0	1238.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1707.0	1	Hispanic or Latino	Unknown	None	0.0191	46,XY,add(12)(p11.2)[6]/46,XY[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1707.0	57.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	63.0
all_phase2_target_2018_pub	TARGET-10-PANYXD	TARGET-10-PANYXD-09	5.0	1557.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3643.0	1.14	Not Hispanic or Latino	Negative	None	NA	53,XY,+X,+4,+6,+14,+18,+21,+21[9]/53,idem,i(17)(q10)[6]/46,XY[10]	Negative	NA	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	3643.0	120.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	11.48
all_phase2_target_2018_pub	TARGET-10-PANYXE	TARGET-10-PANYXE-09	8.0	2693.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3884.0	1	Hispanic or Latino	Negative	None	0.0008	46,XX[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3884.0	128.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	121.2
all_phase2_target_2018_pub	TARGET-10-PANYXR	TARGET-10-PANYXR-09	2.0	541.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3664.0	1.22	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.009000000000000001	0.001	NA	NA	NA	NA	NA	BLL	3664.0	121.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Positive	14.0
all_phase2_target_2018_pub	TARGET-10-PANYYE	TARGET-10-PANYYE-09	12.0	4188.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1455.0	1.204	Not Hispanic or Latino	Unknown	Relapse	0.0211	55,XY,+X,+5,+6,+10,+11,+18,+21,+21,+22[cp4]/56,idem,+1[2]/55,idem,del(5)(q22q23)[cp2]/46,XY[12]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2821.0	93.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	8.6
all_phase2_target_2018_pub	TARGET-10-PANYYV	TARGET-10-PANYYV-03	4.0	1224.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1304.0	1.197	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	1	BLL	3122.0	103.0	0:LIVING	No	AALL0331	White	2	Female	Matched	Unknown	No	NA	0.0333333333333	Positive	14.7
all_phase2_target_2018_pub	TARGET-10-PANYYV	TARGET-10-PANYYV-04	4.0	1224.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1304.0	1.197	Not Hispanic or Latino	Negative	Relapse	0.8951	NA	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3122.0	103.0	0:LIVING	No	AALL0331	White	2	Female	Matched	Unknown	No	NA	NA	Positive	14.7
all_phase2_target_2018_pub	TARGET-10-PANYYW	TARGET-10-PANYYW-09	13.0	4562.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3931.0	1	Hispanic or Latino	Negative	None	0.0131	NA	Unknown	None of the above	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	3931.0	130.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	8.3
all_phase2_target_2018_pub	TARGET-10-PANYZE	TARGET-10-PANYZE-09	5.0	1479.0	NA	NA	VALIDATION;DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1272.0	1.08	Not Hispanic or Latino	Negative	Relapse	0.1197	50,XX,+8,?del(9)(p23),+21,+21,+mar[cp7]/46,XX[13]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	3065.0	101.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	0.1	Negative	8.1
all_phase2_target_2018_pub	TARGET-10-PANYZJ	TARGET-10-PANYZJ-09	12.0	4051.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2537.0	1	Not Hispanic or Latino	Unknown	None	0.0533	46,XX,der(19)t(1;19)(q23;p13)[3]/46,XX[19]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2537.0	84.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Positive	No	NA	NA	Negative	147.7
all_phase2_target_2018_pub	TARGET-10-PANZAM	TARGET-10-PANZAM-04	18.0	6244.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	17.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1286.0	574.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	None of the above	0.01	0.01	0.18	0.01	NA	NA	NA	NA	NA	BLL	1286.0	43.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Unknown	2.7
all_phase2_target_2018_pub	TARGET-10-PANZAM	TARGET-10-PANZAM-09	18.0	6244.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	17.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1286.0	574.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	None of the above	0.01	0.01	0.18	0.01	NA	NA	NA	NA	NA	BLL	1286.0	43.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Unknown	2.7
all_phase2_target_2018_pub	TARGET-10-PANZAR	TARGET-10-PANZAR-09	11.0	3753.0	NA	NA	DISCOVERY	Negative	6.0	0.0	NA	86.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3608.0	1	Hispanic or Latino	Negative	None	0.0077	NA	Unknown	None of the above	0.0	0.001	0.0	0.01	NA	NA	NA	NA	NA	BLL	3608.0	119.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	387.2
all_phase2_target_2018_pub	TARGET-10-PANZBR	TARGET-10-PANZBR-09	2.0	441.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3556.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3556.0	117.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	41.1
all_phase2_target_2018_pub	TARGET-10-PANZBY	TARGET-10-PANZBY-03	3.0	1044.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3742.0	1.189	Not Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+6,+10,+14,+17,+18,+21,+21[20]/46,XX[20]	Negative	NA	NA	NA	0.016	0.01	NA	NA	NA	NA	NA	BLL	3742.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	9.1
all_phase2_target_2018_pub	TARGET-10-PANZCF	TARGET-10-PANZCF-09	9.0	3092.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1274.0	1.1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,-21,+mar[15]/46,XY[8]	Negative	NA	NA	NA	0.07200000000000001	0.001	NA	NA	NA	NA	NA	BLL	3051.0	101.0	1:DECEASED	No	AALL0331	White	1	Male	Matched	Negative	Yes	No	NA	Negative	3.3
all_phase2_target_2018_pub	TARGET-10-PANZCX	TARGET-10-PANZCX-09	6.0	2185.0	Chemotherapy	NA	DISCOVERY	Negative	11.0	4.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3826.0	1	Hispanic or Latino	Negative	None	0.0014	46,XX,t(1;19)(q23;p13.3)[8]/46,idem,del(6)(q12q22)[6]/46,XX[6]	Negative	TCF3-PBX1	0.0	0.01	0.002	0.001	NA	NA	NA	NA	NA	BLL	3826.0	126.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	78.6
all_phase2_target_2018_pub	TARGET-10-PANZDB	TARGET-10-PANZDB-09	7.0	2547.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3729.0	1	Not Hispanic or Latino	Unknown	None	0.0012	47,XX,+X[cp2]/46,XX[28]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3729.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	54.3
all_phase2_target_2018_pub	TARGET-10-PANZEG	TARGET-10-PANZEG-03	3.0	857.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2628.0	1.21	Not Hispanic or Latino	Negative	None	NA	58,XX,+X,+5,+6,+7,+8,+8,+14,+17,+18,+19,+21,+21[20]	Negative	NA	NA	NA	0.11	0.01	NA	NA	NA	NA	NA	BLL	2628.0	87.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	49.98
all_phase2_target_2018_pub	TARGET-10-PANZEV	TARGET-10-PANZEV-04	5.0	1468.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	1517.0	661.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XX,del(9)(p22),+21c[4]/48,idem,+X[6]/49,idem,+X,+del(9)(p22)[4]/47,XX,+21c[9]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1517.0	50.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	119.9
all_phase2_target_2018_pub	TARGET-10-PANZEV	TARGET-10-PANZEV-09	5.0	1468.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	1517.0	661.0	1	Hispanic or Latino	Negative	Relapse	0.0564	47,XX,del(9)(p22),+21c[4]/48,idem,+X[6]/49,idem,+X,+del(9)(p22)[4]/47,XX,+21c[9]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1517.0	50.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	119.9
all_phase2_target_2018_pub	TARGET-10-PANZFN	TARGET-10-PANZFN-09	7.0	2276.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3640.0	1.09	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3640.0	120.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Positive	7.1
all_phase2_target_2018_pub	TARGET-10-PANZFW	TARGET-10-PANZFW-09	17.0	5946.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2324.0	1	Not Hispanic or Latino	Negative	None	0.0390	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2324.0	77.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	78.5
all_phase2_target_2018_pub	TARGET-10-PANZGD	TARGET-10-PANZGD-09	4.0	1111.0	NA	NA	DISCOVERY	Negative	5.0	4.0	NA	51.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3805.0	1.144	Not Hispanic or Latino	Unknown	None	0.1510	NA	Unknown	None of the above	0.0	0.01	0.0043	NA	NA	NA	NA	NA	NA	BLL	3805.0	126.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	299.3
all_phase2_target_2018_pub	TARGET-10-PANZGN	TARGET-10-PANZGN-09	2.0	616.0	NA	NA	VALIDATION	Negative	7.0	2.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	3604.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,del(12)(p12)[7]/46,XY[5]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3604.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	11.5
all_phase2_target_2018_pub	TARGET-10-PANZHD	TARGET-10-PANZHD-09	3.0	799.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	222.0	1	Not Hispanic or Latino	Positive	None	0.0183	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	222.0	8.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	69.3
all_phase2_target_2018_pub	TARGET-10-PANZHL	TARGET-10-PANZHL-09	11.0	3907.0	Chemotherapy	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2732.0	1	Not Hispanic or Latino	Negative	None	0.0073	46,XY,der(18)t(5;18)(q34;p11.32)[11]/46,XY[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2732.0	90.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	10.9
all_phase2_target_2018_pub	TARGET-10-PANZID	TARGET-10-PANZID-09	5.0	1768.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2518.0	1.06	Not Hispanic or Latino	Negative	None	0.0077	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2518.0	83.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	154.5
all_phase2_target_2018_pub	TARGET-10-PANZJG	TARGET-10-PANZJG-09	2.0	701.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3640.0	1	Not Hispanic or Latino	Positive	None	0.0018	46,XY,t(4;13)(q21;q12),del(12)(q12q21)[cp8]/46,XY[12]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3640.0	120.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	382.0
all_phase2_target_2018_pub	TARGET-10-PANZJL	TARGET-10-PANZJL-09	3.0	767.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3676.0	1.314	Not Hispanic or Latino	Negative	None	0.4205	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3676.0	121.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Positive	74.3
all_phase2_target_2018_pub	TARGET-10-PANZKC	TARGET-10-PANZKC-09	9.0	3052.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1849.0	0.94	Not Hispanic or Latino	Negative	Relapse	0.0014	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3561.0	118.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	103.0
all_phase2_target_2018_pub	TARGET-10-PANZLS	TARGET-10-PANZLS-09	16.0	5839.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2423.0	1	Not Hispanic or Latino	Negative	None	0.0016	46,XX,t(4;11)(q21;q23)[19]/46,XX[1]	Positive	MLL-Rearranged	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	2423.0	80.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	321.0
all_phase2_target_2018_pub	TARGET-10-PANZNG	TARGET-10-PANZNG-09	21.0	7316.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3910.0	1	Not Hispanic or Latino	Negative	None	0.0407	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3910.0	129.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	10.04
all_phase2_target_2018_pub	TARGET-10-PANZPJ	TARGET-10-PANZPJ-04	14.0	4756.0	NA	NA	DISCOVERY	Negative	3.0	4.0	4.0	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	953.0	932.0	1	Unknown	Unknown	Relapse	NA	NA	Unknown	None of the above	NA	0.01	1.3	0.01	NA	NA	NA	NA	NA	BLL	953.0	32.0	1:DECEASED	No	AALL0232	Unknown	4	Male	Matched	Unknown	No	No	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PANZPJ	TARGET-10-PANZPJ-09	14.0	4756.0	NA	NA	DISCOVERY	Negative	3.0	4.0	4.0	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	953.0	932.0	1	Unknown	Unknown	Relapse	0.0012	NA	Unknown	None of the above	NA	0.01	1.3	0.01	NA	NA	NA	NA	2	BLL	953.0	32.0	1:DECEASED	No	AALL0232	Unknown	4	Male	Matched	Unknown	No	No	0.0666666666667	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PANZPJ	TARGET-10-PANZPJ-60.1	14.0	4756.0	NA	NA	XENOGRAFT	Negative	3.0	4.0	4.0	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	953.0	932.0	1	Unknown	Unknown	Relapse	NA	NA	Unknown	None of the above	NA	0.01	1.3	0.01	NA	NA	NA	NA	NA	BLL	953.0	32.0	1:DECEASED	No	AALL0232	Unknown	4	Male	Matched	Unknown	No	No	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PANZPJ	TARGET-10-PANZPJ-60.2	14.0	4756.0	NA	NA	XENOGRAFT	Negative	3.0	4.0	4.0	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	953.0	932.0	1	Unknown	Unknown	Relapse	NA	NA	Unknown	None of the above	NA	0.01	1.3	0.01	NA	NA	NA	NA	NA	BLL	953.0	32.0	1:DECEASED	No	AALL0232	Unknown	4	Male	Matched	Unknown	No	No	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PANZPP	TARGET-10-PANZPP-09	16.0	5531.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2092.0	1	Hispanic or Latino	Negative	None	0.0464	NA	Unknown	None of the above	NA	NA	0.006	0.001	NA	NA	NA	NA	NA	BLL	2092.0	69.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	9.1
all_phase2_target_2018_pub	TARGET-10-PANZPU	TARGET-10-PANZPU-09	5.0	1702.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	39.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3757.0	1.25	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	0.0	NA	0.13	0.01	NA	NA	NA	NA	NA	BLL	3757.0	124.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	3.6
all_phase2_target_2018_pub	TARGET-10-PANZRH	TARGET-10-PANZRH-09	16.0	5792.0	Chemotherapy	NA	DISCOVERY	Positive	53.0	16.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	81.0	1	Not Hispanic or Latino	Negative	Death	NA	45,XX,-7,t(9;22)(q34;q11.2)[9]/46,XX[11]	Negative	BCR-ABL1	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	81.0	3.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	175.2
all_phase2_target_2018_pub	TARGET-10-PANZSE	TARGET-10-PANZSE-09	4.0	1183.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3601.0	1.065	Unknown	Negative	None	NA	46,XX,del(13)(q12q2?2)[2]/46,XX[48]	Negative	NA	NA	NA	0.0032	0.0032	NA	NA	NA	NA	NA	BLL	3601.0	119.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	35.6
all_phase2_target_2018_pub	TARGET-10-PANZUE	TARGET-10-PANZUE-09	3.0	766.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	757.0	1	Hispanic or Latino	Positive	None	0.0493	NA	Unknown	ETV6-RUNX1	NA	NA	0.023	0.001	NA	NA	NA	NA	NA	BLL	757.0	25.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	64.8
all_phase2_target_2018_pub	TARGET-10-PANZUI	TARGET-10-PANZUI-09	9.0	3136.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3778.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3778.0	125.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	22.4
all_phase2_target_2018_pub	TARGET-10-PANZWG	TARGET-10-PANZWG-09	4.0	1237.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	475.0	293.0	1.062	Not Hispanic or Latino	Negative	Relapse	NA	46,XX[39]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	475.0	16.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.5
all_phase2_target_2018_pub	TARGET-10-PANZXC	TARGET-10-PANZXC-04	3.0	739.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	67.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1412.0	1115.0	1.092	Not Hispanic or Latino	Negative	Relapse	0.0903	NA	Unknown	None of the above	NA	NA	0.027000000000000003	0.01	NA	NA	NA	NA	NA	BLL	1412.0	47.0	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Unknown	No	No	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PANZXC	TARGET-10-PANZXC-09	3.0	739.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	67.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1412.0	1115.0	1.092	Not Hispanic or Latino	Negative	Relapse	0.0799	NA	Unknown	None of the above	NA	NA	0.027000000000000003	0.01	NA	NA	NA	NA	NA	BLL	1412.0	47.0	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Unknown	No	No	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PANZXZ	TARGET-10-PANZXZ-03	14.0	4845.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2970.0	1	Hispanic or Latino	Negative	None	NA	NA	Unknown	None of the above	NA	NA	0.015	0.001	NA	NA	NA	NA	NA	BLL	2970.0	98.0	0:LIVING	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	6.93
all_phase2_target_2018_pub	TARGET-10-PANZXZ	TARGET-10-PANZXZ-09	14.0	4845.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2970.0	1	Hispanic or Latino	Negative	None	0.0089	NA	Unknown	None of the above	NA	NA	0.015	0.001	NA	NA	NA	NA	3	BLL	2970.0	98.0	0:LIVING	No	AALL0232	White	2	Male	Matched	Unknown	No	No	0.1	Unknown	6.93
all_phase2_target_2018_pub	TARGET-10-PANZYY	TARGET-10-PANZYY-09	2.0	552.0	NA	NA	VALIDATION	Negative	9.0	0.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3774.0	1.23	Not Hispanic or Latino	Negative	None	NA	57,XY,+X,+Y,dup(1)(q21q42),+4,+6,+10,+14,+17,+18,+18,+21,+21[9]/58,XY,+X,+Y,+4,+6,+9,+10,+14,+17,+18,+18,+21,+21[cp3]/46,XY[8]	Negative	NA	0.0	NA	0.016	0.001	NA	NA	NA	NA	NA	BLL	3774.0	125.0	0:LIVING	No	AALL0331	Native Hawaiian or other Pacific Islander	1	Male	Matched	Negative	No	No	NA	Positive	27.6
all_phase2_target_2018_pub	TARGET-10-PANZZC	TARGET-10-PANZZC-09	13.0	4545.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2114.0	1.054	Not Hispanic or Latino	Unknown	None	0.0001	46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2114.0	70.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	7.6
all_phase2_target_2018_pub	TARGET-10-PANZZI	TARGET-10-PANZZI-09	6.0	2123.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3037.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3037.0	100.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	4.5
all_phase2_target_2018_pub	TARGET-10-PANZZX	TARGET-10-PANZZX-09	4.0	1285.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3876.0	1.1	Not Hispanic or Latino	Negative	None	0.0027	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3876.0	128.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Negative	79.9
all_phase2_target_2018_pub	TARGET-10-PAPACP	TARGET-10-PAPACP-03	6.0	2013.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	92.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1303.0	1.193	Unknown	Negative	Relapse	NA	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0072	NA	NA	NA	NA	NA	1	BLL	2378.0	79.0	1:DECEASED	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	0.0333333333333	Positive	2.2
all_phase2_target_2018_pub	TARGET-10-PAPACP	TARGET-10-PAPACP-04	6.0	2013.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	92.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1303.0	1.193	Unknown	Negative	Relapse	0.2049	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0072	NA	NA	NA	NA	NA	NA	BLL	2378.0	79.0	1:DECEASED	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	NA	Positive	2.2
all_phase2_target_2018_pub	TARGET-10-PAPACP	TARGET-10-PAPACP-09	6.0	2013.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	92.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1303.0	1.193	Unknown	Negative	Relapse	0.0010	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0072	NA	NA	NA	NA	NA	NA	BLL	2378.0	79.0	1:DECEASED	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	NA	Positive	2.2
all_phase2_target_2018_pub	TARGET-10-PAPADB	TARGET-10-PAPADB-09	4.0	1184.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	1.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	Yes	NA	605.0	1.07	Not Hispanic or Latino	Negative	SMN	0.0750	47,XX,add(5)(q35),add(11)(q21),+21c,[10]/47,XX,+21c[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3802.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	137.34
all_phase2_target_2018_pub	TARGET-10-PAPADC	TARGET-10-PAPADC-09	16.0	5691.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	21.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	93.0	1	Not Hispanic or Latino	Negative	Death	0.0005	46,XX,t(1;19)(q23;p13.3)[10]/46,XX[10]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	93.0	4.0	1:DECEASED	No	AALL0232	Black or African American	1	Female	Matched	Positive	No	NA	NA	Negative	30.9
all_phase2_target_2018_pub	TARGET-10-PAPADT	TARGET-10-PAPADT-09	2.0	575.0	CHEMOTHERAPY	NA	VALIDATION	Negative	2.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3710.0	1.18	Not Hispanic or Latino	Negative	None	NA	56,XY,+X,+Y,+4,+6,+10,+14,+17,+18,+21,+21[12]/46,XY[7]	Negative	NA	NA	NA	0.005	0.001	NA	NA	NA	NA	NA	BLL	3710.0	122.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	31.0
all_phase2_target_2018_pub	TARGET-10-PAPAEB	TARGET-10-PAPAEB-09	15.0	5416.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3584.0	1	Hispanic or Latino	Negative	None	0.0072	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3584.0	118.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	39.0
all_phase2_target_2018_pub	TARGET-10-PAPAEV	TARGET-10-PAPAEV-09	13.0	4657.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3776.0	1.25	Hispanic or Latino	Negative	None	0.7600	56~57,XX,+X,add(1)(q21),+4,+6,+7,+7,der(7)t(1;7)(q21;p22)x2,+10,+14,+17,+18,+18,+21,+21[cp11]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3776.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	18.48
all_phase2_target_2018_pub	TARGET-10-PAPAFL	TARGET-10-PAPAFL-09	14.0	4918.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	917.0	1.244	Not Hispanic or Latino	Unknown	Censored	0.3424	56,XY,+X,+Y,+4,+6,+10,+11,+14,der(17)t(X;17)(?p11.4;p11.2),+18,+21,+21[4]/56,idem,der(3)t(3;7)(p25;q11.2),der(6)t(3;6)(?p25;?q23)[3]/57,idem,+14[2]/58,idem,del(1)(q23),+14[2]/46,XY[9]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0005	0.01	NA	NA	NA	NA	NA	BLL	917.0	31.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	3.3
all_phase2_target_2018_pub	TARGET-10-PAPAGB	TARGET-10-PAPAGB-09	9.0	2930.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3823.0	1.27	Not Hispanic or Latino	Negative	None	NA	60,XX,+X,+5,+6,+8,+11,+14,+15,+18,+19,+20,+21,+22,+22,+mar[cp12]/46,XX[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3823.0	126.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	8.3
all_phase2_target_2018_pub	TARGET-10-PAPAGF	TARGET-10-PAPAGF-09	4.0	1390.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3731.0	1	Hispanic or Latino	Negative	None	NA	45,X,-Y,dic(9;20)(p13;q11),del(12)(p13),add(19)(q13.4),+mar[7]/46,XY[13]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3731.0	123.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	11.8
all_phase2_target_2018_pub	TARGET-10-PAPAGJ	TARGET-10-PAPAGJ-03	15.0	5244.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	482.0	1	Not Hispanic or Latino	Negative	Relapse	0.0082	46,XX,del(7)(p11.2)[3]/46,idem,add(18)(q23)[10]/46,XX[7]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	776.0	26.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	177.0
all_phase2_target_2018_pub	TARGET-10-PAPAGK	TARGET-10-PAPAGK-03	3.0	853.0	NA	NA	DISCOVERY	Negative	2.0	2.0	NA	19.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	771.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	7	BLL	3529.0	117.0	0:LIVING	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	0.233333333333	Unknown	6.0
all_phase2_target_2018_pub	TARGET-10-PAPAGK	TARGET-10-PAPAGK-04	3.0	853.0	NA	NA	DISCOVERY	Negative	2.0	2.0	NA	19.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	771.0	1	Not Hispanic or Latino	Negative	Relapse	0.0477	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3529.0	117.0	0:LIVING	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	NA	Unknown	6.0
all_phase2_target_2018_pub	TARGET-10-PAPAGK	TARGET-10-PAPAGK-09	3.0	853.0	NA	NA	DISCOVERY	Negative	2.0	2.0	NA	19.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	771.0	1	Not Hispanic or Latino	Negative	Relapse	0.0452	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	4	BLL	3529.0	117.0	0:LIVING	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	0.133333333333	Unknown	6.0
all_phase2_target_2018_pub	TARGET-10-PAPAGS	TARGET-10-PAPAGS-09	7.0	2349.0	NA	NA	VALIDATION	Negative	1.0	2.0	1.0	42.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	3493.0	1	Hispanic or Latino	Negative	None	NA	47,XY,del(7)(p13p15),+21c[7]/47,XY,+21c[14]	Negative	NA	0.002	0.002	1.3	0.01	NA	NA	NA	NA	NA	BLL	3493.0	115.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	26.9
all_phase2_target_2018_pub	TARGET-10-PAPAGT	TARGET-10-PAPAGT-09	14.0	4759.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3760.0	1.09	Not Hispanic or Latino	Negative	None	NA	46,XX,t(4;11)(q21;q23)[10]/46,XX[5]	Positive	MLL-Rearranged	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3760.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	37.0
all_phase2_target_2018_pub	TARGET-10-PAPAGV	TARGET-10-PAPAGV-09	4.0	1104.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3729.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3729.0	123.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	6.8
all_phase2_target_2018_pub	TARGET-10-PAPAGW	TARGET-10-PAPAGW-09	5.0	1586.0	NA	NA	VALIDATION	Positive	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3612.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(9;22)(q34;q11.2)[3]/46,XY[17]	Negative	NA	NA	NA	0.026000000000000002	0.001	NA	NA	NA	NA	NA	BLL	3612.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	5.6
all_phase2_target_2018_pub	TARGET-10-PAPAHL	TARGET-10-PAPAHL-09	12.0	4178.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2670.0	1	Not Hispanic or Latino	Unknown	None	0.0006	NA	Unknown	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	2670.0	88.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	76.3
all_phase2_target_2018_pub	TARGET-10-PAPAHP	TARGET-10-PAPAHP-09	12.0	4340.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3713.0	1	Not Hispanic or Latino	Positive	None	0.0851	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3713.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	38.5
all_phase2_target_2018_pub	TARGET-10-PAPAIZ	TARGET-10-PAPAIZ-09	7.0	2356.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	47.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	932.0	1.143	Not Hispanic or Latino	Negative	Relapse	0.1800	52,XX,+X,+X,+6,+14,+17,+21[22]/46,XX[49]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	3632.0	120.0	0:LIVING	Yes	AALL0331	White	1	Female	Matched	Negative	No	NA	0.1	Negative	15.23
all_phase2_target_2018_pub	TARGET-10-PAPAJT	TARGET-10-PAPAJT-09	9.0	3209.0	NA	NA	DISCOVERY	Negative	NA	2.0	2.0	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1854.0	1	Not Hispanic or Latino	Negative	Relapse	0.0019	46,XY,del(6)(q13q21)[4]/46,XY[22]	Negative	None of the above	0.013999999999999999	0.001	4.6	0.01	NA	NA	NA	NA	NA	BLL	3768.0	124.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	115.1
all_phase2_target_2018_pub	TARGET-10-PAPAJU	TARGET-10-PAPAJU-09	19.0	6704.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3763.0	1	Not Hispanic or Latino	Unknown	None	0.0075	46,XX,add(16)(p13.3)[4]/47,idem,+16,add(16)[2]/46,XX[15]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3763.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	19.4
all_phase2_target_2018_pub	TARGET-10-PAPAJV	TARGET-10-PAPAJV-09	13.0	4462.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2874.0	1	Hispanic or Latino	Negative	None	0.0090	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2874.0	95.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	10.2
all_phase2_target_2018_pub	TARGET-10-PAPAKA	TARGET-10-PAPAKA-09	13.0	4741.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3458.0	1	Not Hispanic or Latino	Unknown	None	0.0129	46,XX,i(9)(q10),add(14)(q32)[1]/46,XX[39]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3458.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.2
all_phase2_target_2018_pub	TARGET-10-PAPAKJ	TARGET-10-PAPAKJ-09	4.0	1256.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2174.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,+21[2]/46,XY[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2174.0	72.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	7.31
all_phase2_target_2018_pub	TARGET-10-PAPAKV	TARGET-10-PAPAKV-03	8.0	2704.0	Chemotherapy; Transplant	NA	DISCOVERY	Positive	7.0	6.0	0.0	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	742.0	1	Unknown	Negative	Relapse	0.0293	NA	Unknown	BCR-ABL1	NA	NA	5.5	0.01	NA	NA	NA	NA	NA	BLL	3818.0	126.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	388.3
all_phase2_target_2018_pub	TARGET-10-PAPALF	TARGET-10-PAPALF-09	13.0	4567.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3584.0	1	Hispanic or Latino	Negative	None	0.0139	45,XY,der(9)t(9;15)(p22;q15),-15[4]/46,XY[11]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3584.0	118.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	16.21
all_phase2_target_2018_pub	TARGET-10-PAPALK	TARGET-10-PAPALK-09	12.0	4333.0	NA	NA	DISCOVERY	Negative	8.0	0.0	0.0	93.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1202.0	1	Hispanic or Latino	Negative	Relapse	0.0006	46,XX,t(2;14)(q13;q32),del(5)(p12p14),del(12)(p12p13),add(21)(q22)[8]/46,XX[7]	Negative	None of the above	0.14	0.01	0.32	0.01	NA	NA	NA	NA	NA	BLL	3611.0	119.0	1:DECEASED	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	9.21
all_phase2_target_2018_pub	TARGET-10-PAPAMA	TARGET-10-PAPAMA-09	7.0	2535.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	3623.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(7;9)(q11.2;p12)[14]/46,XY[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3623.0	120.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	29.34
all_phase2_target_2018_pub	TARGET-10-PAPAMB	TARGET-10-PAPAMB-09	16.0	5589.0	NA	NA	DISCOVERY	Negative	2.0	28.0	NA	18.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1.076	Not Hispanic or Latino	Unknown	Induction failure	0.0107	46,XY[40]	Unknown	None of the above	NA	NA	7.0	0.01	NA	NA	NA	NA	NA	BLL	705.0	24.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	4.3
all_phase2_target_2018_pub	TARGET-10-PAPAME	TARGET-10-PAPAME-09	16.0	5739.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3853.0	1.49	Not Hispanic or Latino	Unknown	None	0.5190	73(36,X,+Y,+1,+5,+6,+8,+9,+10,+14,+18,+19,+20,+21,+22)x2,-X,+14,+mar[cp31]/46,XY[1]	Negative	Hypodiploid	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3853.0	127.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	3.6
all_phase2_target_2018_pub	TARGET-10-PAPAMH	TARGET-10-PAPAMH-09	5.0	1745.0	NA	NA	VALIDATION	Negative	4.0	1.0	1.0	54.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	252.0	1.21	Not Hispanic or Latino	Negative	Death	NA	53,XX,+X,+4,+6,+9,+14,+21,+21[13]/53,idem,-9,+der(9;17)(q10;q10)[6]/46,XX[1]	Negative	NA	0.0	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	252.0	9.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	10.4
all_phase2_target_2018_pub	TARGET-10-PAPAMS	TARGET-10-PAPAMS-09	4.0	1280.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	18.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3553.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,t(12;21)(p13;q22)[32]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3553.0	117.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	4.4
all_phase2_target_2018_pub	TARGET-10-PAPAMX	TARGET-10-PAPAMX-09	2.0	729.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3866.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	ETV6-RUNX1	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	3866.0	128.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	107.4
all_phase2_target_2018_pub	TARGET-10-PAPAMY	TARGET-10-PAPAMY-09	2.0	425.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3535.0	1	Not Hispanic or Latino	Negative	None	0.0147	46,XX,t(3;11)(q27;q23),t(3;14)(q25;q11.2),inv(7)(p22q11.2),del(8)(q21.2),del(15)(q15),add(19)(q13.4).isht(3;11)(MLL3'+;MLL5'+)	Positive	MLL-Rearranged	0.0	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	3535.0	117.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	318.0
all_phase2_target_2018_pub	TARGET-10-PAPANB	TARGET-10-PAPANB-09	6.0	2173.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3817.0	1.3	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3817.0	126.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	26.01
all_phase2_target_2018_pub	TARGET-10-PAPAPC	TARGET-10-PAPAPC-09	3.0	873.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2649.0	1.19	Unknown	Negative	None	NA	57,XX,+X,+4,+6,+8,+10,+14,+17,+18,+18,+21,+21[8]/56,idem,dup(1)(q12q31),-8[3]/46,XX[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2649.0	88.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	3.9
all_phase2_target_2018_pub	TARGET-10-PAPAPG	TARGET-10-PAPAPG-09	13.0	4688.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3767.0	1	Not Hispanic or Latino	Unknown	None	0.1337	46,XX,del(9)(p13p22)[3]/46,XX[27]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3767.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	1.2
all_phase2_target_2018_pub	TARGET-10-PAPAPK	TARGET-10-PAPAPK-09	11.0	3894.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	527.0	1.081	Not Hispanic or Latino	Negative	Death	0.0020	46,XX[48]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	527.0	18.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	8.1
all_phase2_target_2018_pub	TARGET-10-PAPAPX	TARGET-10-PAPAPX-09	5.0	1770.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3561.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3561.0	118.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	22.5
all_phase2_target_2018_pub	TARGET-10-PAPARB	TARGET-10-PAPARB-03	15.0	5329.0	NA	NA	DISCOVERY	Positive	5.0	0.0	NA	36.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3695.0	1	Not Hispanic or Latino	Unknown	None	0.0018	46,XY,t(9;22)(q34;q11.2)[9]/46,XY[11]	Negative	BCR-ABL1	NA	NA	6.4	0.01	NA	NA	NA	NA	NA	BLL	3695.0	122.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	37.9
all_phase2_target_2018_pub	TARGET-10-PAPART	TARGET-10-PAPART-09	3.0	805.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3794.0	1	Not Hispanic or Latino	Positive	None	NA	47,XX,+21[[6]/46,XX,der(12)t(12;15)(p11.2;q13),-15,+21[14]/46,XX[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3794.0	125.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	11.14
all_phase2_target_2018_pub	TARGET-10-PAPASX	TARGET-10-PAPASX-09	3.0	849.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3433.0	1	Hispanic or Latino	Positive	None	0.0096	46,XX,i(21)(q10)[2]/46,XX[14]	Negative	ETV6-RUNX1	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3433.0	113.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	82.62
all_phase2_target_2018_pub	TARGET-10-PAPATR	TARGET-10-PAPATR-03	15.0	5334.0	NA	NA	DISCOVERY	Negative	9.0	2.0	1.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	47.0	1	Not Hispanic or Latino	Unknown	Progression	0.0290	46,XX,del(1)(q25q42),del(7)(q11.1),der(13)ins(13pter->13q?31::1?q25->1?q42::7q22->q32::13q?31->13qter),der(16)ins(16;13)(q22;q?12q?14)[12]/46,XX[12]	Negative	None of the above	NA	NA	4.8	0.01	NA	NA	NA	NA	NA	BLL	1440.0	48.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	105.3
all_phase2_target_2018_pub	TARGET-10-PAPAVC	TARGET-10-PAPAVC-09	13.0	4646.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	502.0	1.115	Not Hispanic or Latino	Unknown	None	0.1582	NA	Unknown	None of the above	NA	NA	0.015	0.01	NA	NA	NA	NA	NA	BLL	502.0	17.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.7
all_phase2_target_2018_pub	TARGET-10-PAPAVK	TARGET-10-PAPAVK-09	18.0	6212.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	264.0	1	Not Hispanic or Latino	Negative	Death	0.0013	46,XX[19]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	264.0	9.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	12.2
all_phase2_target_2018_pub	TARGET-10-PAPAVR	TARGET-10-PAPAVR-09	4.0	1312.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2445.0	1.27	Not Hispanic or Latino	Negative	None	NA	58,XX,+3,+4,+6,+8,+9,+10,+12,add(12)(p11.2),+13,+14,+18,+20,+21[cp10]/46,XX[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2445.0	81.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	4.0
all_phase2_target_2018_pub	TARGET-10-PAPAWB	TARGET-10-PAPAWB-03	4.0	1100.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3885.0	1	Hispanic or Latino	Positive	None	0.0568	45,X,-X,add(9)(p11.2),del(12)(p11.2)[cp9]/46,XX[2]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3885.0	128.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	178.3
all_phase2_target_2018_pub	TARGET-10-PAPAWK	TARGET-10-PAPAWK-09	12.0	4291.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3532.0	1	Not Hispanic or Latino	Unknown	None	0.0113	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3532.0	117.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	90.9
all_phase2_target_2018_pub	TARGET-10-PAPAWY	TARGET-10-PAPAWY-09	5.0	1623.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	312.0	1	Not Hispanic or Latino	Unknown	None	0.0076	NA	Unknown	None of the above	NA	NA	0.0017	NA	NA	NA	NA	NA	NA	BLL	312.0	11.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	73.58
all_phase2_target_2018_pub	TARGET-10-PAPAXH	TARGET-10-PAPAXH-09	3.0	983.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2914.0	1	Not Hispanic or Latino	Negative	None	NA	45,X,t(X;?20;15)(p11.2;q11.2;q11.2),inv(7)(p15q22),del(8)(q11.2q13),del(9)(p13p23),-16[12]/45,idem,add(11)(q23)[2]/46,XX[2]	Negative	NA	NA	NA	0.0025	0.0025	NA	NA	NA	NA	NA	BLL	2914.0	96.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.8
all_phase2_target_2018_pub	TARGET-10-PAPAZA	TARGET-10-PAPAZA-09	9.0	2967.0	CHEMOTHERAPY	NA	VALIDATION	Negative	3.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2422.0	1	Not Hispanic or Latino	Positive	None	NA	45,XX,add(7)(p22),dic(12;19)(p11.2;q13.1),i(21)(q10)[14]/46,XX[8]	Negative	NA	NA	NA	0.047	0.001	NA	NA	NA	NA	NA	BLL	2422.0	80.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	8.0
all_phase2_target_2018_pub	TARGET-10-PAPAZD	TARGET-10-PAPAZD-09	8.0	2557.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3815.0	1.18	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3815.0	126.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	4.6
all_phase2_target_2018_pub	TARGET-10-PAPAZL	TARGET-10-PAPAZL-09	12.0	4225.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3803.0	1	Not Hispanic or Latino	Unknown	None	0.0035	46,XY,t(1;4)(q4?2;q2?5)[8]/46,XY[19]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3803.0	126.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.7
all_phase2_target_2018_pub	TARGET-10-PAPBAI	TARGET-10-PAPBAI-09	3.0	960.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3612.0	1.223	Not Hispanic or Latino	Negative	None	NA	58,XY,+X,+4,+6,+10,+14,+15,+16,+17,+18,+20,+21,+21[1]/46,XY[33]	Negative	NA	NA	NA	0.0033	0.0033	NA	NA	NA	NA	NA	BLL	3612.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	6.6
all_phase2_target_2018_pub	TARGET-10-PAPBAN	TARGET-10-PAPBAN-09	5.0	1816.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3381.0	1.217	Not Hispanic or Latino	Negative	None	NA	57,XX,+X,dup(1)(q21q32),+3,+6,+10,+12,+14,+15,+17,+18,+21,+21[cp8]/46,XX[12]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3381.0	112.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	40.6
all_phase2_target_2018_pub	TARGET-10-PAPBCF	TARGET-10-PAPBCF-09	4.0	1332.0	NA	NA	DISCOVERY	Positive	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3014.0	1	Not Hispanic or Latino	Negative	None	0.0028	46,XX,t(9;22)(q34;q11.2)[12]/46,XX[8]	Negative	BCR-ABL1	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3014.0	100.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	75.0
all_phase2_target_2018_pub	TARGET-10-PAPBCI	TARGET-10-PAPBCI-09	10.0	3625.0	NA	NA	DISCOVERY	Negative	17.0	0.0	NA	67.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2602.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0292	46,XY,del(6)(q15q21),add(7)(p15),-10,add(20)(q13),+mar[15]/46,XY[25]	Negative	None of the above	0.0	0.01	0.89	0.01	NA	NA	NA	NA	NA	BLL	3085.0	102.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	125.7
all_phase2_target_2018_pub	TARGET-10-PAPBCK	TARGET-10-PAPBCK-09	6.0	2088.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	2881.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+21c	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2881.0	95.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.8
all_phase2_target_2018_pub	TARGET-10-PAPBDE	TARGET-10-PAPBDE-03	2.0	598.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3797.0	1	Not Hispanic or Latino	Unknown	None	0.0236	45,dic(9;20)(p13;q11.2)[17]/46,XY[3]	Negative	None of the above	NA	NA	0.4	0.01	NA	NA	NA	NA	NA	BLL	3797.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	228.0
all_phase2_target_2018_pub	TARGET-10-PAPBDI	TARGET-10-PAPBDI-09	3.0	1033.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	18.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3524.0	1	Hispanic or Latino	Positive	None	0.0025	NA	Unknown	ETV6-RUNX1	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	3524.0	116.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	68.07
all_phase2_target_2018_pub	TARGET-10-PAPBDM	TARGET-10-PAPBDM-09	5.0	1661.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1172.0	1	Not Hispanic or Latino	Positive	None	0.0291	46,XX,del(5)(q13q31)[6]/46,XX[14]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1172.0	39.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	95.1
all_phase2_target_2018_pub	TARGET-10-PAPBDR	TARGET-10-PAPBDR-03	13.0	4503.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	45.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1753.0	1	Hispanic or Latino	Positive	Relapse	0.0009	NA	Unknown	ETV6-RUNX1	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	2302.0	76.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	10.8
all_phase2_target_2018_pub	TARGET-10-PAPBES	TARGET-10-PAPBES-03	3.0	812.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2814.0	1.23	Not Hispanic or Latino	Negative	SMN	0.8855	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	0.0	0.01	0.11	0.01	NA	NA	NA	NA	5	BLL	3665.0	121.0	1:DECEASED	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	0.166666666667	Unknown	88.0
all_phase2_target_2018_pub	TARGET-10-PAPBFN	TARGET-10-PAPBFN-09	11.0	3976.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1256.0	1.147	Not Hispanic or Latino	Unknown	SMN	0.3117	52,X,-Y,+X,+4,+6,-7,+10,+11,+14,+21,+22[5]/52,idem,add(9)(p13)[3]/46,XY[12]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0072	NA	NA	NA	NA	NA	11	BLL	1508.0	50.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.366666666667	Positive	8.6
all_phase2_target_2018_pub	TARGET-10-PAPBIK	TARGET-10-PAPBIK-09	4.0	1281.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3869.0	1	Unknown	Unknown	None	0.0063	46,XY,add(8)(p21)[17]/46,XY[25]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3869.0	128.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	63.36
all_phase2_target_2018_pub	TARGET-10-PAPBKV	TARGET-10-PAPBKV-09	2.0	617.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	51.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3418.0	1.14	Not Hispanic or Latino	Negative	None	0.1940	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	3418.0	113.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Positive	97.3
all_phase2_target_2018_pub	TARGET-10-PAPBLU	TARGET-10-PAPBLU-09	6.0	1877.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3697.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0018	0.0018	NA	NA	NA	NA	NA	BLL	3697.0	122.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	16.0
all_phase2_target_2018_pub	TARGET-10-PAPBMI	TARGET-10-PAPBMI-09	15.0	5133.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	850.0	1.05	Not Hispanic or Latino	Unknown	Relapse	0.0148	46,XX,der(21)amp(21)(q22)amp(AML1)[2]/46,XX[10]	Negative	iAMP21	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	1278.0	43.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	1.5
all_phase2_target_2018_pub	TARGET-10-PAPBPC	TARGET-10-PAPBPC-09	8.0	2567.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3527.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,der(9)t(9;9*)(p21;q21),-13,der(19)t(1;19)(q23;p13),+r[15]/46,XY[5]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3527.0	116.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Positive	No	No	NA	Negative	13.6
all_phase2_target_2018_pub	TARGET-10-PAPBRW	TARGET-10-PAPBRW-09	14.0	4973.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1829.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0812	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3487.0	115.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.7
all_phase2_target_2018_pub	TARGET-10-PAPBSB	TARGET-10-PAPBSB-09	12.0	4363.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3738.0	1	Hispanic or Latino	Unknown	None	0.0261	46,XX,del(13)(q12q32)[24]/46,XX[6]	Negative	None of the above	NA	NA	0.0001	NA	NA	NA	NA	NA	NA	BLL	3738.0	123.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.5
all_phase2_target_2018_pub	TARGET-10-PAPBSE	TARGET-10-PAPBSE-09	15.0	5163.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2673.0	1	Not Hispanic or Latino	Negative	None	0.0155	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2673.0	88.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	35.7
all_phase2_target_2018_pub	TARGET-10-PAPBSY	TARGET-10-PAPBSY-09	3.0	883.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	3.0	NA	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	665.0	77.0	1.062	Not Hispanic or Latino	Negative	Relapse	0.0844	46,XY,der(19)t(1;19)(q23;p13)[cp12]/46,XY[11]	Negative	TCF3-PBX1	NA	NA	0.32	0.01	NA	NA	NA	NA	1	BLL	665.0	22.0	1:DECEASED	No	AALL0331	Black or African American	1	Male	Matched	Positive	No	No	NA	Negative	10.4
all_phase2_target_2018_pub	TARGET-10-PAPBTG	TARGET-10-PAPBTG-09	3.0	1042.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3578.0	1	Not Hispanic or Latino	Positive	None	0.0119	46,XX,del(9)(p21p21),der(9)t(9;21)(p21;q22),der(12)t(12;21)(p1?3;q2?2),t(12;21)(p13q22)[12]/46,XX[10]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3578.0	118.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	92.4
all_phase2_target_2018_pub	TARGET-10-PAPBTM	TARGET-10-PAPBTM-09	2.0	489.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1722.0	1	Not Hispanic or Latino	Unknown	None	0.0395	der(19)t(1;19)(q23;p13.3) detected by FISH.	Unknown	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1722.0	57.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Positive	No	No	NA	Unknown	62.1
all_phase2_target_2018_pub	TARGET-10-PAPBUR	TARGET-10-PAPBUR-09	21.0	7368.0	NA	NA	DISCOVERY	Positive	NA	4.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3653.0	1	Hispanic or Latino	Unknown	None	0.0012	NA	Unknown	BCR-ABL1	NA	NA	21.1	0.01	NA	NA	NA	NA	NA	BLL	3653.0	121.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	29.2
all_phase2_target_2018_pub	TARGET-10-PAPBUS	TARGET-10-PAPBUS-09	3.0	765.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3549.0	1	Not Hispanic or Latino	Negative	None	0.0010	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3549.0	117.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	82.1
all_phase2_target_2018_pub	TARGET-10-PAPBVD	TARGET-10-PAPBVD-09	3.0	904.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2113.0	1	Not Hispanic or Latino	Negative	None	NA	45,XY,add(12)(p12,-13,der(19)t(1;19)(q23;p13.3)[12]/46,XY[8]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2113.0	70.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Positive	No	No	NA	Negative	12.7
all_phase2_target_2018_pub	TARGET-10-PAPBWZ	TARGET-10-PAPBWZ-09	2.0	568.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3744.0	1.16	Hispanic or Latino	Negative	None	0.2479	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3744.0	124.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	51.2
all_phase2_target_2018_pub	TARGET-10-PAPBYJ	TARGET-10-PAPBYJ-09	16.0	5490.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2375.0	1	Not Hispanic or Latino	Unknown	None	0.1004	46,X,-X,del(6)(q13q25),t(12;14)(p13;q13),+14,der(14)t(12;14)(p13;q13)[cp9]/46,XX[11]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2375.0	79.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	79.0
all_phase2_target_2018_pub	TARGET-10-PAPBYL	TARGET-10-PAPBYL-09	11.0	3661.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3883.0	1	Hispanic or Latino	Negative	None	0.0022	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3883.0	128.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	12.9
all_phase2_target_2018_pub	TARGET-10-PAPBYM	TARGET-10-PAPBYM-09	3.0	1086.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	36.0	1	Not Hispanic or Latino	Positive	Censored	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	36.0	2.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	4.3
all_phase2_target_2018_pub	TARGET-10-PAPBYU	TARGET-10-PAPBYU-09	3.0	1077.0	Chemotherapy	per AALL0232 but with Dex instead of Pred per mother's request	DISCOVERY	Negative	11.0	3.0	3.0	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2636.0	1.254	Hispanic or Latino	Unknown	None	0.4031	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	0.0	0.01	1.3	0.01	NA	NA	NA	NA	NA	BLL	2636.0	87.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	74.3
all_phase2_target_2018_pub	TARGET-10-PAPBZK	TARGET-10-PAPBZK-03	19.0	6713.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	365.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0010	46,XY[20]	Negative	None of the above	NA	NA	0.04	0.01	NA	NA	NA	NA	2	BLL	790.0	26.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.0666666666667	Negative	13.7
all_phase2_target_2018_pub	TARGET-10-PAPBZK	TARGET-10-PAPBZK-09	19.0	6713.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	365.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY[20]	Negative	None of the above	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	790.0	26.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	13.7
all_phase2_target_2018_pub	TARGET-10-PAPBZW	TARGET-10-PAPBZW-09	4.0	1137.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	54.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2771.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.035	0.001	NA	NA	NA	NA	NA	BLL	2771.0	92.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	29.0
all_phase2_target_2018_pub	TARGET-10-PAPCAF	TARGET-10-PAPCAF-09	2.0	509.0	NA	NA	DISCOVERY	Negative	9.0	0.0	NA	74.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	205.0	1	Hispanic or Latino	Negative	Relapse	0.0176	46,X,del(X)(q24q28)[16]/46,XX[4]	Negative	None of the above	NA	NA	0.19	0.01	NA	NA	NA	NA	NA	BLL	3599.0	119.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	586.8
all_phase2_target_2018_pub	TARGET-10-PAPCBT	TARGET-10-PAPCBT-09	15.0	5179.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3792.0	1.069	Not Hispanic or Latino	Unknown	None	0.0556	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3792.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PAPCCB	TARGET-10-PAPCCB-03	2.0	462.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3753.0	1.208	Not Hispanic or Latino	Unknown	None	0.0433	56,XX,+X,+4,+6,+10,+14,+17,+18,+18,+21,+21[14]/46,XX[1]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3753.0	124.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	56.1
all_phase2_target_2018_pub	TARGET-10-PAPCDC	TARGET-10-PAPCDC-09	16.0	5621.0	Chemotherapy	NA	DISCOVERY	Negative	NA	1.0	NA	74.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1832.0	1	Not Hispanic or Latino	Unknown	None	0.0474	47,XY,+12[7]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1832.0	61.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	95.7
all_phase2_target_2018_pub	TARGET-10-PAPCDE	TARGET-10-PAPCDE-09	14.0	5026.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1547.0	1	Not Hispanic or Latino	Unknown	None	0.0254	48,XX,+20,+21[6]/46,XX[11]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1547.0	51.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	9.1
all_phase2_target_2018_pub	TARGET-10-PAPCED	TARGET-10-PAPCED-09	5.0	1591.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3416.0	1	Hispanic or Latino	Positive	None	NA	46,XX[19]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3416.0	113.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	0.4
all_phase2_target_2018_pub	TARGET-10-PAPCFS	TARGET-10-PAPCFS-09	10.0	3459.0	NA	NA	DISCOVERY	Negative	15.0	0.0	NA	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2545.0	0.51	Not Hispanic or Latino	Negative	None	0.0665	25,X,+X,+21[17]/50,idemx2[2]/46,XX[1]	Negative	Hypodiploid	NA	NA	0.045	0.001	NA	NA	NA	NA	NA	BLL	2545.0	84.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	93.5
all_phase2_target_2018_pub	TARGET-10-PAPCGH	TARGET-10-PAPCGH-09	16.0	5484.0	Transplant; Other	gleevec	DISCOVERY	Positive	5.0	0.0	NA	48.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3557.0	1	Not Hispanic or Latino	Unknown	None	0.0293	48,XY,+X,t(9;22)(q34;q11.2),+17[3]/49,idem,+mar[3]/46,XY[24]	Negative	BCR-ABL1	NA	NA	5.0	0.01	NA	NA	NA	NA	NA	BLL	3557.0	117.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	4.9
all_phase2_target_2018_pub	TARGET-10-PAPCGZ	TARGET-10-PAPCGZ-09	12.0	4106.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	2449.0	1.132	Not Hispanic or Latino	Unknown	SMN	0.5555	NA	Unknown	None of the above	0.0	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	2658.0	88.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	9.2
all_phase2_target_2018_pub	TARGET-10-PAPCHT	TARGET-10-PAPCHT-09	14.0	5108.0	NA	NA	DISCOVERY	Negative	3.0	2.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2406.0	1	Hispanic or Latino	Negative	None	0.0135	46,XY,t(2;9)(p11.2;p21),del(9)(p12)[16]/47,idem,+mar[4]/46,XY[3]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2406.0	80.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	26.0
all_phase2_target_2018_pub	TARGET-10-PAPCJB	TARGET-10-PAPCJB-03	17.0	6099.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1275.0	1	Hispanic or Latino	Unknown	None	0.0010	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1275.0	42.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	39.6
all_phase2_target_2018_pub	TARGET-10-PAPCJR	TARGET-10-PAPCJR-09	3.0	1028.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2837.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2837.0	94.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	16.15
all_phase2_target_2018_pub	TARGET-10-PAPCJS	TARGET-10-PAPCJS-03	2.0	663.0	NA	NA	DISCOVERY	Negative	17.0	0.0	0.0	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	612.0	1	Hispanic or Latino	Negative	Relapse	NA	45,XY,dic(9;9)(p13;p13[14]/46,XY[6]	Negative	TCF3-PBX1	NA	NA	1.05	0.01	NA	NA	NA	NA	NA	BLL	3551.0	117.0	0:LIVING	No	AALL0331	Black or African American	2	Male	Matched	Positive	No	No	NA	Negative	18.5
all_phase2_target_2018_pub	TARGET-10-PAPCJS	TARGET-10-PAPCJS-04	2.0	663.0	NA	NA	DISCOVERY	Negative	17.0	0.0	0.0	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	612.0	1	Hispanic or Latino	Negative	Relapse	NA	45,XY,dic(9;9)(p13;p13[14]/46,XY[6]	Negative	TCF3-PBX1	NA	NA	1.05	0.01	NA	NA	NA	NA	NA	BLL	3551.0	117.0	0:LIVING	No	AALL0331	Black or African American	2	Male	Matched	Positive	No	No	NA	Negative	18.5
all_phase2_target_2018_pub	TARGET-10-PAPCKW	TARGET-10-PAPCKW-09	6.0	2043.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3625.0	1	Not Hispanic or Latino	Unknown	None	0.0509	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3625.0	120.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	74.9
all_phase2_target_2018_pub	TARGET-10-PAPCNG	TARGET-10-PAPCNG-09	13.0	4430.0	NA	NA	DISCOVERY	Negative	2.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3008.0	1.245	Not Hispanic or Latino	Unknown	None	0.5492	56,XY,+X,+4,+4,+6,+10,+11,+14,+18,+21,+21[4]/56,idem,dup(1)(q12q42),add(4)(p14)[11]/46,XY[5]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3008.0	99.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	12.11
all_phase2_target_2018_pub	TARGET-10-PAPCNP	TARGET-10-PAPCNP-09	10.0	3508.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	58.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	58.0	2.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	26.0
all_phase2_target_2018_pub	TARGET-10-PAPCNR	TARGET-10-PAPCNR-09	12.0	4227.0	NA	NA	DISCOVERY	Negative	29.0	0.0	NA	21.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2287.0	1.13	Not Hispanic or Latino	Negative	None	0.1936	51,XX,+4,+6,+14,i(17)(q10),+21,+21[17]/46,XY[3]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	2287.0	76.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	1.5
all_phase2_target_2018_pub	TARGET-10-PAPCPB	TARGET-10-PAPCPB-09	5.0	1525.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3674.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,add(12)(p11.2)[8]/46,XY[11]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3674.0	121.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	1.7
all_phase2_target_2018_pub	TARGET-10-PAPCPC	TARGET-10-PAPCPC-04	3.0	979.0	Chemotherapy	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1017.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2399.0	79.0	1:DECEASED	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PAPCRD	TARGET-10-PAPCRD-09	3.0	933.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3754.0	1.25	Not Hispanic or Latino	Negative	None	NA	58,XY,+X,+4,+6,+8,+10,+14,+14,+17,+18,+21,+21,+mar1[cp4]/58,idem,dup(1)(q21q44),-mar1,+mar2[cp5]/46,XY[5]	Negative	NA	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3754.0	124.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	34.7
all_phase2_target_2018_pub	TARGET-10-PAPCRJ	TARGET-10-PAPCRJ-09	3.0	1032.0	CHEMOTHERAPY	NA	VALIDATION	Negative	3.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3387.0	1.16	Not Hispanic or Latino	Negative	None	NA	54,XX,+X,dup(1)(q21q32),+6,+10,+14,+17,+18,+21,+21[2]/46,XX[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3387.0	112.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PAPCRU	TARGET-10-PAPCRU-03	7.0	2435.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3773.0	1.19	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,dup(1)(q32q21),+4,+6,+9,add(9)(q12),+10,+14,+18,+20,+21[5]/56,idem,+mar[6]/46,XY[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3773.0	125.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	15.2
all_phase2_target_2018_pub	TARGET-10-PAPCSR	TARGET-10-PAPCSR-09	12.0	4278.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3213.0	1.95	Not Hispanic or Latino	Positive	None	0.3910	NA	Unknown	ETV6-RUNX1	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3213.0	106.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	4.6
all_phase2_target_2018_pub	TARGET-10-PAPCSZ	TARGET-10-PAPCSZ-09	10.0	3637.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	4.0	0.0	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1582.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,-21,+mar[20]/46,XY[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2105.0	70.0	1:DECEASED	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	1.4
all_phase2_target_2018_pub	TARGET-10-PAPCUI	TARGET-10-PAPCUI-09	5.0	1524.0	CHEMOTHERAPY	NA	VALIDATION	Negative	4.0	1.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3234.0	1.2	Not Hispanic or Latino	Negative	None	NA	57,XY,+X,+Y,+6,+10,+10,+14,+17,+18,+18,+21,+21[16]/46,XY[3]	Negative	NA	NA	NA	0.07	0.01	NA	NA	NA	NA	NA	BLL	3234.0	107.0	0:LIVING	No	AALL0331	Asian	1	Male	Matched	Negative	No	No	NA	Negative	15.2
all_phase2_target_2018_pub	TARGET-10-PAPCUR	TARGET-10-PAPCUR-04	4.0	1098.0	NA	NA	DISCOVERY	Negative	11.0	0.0	NA	17.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	369.0	222.0	1	Not Hispanic or Latino	Negative	Relapse	0.0007	46,XX[20]	Negative	None of the above	31.5	0.01	NA	NA	NA	NA	NA	NA	NA	BLL	369.0	13.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	8.4
all_phase2_target_2018_pub	TARGET-10-PAPCUR	TARGET-10-PAPCUR-09	4.0	1098.0	NA	NA	DISCOVERY	Negative	11.0	0.0	NA	17.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	369.0	222.0	1	Not Hispanic or Latino	Negative	Relapse	0.0005	46,XX[20]	Negative	None of the above	31.5	0.01	NA	NA	NA	NA	NA	NA	1	BLL	369.0	13.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.0333333333333	Negative	8.4
all_phase2_target_2018_pub	TARGET-10-PAPCVA	TARGET-10-PAPCVA-09	14.0	5040.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1469.0	1302.0	1	Hispanic or Latino	Negative	Relapse	0.0122	46,XY,dup(1)(q32q25),del(6)(q13),?t(9;21)(p22;q22)[12]/46,XY[8]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1469.0	49.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	204.0
all_phase2_target_2018_pub	TARGET-10-PAPCVI	TARGET-10-PAPCVI-09	5.0	1541.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3370.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,del(12)(p11.2p13)[22]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3370.0	111.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	20.0
all_phase2_target_2018_pub	TARGET-10-PAPCVR	TARGET-10-PAPCVR-09	3.0	1029.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	66.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3669.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0015	0.0015	NA	NA	NA	NA	NA	BLL	3669.0	121.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	16.0
all_phase2_target_2018_pub	TARGET-10-PAPCVV	TARGET-10-PAPCVV-09	18.0	6422.0	NA	NA	DISCOVERY	Negative	2.0	0.0	0.0	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1742.0	1.098	Not Hispanic or Latino	Unknown	None	0.0448	NA	Unknown	None of the above	NA	NA	5.0	0.01	NA	NA	NA	NA	NA	BLL	1742.0	58.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.8
all_phase2_target_2018_pub	TARGET-10-PAPCVZ	TARGET-10-PAPCVZ-03	6.0	1833.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1255.0	1.363	Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0048	NA	NA	NA	NA	NA	NA	BLL	3248.0	107.0	0:LIVING	No	AALL0331	Unknown	3	Female	Matched	Unknown	No	NA	NA	Positive	11.6
all_phase2_target_2018_pub	TARGET-10-PAPCVZ	TARGET-10-PAPCVZ-04	6.0	1833.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1255.0	1.363	Hispanic or Latino	Negative	Relapse	0.2470	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0048	NA	NA	NA	NA	NA	NA	BLL	3248.0	107.0	0:LIVING	No	AALL0331	Unknown	3	Female	Matched	Unknown	No	NA	NA	Positive	11.6
all_phase2_target_2018_pub	TARGET-10-PAPCVZ	TARGET-10-PAPCVZ-09	6.0	1833.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1255.0	1.363	Hispanic or Latino	Negative	Relapse	0.2169	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0048	NA	NA	NA	NA	NA	4	BLL	3248.0	107.0	0:LIVING	No	AALL0331	Unknown	3	Female	Matched	Unknown	No	NA	0.133333333333	Positive	11.6
all_phase2_target_2018_pub	TARGET-10-PAPCWJ	TARGET-10-PAPCWJ-09	18.0	6466.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3766.0	1	Hispanic or Latino	Unknown	None	0.0017	46,XY,inv(9)(p24q22)[27]/46,XY,del6)(q13q23)[3]/46,XY[12]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3766.0	124.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	14.33
all_phase2_target_2018_pub	TARGET-10-PAPCWN	TARGET-10-PAPCWN-09	12.0	4231.0	Chemotherapy	NA	DISCOVERY	Negative	10.0	2.0	1.0	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3809.0	1.316	Not Hispanic or Latino	Unknown	None	0.0168	62,XX,+X,+1,+2,+4,+5,+8,+8,+11,+12,+14,+14,+19,+20,+21,+21,+22[cp3]/62,idem,t(7;10)(q22;q24)[5]/46,XX[10]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	3.1	0.01	NA	NA	NA	NA	NA	BLL	3809.0	126.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	12.2
all_phase2_target_2018_pub	TARGET-10-PAPCXR	TARGET-10-PAPCXR-09	16.0	5710.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3c	No	NA	3848.0	1	Not Hispanic or Latino	Unknown	None	0.0025	46,XY,t(5;5)(q13;q31)[12]/46,XY[8]	Negative	None of the above	NA	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	3848.0	127.0	0:LIVING	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	68.9
all_phase2_target_2018_pub	TARGET-10-PAPCXR	TARGET-10-PAPCXR-60.1	16.0	5710.0	NA	NA	XENOGRAFT	Negative	1.0	2.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3c	No	NA	3848.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;5)(q13;q31)[12]/46,XY[8]	Negative	None of the above	NA	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	3848.0	127.0	0:LIVING	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	68.9
all_phase2_target_2018_pub	TARGET-10-PAPCXR	TARGET-10-PAPCXR-60.2	16.0	5710.0	NA	NA	XENOGRAFT	Negative	1.0	2.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3c	No	NA	3848.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;5)(q13;q31)[12]/46,XY[8]	Negative	None of the above	NA	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	3848.0	127.0	0:LIVING	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	68.9
all_phase2_target_2018_pub	TARGET-10-PAPCXR	TARGET-10-PAPCXR-60.3	16.0	5710.0	NA	NA	XENOGRAFT	Negative	1.0	2.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3c	No	NA	3848.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;5)(q13;q31)[12]/46,XY[8]	Negative	None of the above	NA	0.01	0.0	0.01	NA	NA	NA	NA	NA	BLL	3848.0	127.0	0:LIVING	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	68.9
all_phase2_target_2018_pub	TARGET-10-PAPCYX	TARGET-10-PAPCYX-09	15.0	5149.0	NA	NA	DISCOVERY	Negative	1.0	3.0	NA	67.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3549.0	1.085	Not Hispanic or Latino	Unknown	None	0.0823	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3549.0	117.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	5.9
all_phase2_target_2018_pub	TARGET-10-PAPDAU	TARGET-10-PAPDAU-09	2.0	470.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3635.0	1.073	Hispanic or Latino	Negative	None	0.0315	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3635.0	120.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	120.2
all_phase2_target_2018_pub	TARGET-10-PAPDBE	TARGET-10-PAPDBE-09	18.0	6367.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2228.0	1	Hispanic or Latino	Negative	None	0.0236	46,XY,del(9)(p21)[10]/47,idem,+8[3]/46,idem,-10,+r[2]/46,XY[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2228.0	74.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.0
all_phase2_target_2018_pub	TARGET-10-PAPDBX	TARGET-10-PAPDBX-09	4.0	1286.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	37.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	37.0	2.0	0:LIVING	No	AALL0331	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	40.4
all_phase2_target_2018_pub	TARGET-10-PAPDCC	TARGET-10-PAPDCC-09	6.0	1897.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3795.0	1	Hispanic or Latino	Negative	None	0.0473	46,XX,t(1;19)(q23;p13.3)[16]/46,XX[4]	Negative	TCF3-PBX1	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3795.0	125.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	85.2
all_phase2_target_2018_pub	TARGET-10-PAPDCH	TARGET-10-PAPDCH-09	3.0	905.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	2.0	4.0	6.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2129.0	1	Not Hispanic or Latino	Negative	Relapse	0.0142	46,XY,del(12)(p11.2p13),add(15)(p11),?del(16)(q22),add(19)(p13)[8]/46,XY[12]	Negative	None of the above	0.1	0.01	1.4	0.01	NA	NA	NA	NA	NA	BLL	3664.0	121.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	69.0
all_phase2_target_2018_pub	TARGET-10-PAPDCK	TARGET-10-PAPDCK-09	17.0	6139.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3723.0	1	Not Hispanic or Latino	Negative	None	0.0003	46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3723.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	3.7
all_phase2_target_2018_pub	TARGET-10-PAPDCR	TARGET-10-PAPDCR-09	5.0	1519.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3681.0	1.205	Hispanic or Latino	Negative	None	0.3545	55,XY,+X,+Y,+4,+6,+10,+14,+18,+21,+21[3]/46,XY[6]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3681.0	122.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	56.4
all_phase2_target_2018_pub	TARGET-10-PAPDCS	TARGET-10-PAPDCS-09	6.0	1963.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3248.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,del(4)(q31),del(6)(q21)[8]/46,XY[13]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3248.0	107.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	3.2
all_phase2_target_2018_pub	TARGET-10-PAPDCU	TARGET-10-PAPDCU-09	21.0	7532.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1149.0	1	Not Hispanic or Latino	Unknown	None	0.1941	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1149.0	38.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	5.9
all_phase2_target_2018_pub	TARGET-10-PAPDDA	TARGET-10-PAPDDA-09	5.0	1685.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	69.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2921.0	1.1	Not Hispanic or Latino	Negative	None	NA	51,XY,+X,+Y,+10,+21,+21[3]/46,XY[9]	Negative	NA	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	2921.0	97.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	39.33
all_phase2_target_2018_pub	TARGET-10-PAPDEE	TARGET-10-PAPDEE-04	11.0	3798.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1115.0	995.0	1.06	Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1115.0	37.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	8.5
all_phase2_target_2018_pub	TARGET-10-PAPDEE	TARGET-10-PAPDEE-09	11.0	3798.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1115.0	995.0	1.06	Hispanic or Latino	Negative	Relapse	0.0007	46,XY[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1115.0	37.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	8.5
all_phase2_target_2018_pub	TARGET-10-PAPDFS	TARGET-10-PAPDFS-09	5.0	1503.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3829.0	1.11	Not Hispanic or Latino	Negative	None	NA	53,XX,+X,+6,+14,+17,+18,+21,+21[17]/46,XX[3]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3829.0	126.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	18.0
all_phase2_target_2018_pub	TARGET-10-PAPDFU	TARGET-10-PAPDFU-09	11.0	3654.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3597.0	1	Hispanic or Latino	Negative	None	0.0003	46,XX[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3597.0	119.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Unknown	2.6
all_phase2_target_2018_pub	TARGET-10-PAPDFU	TARGET-10-PAPDFU-60.1	11.0	3654.0	NA	NA	XENOGRAFT	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3597.0	1	Hispanic or Latino	Negative	None	NA	46,XX[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3597.0	119.0	0:LIVING	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Unknown	2.6
all_phase2_target_2018_pub	TARGET-10-PAPDGF	TARGET-10-PAPDGF-09	12.0	4113.0	NA	NA	DISCOVERY	Negative	19.0	1.0	NA	36.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2567.0	1.145	Not Hispanic or Latino	Negative	Relapse	0.2150	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.013000000000000001	0.01	NA	NA	NA	NA	NA	BLL	3776.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Positive	3.0
all_phase2_target_2018_pub	TARGET-10-PAPDGX	TARGET-10-PAPDGX-09	12.0	4094.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3156.0	1	Not Hispanic or Latino	Positive	None	0.0214	46,XY,del(8)(q12q22),del(9)(p21),t(11;15)(q21;q24)[16]/46,XY[4]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3156.0	104.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	176.8
all_phase2_target_2018_pub	TARGET-10-PAPDHA	TARGET-10-PAPDHA-09	3.0	776.0	NA	NA	VALIDATION	Negative	8.0	1.0	NA	66.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3794.0	1.18	Not Hispanic or Latino	Negative	None	NA	55,XY,+4,+6,+10,+14,+16,+17,+20,+21,+22[cp6]/46,XY[39]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3794.0	125.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	33.7
all_phase2_target_2018_pub	TARGET-10-PAPDHD	TARGET-10-PAPDHD-03	15.0	5288.0	NA	NA	DISCOVERY	Negative	98.0	9.0	6.0	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3478.0	1	Hispanic or Latino	Unknown	None	0.0020	NA	Unknown	None of the above	NA	NA	41.3	0.01	NA	NA	NA	NA	NA	BLL	3478.0	115.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	584.0
all_phase2_target_2018_pub	TARGET-10-PAPDIZ	TARGET-10-PAPDIZ-03	2.0	717.0	NA	NA	DISCOVERY	Negative	1.0	5.0	2.0	54.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2559.0	1	Not Hispanic or Latino	Negative	Relapse	0.0102	46,XX,t(9;12)(p13;q22),del(20)(q11.2)[20]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3482.0	115.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	332.0
all_phase2_target_2018_pub	TARGET-10-PAPDJM	TARGET-10-PAPDJM-04	3.0	829.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	50.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	722.0	1.268	Not Hispanic or Latino	Negative	Relapse	0.1779	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0063	NA	NA	NA	NA	NA	NA	BLL	722.0	24.0	0:LIVING	No	AALL0331	White	2	Male	Matched	Unknown	No	No	NA	Positive	17.6
all_phase2_target_2018_pub	TARGET-10-PAPDJM	TARGET-10-PAPDJM-09	3.0	829.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	50.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	722.0	1.268	Not Hispanic or Latino	Negative	Relapse	0.2421	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0063	NA	NA	NA	NA	NA	4	BLL	722.0	24.0	0:LIVING	No	AALL0331	White	2	Male	Matched	Unknown	No	No	0.133333333333	Positive	17.6
all_phase2_target_2018_pub	TARGET-10-PAPDJT	TARGET-10-PAPDJT-09	19.0	6782.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Positive	40.0	3.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	99.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0149	NA	Unknown	BCR-ABL1	NA	NA	7.7	0.01	NA	NA	NA	NA	NA	BLL	263.0	9.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	295.0
all_phase2_target_2018_pub	TARGET-10-PAPDKD	TARGET-10-PAPDKD-09	3.0	846.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2075.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	2075.0	69.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	3.81
all_phase2_target_2018_pub	TARGET-10-PAPDKG	TARGET-10-PAPDKG-09	13.0	4568.0	NA	NA	DISCOVERY	Negative	80.0	70.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1	Not Hispanic or Latino	Negative	Induction failure	0.0010	46,XX[30]	Unknown	None of the above	NA	NA	70.0	0.01	NA	NA	NA	NA	NA	BLL	634.0	21.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	103.7
all_phase2_target_2018_pub	TARGET-10-PAPDKJ	TARGET-10-PAPDKJ-04	4.0	1449.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	0.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1456.0	819.0	1	Not Hispanic or Latino	Positive	Relapse	0.0333	46,XY,del(6)(q13q22)[3]/46,idem,t(1;15)(q25;p11.2)[2]/46,XY[15]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1456.0	48.0	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Negative	No	No	NA	Negative	3.5
all_phase2_target_2018_pub	TARGET-10-PAPDKJ	TARGET-10-PAPDKJ-09	4.0	1449.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	0.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1456.0	819.0	1	Not Hispanic or Latino	Positive	Relapse	0.0173	46,XY,del(6)(q13q22)[3]/46,idem,t(1;15)(q25;p11.2)[2]/46,XY[15]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	4	BLL	1456.0	48.0	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Negative	No	No	0.133333333333	Negative	3.5
all_phase2_target_2018_pub	TARGET-10-PAPDKR	TARGET-10-PAPDKR-09	2.0	636.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3718.0	1.23	Not Hispanic or Latino	Negative	None	NA	57,XX,+X,+X,+1,del(1)(p11),+4,+6,+10,+14,+17,+18,+21,+21[16]/46,XX[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3718.0	123.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Positive	33.6
all_phase2_target_2018_pub	TARGET-10-PAPDLH	TARGET-10-PAPDLH-09	5.0	1517.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	39.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3459.0	1.18	Not Hispanic or Latino	Negative	None	0.2077	56,XX,+X,+6,+8,+10,+14,+17,+18,+18,+21,+21[cp5]/46,XX[15]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3459.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	131.8
all_phase2_target_2018_pub	TARGET-10-PAPDLN	TARGET-10-PAPDLN-09	3.0	790.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3805.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3805.0	126.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	25.9
all_phase2_target_2018_pub	TARGET-10-PAPDMU	TARGET-10-PAPDMU-09	6.0	2132.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3716.0	1	Hispanic or Latino	Negative	None	NA	46,XY[24]	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3716.0	123.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	3.9
all_phase2_target_2018_pub	TARGET-10-PAPDNB	TARGET-10-PAPDNB-03	17.0	5945.0	NA	NA	DISCOVERY	Positive	8.0	73.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	20.0	1	Not Hispanic or Latino	Unknown	Induction failure	NA	46,XY,t(9;22)(q34;q11.2)[20]	Negative	BCR-ABL1	NA	NA	66.0	0.01	NA	NA	NA	NA	NA	BLL	661.0	22.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	487.4
all_phase2_target_2018_pub	TARGET-10-PAPDNB	TARGET-10-PAPDNB-09	17.0	5945.0	NA	NA	DISCOVERY	Positive	8.0	73.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	20.0	1	Not Hispanic or Latino	Unknown	Induction failure	0.0012	46,XY,t(9;22)(q34;q11.2)[20]	Negative	BCR-ABL1	NA	NA	66.0	0.01	NA	NA	NA	NA	NA	BLL	661.0	22.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	487.4
all_phase2_target_2018_pub	TARGET-10-PAPDRD	TARGET-10-PAPDRD-09	2.0	449.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3629.0	1	Hispanic or Latino	Unknown	None	0.0690	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3629.0	120.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	124.7
all_phase2_target_2018_pub	TARGET-10-PAPDRL	TARGET-10-PAPDRL-09	15.0	5197.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	1.0	NA	43.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3549.0	1.206	Not Hispanic or Latino	Unknown	None	0.4229	56,XX,+X,dup(1)(q23q42),+4,+4,+6,+i(7)(q10),+10,+14,+17,+18,+21,+21[10]/46,XX[10]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3549.0	117.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Positive	29.0
all_phase2_target_2018_pub	TARGET-10-PAPDRP	TARGET-10-PAPDRP-09	5.0	1679.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	44.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2048.0	1	Unknown	Positive	None	NA	46,XY,t(5;16)(q13;q23),t(9;10)(q34;q22),add(12)(p11.2)[11]/46,XY[7]	Negative	NA	NA	NA	0.028999999999999998	0.001	NA	NA	NA	NA	NA	BLL	2048.0	68.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	32.49
all_phase2_target_2018_pub	TARGET-10-PAPDRX	TARGET-10-PAPDRX-09	6.0	1966.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3792.0	1.065	Hispanic or Latino	Unknown	None	0.0130	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3792.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	55.3
all_phase2_target_2018_pub	TARGET-10-PAPDSW	TARGET-10-PAPDSW-09	4.0	1306.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	65.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3150.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.01	0.01	NA	NA	NA	NA	NA	BLL	3150.0	104.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	17.6
all_phase2_target_2018_pub	TARGET-10-PAPDTN	TARGET-10-PAPDTN-09	4.0	1384.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2327.0	1.217	Hispanic or Latino	Unknown	None	0.5210	56,X,-Y,+X,+4,+6,+8,+10,+14,+14,+17,+18,+21,+21[20]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2327.0	77.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	225.4
all_phase2_target_2018_pub	TARGET-10-PAPDUF	TARGET-10-PAPDUF-09	4.0	1217.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1191.0	1.177	Not Hispanic or Latino	Negative	Relapse	0.2698	56,XY,+X,+4,+6,+10,+14,+15,+17,+21,+21,+21[9]/46,XY[4]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0071	NA	NA	NA	NA	NA	6	BLL	3669.0	121.0	0:LIVING	Yes	AALL0331	White	1	Male	Matched	Negative	No	No	0.2	Positive	5.6
all_phase2_target_2018_pub	TARGET-10-PAPDUV	TARGET-10-PAPDUV-04	6.0	1986.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION;DISCOVERY	Negative	2.0	0.0	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1524.0	1.139	Not Hispanic or Latino	Negative	Relapse	0.0114	46,XX,der(21)amp(21)(q22)del(21)(q22)[16]/46,XX[2]	Negative	iAMP21	NA	NA	0.48	0.01	NA	NA	NA	NA	NA	BLL	3501.0	116.0	0:LIVING	No	AALL0331	Asian	2	Female	Matched	Negative	No	NA	NA	Negative	31.2
all_phase2_target_2018_pub	TARGET-10-PAPDUV	TARGET-10-PAPDUV-09	6.0	1986.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION;DISCOVERY	Negative	2.0	0.0	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1524.0	1.139	Not Hispanic or Latino	Negative	Relapse	0.0113	46,XX,der(21)amp(21)(q22)del(21)(q22)[16]/46,XX[2]	Negative	iAMP21	NA	NA	0.48	0.01	NA	NA	NA	NA	8	BLL	3501.0	116.0	0:LIVING	No	AALL0331	Asian	2	Female	Matched	Negative	No	NA	0.266666666667	Negative	31.2
all_phase2_target_2018_pub	TARGET-10-PAPDUX	TARGET-10-PAPDUX-09	4.0	1359.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2380.0	1.06	Not Hispanic or Latino	Negative	None	NA	46,XX,t(11;12)(q13;q24.3),add(14)(p13)[cp10]/46,XX[9]	Negative	NA	0.0029	0.0029	0.14	0.01	NA	NA	NA	NA	NA	BLL	2380.0	79.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	43.1
all_phase2_target_2018_pub	TARGET-10-PAPDVA	TARGET-10-PAPDVA-09	19.0	6754.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1623.0	1	Not Hispanic or Latino	Negative	Relapse	0.0030	46,XY[21]	Unknown	None of the above	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	3092.0	102.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	236.7
all_phase2_target_2018_pub	TARGET-10-PAPDVF	TARGET-10-PAPDVF-09	4.0	1137.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3298.0	1	Not Hispanic or Latino	Unknown	None	0.0014	NA	Unknown	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3298.0	109.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	7.9
all_phase2_target_2018_pub	TARGET-10-PAPDVG	TARGET-10-PAPDVG-09	8.0	2675.0	NA	NA	VALIDATION	Positive	0.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3427.0	1.05	Hispanic or Latino	Negative	Death	NA	NA	Unknown	NA	NA	NA	1.6	0.01	NA	NA	NA	NA	NA	BLL	3427.0	113.0	1:DECEASED	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	8.0
all_phase2_target_2018_pub	TARGET-10-PAPDVX	TARGET-10-PAPDVX-09	15.0	5478.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2130.0	1	Not Hispanic or Latino	Positive	None	0.0400	46,XY,add(1)(q43),dup(3)(q21q29),add(13)(q32)[10]/46,XY,add(1)(q43),add(13)(q32),add(14)(q24)[2]/46,XY[9]	Negative	ETV6-RUNX1	NA	NA	0.006	0.001	NA	NA	NA	NA	NA	BLL	2130.0	71.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.0
all_phase2_target_2018_pub	TARGET-10-PAPDWT	TARGET-10-PAPDWT-04	6.0	2146.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	868.0	1.147	Not Hispanic or Latino	Negative	Relapse	0.2429	NA	Unknown	None of the above	NA	NA	0.076	0.001	NA	NA	NA	NA	NA	BLL	3470.0	115.0	0:LIVING	No	AALL0331	Asian	2	Female	Matched	Unknown	No	NA	NA	Negative	13.4
all_phase2_target_2018_pub	TARGET-10-PAPDWT	TARGET-10-PAPDWT-09	6.0	2146.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	868.0	1.147	Not Hispanic or Latino	Negative	Relapse	0.2835	NA	Unknown	None of the above	NA	NA	0.076	0.001	NA	NA	NA	NA	5	BLL	3470.0	115.0	0:LIVING	No	AALL0331	Asian	2	Female	Matched	Unknown	No	NA	0.166666666667	Negative	13.4
all_phase2_target_2018_pub	TARGET-10-PAPDXF	TARGET-10-PAPDXF-09	2.0	679.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	1650.0	1.15	Not Hispanic or Latino	Negative	Relapse	0.2088	54,XY,+X,+4,+6,del(6)(q21q23),+14,+17,+18,+21,+21[6]/55,idem,+10[4]/54,idem,dup(1)(q21q42),+10[8]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3760.0	124.0	0:LIVING	Yes	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	138.2
all_phase2_target_2018_pub	TARGET-10-PAPDXH	TARGET-10-PAPDXH-09	11.0	3669.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Positive	0.0	1.0	NA	34.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	259.0	0.831	Not Hispanic or Latino	Unknown	Death	0.0159	45,XX,t(9;22)(q34;q11.2),dic(13;20)(p12;q11.2)[10]/46,idem,+mar[3]/46,XX[4]	Negative	BCR-ABL1	NA	NA	0.047	0.001	NA	NA	NA	NA	NA	BLL	259.0	9.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	168.7
all_phase2_target_2018_pub	TARGET-10-PAPDXN	TARGET-10-PAPDXN-09	16.0	5505.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3450.0	1	Hispanic or Latino	Unknown	None	0.0016	46,XX[25]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3450.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	51.5
all_phase2_target_2018_pub	TARGET-10-PAPDYE	TARGET-10-PAPDYE-09	7.0	2408.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3772.0	1.23	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3772.0	125.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	3.2
all_phase2_target_2018_pub	TARGET-10-PAPDZD	TARGET-10-PAPDZD-09	3.0	734.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3429.0	1	Not Hispanic or Latino	Positive	None	0.0152	47,XX,+21[5]/46,XX[12]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3429.0	113.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	91.6
all_phase2_target_2018_pub	TARGET-10-PAPEAB	TARGET-10-PAPEAB-03	4.0	1355.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1340.0	1.236	Not Hispanic or Latino	Negative	Relapse	NA	57,XX,+X,dup(1)(q21q42),+4,+6,+8,+10,+14,+14,+17,+18,+18,+21[17]/46,XX[3]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.28	0.01	NA	NA	NA	NA	NA	BLL	3353.0	111.0	0:LIVING	Yes	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Positive	4.8
all_phase2_target_2018_pub	TARGET-10-PAPEAB	TARGET-10-PAPEAB-04	4.0	1355.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1340.0	1.236	Not Hispanic or Latino	Negative	Relapse	0.9482	57,XX,+X,dup(1)(q21q42),+4,+6,+8,+10,+14,+14,+17,+18,+18,+21[17]/46,XX[3]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.28	0.01	NA	NA	NA	NA	NA	BLL	3353.0	111.0	0:LIVING	Yes	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Positive	4.8
all_phase2_target_2018_pub	TARGET-10-PAPEAB	TARGET-10-PAPEAB-09	4.0	1355.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1340.0	1.236	Not Hispanic or Latino	Negative	Relapse	0.0012	57,XX,+X,dup(1)(q21q42),+4,+6,+8,+10,+14,+14,+17,+18,+18,+21[17]/46,XX[3]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.28	0.01	NA	NA	NA	NA	NA	BLL	3353.0	111.0	0:LIVING	Yes	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Positive	4.8
all_phase2_target_2018_pub	TARGET-10-PAPECF	TARGET-10-PAPECF-04	3.0	785.0	NA	NA	DISCOVERY	Negative	3.0	2.0	NA	49.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1178.0	1	Not Hispanic or Latino	Positive	Relapse	0.0218	48,XX,+10,t(12;21)(p13;q22),+21[cp8]/46,XX[10]	Negative	ETV6-RUNX1	NA	NA	0.059000000000000004	0.001	NA	NA	NA	NA	NA	BLL	1290.0	43.0	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	22.6
all_phase2_target_2018_pub	TARGET-10-PAPECF	TARGET-10-PAPECF-09	3.0	785.0	NA	NA	DISCOVERY	Negative	3.0	2.0	NA	49.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1178.0	1	Not Hispanic or Latino	Positive	Relapse	0.0607	48,XX,+10,t(12;21)(p13;q22),+21[cp8]/46,XX[10]	Negative	ETV6-RUNX1	NA	NA	0.059000000000000004	0.001	NA	NA	NA	NA	1	BLL	1290.0	43.0	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.0333333333333	Negative	22.6
all_phase2_target_2018_pub	TARGET-10-PAPECI	TARGET-10-PAPECI-09	4.0	1238.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3460.0	1.24	Hispanic or Latino	Negative	None	0.9241	58,XX,+4,+5,+6,+10,+11,+12,+14,+16,+17,+18,+21,+21[14]/46,XX[1]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3460.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	61.2
all_phase2_target_2018_pub	TARGET-10-PAPECK	TARGET-10-PAPECK-09	2.0	394.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3478.0	1	Unknown	Negative	None	0.0008	46,XX,der(1)t(1;9)(q25;p22),der(9)t(9;11)(p22;q23),der(11)t(9;11)(p22;q23)t(1;11)(q25;q23)[20]	Positive	MLL-Rearranged	NA	NA	0.006999999999999999	0.001	NA	NA	NA	NA	NA	BLL	3478.0	115.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	54.8
all_phase2_target_2018_pub	TARGET-10-PAPECV	TARGET-10-PAPECV-09	5.0	1568.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	0.58	Hispanic or Latino	Negative	None	0.1086	27,X,+Y,+8,+10,+21[5]/52,idemx2,-Y,-8[3]/46,XY[14]	Negative	Hypodiploid	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	28.0	1.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	190.9
all_phase2_target_2018_pub	TARGET-10-PAPEET	TARGET-10-PAPEET-09	18.0	6395.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	82.0	1.08	Hispanic or Latino	Unknown	Censored	0.0022	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	82.0	3.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.1
all_phase2_target_2018_pub	TARGET-10-PAPEFH	TARGET-10-PAPEFH-03	7.0	2543.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	852.0	816.0	1.077	Unknown	Negative	Relapse	NA	48,XX,+21c,+mar1[7]/48,idem,-X,+mar2[4]/47,XX,+21c[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	10	BLL	852.0	29.0	1:DECEASED	No	AALL0331	White	3	Female	Matched	Negative	No	NA	0.333333333333	Negative	18.0
all_phase2_target_2018_pub	TARGET-10-PAPEFH	TARGET-10-PAPEFH-04	7.0	2543.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	852.0	816.0	1.077	Unknown	Negative	Relapse	0.0645	48,XX,+21c,+mar1[7]/48,idem,-X,+mar2[4]/47,XX,+21c[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	852.0	29.0	1:DECEASED	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	18.0
all_phase2_target_2018_pub	TARGET-10-PAPEFH	TARGET-10-PAPEFH-09	7.0	2543.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	Yes	852.0	816.0	1.077	Unknown	Negative	Relapse	0.0232	48,XX,+21c,+mar1[7]/48,idem,-X,+mar2[4]/47,XX,+21c[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	852.0	29.0	1:DECEASED	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	18.0
all_phase2_target_2018_pub	TARGET-10-PAPEGV	TARGET-10-PAPEGV-04	11.0	3872.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	0.0	NA	49.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	923.0	787.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,add(10)(q22)[11]/46,XX[61]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	923.0	31.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	51.5
all_phase2_target_2018_pub	TARGET-10-PAPEGV	TARGET-10-PAPEGV-09	11.0	3872.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	0.0	NA	49.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	923.0	787.0	1	Not Hispanic or Latino	Negative	Relapse	0.0012	46,XX,add(10)(q22)[11]/46,XX[61]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	923.0	31.0	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	51.5
all_phase2_target_2018_pub	TARGET-10-PAPEHX	TARGET-10-PAPEHX-09	2.0	720.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3723.0	1.09	Hispanic or Latino	Negative	None	0.0296	46,XX,der(19)t(1;19)(q23;p13)[3]/51,idem,+5,+8,+9,+21,+22[2]/46,XX[16]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3723.0	123.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Positive	No	NA	NA	Negative	85.1
all_phase2_target_2018_pub	TARGET-10-PAPEHY	TARGET-10-PAPEHY-09	7.0	2532.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3569.0	1	Not Hispanic or Latino	Positive	None	0.0347	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3569.0	118.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	90.8
all_phase2_target_2018_pub	TARGET-10-PAPEIC	TARGET-10-PAPEIC-09	12.0	4243.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	1.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	1401.0	1	Not Hispanic or Latino	Negative	None	0.0256	46,XX[20]	Unknown	None of the above	NA	NA	0.045	0.001	NA	NA	NA	NA	NA	BLL	1401.0	47.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	40.4
all_phase2_target_2018_pub	TARGET-10-PAPEJA	TARGET-10-PAPEJA-09	4.0	1221.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	77.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3582.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,del(12)(p11.2p12)[5]/46,XY,der(12)del(12)(p11.2p12)del(12)(q13q21),t(4;19)(q25;q13)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3582.0	118.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	5.7
all_phase2_target_2018_pub	TARGET-10-PAPEJL	TARGET-10-PAPEJL-09	10.0	3475.0	NA	NA	VALIDATION	Negative	42.0	1.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3173.0	1	Not Hispanic or Latino	Positive	None	NA	47,XX,+21[6]/46,XX[11]	Negative	NA	0.0	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3173.0	105.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.3
all_phase2_target_2018_pub	TARGET-10-PAPEJM	TARGET-10-PAPEJM-09	4.0	1344.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3472.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3472.0	115.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	5.4
all_phase2_target_2018_pub	TARGET-10-PAPEJN	TARGET-10-PAPEJN-04	4.0	1129.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION;DISCOVERY	Negative	0.0	1.0	NA	38.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	934.0	342.0	1	Unknown	Positive	Relapse	0.0934	NA	Unknown	ETV6-RUNX1	NA	NA	0.017	0.001	NA	NA	NA	NA	NA	BLL	934.0	31.0	1:DECEASED	No	AALL0331	Unknown	2	Male	Matched	Unknown	No	No	NA	Unknown	12.5
all_phase2_target_2018_pub	TARGET-10-PAPEJN	TARGET-10-PAPEJN-09	4.0	1129.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION;DISCOVERY	Negative	0.0	1.0	NA	38.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	934.0	342.0	1	Unknown	Positive	Relapse	0.0250	NA	Unknown	ETV6-RUNX1	NA	NA	0.017	0.001	NA	NA	NA	NA	7	BLL	934.0	31.0	1:DECEASED	No	AALL0331	Unknown	2	Male	Matched	Unknown	No	No	0.233333333333	Unknown	12.5
all_phase2_target_2018_pub	TARGET-10-PAPELE	TARGET-10-PAPELE-09	11.0	3749.0	NA	NA	DISCOVERY	Negative	30.0	1.0	NA	40.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1550.0	1244.0	1	Unknown	Negative	Relapse	0.0367	45,XY,del(6)(p21.3),dic(7;9)(p11.1;p11)[20]	Negative	None of the above	NA	NA	0.29	0.01	NA	NA	NA	NA	NA	BLL	1550.0	51.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	78.9
all_phase2_target_2018_pub	TARGET-10-PAPELV	TARGET-10-PAPELV-09	14.0	4961.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3027.0	1	Hispanic or Latino	Negative	None	0.0474	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3027.0	100.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	0.5
all_phase2_target_2018_pub	TARGET-10-PAPELY	TARGET-10-PAPELY-09	15.0	5157.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3109.0	1	Not Hispanic or Latino	Unknown	None	0.0491	46,XY[20]	Unknown	None of the above	NA	NA	0.0035	NA	NA	NA	NA	NA	NA	BLL	3109.0	103.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.7
all_phase2_target_2018_pub	TARGET-10-PAPEMC	TARGET-10-PAPEMC-09	3.0	962.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	28.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	2192.0	1.3	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3689.0	122.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	Yes	No	NA	Positive	4.5
all_phase2_target_2018_pub	TARGET-10-PAPEMZ	TARGET-10-PAPEMZ-09	5.0	1674.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	3745.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,+21c[27]	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3745.0	124.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	7.0
all_phase2_target_2018_pub	TARGET-10-PAPENI	TARGET-10-PAPENI-09	2.0	415.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3769.0	1.088	Not Hispanic or Latino	Negative	None	0.0296	46,XX,der(19)t(1;19)(q23;p13)[15]	Negative	TCF3-PBX1	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	3769.0	124.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Positive	No	NA	NA	Negative	472.0
all_phase2_target_2018_pub	TARGET-10-PAPEPP	TARGET-10-PAPEPP-09	18.0	6324.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1823.0	1.23	Not Hispanic or Latino	Negative	None	0.8670	56,XX,+X,+4,+5,+6,+8,+10,+14,+17,+21,+21[5]/46,XX[7]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1823.0	60.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	1.5
all_phase2_target_2018_pub	TARGET-10-PAPEPR	TARGET-10-PAPEPR-09	12.0	4184.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3591.0	1	Not Hispanic or Latino	Negative	None	0.0572	46,XX,+1,der(1;9)(q10;q10)[10]/46,XX[1]	Negative	None of the above	NA	NA	0.0019	NA	NA	NA	NA	NA	NA	BLL	3591.0	119.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	30.29
all_phase2_target_2018_pub	TARGET-10-PAPERG	TARGET-10-PAPERG-04	19.0	6740.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	53.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	763.0	1.059	Hispanic or Latino	Negative	Relapse	NA	46,XY,t(9;16)(p24;q22)[10]	Negative	None of the above	NA	NA	0.077	0.001	NA	NA	NA	NA	NA	BLL	2906.0	96.0	0:LIVING	No	AALL0232	Unknown	2	Male	Matched	Negative	No	No	NA	Negative	31.3
all_phase2_target_2018_pub	TARGET-10-PAPERG	TARGET-10-PAPERG-09	19.0	6740.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	53.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	763.0	1.059	Hispanic or Latino	Negative	Relapse	0.0013	46,XY,t(9;16)(p24;q22)[10]	Negative	None of the above	NA	NA	0.077	0.001	NA	NA	NA	NA	NA	BLL	2906.0	96.0	0:LIVING	No	AALL0232	Unknown	2	Male	Matched	Negative	No	No	NA	Negative	31.3
all_phase2_target_2018_pub	TARGET-10-PAPERK	TARGET-10-PAPERK-09	3.0	994.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3567.0	1.214	Not Hispanic or Latino	Negative	None	0.1482	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	3567.0	118.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Negative	77.0
all_phase2_target_2018_pub	TARGET-10-PAPERM	TARGET-10-PAPERM-09	3.0	890.0	NA	NA	VALIDATION	Negative	1.0	2.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3307.0	1	Unknown	Positive	None	NA	47,XX,+10,add(12)(p11.2)[9]/46,XX[7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3307.0	109.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	13.07
all_phase2_target_2018_pub	TARGET-10-PAPERN	TARGET-10-PAPERN-09	4.0	1384.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1133.0	0.56	Not Hispanic or Latino	Negative	Death	NA	27,X,+Y,add(2)(p11.2),+9,add(9)(p13),+14,add(14)(q13),+21[11]/46,XY[9]	Negative	NA	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	1133.0	38.0	1:DECEASED	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	14.8
all_phase2_target_2018_pub	TARGET-10-PAPERU	TARGET-10-PAPERU-09	6.0	2133.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1637.0	1	Not Hispanic or Latino	Positive	Relapse	NA	45,X,-X[4]/46,XX[16]	Negative	NA	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	3688.0	122.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	12.9
all_phase2_target_2018_pub	TARGET-10-PAPERV	TARGET-10-PAPERV-09	16.0	5801.0	Chemotherapy; Transplant	NA	DISCOVERY	Positive	15.0	1.0	NA	92.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	470.0	1	Not Hispanic or Latino	Negative	Death	0.0820	46,XX,dic(8;20)(p11.2;q13.1),+dic(8;20)(p11.2;q13.1),del(9)(p12),t(9;22)(q34;q11.2)[17]/46,XX[3]	Negative	BCR-ABL1	NA	NA	1.6	0.01	NA	NA	NA	NA	NA	BLL	470.0	16.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	205.0
all_phase2_target_2018_pub	TARGET-10-PAPERW	TARGET-10-PAPERW-09	6.0	2002.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3813.0	1.22	Not Hispanic or Latino	Negative	None	NA	58,XX,+X,+X,dup(1)(q21q42),+4,+6,+8,+10,+14,+17,+18,+21,+21,+21[7]/46,XX[3]	Negative	NA	NA	NA	0.031	0.001	NA	NA	NA	NA	NA	BLL	3813.0	126.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	6.4
all_phase2_target_2018_pub	TARGET-10-PAPESB	TARGET-10-PAPESB-09	5.0	1535.0	NA	NA	VALIDATION	Negative	6.0	1.0	NA	58.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3480.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q21q23),der(10)t(10;12)(q24;q13),-12,del(12)(p11.2p13),-21,+mar1,+mar2[15]/47,idem,+10[2]	Negative	NA	NA	0.01	0.028999999999999998	0.001	NA	NA	NA	NA	NA	BLL	3480.0	115.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	7.3
all_phase2_target_2018_pub	TARGET-10-PAPESW	TARGET-10-PAPESW-09	3.0	1054.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	86.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1120.0	1.205	Not Hispanic or Latino	Negative	Relapse	0.5635	57,XX,+X,+X,+4,+6,+8,+9,del(9)(p21),+14,+14,+17,+21,+21[5]/46,XX[20]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.013999999999999999	0.01	NA	NA	NA	NA	NA	BLL	3542.0	117.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.1
all_phase2_target_2018_pub	TARGET-10-PAPESY	TARGET-10-PAPESY-09	3.0	818.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3614.0	1.18	Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+6,+10,+14,+17,+18,add(19)(p13.2),+21,+mar[cp12]/46,XX[2]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3614.0	119.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	15.0
all_phase2_target_2018_pub	TARGET-10-PAPESZ	TARGET-10-PAPESZ-09	4.0	1418.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3443.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,del(6)(q21q25),add(10)(q22)[8]/46,idem,del(12)(p11p13)[7]/46,XY[5]	Negative	NA	NA	NA	0.015	0.001	NA	NA	NA	NA	NA	BLL	3443.0	114.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	4.8
all_phase2_target_2018_pub	TARGET-10-PAPETC	TARGET-10-PAPETC-09	5.0	1727.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	2.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3733.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3733.0	123.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	13.55
all_phase2_target_2018_pub	TARGET-10-PAPETT	TARGET-10-PAPETT-09	12.0	4267.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3751.0	1	Not Hispanic or Latino	Negative	None	0.0302	47,XX,+21[10]/46,XX[1]	Negative	None of the above	NA	NA	0.0021	0.01	NA	NA	NA	NA	NA	BLL	3751.0	124.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.9
all_phase2_target_2018_pub	TARGET-10-PAPEUN	TARGET-10-PAPEUN-09	12.0	4300.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3577.0	1.192	Not Hispanic or Latino	Negative	None	0.2673	NA	Unknown	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3577.0	118.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Positive	16.5
all_phase2_target_2018_pub	TARGET-10-PAPEUY	TARGET-10-PAPEUY-09	11.0	3860.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3390.0	1	Hispanic or Latino	Positive	None	0.0365	46,XY[20]	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3390.0	112.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	60.24
all_phase2_target_2018_pub	TARGET-10-PAPEVU	TARGET-10-PAPEVU-09	4.0	1455.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3647.0	1.126	Not Hispanic or Latino	Negative	None	0.2532	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3647.0	120.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	56.5
all_phase2_target_2018_pub	TARGET-10-PAPEWA	TARGET-10-PAPEWA-09	10.0	3491.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3493.0	1.075	Not Hispanic or Latino	Positive	None	0.0070	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3493.0	115.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	90.1
all_phase2_target_2018_pub	TARGET-10-PAPEWB	TARGET-10-PAPEWB-09	8.0	2606.0	NA	NA	DISCOVERY	Negative	NA	NA	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3430.0	1	Hispanic or Latino	Negative	None	0.0270	46,X,der(X;3)(p10;p10),del(15)(q24)[1]/46,idem,add(12)(p13)[2]/46,XX[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	10	BLL	3430.0	113.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	0.333333333333	Negative	88.3
all_phase2_target_2018_pub	TARGET-10-PAPEWV	TARGET-10-PAPEWV-09	5.0	1551.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3485.0	1	Not Hispanic or Latino	Positive	None	0.0272	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3485.0	115.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	85.0
all_phase2_target_2018_pub	TARGET-10-PAPEXA	TARGET-10-PAPEXA-09	3.0	1037.0	NA	NA	DISCOVERY	Negative	0.0	0.0	3.0	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1258.0	1.945	Not Hispanic or Latino	Positive	Censored	0.1311	NA	Unknown	ETV6-RUNX1	0.0078	0.01	1.2	0.01	NA	NA	NA	NA	NA	BLL	1258.0	42.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Positive	54.5
all_phase2_target_2018_pub	TARGET-10-PAPEXI	TARGET-10-PAPEXI-09	5.0	1506.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3576.0	1.223	Not Hispanic or Latino	Negative	None	0.7166	58,XX,dup(1)(q21q42),+4,+6,+8,+10,+12,+14,+14,+17,+21,+21,+22,+mar1[4]/59,idem,+mar2[2]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3576.0	118.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	86.7
all_phase2_target_2018_pub	TARGET-10-PAPEYA	TARGET-10-PAPEYA-09	3.0	903.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	36.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3687.0	1	Not Hispanic or Latino	Positive	None	0.0006	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3687.0	122.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	79.3
all_phase2_target_2018_pub	TARGET-10-PAPEYT	TARGET-10-PAPEYT-09	14.0	4799.0	NA	NA	DISCOVERY	Negative	45.0	1.0	0.0	83.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2294.0	NA	Hispanic or Latino	Negative	None	0.0014	46,XY,add(9)(p22)[cp5]/46,XY[18]	Negative	None of the above	NA	NA	10.9	0.01	NA	NA	NA	NA	NA	BLL	2294.0	76.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	101.1
all_phase2_target_2018_pub	TARGET-10-PAPEZL	TARGET-10-PAPEZL-09	6.0	1904.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3719.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,del(12)(p12p13),t(12;21)(p13;q22)[11]/45,idem,-X[11]	Negative	NA	NA	NA	0.0058	0.0058	NA	NA	NA	NA	NA	BLL	3719.0	123.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	18.3
all_phase2_target_2018_pub	TARGET-10-PAPEZR	TARGET-10-PAPEZR-09	2.0	665.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3732.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3732.0	123.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	5.8
all_phase2_target_2018_pub	TARGET-10-PAPEZS	TARGET-10-PAPEZS-09	13.0	4444.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3259.0	1	Not Hispanic or Latino	Negative	None	0.0543	46,XY,t(1;19)(q23;p13),i(7)(q10)[3]/47,idem,+8[6]/46,XY,i(7)(q10),der(19)t(1;19)(q23p13)[2]/46,XY[9]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3259.0	108.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	14.4
all_phase2_target_2018_pub	TARGET-10-PAPEZX	TARGET-10-PAPEZX-09	13.0	4687.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3587.0	1.056	Not Hispanic or Latino	Positive	None	0.0629	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3587.0	118.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	2.5
all_phase2_target_2018_pub	TARGET-10-PAPFAT	TARGET-10-PAPFAT-09	7.0	2204.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	858.0	1	Hispanic or Latino	Negative	Censored	NA	45,XX,-9,i(9)(q10),del(17)(p11.2),del(20)(q13.1[14]/46,XX[5]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	858.0	29.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	12.7
all_phase2_target_2018_pub	TARGET-10-PAPFBR	TARGET-10-PAPFBR-09	3.0	1042.0	NA	NA	VALIDATION	Negative	12.0	1.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3532.0	1.09	Hispanic or Latino	Positive	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.001	0.001	NA	NA	NA	NA	NA	BLL	3532.0	117.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Positive	4.4
all_phase2_target_2018_pub	TARGET-10-PAPFBX	TARGET-10-PAPFBX-09	5.0	1624.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	58.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2884.0	1.24	Not Hispanic or Latino	Negative	None	NA	57,XX,+X,+1,del(1)(p13p36),+4,+6,+10,+11,+14,+17,+18,+21,+21[7]/46,XX[24]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2884.0	95.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	46.5
all_phase2_target_2018_pub	TARGET-10-PAPFCM	TARGET-10-PAPFCM-09	3.0	1020.0	NA	NA	DISCOVERY	Negative	0.0	3.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3617.0	1.193	Not Hispanic or Latino	Negative	None	0.6691	55,XY,+X,+4,+6,+8,+10,+17,+18,+21,+21[15]/46,XY[5]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3617.0	119.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	57.0
all_phase2_target_2018_pub	TARGET-10-PAPFCS	TARGET-10-PAPFCS-09	5.0	1471.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2624.0	1	Not Hispanic or Latino	Negative	None	0.0295	46,XX,der(19)t(1;19)(q23;p13.3)[7]/46,XX[13]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2624.0	87.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Positive	No	NA	NA	Negative	106.1
all_phase2_target_2018_pub	TARGET-10-PAPFDT	TARGET-10-PAPFDT-04	3.0	1095.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	873.0	1.196	Unknown	Negative	Relapse	NA	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.096	0.001	NA	NA	NA	NA	NA	BLL	2834.0	94.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	4.1
all_phase2_target_2018_pub	TARGET-10-PAPFEG	TARGET-10-PAPFEG-09	5.0	1782.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	38.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	856.0	1.164	Not Hispanic or Latino	Negative	Censored	0.3286	54,XX,+X,+4,+6,+10,+14,+17,+18,+21[4]/46,XX[6]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	856.0	29.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	63.8
all_phase2_target_2018_pub	TARGET-10-PAPFEK	TARGET-10-PAPFEK-09	12.0	4263.0	NA	NA	DISCOVERY	Positive	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	3434.0	1	Not Hispanic or Latino	Unknown	None	0.0214	46,XY,t(9;22)(q34;q11.2)[17]/46,XY[5]	Negative	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3434.0	113.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	19.5
all_phase2_target_2018_pub	TARGET-10-PAPFEL	TARGET-10-PAPFEL-09	11.0	3808.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2808.0	1	Hispanic or Latino	Negative	None	0.0011	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2808.0	93.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	1.6
all_phase2_target_2018_pub	TARGET-10-PAPFFK	TARGET-10-PAPFFK-09	2.0	395.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3534.0	1	Hispanic or Latino	Negative	None	0.0007	46,XX,t(4;11)(q21;q23)[10]/46,idem,add(X)(q24),del(X)(q22q26),der(2)dup(2)(q11.2q33)t(1;2)(q25;q35)[3]/46,XX[7]	Positive	MLL-Rearranged	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3534.0	117.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	90.1
all_phase2_target_2018_pub	TARGET-10-PAPFFW	TARGET-10-PAPFFW-09	4.0	1148.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3085.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,del(12)(p13)[3]/46,XY[32]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3085.0	102.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	5.1
all_phase2_target_2018_pub	TARGET-10-PAPFGA	TARGET-10-PAPFGA-09	18.0	6443.0	NA	NA	DISCOVERY	Negative	6.0	1.0	NA	82.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	286.0	1	Not Hispanic or Latino	Negative	Censored	0.0359	46,XX,der(19)t(1;19)(q21;p13)[16]/46,XX[4]	Negative	TCF3-PBX1	NA	NA	0.045	0.001	NA	NA	NA	NA	NA	BLL	286.0	10.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	19.98
all_phase2_target_2018_pub	TARGET-10-PAPFGV	TARGET-10-PAPFGV-09	15.0	5269.0	NA	NA	DISCOVERY	Positive	1.0	2.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	411.0	1	Not Hispanic or Latino	Unknown	Death	0.0270	46,XX,t(9;22)(q34;q11.2)[3]/46,XX,-7,der((9)del(9)(p13)t(9;22)(q34;q11.2),der(22)t(9;22)(q34;q11.2),+mar1[3]/46,XX[30]	Negative	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	411.0	14.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	5.0
all_phase2_target_2018_pub	TARGET-10-PAPFGW	TARGET-10-PAPFGW-09	13.0	4543.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3689.0	1	Not Hispanic or Latino	Negative	None	0.0039	NA	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3689.0	122.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	92.0
all_phase2_target_2018_pub	TARGET-10-PAPFHD	TARGET-10-PAPFHD-09	18.0	6310.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3535.0	1	Hispanic or Latino	Negative	None	0.0035	NA	Unknown	None of the above	NA	NA	0.040999999999999995	0.001	NA	NA	NA	NA	NA	BLL	3535.0	117.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	102.2
all_phase2_target_2018_pub	TARGET-10-PAPFHH	TARGET-10-PAPFHH-09	5.0	1795.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3336.0	1.16	Unknown	Negative	None	NA	54,XX,+X,+4,+10,+11,+14,+18,+21,+21[18]/46,XX[2]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3336.0	110.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Positive	2.9
all_phase2_target_2018_pub	TARGET-10-PAPFHJ	TARGET-10-PAPFHJ-09	16.0	5839.0	NA	NA	DISCOVERY	Negative	6.0	0.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3786.0	0.9	Not Hispanic or Latino	Negative	None	0.0201	47,XYY?c,del(6)(q13q23)[cp2]/47,XYY?c[19]	Negative	None of the above	0.001	0.001	0.25	0.01	NA	NA	NA	NA	NA	BLL	3786.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PAPFHP	TARGET-10-PAPFHP-09	2.0	600.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3791.0	1	Not Hispanic or Latino	Unknown	None	0.0032	46,XY,del(12)(p13)[2]/46,XY[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3791.0	125.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	50.8
all_phase2_target_2018_pub	TARGET-10-PAPFHR	TARGET-10-PAPFHR-09	3.0	874.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3465.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3465.0	114.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	20.4
all_phase2_target_2018_pub	TARGET-10-PAPFHT	TARGET-10-PAPFHT-09	13.0	4684.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	28.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1869.0	1.174	Not Hispanic or Latino	Negative	None	0.5835	55,XX,+X,+4,+6,+10,+14,+17,+18,+21,+21[9]/46,XX[11]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1869.0	62.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	2.1
all_phase2_target_2018_pub	TARGET-10-PAPFHX	TARGET-10-PAPFHX-09	10.0	3439.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	2409.0	1.04	Not Hispanic or Latino	Negative	None	NA	46,XX,der(7)t(7;12)(p11.2;q11.2),del(12)(q11.2),i(21)(q10)[15]/46,XX[3]	Negative	NA	0.0	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2409.0	80.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	24.5
all_phase2_target_2018_pub	TARGET-10-PAPFIB	TARGET-10-PAPFIB-09	6.0	2075.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3391.0	1	Not Hispanic or Latino	Negative	None	0.0246	45,XY,dic(9;20)(p11;q11)[16]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3391.0	112.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	76.3
all_phase2_target_2018_pub	TARGET-10-PAPFIW	TARGET-10-PAPFIW-09	16.0	5603.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	178.0	1	Hispanic or Latino	Negative	SMN	0.0129	NA	Unknown	None of the above	0.017	0.001	0.58	0.01	NA	NA	NA	NA	NA	BLL	322.0	11.0	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	34.2
all_phase2_target_2018_pub	TARGET-10-PAPFIX	TARGET-10-PAPFIX-09	3.0	822.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	35.0	1.29	Hispanic or Latino	Negative	None	NA	62,XX,+4,+5,+6,+7,+8,+10,+14,+14,+15,+17,+18,+19,+20,+21,+21,+22[cp13]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	35.0	2.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	15.8
all_phase2_target_2018_pub	TARGET-10-PAPFJA	TARGET-10-PAPFJA-09	14.0	4816.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1940.0	1	Not Hispanic or Latino	Negative	None	0.0005	46,XY,t(1;19)(q23;p13)[16]/46,XY[4]	Negative	TCF3-PBX1	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	1940.0	64.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	1.5
all_phase2_target_2018_pub	TARGET-10-PAPFJB	TARGET-10-PAPFJB-09	12.0	4037.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3438.0	1.177	Not Hispanic or Latino	Unknown	None	0.0087	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3438.0	114.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.18
all_phase2_target_2018_pub	TARGET-10-PAPFKA	TARGET-10-PAPFKA-09	4.0	1301.0	NA	NA	VALIDATION	Negative	1.0	1.0	0.0	68.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2605.0	1.213	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	0.01	1.05	0.01	NA	NA	NA	NA	NA	BLL	2605.0	86.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Positive	4.4
all_phase2_target_2018_pub	TARGET-10-PAPFKS	TARGET-10-PAPFKS-09	12.0	4053.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	74.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2055.0	1.086	Not Hispanic or Latino	Unknown	None	NA	54 XY,+Y,+5,+6,+14,+?16,+20,+21,+21[cp7]/46,XY[5]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2055.0	68.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	4.7
all_phase2_target_2018_pub	TARGET-10-PAPFLI	TARGET-10-PAPFLI-09	3.0	833.0	NA	NA	DISCOVERY	Negative	0.0	3.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3598.0	1.087	Hispanic or Latino	Unknown	None	0.0063	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3598.0	119.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	319.0
all_phase2_target_2018_pub	TARGET-10-PAPFMB	TARGET-10-PAPFMB-09	13.0	4669.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3436.0	1	Hispanic or Latino	Negative	None	0.0040	47,XY,+X,t(8;14)(q11.2;q32)[9]/46,XY[20]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3436.0	113.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	0.7
all_phase2_target_2018_pub	TARGET-10-PAPFNA	TARGET-10-PAPFNA-09	18.0	6279.0	NA	NA	DISCOVERY	Negative	0.0	4.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2184.0	1.087	Not Hispanic or Latino	Unknown	Relapse	0.0489	48,XY,+X,+10[12]/46,XY[8]	Negative	None of the above	0.013000000000000001	0.001	0.69	0.01	NA	NA	NA	NA	NA	BLL	2184.0	72.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	22.25
all_phase2_target_2018_pub	TARGET-10-PAPFNN	TARGET-10-PAPFNN-03	3.0	942.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3729.0	1.22	Unknown	Unknown	None	0.1664	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3729.0	123.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	20.72
all_phase2_target_2018_pub	TARGET-10-PAPFNV	TARGET-10-PAPFNV-09	5.0	1654.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3467.0	1	Not Hispanic or Latino	Positive	None	NA	45,X,-X,del(3)(p21p25),del(11)(q23q25),add(12)(p13),del(13)(q12q34)[13]/46,XX[9]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3467.0	114.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	21.74
all_phase2_target_2018_pub	TARGET-10-PAPFPR	TARGET-10-PAPFPR-09	11.0	3826.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3477.0	1.056	Not Hispanic or Latino	Unknown	None	0.1601	50,XY,del(6)(q15),+9,+10,+21,+mar[4]/46,XY[17]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3477.0	115.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	10.7
all_phase2_target_2018_pub	TARGET-10-PAPFPU	TARGET-10-PAPFPU-03	9.0	3067.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1020.0	1	Hispanic or Latino	Positive	Relapse	0.0105	46,XY,add(2)(p11.2)[19]/46,XY[1]	Negative	ETV6-RUNX1	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	3709.0	122.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	56.1
all_phase2_target_2018_pub	TARGET-10-PAPFPZ	TARGET-10-PAPFPZ-09	7.0	2364.0	NA	NA	VALIDATION	Negative	2.0	2.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3608.0	1	Not Hispanic or Latino	Positive	None	NA	45,X,-X,del(11)(q21),del(12)(p12)[cp3]/45,idem,add(14)(p11.2[2]/46,XX[4]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3608.0	119.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	29.6
all_phase2_target_2018_pub	TARGET-10-PAPFTJ	TARGET-10-PAPFTJ-09	6.0	2130.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3475.0	1	Hispanic or Latino	Positive	None	NA	46,XX[42]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3475.0	115.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	5.3
all_phase2_target_2018_pub	TARGET-10-PAPFUF	TARGET-10-PAPFUF-09	8.0	2747.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2212.0	1	Not Hispanic or Latino	Positive	None	NA	49,XX,+10,+14,+21[cp20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2212.0	73.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	23.36
all_phase2_target_2018_pub	TARGET-10-PAPFWE	TARGET-10-PAPFWE-09	9.0	3100.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2304.0	1	Hispanic or Latino	Positive	None	0.0246	46,X,add(X)(q24)[5]/46,idem,add(6)(p25)[10]/46,XX[5]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2304.0	76.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	50.7
all_phase2_target_2018_pub	TARGET-10-PAPFWH	TARGET-10-PAPFWH-09	17.0	6103.0	Chemotherapy	Patient following AALL0232 therapy	DISCOVERY	Negative	0.0	0.0	0.0	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	819.0	711.0	1	Hispanic or Latino	Negative	Relapse	0.0017	46,XX,inv(5)(q31q35)[20]	Negative	None of the above	NA	NA	3.0	0.01	NA	NA	NA	NA	3	BLL	819.0	27.0	1:DECEASED	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	0.1	Negative	15.9
all_phase2_target_2018_pub	TARGET-10-PAPFWZ	TARGET-10-PAPFWZ-09	4.0	1106.0	NA	NA	DISCOVERY	Positive	3.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1133.0	1	Not Hispanic or Latino	Unknown	None	0.0083	46,XX,del(9)(p22),t(9;22)(q34;q11.2)[5]/47,idem,+der(22)t(9;22)[4]/46,XX[9]	Negative	BCR-ABL1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1133.0	38.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	268.0
all_phase2_target_2018_pub	TARGET-10-PAPFXN	TARGET-10-PAPFXN-09	2.0	673.0	NA	NA	DISCOVERY	Negative	6.0	6.0	0.0	56.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	1160.0	1.19	Hispanic or Latino	Negative	None	NA	55,XX,+X,dup(1)(q42q21),del(6)(q13q23),+6,+10,+14,+17,+18,+18,+21,+21[cp18]/46,XX[2]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.01	0.001	0.001	NA	NA	NA	NA	NA	BLL	1160.0	39.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	50.9
all_phase2_target_2018_pub	TARGET-10-PAPFYW	TARGET-10-PAPFYW-09	11.0	3851.0	NA	NA	DISCOVERY	Negative	1.0	2.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3455.0	1	Not Hispanic or Latino	Unknown	None	0.0683	46,XX,i(9)(q10),der(19)t(1;19)(q23;p13)[4]/46,XX[16]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3455.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	33.2
all_phase2_target_2018_pub	TARGET-10-PAPFYX	TARGET-10-PAPFYX-09	15.0	5118.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3473.0	1	Hispanic or Latino	Unknown	None	0.0019	46,XX,t(9;19)(p13;p13.3)[8]/46,XX[17]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3473.0	115.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	2.2
all_phase2_target_2018_pub	TARGET-10-PAPFZD	TARGET-10-PAPFZD-09	14.0	4823.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2152.0	1	Not Hispanic or Latino	Negative	None	0.0848	46,XY,add(7)(p14),der(19)t(1;19)(q23;p13.3)[5]/46,XY,del(9)(p21),der(19)t(1;19)(q23;p13)[4]/46,XY[6]	Negative	TCF3-PBX1	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2152.0	71.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Positive	No	No	NA	Negative	72.8
all_phase2_target_2018_pub	TARGET-10-PAPFZF	TARGET-10-PAPFZF-09	4.0	1317.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3505.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[30]	Unknown	NA	NA	NA	0.003	0.001	NA	NA	NA	NA	NA	BLL	3505.0	116.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	9.0
all_phase2_target_2018_pub	TARGET-10-PAPFZJ	TARGET-10-PAPFZJ-09	11.0	3894.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	85.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3467.0	1.104	Not Hispanic or Latino	Unknown	None	0.1167	NA	Unknown	None of the above	NA	NA	0.067	0.001	NA	NA	NA	NA	NA	BLL	3467.0	114.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	23.3
all_phase2_target_2018_pub	TARGET-10-PAPFZL	TARGET-10-PAPFZL-09	3.0	917.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3437.0	1.16	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3437.0	113.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	6.7
all_phase2_target_2018_pub	TARGET-10-PAPFZX	TARGET-10-PAPFZX-09	4.0	1177.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3745.0	1	Hispanic or Latino	Positive	None	NA	46,XX[20]	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3745.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	10.7
all_phase2_target_2018_pub	TARGET-10-PAPGAA	TARGET-10-PAPGAA-09	4.0	1448.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3542.0	1	Not Hispanic or Latino	Positive	None	0.0414	45,XY,del(6)(q15q25),psu dic(11;9)(q21;p21),add(12)(p13),add(16)(q23),add(19)(p13.3),add(21)(q22)[4]/44,idem,-Y,-4,-add(16),-add(21),+der(21)dup(21)(q22q22)t(4;21)(q12;q22),t(21;21)(q22;q21)[15]/46,XY[6]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3542.0	117.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	14.9
all_phase2_target_2018_pub	TARGET-10-PAPGBY	TARGET-10-PAPGBY-09	20.0	7287.0	NA	NA	DISCOVERY	Positive	NA	NA	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1347.0	1	Not Hispanic or Latino	Unknown	Death	NA	46,XY,t(9;22)(q34;q11.2)[5]/46,XY[15]	Negative	BCR-ABL1	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	1347.0	45.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	66.79
all_phase2_target_2018_pub	TARGET-10-PAPGDR	TARGET-10-PAPGDR-09	16.0	5599.0	NA	NA	DISCOVERY	Negative	6.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3262.0	1.205	Not Hispanic or Latino	Negative	None	0.2927	55,XX,+X,+X,+4,+6,+10,+14,+17,+21,+21[16]/46,XX[4]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.22	0.01	NA	NA	NA	NA	NA	BLL	3262.0	108.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	3.43
all_phase2_target_2018_pub	TARGET-10-PAPGEE	TARGET-10-PAPGEE-09	10.0	3291.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	4.0	NA	75.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3024.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,add(12)(p11.2)[2]/46,XX[19]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3024.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	39.7
all_phase2_target_2018_pub	TARGET-10-PAPGEJ	TARGET-10-PAPGEJ-09	5.0	1519.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3292.0	1	Hispanic or Latino	Negative	None	0.0679	46,XX[20]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3292.0	109.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	64.1
all_phase2_target_2018_pub	TARGET-10-PAPGFD	TARGET-10-PAPGFD-09	4.0	1197.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3688.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(3)(q27),add(12)(p11.2),ider(21)add(21)(q22)[2]/46,XY[19]	Negative	NA	0.0	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	3688.0	122.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	9.2
all_phase2_target_2018_pub	TARGET-10-PAPGFP	TARGET-10-PAPGFP-04	10.0	3519.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	35.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	945.0	859.0	1.05	Not Hispanic or Latino	Negative	Relapse	0.0017	46,XX[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	945.0	32.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	5.0
all_phase2_target_2018_pub	TARGET-10-PAPGFP	TARGET-10-PAPGFP-09	10.0	3519.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	35.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	945.0	859.0	1.05	Not Hispanic or Latino	Negative	Relapse	0.0020	46,XX[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	945.0	32.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.166666666667	Negative	5.0
all_phase2_target_2018_pub	TARGET-10-PAPGGT	TARGET-10-PAPGGT-03	15.0	5273.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2507.0	1	Unknown	Unknown	None	0.0607	45,XY,-7,del(9)(p13p22)[19]/46,XY[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2507.0	83.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	369.4
all_phase2_target_2018_pub	TARGET-10-PAPGHE	TARGET-10-PAPGHE-09	17.0	6071.0	NA	NA	DISCOVERY	Negative	1.0	3.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1372.0	1.082	Not Hispanic or Latino	Negative	Relapse	0.0139	NA	Unknown	None of the above	0.005	0.001	0.12	0.01	NA	NA	NA	NA	NA	BLL	1550.0	51.0	1:DECEASED	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	7.7
all_phase2_target_2018_pub	TARGET-10-PAPGIZ	TARGET-10-PAPGIZ-09	12.0	4182.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1918.0	1	Not Hispanic or Latino	Positive	None	0.0305	46,XX[20]	Unknown	ETV6-RUNX1	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	1918.0	64.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	25.1
all_phase2_target_2018_pub	TARGET-10-PAPGKP	TARGET-10-PAPGKP-09	7.0	2285.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3424.0	1	Hispanic or Latino	Negative	None	NA	45,X,der(X)t(X;1)(q28;q11),der(13;14)(q10;q10)c[5]/45,der(13;14)(q10;q10)c[15]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3424.0	113.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	11.0
all_phase2_target_2018_pub	TARGET-10-PAPGLD	TARGET-10-PAPGLD-09	7.0	2279.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3471.0	1	Hispanic or Latino	Negative	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	3471.0	115.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	17.8
all_phase2_target_2018_pub	TARGET-10-PAPGLJ	TARGET-10-PAPGLJ-09	10.0	3346.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3728.0	1	Not Hispanic or Latino	Negative	None	0.0042	46,XY,add(9)(p23)[8]/46,idem,del(13)(q14q32)[3]/46,Y,t(X;9;6)(p22.3;p22;q15),add(9)(p23)[9]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3728.0	123.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	60.7
all_phase2_target_2018_pub	TARGET-10-PAPGLS	TARGET-10-PAPGLS-09	10.0	3592.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2856.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,?add(5)(q31),add(9)(q22),del(12)(p13.3),del(13)(q14q22[10]/46,XY[10]	Negative	NA	NA	NA	0.00098	0.00098	NA	NA	NA	NA	NA	BLL	2856.0	94.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	6.6
all_phase2_target_2018_pub	TARGET-10-PAPGMC	TARGET-10-PAPGMC-09	18.0	6428.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3726.0	1	Not Hispanic or Latino	Negative	None	0.0015	NA	Unknown	None of the above	0.0	0.01	0.32	0.01	NA	NA	NA	NA	NA	BLL	3726.0	123.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	42.2
all_phase2_target_2018_pub	TARGET-10-PAPGME	TARGET-10-PAPGME-09	14.0	4751.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3141.0	1.813	Not Hispanic or Latino	Positive	None	0.0616	90-92<4n>,XXYY,der(1)(1pter->1p13::1q12->1cen::1cen->1qter)x2,t(2;9)(p12-13;p21)x2,-3,-3,-12,-15,+?21,+7-9mar[cp10]/46,XY[1]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3141.0	104.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	2.4
all_phase2_target_2018_pub	TARGET-10-PAPGMT	TARGET-10-PAPGMT-09	4.0	1372.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3123.0	1.134	Not Hispanic or Latino	Negative	None	NA	53,XX,+6,+10,+14,+17,+18,+21,+21[20]	Negative	NA	NA	NA	0.046	0.001	NA	NA	NA	NA	NA	BLL	3123.0	103.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.5
all_phase2_target_2018_pub	TARGET-10-PAPGMV	TARGET-10-PAPGMV-09	13.0	4559.0	NA	NA	DISCOVERY	Negative	41.0	64.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1.083	Not Hispanic or Latino	Unknown	Induction failure	0.0083	NA	Unknown	None of the above	NA	NA	87.8	0.01	NA	NA	NA	NA	NA	BLL	759.0	25.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	318.4
all_phase2_target_2018_pub	TARGET-10-PAPGNC	TARGET-10-PAPGNC-03	16.0	5652.0	NA	NA	DISCOVERY	Negative	35.0	11.0	5.0	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1889.0	1	Not Hispanic or Latino	Negative	Relapse	0.0020	46,XX[20]	Unknown	None of the above	NA	NA	26.0	0.01	NA	NA	NA	NA	NA	BLL	1914.0	63.0	1:DECEASED	Yes	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	274.9
all_phase2_target_2018_pub	TARGET-10-PAPGNK	TARGET-10-PAPGNK-09	2.0	368.0	NA	NA	DISCOVERY	Negative	4.0	3.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3560.0	1	Hispanic or Latino	Negative	None	0.0056	46,XY,t(9;10)(q34;q24)[cp4]/46,XY[18]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3560.0	118.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	64.1
all_phase2_target_2018_pub	TARGET-10-PAPGPJ	TARGET-10-PAPGPJ-09	3.0	973.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	39.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3420.0	1.104	Hispanic or Latino	Negative	None	0.0367	NA	Unknown	None of the above	NA	NA	0.47	0.01	NA	NA	NA	NA	NA	BLL	3420.0	113.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	50.7
all_phase2_target_2018_pub	TARGET-10-PAPGPW	TARGET-10-PAPGPW-09	7.0	2478.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	2660.0	1	Not Hispanic or Latino	Positive	None	0.0313	46,XY,del(3)(p23),del(6)(q22q25),der(7)t(1;7)(q23;p15),adD(9)(q13),add(12)(p12)[12]/46,XY[2]	Negative	ETV6-RUNX1	NA	NA	0.0085	NA	NA	NA	NA	NA	NA	BLL	2660.0	88.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	222.7
all_phase2_target_2018_pub	TARGET-10-PAPGPZ	TARGET-10-PAPGPZ-09	12.0	4234.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2527.0	1	Not Hispanic or Latino	Negative	None	0.0016	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2527.0	84.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	20.6
all_phase2_target_2018_pub	TARGET-10-PAPGRA	TARGET-10-PAPGRA-09	4.0	1219.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	871.0	1	Not Hispanic or Latino	Positive	Censored	0.0251	NA	Unknown	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	871.0	29.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	67.4
all_phase2_target_2018_pub	TARGET-10-PAPGRM	TARGET-10-PAPGRM-09	6.0	2180.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3578.0	1	Not Hispanic or Latino	Unknown	None	0.0648	45,X,-X,add(12)(p11.2),del(18)(q21)[cp10]/46,XX[5]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3578.0	118.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	117.6
all_phase2_target_2018_pub	TARGET-10-PAPGRZ	TARGET-10-PAPGRZ-03	4.0	1132.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Positive	NA	0.0115	46,XX,add(1)(p36.3),inv(12)(p13q13),del(20)(p12[11]/46,XX[9]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	NA	NA	NA	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	55.6
all_phase2_target_2018_pub	TARGET-10-PAPGWN	TARGET-10-PAPGWN-09	8.0	2830.0	CHEMOTHERAPY	NA	VALIDATION	Negative	2.0	0.0	NA	66.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3475.0	1.08	Not Hispanic or Latino	Negative	None	NA	50,XY,+X,+14,-15,-21,+mar1x3,+mar2[4]/46,XY[16]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3475.0	115.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	1.1
all_phase2_target_2018_pub	TARGET-10-PAPGXB	TARGET-10-PAPGXB-09	11.0	3869.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	492.0	1	Not Hispanic or Latino	Negative	None	0.0490	47,XX,+mar[cp5]/48,idem,+mar[cp5]/46,XX[1]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	492.0	NA	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	4.3
all_phase2_target_2018_pub	TARGET-10-PAPGYC	TARGET-10-PAPGYC-04	4.0	1335.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	1.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	2003.0	1186.0	1.05	Not Hispanic or Latino	Negative	Relapse	NA	48,XX,+X,+21[15]/46,XX[5]	Negative	None of the above	0.004	0.001	0.3	0.01	NA	NA	NA	NA	NA	BLL	2003.0	NA	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	7.7
all_phase2_target_2018_pub	TARGET-10-PAPGYC	TARGET-10-PAPGYC-09	4.0	1335.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	1.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	2003.0	1186.0	1.05	Not Hispanic or Latino	Negative	Relapse	0.0659	48,XX,+X,+21[15]/46,XX[5]	Negative	None of the above	0.004	0.001	0.3	0.01	NA	NA	NA	NA	3	BLL	2003.0	NA	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.1	Negative	7.7
all_phase2_target_2018_pub	TARGET-10-PAPGZL	TARGET-10-PAPGZL-09	16.0	5837.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3527.0	1	Not Hispanic or Latino	Negative	None	0.0012	NA	Unknown	None of the above	NA	NA	0.023	0.001	NA	NA	NA	NA	NA	BLL	3527.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	2.0
all_phase2_target_2018_pub	TARGET-10-PAPHAG	TARGET-10-PAPHAG-09	15.0	5149.0	NA	NA	DISCOVERY	Negative	2.0	2.0	NA	24.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1142.0	1	Not Hispanic or Latino	Negative	Relapse	0.0039	46,XX,t(2;15)(p15;q22)[12]/46,XX[12]	Negative	None of the above	0.0	0.01	0.58	0.01	NA	NA	NA	NA	NA	BLL	1604.0	NA	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	57.9
all_phase2_target_2018_pub	TARGET-10-PAPHAM	TARGET-10-PAPHAM-09	3.0	1003.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3683.0	1	Unknown	Positive	None	NA	46,XY,t(7;15)(q11.2;q15),?t(9;12)(p21;p11.2),add(13)(p11.2)[19]/46,XY[15]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3683.0	122.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	6.5
all_phase2_target_2018_pub	TARGET-10-PAPHBN	TARGET-10-PAPHBN-09	3.0	848.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3763.0	1	Hispanic or Latino	Positive	None	0.0012	46,XX[20]	Unknown	ETV6-RUNX1	NA	NA	0.05	0.01	NA	NA	NA	NA	NA	BLL	3763.0	NA	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	54.1
all_phase2_target_2018_pub	TARGET-10-PAPHBW	TARGET-10-PAPHBW-09	7.0	2362.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3535.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,der(19)t(1;19)(q23;p13),+mar[6]/46,XY[16]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3535.0	117.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Positive	No	No	NA	Negative	40.0
all_phase2_target_2018_pub	TARGET-10-PAPHCA	TARGET-10-PAPHCA-09	3.0	892.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3751.0	1.25	Not Hispanic or Latino	Negative	None	NA	58,XX,+4,+6,+7,+8,+10,+12,+14,+17,+18,+21,+21,+22[cp3]/46,XX[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3751.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	3.4
all_phase2_target_2018_pub	TARGET-10-PAPHCD	TARGET-10-PAPHCD-09	11.0	3790.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3444.0	1	Hispanic or Latino	Positive	None	0.0537	45,XY,del(6)(q13q25),der(14;21)(q10;q10)[15]/46,XY[16]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3444.0	NA	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	5.0
all_phase2_target_2018_pub	TARGET-10-PAPHCJ	TARGET-10-PAPHCJ-09	18.0	6210.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	256.0	1.17	Not Hispanic or Latino	Negative	Censored	0.0751	57,XY,+X,+4,+6,+9,+10,+14,+14,+18,+21,+21,+mar[7]/46,XY[13]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.005	0.001	NA	NA	NA	NA	NA	BLL	256.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	2.1
all_phase2_target_2018_pub	TARGET-10-PAPHDH	TARGET-10-PAPHDH-09	17.0	6166.0	Chemotherapy	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3643.0	1	Not Hispanic or Latino	Unknown	None	0.0024	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3643.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	48.0
all_phase2_target_2018_pub	TARGET-10-PAPHDN	TARGET-10-PAPHDN-09	5.0	1703.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3770.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,del(6)(q13q23)[6]/46,XX[16]	Negative	NA	NA	NA	0.006	0.001	NA	NA	NA	NA	NA	BLL	3770.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.34
all_phase2_target_2018_pub	TARGET-10-PAPHDX	TARGET-10-PAPHDX-09	3.0	791.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	3762.0	1.38	Not Hispanic or Latino	Negative	None	NA	61,XX,+del(X)(q22q26),del(2)(q33q37),der(2)t(1;2)(q21;q37),+2,+4,+5,+6,+8,+10,+10,+11,+12,+14,+17,+18,+21,+21[cp18]/46,XX[17]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3762.0	124.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	42.6
all_phase2_target_2018_pub	TARGET-10-PAPHED	TARGET-10-PAPHED-09	3.0	755.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3392.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX[20]	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3392.0	112.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	19.2
all_phase2_target_2018_pub	TARGET-10-PAPHEK	TARGET-10-PAPHEK-03	9.0	3187.0	NA	NA	DISCOVERY	Positive	15.0	4.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	647.0	647.0	1	Not Hispanic or Latino	Negative	Death	0.5179	46,XX,t(9;22)(q34;q11.2)[20]	Negative	BCR-ABL1	NA	NA	11.0	0.01	NA	NA	NA	NA	2	BLL	647.0	NA	1:DECEASED	No	AALL0232	Unknown	2	Female	Matched	Negative	No	NA	0.0666666666667	Negative	465.0
all_phase2_target_2018_pub	TARGET-10-PAPHEK	TARGET-10-PAPHEK-04	9.0	3187.0	NA	NA	DISCOVERY	Positive	15.0	4.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	647.0	647.0	1	Not Hispanic or Latino	Negative	Death	NA	46,XX,t(9;22)(q34;q11.2)[20]	Negative	BCR-ABL1	NA	NA	11.0	0.01	NA	NA	NA	NA	NA	BLL	647.0	NA	1:DECEASED	No	AALL0232	Unknown	2	Female	Matched	Negative	No	NA	NA	Negative	465.0
all_phase2_target_2018_pub	TARGET-10-PAPHEV	TARGET-10-PAPHEV-09	3.0	858.0	NA	NA	DISCOVERY	Negative	1.0	3.0	NA	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3482.0	1.152	Not Hispanic or Latino	Negative	None	0.2141	53,XY,+X,+4,+6,+14,+17,+18,+19[cp5]/46,XY[13]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.073	0.001	NA	NA	NA	NA	NA	BLL	3482.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	61.3
all_phase2_target_2018_pub	TARGET-10-PAPHGD	TARGET-10-PAPHGD-09	2.0	651.0	NA	NA	DISCOVERY	Negative	0.0	3.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	926.0	1	Hispanic or Latino	Negative	Relapse	0.0476	45,XY,add(3)(q29),-7,del(9)(p22)[19]/46,XY[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	3579.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	0.0666666666667	Negative	81.8
all_phase2_target_2018_pub	TARGET-10-PAPHHE	TARGET-10-PAPHHE-09	6.0	1895.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3458.0	1.076	Not Hispanic or Latino	Positive	None	0.0257	47,X,del(X)(p11),del(12)(p12),add(16)(q24),?i(21)(q10),+21,add(22)(p11)[11]/46,XX[5]	Negative	ETV6-RUNX1	NA	NA	0.024	0.001	NA	NA	NA	NA	NA	BLL	3458.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	66.76
all_phase2_target_2018_pub	TARGET-10-PAPHHF	TARGET-10-PAPHHF-09	15.0	5177.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1541.0	1	Not Hispanic or Latino	Negative	None	0.0053	46,XX,del(9)(p22)x2[10]/45,idem,-del(9),+der(9;17)(q10;q10),-17[6]/46,idem,-del(9),+mar[4]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1541.0	NA	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	38.0
all_phase2_target_2018_pub	TARGET-10-PAPHHP	TARGET-10-PAPHHP-09	6.0	2013.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	18.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3738.0	1.157	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.017	0.001	NA	NA	NA	NA	NA	BLL	3738.0	123.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	5.8
all_phase2_target_2018_pub	TARGET-10-PAPHIG	TARGET-10-PAPHIG-09	3.0	882.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	97.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3339.0	1.16	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	3339.0	110.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	28.0
all_phase2_target_2018_pub	TARGET-10-PAPHJF	TARGET-10-PAPHJF-04	7.0	2511.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	483.0	282.0	1	Hispanic or Latino	Negative	Relapse	0.0693	46,XX,t(1;19)(q23;p13.3),i(9)(q10),del(13)(q12)[7]/46,XX[13]	Negative	TCF3-PBX1	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	483.0	16.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Positive	No	NA	NA	Negative	30.5
all_phase2_target_2018_pub	TARGET-10-PAPHJF	TARGET-10-PAPHJF-09	7.0	2511.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	483.0	282.0	1	Hispanic or Latino	Negative	Relapse	0.0759	46,XX,t(1;19)(q23;p13.3),i(9)(q10),del(13)(q12)[7]/46,XX[13]	Negative	TCF3-PBX1	NA	NA	0.0	0.001	NA	NA	NA	NA	5	BLL	483.0	16.0	1:DECEASED	No	AALL0331	White	2	Female	Matched	Positive	No	NA	0.166666666667	Negative	30.5
all_phase2_target_2018_pub	TARGET-10-PAPHJS	TARGET-10-PAPHJS-09	15.0	5307.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2426.0	1	Not Hispanic or Latino	Unknown	None	0.0366	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2426.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	8.5
all_phase2_target_2018_pub	TARGET-10-PAPHLA	TARGET-10-PAPHLA-09	6.0	1896.0	Chemotherapy	NA	DISCOVERY	Negative	NA	NA	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	724.0	0.56	Hispanic or Latino	Negative	None	NA	NA	Unknown	Hypodiploid	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	1626.0	NA	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	78.9
all_phase2_target_2018_pub	TARGET-10-PAPHLH	TARGET-10-PAPHLH-09	5.0	1666.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2416.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,add(4)(q31.3),del(6)(q13q23),add(9)(p21),der(9)t(9;9')(p11;q22),add(14)(q24),del(20)(q11.2q13.3)[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2416.0	80.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	30.5
all_phase2_target_2018_pub	TARGET-10-PAPHLJ	TARGET-10-PAPHLJ-09	14.0	4793.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3157.0	1.062	Not Hispanic or Latino	Unknown	None	0.0013	46,XX,der(19)t(1;19)(q23;p13.3)[8]/47,idem,+8[5]/46,XX[7]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3157.0	NA	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Positive	No	NA	NA	Negative	8.5
all_phase2_target_2018_pub	TARGET-10-PAPHMH	TARGET-10-PAPHMH-09	30.0	10946.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	397.0	322.0	1	Not Hispanic or Latino	Negative	Relapse	0.0008	46,XX,t(4;11)(q21;q23)[16]/46,XX[4]	Positive	MLL-Rearranged	NA	NA	0.019	0.01	NA	NA	NA	NA	5	BLL	397.0	NA	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	0.166666666667	Negative	39.7
all_phase2_target_2018_pub	TARGET-10-PAPHMI	TARGET-10-PAPHMI-09	3.0	1013.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	668.0	1	Hispanic or Latino	Unknown	None	0.0054	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	668.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	54.7
all_phase2_target_2018_pub	TARGET-10-PAPHNM	TARGET-10-PAPHNM-09	2.0	563.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	790.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	790.0	26.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	43.2
all_phase2_target_2018_pub	TARGET-10-PAPHNR	TARGET-10-PAPHNR-09	10.0	3325.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3493.0	1.17	Not Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+6,+8,+10,+12,del(12)(p11.2),+17,+21,+mar[13]/46,XX[7]	Negative	NA	0.0	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	3493.0	115.0	0:LIVING	No	AALL0331	Native Hawaiian or other Pacific Islander	1	Female	Matched	Negative	No	NA	NA	Positive	2.9
all_phase2_target_2018_pub	TARGET-10-PAPHNS	TARGET-10-PAPHNS-09	12.0	4099.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	390.0	0.529	Not Hispanic or Latino	Negative	Death	0.0022	25,X,+Y,+21[1]/50,idemx2[19]	Negative	Hypodiploid	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	390.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	5.83
all_phase2_target_2018_pub	TARGET-10-PAPHPX	TARGET-10-PAPHPX-09	6.0	1887.0	NA	NA	DISCOVERY	Negative	0.0	2.0	0.0	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3632.0	1	Unknown	Negative	None	0.1641	47,XX,+7,dic(9;20)(p11;q11),+mar[2]/46,XX[21]	Negative	None of the above	0.0	0.01	1.6	0.01	NA	NA	NA	NA	NA	BLL	3632.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	82.51
all_phase2_target_2018_pub	TARGET-10-PAPHRT	TARGET-10-PAPHRT-09	19.0	6631.0	NA	NA	DISCOVERY	Negative	55.0	72.0	NA	88.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1	Not Hispanic or Latino	Unknown	Induction failure	0.0054	NA	Unknown	None of the above	NA	NA	32.8	0.01	NA	NA	NA	NA	NA	BLL	2150.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	45.58
all_phase2_target_2018_pub	TARGET-10-PAPHRV	TARGET-10-PAPHRV-09	4.0	1226.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1873.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	1873.0	62.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	16.79
all_phase2_target_2018_pub	TARGET-10-PAPHSV	TARGET-10-PAPHSV-09	4.0	1245.0	NA	NA	DISCOVERY	Negative	NA	4.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3652.0	1	Not Hispanic or Latino	Unknown	None	0.0002	46,XX[20]	Negative	None of the above	0.0	0.01	0.0032	NA	NA	NA	NA	NA	NA	BLL	3652.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.4
all_phase2_target_2018_pub	TARGET-10-PAPHTZ	TARGET-10-PAPHTZ-09	2.0	568.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	839.0	1	Not Hispanic or Latino	Negative	Relapse	0.0007	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3653.0	NA	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	102.0
all_phase2_target_2018_pub	TARGET-10-PAPHVX	TARGET-10-PAPHVX-09	20.0	6955.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1264.0	1	Not Hispanic or Latino	Negative	Relapse	0.3032	46,XX,t(5;5)(q13;q33),add(13)(q34)[5]/47,idem,+21[4]/46,XX[11]	Negative	None of the above	NA	NA	0.017	0.001	NA	NA	NA	NA	NA	BLL	3644.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	13.2
all_phase2_target_2018_pub	TARGET-10-PAPHWE	TARGET-10-PAPHWE-09	5.0	1570.0	NA	NA	VALIDATION	Negative	19.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3445.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[22]	Unknown	NA	0.0	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3445.0	114.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	4.2
all_phase2_target_2018_pub	TARGET-10-PAPHWH	TARGET-10-PAPHWH-09	15.0	5245.0	NA	NA	DISCOVERY	Positive	31.0	26.0	NA	69.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	32.0	1	Not Hispanic or Latino	Unknown	Induction failure	0.0004	45,XY,-7,t(9;22)(q34;q11.2)[16]/46,XY[4]	Negative	BCR-ABL1	NA	NA	59.5	0.01	NA	NA	NA	NA	NA	BLL	1634.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	183.0
all_phase2_target_2018_pub	TARGET-10-PAPHWJ	TARGET-10-PAPHWJ-09	12.0	4341.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3374.0	1	Not Hispanic or Latino	Unknown	None	0.0003	47,XY,+5,t(9;15)(q34.1;q15)[10]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3374.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	6.14
all_phase2_target_2018_pub	TARGET-10-PAPHXH	TARGET-10-PAPHXH-09	13.0	4715.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	329.0	0.7	Not Hispanic or Latino	Negative	Relapse	NA	62(35,X,+X,+5,+6,+10,+11,+13,+15,+16,+19,+20,+21,+22)x2,-X,-6,-10,-13,-15,-16,-19,-20[cp2]/46,XX[16]	Negative	Hypodiploid	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	613.0	NA	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	15.6
all_phase2_target_2018_pub	TARGET-10-PAPHXJ	TARGET-10-PAPHXJ-09	8.0	2768.0	CHEMOTHERAPY	Chemotherapy per AALL0331 on maintenance	VALIDATION	Negative	1.0	4.0	NA	62.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1555.0	1.17	Not Hispanic or Latino	Negative	None	NA	52,XX,+X,+X,+5,+6,+14,+17,-21,+r[6]/46,XX[14]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1555.0	52.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	4.2
all_phase2_target_2018_pub	TARGET-10-PAPHXN	TARGET-10-PAPHXN-03	17.0	5998.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	724.0	499.0	1.346	Not Hispanic or Latino	Unknown	Relapse	0.6077	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.011000000000000001	0.001	NA	NA	NA	NA	NA	BLL	724.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Negative	8.7
all_phase2_target_2018_pub	TARGET-10-PAPHXN	TARGET-10-PAPHXN-04	17.0	5998.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	724.0	499.0	1.346	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Unknown	Hyperdiploid; status of 4 and 10 unknown	NA	NA	0.011000000000000001	0.001	NA	NA	NA	NA	NA	BLL	724.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Negative	8.7
all_phase2_target_2018_pub	TARGET-10-PAPHYH	TARGET-10-PAPHYH-09	19.0	6770.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1478.0	1	Not Hispanic or Latino	Negative	None	0.0015	46,XY,add(3)(q21),add(9)(p22),add(16)(q22)[5]/46,XY[6]	Negative	None of the above	NA	NA	0.08	0.01	NA	NA	NA	NA	NA	BLL	1478.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	102.6
all_phase2_target_2018_pub	TARGET-10-PAPHYM	TARGET-10-PAPHYM-09	10.0	3309.0	NA	NA	VALIDATION	Negative	5.0	0.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	2739.0	1.22	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	0.0	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2739.0	91.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Positive	4.4
all_phase2_target_2018_pub	TARGET-10-PAPHYN	TARGET-10-PAPHYN-09	6.0	2079.0	NA	NA	DISCOVERY	Negative	56.0	0.0	NA	78.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	3012.0	1	Not Hispanic or Latino	Negative	None	0.0898	46,XY,del(6)(q13q21),+8,dic(9;20)(p11;q11.1)[7]/46,idem,del(12)(p13)[5]/46,idem,add(7)(p11.2),[7]/46,XY[1]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3012.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	198.2
all_phase2_target_2018_pub	TARGET-10-PAPHYV	TARGET-10-PAPHYV-09	3.0	987.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3438.0	1	Unknown	Positive	None	NA	46,XY,add(12)(p11.2)[2]/47,idem,add(12)(p13),+mar[2]/46,XY[46]	Negative	NA	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	3438.0	114.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	16.4
all_phase2_target_2018_pub	TARGET-10-PAPHYY	TARGET-10-PAPHYY-03	3.0	760.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2721.0	1	Not Hispanic or Latino	Negative	None	0.0253	NA	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2721.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	192.0
all_phase2_target_2018_pub	TARGET-10-PAPHZT	TARGET-10-PAPHZT-09	2.0	551.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3393.0	1.093	Not Hispanic or Latino	Unknown	None	0.0014	46,XX,der(9;22)(q10;q10),add(20)(q11.2),+mar[10]/46,idem,t(6;8)(p23;q13)[2]/46,XX[8]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3393.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	123.1
all_phase2_target_2018_pub	TARGET-10-PAPIAH	TARGET-10-PAPIAH-09	4.0	1285.0	NA	NA	DISCOVERY	Positive	2.0	0.0	NA	36.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3533.0	1	Not Hispanic or Latino	Negative	None	0.3683	46,XY,t(9;22)(q34;q11.2)[20]	Negative	BCR-ABL1	NA	NA	0.2	0.01	NA	NA	NA	NA	NA	BLL	3533.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	132.4
all_phase2_target_2018_pub	TARGET-10-PAPIBW	TARGET-10-PAPIBW-09	18.0	6340.0	NA	NA	DISCOVERY	Negative	1.0	4.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2715.0	0.839	Not Hispanic or Latino	Unknown	None	0.9462	35,X,+1,+4,+5,+6,+8,+9,+10,+11,+18,+19,+21,+22[cp13]/46,XY[7]	Negative	Hypodiploid	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2715.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	52.9
all_phase2_target_2018_pub	TARGET-10-PAPICC	TARGET-10-PAPICC-09	5.0	1508.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3440.0	1.19	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+4,+6,+10,+14,+14,+18,+21,+21[9]/46,XY[11]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3440.0	114.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	4.0
all_phase2_target_2018_pub	TARGET-10-PAPIDE	TARGET-10-PAPIDE-03	18.0	6245.0	Chemotherapy	NA	DISCOVERY	Positive	NA	NA	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 3	No	NA	263.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,t(9;22)(q34;q11.2)[16]/46,XY[4]	Negative	BCR-ABL1	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	350.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	Yes	NA	Negative	463.0
all_phase2_target_2018_pub	TARGET-10-PAPIDR	TARGET-10-PAPIDR-09	14.0	5109.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2534.0	1.113	Not Hispanic or Latino	Unknown	None	0.0013	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2534.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	3.4
all_phase2_target_2018_pub	TARGET-10-PAPIDV	TARGET-10-PAPIDV-09	14.0	4756.0	NA	NA	DISCOVERY	Negative	50.0	0.0	NA	63.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	42.0	1	Not Hispanic or Latino	Negative	Death without Remissio	0.0046	46,XY[4]	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	42.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	630.0
all_phase2_target_2018_pub	TARGET-10-PAPIDY	TARGET-10-PAPIDY-04	3.0	918.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	0.0	NA	27.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	986.0	1	Not Hispanic or Latino	Negative	Relapse	0.0025	47,XX,+mar[cp2]/46,XX[21]	Negative	None of the above	NA	NA	0.0066	NA	NA	NA	NA	NA	NA	BLL	3505.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	1.6
all_phase2_target_2018_pub	TARGET-10-PAPIDY	TARGET-10-PAPIDY-09	3.0	918.0	Chemotherapy	NA	DISCOVERY	Negative	4.0	0.0	NA	27.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	986.0	1	Not Hispanic or Latino	Negative	Relapse	0.0022	47,XX,+mar[cp2]/46,XX[21]	Negative	None of the above	NA	NA	0.0066	NA	NA	NA	NA	NA	NA	BLL	3505.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	1.6
all_phase2_target_2018_pub	TARGET-10-PAPIEW	TARGET-10-PAPIEW-09	6.0	2059.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3692.0	1.16	Hispanic or Latino	Negative	None	NA	54,XY,+X,+6,+10,+14,+17,+18,+21,+21[6]/54,idem,+mar[cp2]/46,XY[8]	Negative	NA	NA	NA	0.095	0.001	NA	NA	NA	NA	NA	BLL	3692.0	122.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	17.6
all_phase2_target_2018_pub	TARGET-10-PAPIGD	TARGET-10-PAPIGD-09	6.0	1876.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3683.0	1	Hispanic or Latino	Positive	None	NA	48,XX,add(5)(q31),+10,add(12)(p13),+16[9]/46,XX[1]	Negative	NA	NA	NA	0.0081	0.0081	NA	NA	NA	NA	NA	BLL	3683.0	122.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	20.9
all_phase2_target_2018_pub	TARGET-10-PAPIGH	TARGET-10-PAPIGH-09	14.0	4800.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3662.0	1.078	Not Hispanic or Latino	Negative	None	0.0300	46,XY[27]	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3662.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	14.3
all_phase2_target_2018_pub	TARGET-10-PAPIGJ	TARGET-10-PAPIGJ-09	13.0	4584.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3376.0	1	Hispanic or Latino	Positive	None	0.0952	45,X,-X,inv(1)(p13q32),del(1)(p13p32),del(6)(q?21q2?5)[13]/46,sl,+mar1[3]/47,sdl1,+mar2[2]/46,XX[8]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3376.0	NA	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	58.7
all_phase2_target_2018_pub	TARGET-10-PAPIGV	TARGET-10-PAPIGV-09	4.0	1387.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1959.0	1	Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.23	0.01	NA	NA	NA	NA	NA	BLL	1959.0	65.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	19.7
all_phase2_target_2018_pub	TARGET-10-PAPIGX	TARGET-10-PAPIGX-03	15.0	5231.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	644.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	None of the above	NA	NA	NA	NA	NA	NA	NA	NA	1	BLL	644.0	NA	0:LIVING	No	AALL0232	Black or African American	2	Female	Matched	Unknown	No	NA	0.0333333333333	Unknown	51.6
all_phase2_target_2018_pub	TARGET-10-PAPIGX	TARGET-10-PAPIGX-09	15.0	5231.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	644.0	1	Not Hispanic or Latino	Negative	None	0.0044	NA	Unknown	None of the above	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	644.0	NA	0:LIVING	No	AALL0232	Black or African American	2	Female	Matched	Unknown	No	NA	NA	Unknown	51.6
all_phase2_target_2018_pub	TARGET-10-PAPIHH	TARGET-10-PAPIHH-09	5.0	1743.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1449.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,t(1;12)(p34;p13),del(6)(q13q23)[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	1449.0	48.0	0:LIVING	No	AALL0331	Asian	1	Male	Matched	Negative	No	No	NA	Negative	9.4
all_phase2_target_2018_pub	TARGET-10-PAPIHT	TARGET-10-PAPIHT-09	3.0	953.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3359.0	1.19	Not Hispanic or Latino	Negative	None	NA	56,XX,+X,+4,+6,+10,+14,+15,+17,+18,+21,+21[cp5]/56,idem,der(6)t(6;9)(p21;q13)[3]/46,XX[12]	Negative	NA	NA	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3359.0	111.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	19.8
all_phase2_target_2018_pub	TARGET-10-PAPIHU	TARGET-10-PAPIHU-09	4.0	1295.0	NA	NA	VALIDATION	Negative	10.0	3.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3395.0	1.12	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	0.0	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3395.0	112.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	10.4
all_phase2_target_2018_pub	TARGET-10-PAPIHV	TARGET-10-PAPIHV-09	15.0	5355.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3559.0	1	Not Hispanic or Latino	Negative	None	0.0014	46,XY[27]	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3559.0	NA	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	2.1
all_phase2_target_2018_pub	TARGET-10-PAPIHY	TARGET-10-PAPIHY-03	14.0	5086.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	914.0	1	Not Hispanic or Latino	Negative	Relapse	0.0266	NA	Unknown	None of the above	NA	NA	0.59	0.01	NA	NA	NA	NA	NA	BLL	1677.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	96.4
all_phase2_target_2018_pub	TARGET-10-PAPIIB	TARGET-10-PAPIIB-09	5.0	1538.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	43.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3593.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3593.0	119.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	43.6
all_phase2_target_2018_pub	TARGET-10-PAPIII	TARGET-10-PAPIII-09	4.0	1412.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1244.0	1.192	Hispanic or Latino	Positive	Relapse	0.0486	NA	Unknown	ETV6-RUNX1	NA	NA	0.021	0.001	NA	NA	NA	NA	NA	BLL	1679.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	52.3
all_phase2_target_2018_pub	TARGET-10-PAPIIX	TARGET-10-PAPIIX-09	7.0	2337.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2962.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,add(5)(p12),-9,+mar[17]/46,XY[3]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2962.0	98.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	10.8
all_phase2_target_2018_pub	TARGET-10-PAPIJB	TARGET-10-PAPIJB-04	6.0	2005.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	588.0	1.12	Not Hispanic or Latino	Negative	Relapse	0.1558	52,XX,+6,+14,+17,+18,+21,+21[6]/46,XX[25]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	3715.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	1.05
all_phase2_target_2018_pub	TARGET-10-PAPIJB	TARGET-10-PAPIJB-09	6.0	2005.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	588.0	1.12	Not Hispanic or Latino	Negative	Relapse	0.1560	52,XX,+6,+14,+17,+18,+21,+21[6]/46,XX[25]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.02	0.01	NA	NA	NA	NA	3	BLL	3715.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.1	Negative	1.05
all_phase2_target_2018_pub	TARGET-10-PAPIJD	TARGET-10-PAPIJD-09	4.0	1226.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	3469.0	1.15	Hispanic or Latino	Negative	None	NA	55,XY,+X,+6,+10,+14,+17,+18,+21,+21,+21[6]/46,XY[14]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3469.0	115.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	12.5
all_phase2_target_2018_pub	TARGET-10-PAPIJF	TARGET-10-PAPIJF-09	14.0	5052.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	349.0	1.082	Not Hispanic or Latino	Negative	Relapse	0.0020	NA	Unknown	None of the above	NA	NA	0.055999999999999994	0.001	NA	NA	NA	NA	NA	BLL	2100.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	31.1
all_phase2_target_2018_pub	TARGET-10-PAPIJM	TARGET-10-PAPIJM-09	11.0	3979.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1203.0	1.216	Not Hispanic or Latino	Negative	None	0.2432	NA	Unknown	Trisomy of both chromosomes 4 and 10	0.0	0.1	0.0	0.01	NA	NA	NA	NA	10	BLL	1203.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	0.333333333333	Positive	19.8
all_phase2_target_2018_pub	TARGET-10-PAPIKG	TARGET-10-PAPIKG-09	17.0	6031.0	NA	NA	DISCOVERY	Positive	80.0	38.0	NA	88.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	31.0	1	Not Hispanic or Latino	Negative	Induction failure	0.0035	46,XY,t(9;22)(q34;q11.2)[4]/46,idem,t(1;20)(q21;q11.2),der(20)t(1;20)[12]/46,XY[4]	Negative	BCR-ABL1	NA	NA	66.2	0.01	NA	NA	NA	NA	NA	BLL	2051.0	NA	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	190.7
all_phase2_target_2018_pub	TARGET-10-PAPIKR	TARGET-10-PAPIKR-09	11.0	3916.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	45.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3285.0	1	Not Hispanic or Latino	Negative	None	0.0013	46,XX[21]	Negative	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3285.0	NA	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	1.6
all_phase2_target_2018_pub	TARGET-10-PAPIKU	TARGET-10-PAPIKU-09	13.0	4447.0	NA	NA	DISCOVERY	Negative	20.0	4.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3488.0	1.148	Not Hispanic or Latino	Negative	None	0.2633	55,XY,+X,+4,+6,+10,+14,+14,+17,+18,+21[23]/46,XY[2]	Negative	Trisomy of both chromosomes 4 and 10	0.01	0.01	0.34	0.01	NA	NA	NA	NA	NA	BLL	3488.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	53.3
all_phase2_target_2018_pub	TARGET-10-PAPIKY	TARGET-10-PAPIKY-09	7.0	2430.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3087.0	1	Hispanic or Latino	Negative	None	0.0459	46,XY,der(19)t(1;19)(q23;p13.3)[4]/46,XY[16]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3087.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	145.0
all_phase2_target_2018_pub	TARGET-10-PAPILB	TARGET-10-PAPILB-09	5.0	1622.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3621.0	0.549	Not Hispanic or Latino	Negative	None	NA	27,X,+X,+8,+18,+21[11]/54,idemx2[7]/46,XX[2]	Negative	Hypodiploid	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3621.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	133.6
all_phase2_target_2018_pub	TARGET-10-PAPILF	TARGET-10-PAPILF-09	5.0	1657.0	NA	NA	VALIDATION	Negative	60.0	0.0	NA	95.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3413.0	1.17	Hispanic or Latino	Negative	None	NA	54,XY,+X,dup(1)(q21q44),+6,+10,+14,+17,+18,+21,+21[12]/55,XY,+X,+6,+9,der(9)t(1;9)(q21;q11),+10,+14,+17,+18,+21,+21[5]/46,XY[3]	Negative	NA	0.0	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	3413.0	113.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	4.3
all_phase2_target_2018_pub	TARGET-10-PAPILG	TARGET-10-PAPILG-09	3.0	1027.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3657.0	1.16	Hispanic or Latino	Negative	None	NA	53,X,-Y,+X,+4,+6,+10,+14,+14,+17,+21[6]/46,XY[14]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3657.0	121.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	3.9
all_phase2_target_2018_pub	TARGET-10-PAPIMH	TARGET-10-PAPIMH-09	15.0	5177.0	NA	NA	DISCOVERY	Positive	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3643.0	1	Not Hispanic or Latino	Negative	None	0.0643	44,XX,t(9;22)(q34;q11.2)[cp7]/44,XX,-7,der(3;9)(q10;q10)t(9;22)(q34;q11.2),add(13)(q32),der(22)t(9;22)[3]/44,XX,-7,der(3;9)(q10;q10)t(9;22)(q34;q11.2),add(10(q26),add(13)(q32),der(22)t(9;22)(q34;q11.2)[4]/46,XX[11]	Negative	BCR-ABL1	NA	NA	0.76	0.01	NA	NA	NA	NA	NA	BLL	3643.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.5
all_phase2_target_2018_pub	TARGET-10-PAPIML	TARGET-10-PAPIML-09	2.0	450.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1007.0	1.158	Not Hispanic or Latino	Negative	Relapse	0.1809	NA	Negative	None of the above	NA	NA	0.021	0.001	NA	NA	NA	NA	NA	BLL	3184.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	172.1
all_phase2_target_2018_pub	TARGET-10-PAPIPG	TARGET-10-PAPIPG-09	5.0	1576.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3372.0	1.2	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3372.0	111.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	17.91
all_phase2_target_2018_pub	TARGET-10-PAPIPW	TARGET-10-PAPIPW-04	10.0	3417.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1459.0	1438.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,add(2)(q21),add(4)(q35)[6]/46,XX[14]	Negative	None of the above	0.0	0.01	0.15	0.01	NA	NA	NA	NA	NA	BLL	1459.0	NA	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.0
all_phase2_target_2018_pub	TARGET-10-PAPIRD	TARGET-10-PAPIRD-09	13.0	4483.0	NA	NA	DISCOVERY	Negative	0.0	3.0	NA	52.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	3106.0	1	Not Hispanic or Latino	Negative	None	0.0023	NA	Unknown	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	3106.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	61.4
all_phase2_target_2018_pub	TARGET-10-PAPIRZ	TARGET-10-PAPIRZ-09	14.0	4892.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	80.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	1008.0	685.0	1.05	Not Hispanic or Latino	Negative	Relapse	0.0776	NA	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	4	BLL	1008.0	NA	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	0.1	Unknown	70.0
all_phase2_target_2018_pub	TARGET-10-PAPISG	TARGET-10-PAPISG-03	15.0	5203.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1013.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Unknown	None of the above	0.035	0.001	0.42	0.01	NA	NA	NA	NA	5	BLL	3491.0	NA	0:LIVING	No	AALL0232	White	3	Female	Matched	Unknown	No	NA	0.166666666667	Unknown	71.0
all_phase2_target_2018_pub	TARGET-10-PAPISG	TARGET-10-PAPISG-04	15.0	5203.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1013.0	1	Hispanic or Latino	Negative	Relapse	0.0035	46,XX[20]	Unknown	None of the above	0.035	0.001	0.42	0.01	NA	NA	NA	NA	NA	BLL	3491.0	NA	0:LIVING	No	AALL0232	White	3	Female	Matched	Unknown	No	NA	NA	Unknown	71.0
all_phase2_target_2018_pub	TARGET-10-PAPISG	TARGET-10-PAPISG-09	15.0	5203.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1013.0	1	Hispanic or Latino	Negative	Relapse	0.0028	46,XX[20]	Unknown	None of the above	0.035	0.001	0.42	0.01	NA	NA	NA	NA	NA	BLL	3491.0	NA	0:LIVING	No	AALL0232	White	3	Female	Matched	Unknown	No	NA	NA	Unknown	71.0
all_phase2_target_2018_pub	TARGET-10-PAPJHB	TARGET-10-PAPJHB-04	6.0	2005.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1260.0	1	Not Hispanic or Latino	Negative	Relapse	0.0478	47,XX,add(9)(p13),+21[6]/45,idem,-X,-20[3]/48,idem,+8[7]/46,XX[4]	Negative	None of the above	0.0	0.1	0.1	0.01	NA	NA	NA	NA	NA	BLL	1870.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	13.7
all_phase2_target_2018_pub	TARGET-10-PAPJHB	TARGET-10-PAPJHB-09	6.0	2005.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	26.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1260.0	1	Not Hispanic or Latino	Negative	Relapse	0.0935	47,XX,add(9)(p13),+21[6]/45,idem,-X,-20[3]/48,idem,+8[7]/46,XX[4]	Negative	None of the above	0.0	0.1	0.1	0.01	NA	NA	NA	NA	6	BLL	1870.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.2	Negative	13.7
all_phase2_target_2018_pub	TARGET-10-PAPJHR	TARGET-10-PAPJHR-04	11.0	4016.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	0.0	NA	21.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1186.0	1129.0	1.064	Not Hispanic or Latino	Negative	Relapse	0.0311	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1186.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	9.73
all_phase2_target_2018_pub	TARGET-10-PAPJHR	TARGET-10-PAPJHR-09	11.0	4016.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	0.0	NA	21.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1186.0	1129.0	1.064	Not Hispanic or Latino	Negative	Relapse	0.0095	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	1186.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	0.166666666667	Unknown	9.73
all_phase2_target_2018_pub	TARGET-10-PAPJIB	TARGET-10-PAPJIB-03	3.0	903.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1344.0	851.0	1.19	Not Hispanic or Latino	Negative	Relapse	NA	53,XX,+X,+6,+14,+15,+17,+21,+21[cp9]/46,XX[2]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	11	BLL	1344.0	NA	1:DECEASED	No	AALL0331	White	3	Female	Matched	Negative	No	NA	0.366666666667	Negative	1.3
all_phase2_target_2018_pub	TARGET-10-PAPJIB	TARGET-10-PAPJIB-04	3.0	903.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1344.0	851.0	1.19	Not Hispanic or Latino	Negative	Relapse	0.1091	53,XX,+X,+6,+14,+15,+17,+21,+21[cp9]/46,XX[2]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1344.0	NA	1:DECEASED	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	1.3
all_phase2_target_2018_pub	TARGET-10-PAPJIB	TARGET-10-PAPJIB-09	3.0	903.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1344.0	851.0	1.19	Not Hispanic or Latino	Negative	Relapse	0.2068	53,XX,+X,+6,+14,+15,+17,+21,+21[cp9]/46,XX[2]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	1344.0	NA	1:DECEASED	No	AALL0331	White	3	Female	Matched	Negative	No	NA	0.1	Negative	1.3
all_phase2_target_2018_pub	TARGET-10-PAPJPH	TARGET-10-PAPJPH-03	16.0	5620.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	378.0	331.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[30]	Unknown	None of the above	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	378.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	115.6
all_phase2_target_2018_pub	TARGET-10-PAPJPH	TARGET-10-PAPJPH-04	16.0	5620.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	378.0	331.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[30]	Unknown	None of the above	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	378.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Unknown	115.6
all_phase2_target_2018_pub	TARGET-10-PAPJRR	TARGET-10-PAPJRR-60.1	8.0	2857.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1843.0	0.54	Not Hispanic or Latino	Negative	None	NA	52(26,X,+Y,+14,+21)x2[4]/46,XY[17]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1843.0	61.0	0:LIVING	No	AALL0331	White	4	Male	Matched	Negative	No	No	NA	Negative	1.0
all_phase2_target_2018_pub	TARGET-10-PAPJRR	TARGET-10-PAPJRR-60.10	8.0	2857.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1843.0	0.54	Not Hispanic or Latino	Negative	None	NA	52(26,X,+Y,+14,+21)x2[4]/46,XY[17]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1843.0	61.0	0:LIVING	No	AALL0331	White	4	Male	Matched	Negative	No	No	NA	Negative	1.0
all_phase2_target_2018_pub	TARGET-10-PAPJRR	TARGET-10-PAPJRR-60.6	8.0	2857.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1843.0	0.54	Not Hispanic or Latino	Negative	None	NA	52(26,X,+Y,+14,+21)x2[4]/46,XY[17]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1843.0	61.0	0:LIVING	No	AALL0331	White	4	Male	Matched	Negative	No	No	NA	Negative	1.0
all_phase2_target_2018_pub	TARGET-10-PAPJRR	TARGET-10-PAPJRR-60.8	8.0	2857.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1843.0	0.54	Not Hispanic or Latino	Negative	None	NA	52(26,X,+Y,+14,+21)x2[4]/46,XY[17]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1843.0	61.0	0:LIVING	No	AALL0331	White	4	Male	Matched	Negative	No	No	NA	Negative	1.0
all_phase2_target_2018_pub	TARGET-10-PAPJXI	TARGET-10-PAPJXI-04	9.0	3250.0	Chemotherapy	NA	DISCOVERY	Negative	NA	4.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1409.0	1	Not Hispanic or Latino	Negative	Relapse	0.0743	45,XX,add(1)(q42),t(11;22)(q13;q13),-15,der(15;22)(q10;q10),der(21)add(21)(p11.2)add(21)(q21)amp(AML1),+mar[6]/46,XX[14]	Negative	iAMP21	NA	NA	0.028999999999999998	0.001	NA	NA	NA	NA	NA	BLL	3229.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	2.3
all_phase2_target_2018_pub	TARGET-10-PAPJXI	TARGET-10-PAPJXI-09	9.0	3250.0	Chemotherapy	NA	DISCOVERY	Negative	NA	4.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1409.0	1	Not Hispanic or Latino	Negative	Relapse	0.0324	45,XX,add(1)(q42),t(11;22)(q13;q13),-15,der(15;22)(q10;q10),der(21)add(21)(p11.2)add(21)(q21)amp(AML1),+mar[6]/46,XX[14]	Negative	iAMP21	NA	NA	0.028999999999999998	0.001	NA	NA	NA	NA	NA	BLL	3229.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	2.3
all_phase2_target_2018_pub	TARGET-10-PAPKGY	TARGET-10-PAPKGY-04	17.0	5856.0	NA	NA	DISCOVERY	Negative	82.0	2.0	NA	100.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1500.0	1222.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[5]	Unknown	None of the above	0.19	0.01	0.78	0.01	NA	NA	NA	NA	NA	BLL	1500.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	107.6
all_phase2_target_2018_pub	TARGET-10-PAPKGY	TARGET-10-PAPKGY-09	17.0	5856.0	NA	NA	DISCOVERY	Negative	82.0	2.0	NA	100.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1500.0	1222.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[5]	Unknown	None of the above	0.19	0.01	0.78	0.01	NA	NA	NA	NA	NA	BLL	1500.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	107.6
all_phase2_target_2018_pub	TARGET-10-PAPKNC	TARGET-10-PAPKNC-09	19.0	6599.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1413.0	980.0	1	Not Hispanic or Latino	Negative	Relapse	0.0597	NA	Unknown	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	4	BLL	1413.0	NA	1:DECEASED	No	AALL0232	Black or African American	1	Male	Matched	Unknown	No	No	0.133333333333	Unknown	2.8
all_phase2_target_2018_pub	TARGET-10-PAPLDL	TARGET-10-PAPLDL-03	8.0	2677.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	1.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1187.0	544.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,add(21)(q22)amp(AML1)[13]/46,XX[7]	Negative	iAMP21	NA	NA	0.01	0.01	NA	NA	NA	NA	10	BLL	1187.0	NA	1:DECEASED	No	AALL0331	Unknown	3	Female	Matched	Negative	No	NA	0.333333333333	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PAPLDL	TARGET-10-PAPLDL-04	8.0	2677.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	1.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1187.0	544.0	1	Hispanic or Latino	Negative	Relapse	0.0154	46,XX,add(21)(q22)amp(AML1)[13]/46,XX[7]	Negative	iAMP21	NA	NA	0.01	0.01	NA	NA	NA	NA	NA	BLL	1187.0	NA	1:DECEASED	No	AALL0331	Unknown	3	Female	Matched	Negative	No	NA	NA	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PAPLDL	TARGET-10-PAPLDL-09	8.0	2677.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	1.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1187.0	544.0	1	Hispanic or Latino	Negative	Relapse	0.0222	46,XX,add(21)(q22)amp(AML1)[13]/46,XX[7]	Negative	iAMP21	NA	NA	0.01	0.01	NA	NA	NA	NA	6	BLL	1187.0	NA	1:DECEASED	No	AALL0331	Unknown	3	Female	Matched	Negative	No	NA	0.2	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PAPLDM	TARGET-10-PAPLDM-04	4.0	1124.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	0.0	NA	12.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1212.0	1.168	Not Hispanic or Latino	Negative	Relapse	NA	55,XX,+X,+4,+8,+14,+15,+17,+20,+21,+22[cp4]/46,XX[21]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3280.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	7.8
all_phase2_target_2018_pub	TARGET-10-PAPLDM	TARGET-10-PAPLDM-09	4.0	1124.0	Chemotherapy	NA	DISCOVERY	Negative	2.0	0.0	NA	12.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1212.0	1.168	Not Hispanic or Latino	Negative	Relapse	NA	55,XX,+X,+4,+8,+14,+15,+17,+20,+21,+22[cp4]/46,XX[21]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	3280.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.0666666666667	Negative	7.8
all_phase2_target_2018_pub	TARGET-10-PAPLTZ	TARGET-10-PAPLTZ-04	6.0	2030.0	NA	NA	DISCOVERY	Negative	2.0	3.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1321.0	1	Not Hispanic or Latino	Positive	Relapse	0.0840	51,XY,der(2)t(2;21)(q37;q22),+2,t(2;12;21)(q37;p13;q22),del(9)(p22),+19,+20,+2mar[cp]/51,idem,del(6)(q15q25)[cp]	Negative	ETV6-RUNX1	NA	NA	0.0013	0.01	NA	NA	NA	NA	NA	BLL	2585.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PAPLTZ	TARGET-10-PAPLTZ-09	6.0	2030.0	NA	NA	DISCOVERY	Negative	2.0	3.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1321.0	1	Not Hispanic or Latino	Positive	Relapse	0.0437	51,XY,der(2)t(2;21)(q37;q22),+2,t(2;12;21)(q37;p13;q22),del(9)(p22),+19,+20,+2mar[cp]/51,idem,del(6)(q15q25)[cp]	Negative	ETV6-RUNX1	NA	NA	0.0013	0.01	NA	NA	NA	NA	NA	BLL	2585.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PAPLUG	TARGET-10-PAPLUG-04	2.0	506.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1155.0	784.0	1	Hispanic or Latino	Negative	Relapse	0.0043	NA	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	1155.0	NA	1:DECEASED	No	AALL0331	Unknown	2	Male	Matched	Unknown	No	No	NA	Unknown	44.0
all_phase2_target_2018_pub	TARGET-10-PAPLUG	TARGET-10-PAPLUG-09	2.0	506.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1155.0	784.0	1	Hispanic or Latino	Negative	Relapse	0.0046	NA	Unknown	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	14	BLL	1155.0	NA	1:DECEASED	No	AALL0331	Unknown	2	Male	Matched	Unknown	No	No	0.466666666667	Unknown	44.0
all_phase2_target_2018_pub	TARGET-10-PAPMFI	TARGET-10-PAPMFI-04	5.0	1711.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	97.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1343.0	1	Not Hispanic or Latino	Positive	Relapse	0.0196	47,XY,inv(7)(q11.2q22),del(12)(p11.2p13),+21[20]	Negative	ETV6-RUNX1	NA	NA	0.36	0.01	NA	NA	NA	NA	NA	BLL	2585.0	NA	1:DECEASED	No	AALL0331	Native Hawaiian or other Pacific Islander	2	Male	Matched	Negative	No	No	NA	Negative	9.5
all_phase2_target_2018_pub	TARGET-10-PAPMFI	TARGET-10-PAPMFI-09	5.0	1711.0	NA	NA	DISCOVERY	Negative	4.0	0.0	NA	97.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1343.0	1	Not Hispanic or Latino	Positive	Relapse	0.0173	47,XY,inv(7)(q11.2q22),del(12)(p11.2p13),+21[20]	Negative	ETV6-RUNX1	NA	NA	0.36	0.01	NA	NA	NA	NA	NA	BLL	2585.0	NA	1:DECEASED	No	AALL0331	Native Hawaiian or other Pacific Islander	2	Male	Matched	Negative	No	No	NA	Negative	9.5
all_phase2_target_2018_pub	TARGET-10-PAPMVB	TARGET-10-PAPMVB-04	2.0	699.0	NA	NA	DISCOVERY	Negative	4.0	3.0	2.0	78.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1413.0	776.0	1	Not Hispanic or Latino	Positive	Relapse	0.0011	47,XY,der(2)t(2;?12)(p13;q13),del(6)(q21q23),-12,add(12)(p13),+21,+mar[3]/46,XY[17]	Negative	ETV6-RUNX1	0.011000000000000001	0.001	1.8	0.01	NA	NA	NA	NA	NA	BLL	1413.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	77.9
all_phase2_target_2018_pub	TARGET-10-PAPMVB	TARGET-10-PAPMVB-09	2.0	699.0	NA	NA	DISCOVERY	Negative	4.0	3.0	2.0	78.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1413.0	776.0	1	Not Hispanic or Latino	Positive	Relapse	0.0156	47,XY,der(2)t(2;?12)(p13;q13),del(6)(q21q23),-12,add(12)(p13),+21,+mar[3]/46,XY[17]	Negative	ETV6-RUNX1	0.011000000000000001	0.001	1.8	0.01	NA	NA	NA	NA	1	BLL	1413.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.0333333333333	Negative	77.9
all_phase2_target_2018_pub	TARGET-10-PAPMYD	TARGET-10-PAPMYD-03	14.0	5103.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	692.0	496.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,del(9)(p21),der(19)t(1;19)(q23;p13),-22,+mar[4]/46,XY[20]	Negative	TCF3-PBX1	NA	NA	0.004	0.001	NA	NA	NA	NA	2	BLL	692.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Positive	No	No	0.0666666666667	Negative	143.5
all_phase2_target_2018_pub	TARGET-10-PAPMYD	TARGET-10-PAPMYD-09	14.0	5103.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	692.0	496.0	1	Not Hispanic or Latino	Negative	Relapse	0.0865	46,XY,del(9)(p21),der(19)t(1;19)(q23;p13),-22,+mar[4]/46,XY[20]	Negative	TCF3-PBX1	NA	NA	0.004	0.001	NA	NA	NA	NA	NA	BLL	692.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Positive	No	No	NA	Negative	143.5
all_phase2_target_2018_pub	TARGET-10-PAPNFY	TARGET-10-PAPNFY-03	12.0	4151.0	NA	NA	DISCOVERY	Negative	10.0	2.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1083.0	1.204	Not Hispanic or Latino	Negative	Relapse	NA	56,XY,+X,+4,+6,+8,+10,del(10)(q22q24),+14,+17,+21,+21,+mar[20]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.49	0.01	NA	NA	NA	NA	2	BLL	1217.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	0.0666666666667	Positive	28.8
all_phase2_target_2018_pub	TARGET-10-PAPNFY	TARGET-10-PAPNFY-04	12.0	4151.0	NA	NA	DISCOVERY	Negative	10.0	2.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1083.0	1.204	Not Hispanic or Latino	Negative	Relapse	0.2216	56,XY,+X,+4,+6,+8,+10,del(10)(q22q24),+14,+17,+21,+21,+mar[20]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.49	0.01	NA	NA	NA	NA	NA	BLL	1217.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Positive	28.8
all_phase2_target_2018_pub	TARGET-10-PAPNFY	TARGET-10-PAPNFY-09	12.0	4151.0	NA	NA	DISCOVERY	Negative	10.0	2.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1083.0	1.204	Not Hispanic or Latino	Negative	Relapse	0.5022	56,XY,+X,+4,+6,+8,+10,del(10)(q22q24),+14,+17,+21,+21,+mar[20]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.49	0.01	NA	NA	NA	NA	NA	BLL	1217.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Positive	28.8
all_phase2_target_2018_pub	TARGET-10-PAPNMY	TARGET-10-PAPNMY-04	14.0	5109.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	881.0	1	Hispanic or Latino	Negative	Relapse	0.0850	46,XY,-7,del(8)(p21p23),del(10)(q24),del(16)(q22),add(17)(p11.2),der(21)add(21)(pq)amp(AML1),+mar[cp18]/46,XY[2]	Negative	iAMP21	NA	NA	0.05	0.01	NA	NA	NA	NA	NA	BLL	1967.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	11.9
all_phase2_target_2018_pub	TARGET-10-PAPNMY	TARGET-10-PAPNMY-09	14.0	5109.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	881.0	1	Hispanic or Latino	Negative	Relapse	0.1053	46,XY,-7,del(8)(p21p23),del(10)(q24),del(16)(q22),add(17)(p11.2),der(21)add(21)(pq)amp(AML1),+mar[cp18]/46,XY[2]	Negative	iAMP21	NA	NA	0.05	0.01	NA	NA	NA	NA	9	BLL	1967.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	0.3	Negative	11.9
all_phase2_target_2018_pub	TARGET-10-PAPNMY	TARGET-10-PAPNMY-40	14.0	5109.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	881.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,-7,del(8)(p21p23),del(10)(q24),del(16)(q22),add(17)(p11.2),der(21)add(21)(pq)amp(AML1),+mar[cp18]/46,XY[2]	Negative	iAMP21	NA	NA	0.05	0.01	NA	NA	NA	NA	NA	BLL	1967.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	11.9
all_phase2_target_2018_pub	TARGET-10-PAPNNX	TARGET-10-PAPNNX-03	16.0	5486.0	NA	NA	DISCOVERY	Negative	89.0	0.0	NA	50.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	846.0	686.0	1.09	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,der(16)t(1;16)(q12;q24)[10]/46,XY[10]	Negative	None of the above	0.0	0.01	0.002	0.001	NA	NA	NA	NA	7	BLL	846.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Male	Matched	Negative	No	No	0.233333333333	Negative	8.0
all_phase2_target_2018_pub	TARGET-10-PAPNNX	TARGET-10-PAPNNX-04	16.0	5486.0	NA	NA	DISCOVERY	Negative	89.0	0.0	NA	50.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	846.0	686.0	1.09	Not Hispanic or Latino	Negative	Relapse	0.0593	46,XY,der(16)t(1;16)(q12;q24)[10]/46,XY[10]	Negative	None of the above	0.0	0.01	0.002	0.001	NA	NA	NA	NA	NA	BLL	846.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Male	Matched	Negative	No	No	NA	Negative	8.0
all_phase2_target_2018_pub	TARGET-10-PAPNNX	TARGET-10-PAPNNX-09	16.0	5486.0	NA	NA	DISCOVERY	Negative	89.0	0.0	NA	50.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	846.0	686.0	1.09	Not Hispanic or Latino	Negative	Relapse	0.0363	46,XY,der(16)t(1;16)(q12;q24)[10]/46,XY[10]	Negative	None of the above	0.0	0.01	0.002	0.001	NA	NA	NA	NA	NA	BLL	846.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Male	Matched	Negative	No	No	NA	Negative	8.0
all_phase2_target_2018_pub	TARGET-10-PAPNTA	TARGET-10-PAPNTA-04	5.0	1563.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	64.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1405.0	583.0	1.2	Not Hispanic or Latino	Negative	Relapse	NA	54,XY,+X,+4,+6,+10,+14,+17,+21,+21[cp7]/46,XY[24]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	1405.0	NA	1:DECEASED	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	5.4
all_phase2_target_2018_pub	TARGET-10-PAPNZE	TARGET-10-PAPNZE-09	15.0	5435.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1044.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,der(21)t(5;21)(q13;q22)[11]/46,XY[9]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3507.0	NA	0:LIVING	Yes	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	3.57
all_phase2_target_2018_pub	TARGET-10-PAPPGN	TARGET-10-PAPPGN-03	2.0	396.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	387.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,del(9)(p13),add(12)(q24.3)[5]/46,XY[6]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	3	BLL	2256.0	NA	0:LIVING	No	AALL0232	White	3	Male	Matched	Negative	No	No	0.1	Negative	53.8
all_phase2_target_2018_pub	TARGET-10-PAPPGN	TARGET-10-PAPPGN-04	2.0	396.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	387.0	1	Not Hispanic or Latino	Negative	Relapse	0.0074	46,XY,del(9)(p13),add(12)(q24.3)[5]/46,XY[6]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	2256.0	NA	0:LIVING	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	53.8
all_phase2_target_2018_pub	TARGET-10-PAPPGN	TARGET-10-PAPPGN-09	2.0	396.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	387.0	1	Not Hispanic or Latino	Negative	Relapse	0.0085	46,XY,del(9)(p13),add(12)(q24.3)[5]/46,XY[6]	Negative	None of the above	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	2256.0	NA	0:LIVING	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	53.8
all_phase2_target_2018_pub	TARGET-10-PAPPHL	TARGET-10-PAPPHL-04	8.0	2695.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1332.0	1	Not Hispanic or Latino	Positive	Relapse	NA	NA	Unknown	ETV6-RUNX1	NA	NA	0.0047	0.01	NA	NA	NA	NA	NA	BLL	3153.0	NA	0:LIVING	No	AALL0331	White	2	Male	Matched	Unknown	No	No	NA	Unknown	2.59
all_phase2_target_2018_pub	TARGET-10-PAPPHL	TARGET-10-PAPPHL-09	8.0	2695.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1332.0	1	Not Hispanic or Latino	Positive	Relapse	NA	NA	Unknown	ETV6-RUNX1	NA	NA	0.0047	0.01	NA	NA	NA	NA	NA	BLL	3153.0	NA	0:LIVING	No	AALL0331	White	2	Male	Matched	Unknown	No	No	NA	Unknown	2.59
all_phase2_target_2018_pub	TARGET-10-PAPRCS	TARGET-10-PAPRCS-04	15.0	5147.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	460.0	353.0	1	Not Hispanic or Latino	Negative	Relapse	0.0022	46,X,r(Y)[17]/46,XY[3]	Negative	None of the above	NA	NA	0.019	0.001	NA	NA	2.3	0.01	NA	BLL	460.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	71.9
all_phase2_target_2018_pub	TARGET-10-PAPRCS	TARGET-10-PAPRCS-09	15.0	5147.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	460.0	353.0	1	Not Hispanic or Latino	Negative	Relapse	0.0025	46,X,r(Y)[17]/46,XY[3]	Negative	None of the above	NA	NA	0.019	0.001	NA	NA	2.3	0.01	8	BLL	460.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.266666666667	Negative	71.9
all_phase2_target_2018_pub	TARGET-10-PAPRFE	TARGET-10-PAPRFE-09	3.0	940.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	391.0	391.0	1	Hispanic or Latino	Negative	Death	0.0017	46,XX,t(1;19)(q23;p13)[15]/46,XX[5]	Negative	TCF3-PBX1	0.0	0.01	0.0	0.001	NA	NA	NA	NA	2	BLL	391.0	NA	1:DECEASED	No	AALL0331	White	1	Female	Matched	Positive	No	NA	0.0666666666667	Negative	7.6
all_phase2_target_2018_pub	TARGET-10-PAPRYB	TARGET-10-PAPRYB-03	7.0	2334.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	5.0	1.0	54.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	647.0	475.0	1	Not Hispanic or Latino	Negative	Relapse	NA	48,XY,+X,i(17)(q10),+21[10]/46,XY[13]	Negative	None of the above	NA	NA	9.5	0.01	NA	NA	53.0	0.01	NA	BLL	647.0	NA	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	63.1
all_phase2_target_2018_pub	TARGET-10-PAPRYB	TARGET-10-PAPRYB-04	7.0	2334.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	5.0	1.0	54.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	647.0	475.0	1	Not Hispanic or Latino	Negative	Relapse	NA	48,XY,+X,i(17)(q10),+21[10]/46,XY[13]	Negative	None of the above	NA	NA	9.5	0.01	NA	NA	53.0	0.01	NA	BLL	647.0	NA	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	63.1
all_phase2_target_2018_pub	TARGET-10-PAPRYB	TARGET-10-PAPRYB-09	7.0	2334.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	5.0	1.0	54.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	647.0	475.0	1	Not Hispanic or Latino	Negative	Relapse	NA	48,XY,+X,i(17)(q10),+21[10]/46,XY[13]	Negative	None of the above	NA	NA	9.5	0.01	NA	NA	53.0	0.01	NA	BLL	647.0	NA	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	63.1
all_phase2_target_2018_pub	TARGET-10-PAPRYB	TARGET-10-PAPRYB-40	7.0	2334.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	5.0	1.0	54.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	647.0	475.0	1	Not Hispanic or Latino	Negative	Relapse	NA	48,XY,+X,i(17)(q10),+21[10]/46,XY[13]	Negative	None of the above	NA	NA	9.5	0.01	NA	NA	53.0	0.01	NA	BLL	647.0	NA	1:DECEASED	No	AALL0232	White	4	Male	Matched	Negative	No	No	NA	Negative	63.1
all_phase2_target_2018_pub	TARGET-10-PAPSPG	TARGET-10-PAPSPG-03	14.0	4782.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1533.0	965.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+X?c[5]/46,XY[15]	Negative	None of the above	NA	NA	0.013000000000000001	0.001	NA	NA	1.66	0.01	5	BLL	1533.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Negative	Yes	No	0.166666666667	Negative	326.0
all_phase2_target_2018_pub	TARGET-10-PAPSPG	TARGET-10-PAPSPG-04	14.0	4782.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1533.0	965.0	1	Hispanic or Latino	Negative	Relapse	0.0015	47,XY,+X?c[5]/46,XY[15]	Negative	None of the above	NA	NA	0.013000000000000001	0.001	NA	NA	1.66	0.01	NA	BLL	1533.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Negative	Yes	No	NA	Negative	326.0
all_phase2_target_2018_pub	TARGET-10-PAPSPG	TARGET-10-PAPSPG-09	14.0	4782.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	1533.0	965.0	1	Hispanic or Latino	Negative	Relapse	0.0025	47,XY,+X?c[5]/46,XY[15]	Negative	None of the above	NA	NA	0.013000000000000001	0.001	NA	NA	1.66	0.01	NA	BLL	1533.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Negative	Yes	No	NA	Negative	326.0
all_phase2_target_2018_pub	TARGET-10-PAPSPN	TARGET-10-PAPSPN-03	12.0	4173.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	22.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	733.0	528.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[30]	Negative	None of the above	NA	NA	0.0048	NA	NA	NA	NA	NA	5	BLL	733.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	0.166666666667	Negative	205.0
all_phase2_target_2018_pub	TARGET-10-PAPSPN	TARGET-10-PAPSPN-04	12.0	4173.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	22.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	733.0	528.0	1	Not Hispanic or Latino	Negative	Relapse	0.0026	46,XY[30]	Negative	None of the above	NA	NA	0.0048	NA	NA	NA	NA	NA	NA	BLL	733.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	NA	Negative	205.0
all_phase2_target_2018_pub	TARGET-10-PAPSPN	TARGET-10-PAPSPN-09	12.0	4173.0	NA	NA	DISCOVERY	Negative	2.0	0.0	NA	22.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	733.0	528.0	1	Not Hispanic or Latino	Negative	Relapse	0.0014	46,XY[30]	Negative	None of the above	NA	NA	0.0048	NA	NA	NA	NA	NA	5	BLL	733.0	NA	1:DECEASED	No	AALL0232	White	3	Male	Matched	Negative	No	No	0.2	Negative	205.0
all_phase2_target_2018_pub	TARGET-10-PAPTGG	TARGET-10-PAPTGG-09	5.0	1610.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	44.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	664.0	1.18	Not Hispanic or Latino	Negative	Relapse	NA	59,XY,+X,+Y,+4,+6,+7,+8,+10,+14,+14,+17,+21,+21,+22[cp3]/46,XY[17]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	3455.0	NA	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	1.6
all_phase2_target_2018_pub	TARGET-10-PAPTHJ	TARGET-10-PAPTHJ-03	4.0	1221.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1012.0	1.2	Not Hispanic or Latino	Negative	Relapse	NA	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2911.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Unknown	No	NA	NA	Negative	41.8
all_phase2_target_2018_pub	TARGET-10-PAPTHJ	TARGET-10-PAPTHJ-04	4.0	1221.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1012.0	1.2	Not Hispanic or Latino	Negative	Relapse	0.0251	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2911.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Unknown	No	NA	NA	Negative	41.8
all_phase2_target_2018_pub	TARGET-10-PAPTHJ	TARGET-10-PAPTHJ-09	4.0	1221.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1012.0	1.2	Not Hispanic or Latino	Negative	Relapse	0.0454	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2911.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Unknown	No	NA	NA	Negative	41.8
all_phase2_target_2018_pub	TARGET-10-PAPTLM	TARGET-10-PAPTLM-09	2.0	679.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	919.0	531.0	1	Hispanic or Latino	Negative	Relapse	0.0011	46,XX[20]	Negative	None of the above	NA	NA	0.009000000000000001	0.001	NA	NA	NA	NA	3	BLL	919.0	NA	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	0.1	Negative	46.49
all_phase2_target_2018_pub	TARGET-10-PAPUDR	TARGET-10-PAPUDR-09	4.0	1305.0	NA	NA	DISCOVERY	Negative	10.0	7.0	6.0	84.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	889.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of the above	NA	NA	44.5	0.01	NA	NA	4.0	0.01	NA	BLL	1257.0	NA	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	7.3
all_phase2_target_2018_pub	TARGET-10-PAPVNW	TARGET-10-PAPVNW-09	2.0	388.0	NA	NA	DISCOVERY	Negative	3.0	2.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	456.0	1	Not Hispanic or Latino	Negative	Relapse	0.0417	45,XX,der(3)t(3;9)(q28;q34),add(7)(p11.2),-9,der(9)t(7;9)(p11.2;q34),add(13)(q13)[12]/46,XX[28]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.91	0.01	NA	BLL	1952.0	NA	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	13.99
all_phase2_target_2018_pub	TARGET-10-PAPVTA	TARGET-10-PAPVTA-04	3.0	1020.0	NA	NA	DISCOVERY	Negative	25.0	1.0	NA	46.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1012.0	1.11	Not Hispanic or Latino	Negative	Relapse	0.1787	51,XY,+X,+6,+14,+21,+21[12]/46,XY[8]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.01	0.16	0.01	NA	NA	10.8	0.01	NA	BLL	3217.0	NA	0:LIVING	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	6.4
all_phase2_target_2018_pub	TARGET-10-PAPVTA	TARGET-10-PAPVTA-09	3.0	1020.0	NA	NA	DISCOVERY	Negative	25.0	1.0	NA	46.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1012.0	1.11	Not Hispanic or Latino	Negative	Relapse	0.1021	51,XY,+X,+6,+14,+21,+21[12]/46,XY[8]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	0.0	0.01	0.16	0.01	NA	NA	10.8	0.01	4	BLL	3217.0	NA	0:LIVING	No	AALL0331	White	2	Male	Matched	Negative	No	No	0.133333333333	Negative	6.4
all_phase2_target_2018_pub	TARGET-10-PAPXED	TARGET-10-PAPXED-04	17.0	6057.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	34.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1185.0	1088.0	1.2	Not Hispanic or Latino	Negative	Relapse	NA	56,XX,+X,+4,+6,+10,+14,+14,+17,add(17)(p11.2),+18,+21,+21[16]/46,XX[4]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.14	0.01	NA	NA	NA	NA	NA	BLL	1185.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Positive	1.1
all_phase2_target_2018_pub	TARGET-10-PAPXED	TARGET-10-PAPXED-09	17.0	6057.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	34.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1185.0	1088.0	1.2	Not Hispanic or Latino	Negative	Relapse	NA	56,XX,+X,+4,+6,+10,+14,+14,+17,add(17)(p11.2),+18,+21,+21[16]/46,XX[4]	Negative	Trisomy of both chromosomes 4 and 10	0.0	0.01	0.14	0.01	NA	NA	NA	NA	NA	BLL	1185.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Positive	1.1
all_phase2_target_2018_pub	TARGET-10-PAPYEX	TARGET-10-PAPYEX-04	14.0	4860.0	Chemotherapy	NA	DISCOVERY	Negative	15.0	0.0	1.0	70.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1146.0	888.0	1	Hispanic or Latino	Negative	Relapse	NA	45,XY,add(4)(q23),del(7)(q22),add(11)(q21),-14,-17,-19,der(21)add(21)(p11.2)(AML1x4),+mar1,+mar2[cp11]/46,XY[9]	Negative	iAMP21	NA	NA	10.4	0.01	NA	NA	0.58	0.01	NA	BLL	1146.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	5.3
all_phase2_target_2018_pub	TARGET-10-PAPZGR	TARGET-10-PAPZGR-04	14.0	4993.0	Transplant	NA	DISCOVERY	Negative	0.0	1.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	859.0	404.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;11)(q21;q23)[19]/46,XY[2]	Positive	MLL-Rearranged	NA	NA	0.16	0.01	NA	NA	NA	NA	NA	BLL	859.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	841.0
all_phase2_target_2018_pub	TARGET-10-PAPZGR	TARGET-10-PAPZGR-09	14.0	4993.0	Transplant	NA	DISCOVERY	Negative	0.0	1.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	859.0	404.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;11)(q21;q23)[19]/46,XY[2]	Positive	MLL-Rearranged	NA	NA	0.16	0.01	NA	NA	NA	NA	NA	BLL	859.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	841.0
all_phase2_target_2018_pub	TARGET-10-PAPZNK	TARGET-10-PAPZNK-03	11.0	3658.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	883.0	625.0	1.149	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	883.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Unknown	No	NA	0.166666666667	Negative	84.7
all_phase2_target_2018_pub	TARGET-10-PAPZNK	TARGET-10-PAPZNK-04	11.0	3658.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	883.0	625.0	1.149	Hispanic or Latino	Negative	Relapse	0.0533	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	883.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Unknown	No	NA	NA	Negative	84.7
all_phase2_target_2018_pub	TARGET-10-PAPZNK	TARGET-10-PAPZNK-09	11.0	3658.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	883.0	625.0	1.149	Hispanic or Latino	Negative	Relapse	0.0064	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	4	BLL	883.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Unknown	No	NA	0.133333333333	Negative	84.7
all_phase2_target_2018_pub	TARGET-10-PAPZPJ	TARGET-10-PAPZPJ-09	5.0	1484.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3344.0	1.15	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+4,+6,+10,+14,+17,+18,+21[11]/54,idem,t(11;15)(q25;q22)[4]/46,XY[5]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3344.0	110.0	0:LIVING	No	AALL0331	Asian	1	Male	Matched	Negative	No	No	NA	Positive	2.2
all_phase2_target_2018_pub	TARGET-10-PAPZPZ	TARGET-10-PAPZPZ-09	4.0	1232.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3400.0	1.15	Not Hispanic or Latino	Negative	None	NA	54,XX,+X,+4,+6,t(9;12)(q34;q13),+14,+17,+18,+21,+21[cp6]/46,XX[20]	Negative	NA	NA	NA	0.07	0.01	NA	NA	NA	NA	NA	BLL	3400.0	112.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.0
all_phase2_target_2018_pub	TARGET-10-PAPZRA	TARGET-10-PAPZRA-09	4.0	1448.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	58.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	1358.0	1	Hispanic or Latino	Positive	Relapse	NA	NA	Negative	NA	NA	NA	0.07	0.01	NA	NA	0.2	0.01	NA	BLL	1594.0	53.0	1:DECEASED	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	9.2
all_phase2_target_2018_pub	TARGET-10-PAPZRB	TARGET-10-PAPZRB-09	3.0	927.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3045.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3045.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	40.2
all_phase2_target_2018_pub	TARGET-10-PAPZST	TARGET-10-PAPZST-04	16.0	5491.0	NA	NA	DISCOVERY	Negative	4.0	2.0	2.0	32.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	171.0	1	Not Hispanic or Latino	Negative	Relapse	0.0007	NA	Negative	None of the above	3.3	0.01	1.8	0.01	NA	NA	1.1	0.01	NA	BLL	859.0	NA	0:LIVING	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Negative	65.0
all_phase2_target_2018_pub	TARGET-10-PAPZST	TARGET-10-PAPZST-09	16.0	5491.0	NA	NA	DISCOVERY	Negative	4.0	2.0	2.0	32.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	171.0	1	Not Hispanic or Latino	Negative	Relapse	0.0333	NA	Negative	None of the above	3.3	0.01	1.8	0.01	NA	NA	1.1	0.01	2	BLL	859.0	NA	0:LIVING	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	0.0666666666667	Negative	65.0
all_phase2_target_2018_pub	TARGET-10-PAPZTD	TARGET-10-PAPZTD-09	9.0	3010.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2999.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0062	0.0062	NA	NA	0.14	0.01	NA	BLL	2999.0	99.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Unknown	8.2
all_phase2_target_2018_pub	TARGET-10-PAPZTL	TARGET-10-PAPZTL-09	8.0	2773.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	94.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3406.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,t(2;15)(q13;q15)[48]/46,XY[3]	Negative	NA	0.0	NA	0.23	0.01	NA	NA	0.83	0.01	NA	BLL	3406.0	112.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	9.92
all_phase2_target_2018_pub	TARGET-10-PAPZTS	TARGET-10-PAPZTS-09	6.0	2190.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1286.0	1.18	Not Hispanic or Latino	Positive	None	NA	46,XY,t(3;19)(p21;p13.3)[cp9]/46,idem,+del(3)(q21),-10[2]/46,XY[12]	Negative	NA	NA	NA	0.2	0.01	NA	NA	NA	NA	NA	BLL	1286.0	43.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	1.2
all_phase2_target_2018_pub	TARGET-10-PAPZUE	TARGET-10-PAPZUE-03	4.0	1444.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3220.0	1.118	Not Hispanic or Latino	Negative	None	NA	52,XY,+X,+6,t(7;14)(p13;q11.2),+10,-13,+18,+21,+21,+mar1[17]/52,idem,+mar2[3]	Negative	NA	NA	0.01	0.11	0.01	NA	NA	1.4	0.01	NA	BLL	3220.0	106.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	18.6
all_phase2_target_2018_pub	TARGET-10-PAPZUW	TARGET-10-PAPZUW-09	4.0	1329.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3066.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,t(3;9;13)(p21;p13;q12),add(9)(p11.2)[cp4]/46,idem,,i(21)(q10)[cp3]/46,XY[23]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3066.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	2.0
all_phase2_target_2018_pub	TARGET-10-PAPZVI	TARGET-10-PAPZVI-09	3.0	867.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	2976.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,del(12)(p11.2p13),+21[cp3]/46,XY[45]	Negative	NA	NA	NA	0.00081	0.01	NA	NA	0.13	0.01	NA	BLL	2976.0	98.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	23.3
all_phase2_target_2018_pub	TARGET-10-PAPZWP	TARGET-10-PAPZWP-09	3.0	1029.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3163.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,inv(1)(q32q42),der(19)t(1;19)(q23;p13)[12]/46,XY[9]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3163.0	104.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	35.57
all_phase2_target_2018_pub	TARGET-10-PAPZXI	TARGET-10-PAPZXI-09	4.0	1107.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3063.0	1.169	Not Hispanic or Latino	Negative	None	NA	56,XX,+X,+6,+10,+14,+14,+15,+17,+18,+21,+21[cp18]/46,XX[5]	Negative	NA	NA	NA	0.009000000000000001	0.001	NA	NA	1.4	0.01	NA	BLL	3063.0	101.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.3
all_phase2_target_2018_pub	TARGET-10-PAPZZJ	TARGET-10-PAPZZJ-09	2.0	691.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3310.0	1.31	Hispanic or Latino	Negative	None	NA	60,XY,+X,+4,+5,+6,+8,+10,+10,+11,+12,+14,+14,+17,+21,+21[3]/46,XY[14]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.025	0.001	NA	BLL	3310.0	109.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	2.6
all_phase2_target_2018_pub	TARGET-10-PARABL	TARGET-10-PARABL-09	6.0	2187.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1466.0	1.85	Hispanic or Latino	Positive	Relapse	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3294.0	109.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	34.9
all_phase2_target_2018_pub	TARGET-10-PARABU	TARGET-10-PARABU-09	10.0	3451.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3427.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p13)[12]/46,XY[8]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3427.0	113.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	26.1
all_phase2_target_2018_pub	TARGET-10-PARACA	TARGET-10-PARACA-04	3.0	972.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	806.0	126.0	1	Not Hispanic or Latino	Negative	Relapse	0.1404	46,XY,t(1;19)(q23;p13.3)[11]/46,XY[9]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	1.2	0.01	NA	BLL	806.0	NA	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Positive	No	No	NA	Negative	41.0
all_phase2_target_2018_pub	TARGET-10-PARACA	TARGET-10-PARACA-09	3.0	972.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	806.0	126.0	1	Not Hispanic or Latino	Negative	Relapse	0.0012	46,XY,t(1;19)(q23;p13.3)[11]/46,XY[9]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	1.2	0.01	2	BLL	806.0	NA	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Positive	No	No	0.0666666666667	Negative	41.0
all_phase2_target_2018_pub	TARGET-10-PARACE	TARGET-10-PARACE-09	7.0	2468.0	CHEMOTHERAPY; RADIATION (NOS)	NA	VALIDATION	Negative	0.0	0.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	35.0	1.15	Not Hispanic or Latino	Negative	Censored	NA	52,XX,+4,+6,+14,+17,+21,+mar[cp10]	Negative	NA	NA	NA	0.0	0.001	NA	NA	9.4	0.01	NA	BLL	35.0	2.0	0:LIVING	No	AALL0331	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	20.8
all_phase2_target_2018_pub	TARGET-10-PARAFH	TARGET-10-PARAFH-09	5.0	1545.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3225.0	1.07	Not Hispanic or Latino	Positive	None	NA	49,XY,+X,+10,+21[10]/46,XY[10]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.13	0.01	NA	BLL	3225.0	107.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	7.5
all_phase2_target_2018_pub	TARGET-10-PARAFI	TARGET-10-PARAFI-09	6.0	1885.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3198.0	1.32	Not Hispanic or Latino	Negative	None	NA	60,XY,+X,dup(1)(q11q32),+4,+5,t(7;12)(q22;p13),+9,+10,+11,+12,+14,+psudic(16;6)(p13.3;q13),+17,+18,+21,+21,+22[4]/46,XY[16]	Negative	NA	NA	NA	0.0	0.01	NA	NA	1.36	0.01	NA	BLL	3198.0	106.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	2.3
all_phase2_target_2018_pub	TARGET-10-PARAGW	TARGET-10-PARAGW-09	4.0	1378.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	53.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3156.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,add(15)(p11.2)[11]/46,XY[7]	Negative	NA	NA	NA	0.0014	0.0014	NA	NA	NA	NA	NA	BLL	3156.0	104.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	11.5
all_phase2_target_2018_pub	TARGET-10-PARAJY	TARGET-10-PARAJY-09	3.0	862.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2829.0	1.108	Not Hispanic or Latino	Negative	None	NA	53,XY,+X,+4,+8,+14,+17,+18,+21[15]/46,XX[3]	Negative	NA	NA	NA	0.016	0.001	NA	NA	NA	NA	NA	BLL	2829.0	94.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	10.6
all_phase2_target_2018_pub	TARGET-10-PARAKF	TARGET-10-PARAKF-03	9.0	3051.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1088.0	1	Hispanic or Latino	Positive	Relapse	NA	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	13	BLL	1942.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Unknown	No	NA	0.433333333333	Negative	28.3
all_phase2_target_2018_pub	TARGET-10-PARAKF	TARGET-10-PARAKF-04	9.0	3051.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1088.0	1	Hispanic or Latino	Positive	Relapse	0.0549	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1942.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Unknown	No	NA	NA	Negative	28.3
all_phase2_target_2018_pub	TARGET-10-PARAKF	TARGET-10-PARAKF-09	9.0	3051.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1088.0	1	Hispanic or Latino	Positive	Relapse	0.0565	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	NA	NA	1	BLL	1942.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Unknown	No	NA	0.0333333333333	Negative	28.3
all_phase2_target_2018_pub	TARGET-10-PARANN	TARGET-10-PARANN-09	2.0	540.0	NA	NA	VALIDATION	Negative	8.0	0.0	NA	43.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3138.0	1.215	Not Hispanic or Latino	Negative	None	NA	56,XX,+X,+4,+6,+8,+10,+14,+17,+18,+21,+21[16]/46,XX[4]	Negative	NA	NA	NA	0.0032	0.01	NA	NA	NA	NA	NA	BLL	3138.0	104.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	11.1
all_phase2_target_2018_pub	TARGET-10-PARAPT	TARGET-10-PARAPT-09	5.0	1577.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	31.0	1.11	Hispanic or Latino	Negative	None	NA	52,XX,+6,+10,+14,+17,+21,+21[9]/53,idem,+X[5]/46,XX[6]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.32	0.01	NA	BLL	31.0	2.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	1.1
all_phase2_target_2018_pub	TARGET-10-PARARJ	TARGET-10-PARARJ-04	4.0	1129.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	455.0	397.0	1	Not Hispanic or Latino	Negative	Relapse	0.0004	NA	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	455.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Negative	71.8
all_phase2_target_2018_pub	TARGET-10-PARARJ	TARGET-10-PARARJ-09	4.0	1129.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	455.0	397.0	1	Not Hispanic or Latino	Negative	Relapse	0.0019	NA	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	NA	NA	5	BLL	455.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	0.166666666667	Negative	71.8
all_phase2_target_2018_pub	TARGET-10-PARASC	TARGET-10-PARASC-09	6.0	1994.0	NA	NA	VALIDATION	Negative	7.0	2.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3393.0	1.18	Not Hispanic or Latino	Negative	None	NA	55,XX,+X,+1,+4,+6,+14,+15,+17,+21,+21[cp13]/46,XX[6]	Negative	NA	0.0	NA	0.0	0.001	NA	NA	4.1	0.01	NA	BLL	3393.0	112.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	5.6
all_phase2_target_2018_pub	TARGET-10-PARASN	TARGET-10-PARASN-09	10.0	3609.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2950.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(1;6)(p36.3;q22)[3]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	5.76	0.01	NA	BLL	2950.0	97.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	8.9
all_phase2_target_2018_pub	TARGET-10-PARASZ	TARGET-10-PARASZ-09	5.0	1610.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	3087.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[30]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3087.0	102.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	27.0
all_phase2_target_2018_pub	TARGET-10-PARATY	TARGET-10-PARATY-09	3.0	949.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3373.0	1.42	Not Hispanic or Latino	Negative	None	NA	64,XY,+X,+Y,add(2)(q37),+3,+4,+5,+6,+8,+9,+10,+11,+12,+14,+16,+17,+18,+19,+21,+21[cp9]/46,XY[11]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3373.0	111.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	9.3
all_phase2_target_2018_pub	TARGET-10-PARAUE	TARGET-10-PARAUE-09	4.0	1223.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3254.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,?inv(12)(p12p13)[8]/46,XY[12]	Negative	NA	NA	NA	0.0113	0.01	NA	NA	NA	NA	NA	BLL	3254.0	107.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PARAXH	TARGET-10-PARAXH-09	4.0	1376.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3072.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,t(9;12)(q22;p13),t(11;19)(q13;q13.3)[7]/46,XX[14]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.013999999999999999	0.001	NA	BLL	3072.0	101.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.0
all_phase2_target_2018_pub	TARGET-10-PARAYM	TARGET-10-PARAYM-09	16.0	5569.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	3399.0	1	Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p22)[14]/46,XY[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3399.0	112.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	400.0
all_phase2_target_2018_pub	TARGET-10-PARAZN	TARGET-10-PARAZN-09	3.0	902.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	490.0	1	Hispanic or Latino	Negative	None	NA	46,XX,-7,add(9)(p13),add(12)(p11.2),+mar[cp14]/46,XX[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.12	0.01	NA	BLL	490.0	17.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.2
all_phase2_target_2018_pub	TARGET-10-PARBBV	TARGET-10-PARBBV-09	4.0	1220.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3222.0	1.185	Not Hispanic or Latino	Negative	None	NA	55,XX,+X,+6,+10,+10,+11,+14,+18,+21,+21[4]/55,idem,add(13)(q12)[11]/46,XX[5]	Negative	NA	NA	NA	0.016	0.001	NA	NA	1.0	0.01	NA	BLL	3222.0	106.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	43.5
all_phase2_target_2018_pub	TARGET-10-PARBCW	TARGET-10-PARBCW-09	7.0	2264.0	NA	NA	VALIDATION	Negative	NA	0.0	1.0	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3046.0	1.075	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	0.01	1.8	0.01	NA	NA	NA	NA	NA	BLL	3046.0	101.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	26.3
all_phase2_target_2018_pub	TARGET-10-PARBDN	TARGET-10-PARBDN-03	6.0	2071.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1096.0	919.0	1	Not Hispanic or Latino	Positive	Relapse	NA	48,XY,dup(1)(q21q42),+16,+18,add(19)(p13.3),-20,+21[3]/46,XY[15]	Negative	ETV6-RUNX1	NA	NA	0.006999999999999999	0.001	NA	NA	0.024	0.001	NA	BLL	1096.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Negative	26.5
all_phase2_target_2018_pub	TARGET-10-PARBDN	TARGET-10-PARBDN-04	6.0	2071.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1096.0	919.0	1	Not Hispanic or Latino	Positive	Relapse	NA	48,XY,dup(1)(q21q42),+16,+18,add(19)(p13.3),-20,+21[3]/46,XY[15]	Negative	ETV6-RUNX1	NA	NA	0.006999999999999999	0.001	NA	NA	0.024	0.001	NA	BLL	1096.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Negative	26.5
all_phase2_target_2018_pub	TARGET-10-PARBDN	TARGET-10-PARBDN-09	6.0	2071.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1096.0	919.0	1	Not Hispanic or Latino	Positive	Relapse	NA	48,XY,dup(1)(q21q42),+16,+18,add(19)(p13.3),-20,+21[3]/46,XY[15]	Negative	ETV6-RUNX1	NA	NA	0.006999999999999999	0.001	NA	NA	0.024	0.001	NA	BLL	1096.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Negative	26.5
all_phase2_target_2018_pub	TARGET-10-PARBDP	TARGET-10-PARBDP-09	4.0	1411.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	2772.0	1	Unknown	Negative	None	NA	48,XY,+8,+21[12]/48,idem,i(7)(q10)[4]/46,XY[4]	Negative	NA	NA	NA	0.24	0.01	NA	NA	5.7	0.01	NA	BLL	2772.0	92.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	32.6
all_phase2_target_2018_pub	TARGET-10-PARBGG	TARGET-10-PARBGG-09	2.0	685.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2869.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[22]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2869.0	95.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	35.4
all_phase2_target_2018_pub	TARGET-10-PARBHI	TARGET-10-PARBHI-09	4.0	1248.0	NA	NA	VALIDATION	Negative	10.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3a	No	NA	3093.0	1.24	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	0.0	NA	0.0	0.001	NA	NA	0.04	0.01	NA	BLL	3093.0	102.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Positive	13.7
all_phase2_target_2018_pub	TARGET-10-PARBIX	TARGET-10-PARBIX-03	3.0	811.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	Yes	NA	2244.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+21c	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.98	0.01	NA	BLL	2244.0	74.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	16.9
all_phase2_target_2018_pub	TARGET-10-PARBKG	TARGET-10-PARBKG-09	2.0	671.0	CHEMOTHERAPY	NA	VALIDATION	Negative	2.0	1.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	87.0	1.16	Not Hispanic or Latino	Negative	None	NA	53,XX,+X,+4,+6,+14,+17,+18,+21[16]/54,idem,+9,del(13)(q14q32)[2]/46,XX[2]	Negative	NA	NA	NA	0.06	0.001	NA	NA	1.8	0.01	NA	BLL	87.0	3.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	5.0
all_phase2_target_2018_pub	TARGET-10-PARBKP	TARGET-10-PARBKP-09	6.0	2115.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2999.0	1	Hispanic or Latino	Negative	None	NA	46,XY[28]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.14	0.01	NA	BLL	2999.0	99.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PARBLL	TARGET-10-PARBLL-09	6.0	1963.0	NA	NA	VALIDATION	Negative	2.0	2.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2886.0	1.17	Hispanic or Latino	Negative	None	NA	53,XY,+X,+4,+6,+14,+17,+18,+21,[21]	Negative	NA	0.0	NA	0.2	0.01	NA	NA	4.2	0.01	NA	BLL	2886.0	95.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	4.5
all_phase2_target_2018_pub	TARGET-10-PARBLS	TARGET-10-PARBLS-09	3.0	1013.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3066.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	3066.0	101.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	5.6
all_phase2_target_2018_pub	TARGET-10-PARBND	TARGET-10-PARBND-09	5.0	1539.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2303.0	1.18	Not Hispanic or Latino	Negative	None	NA	56,XY,+X,+4,+6,+9,+10,+18,+21,+21,+2mar[cp13]/46,XY[7]	Negative	NA	NA	NA	0.17	0.01	NA	NA	1.27	0.01	NA	BLL	2303.0	76.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	6.5
all_phase2_target_2018_pub	TARGET-10-PARBNY	TARGET-10-PARBNY-09	3.0	991.0	NA	NA	VALIDATION	Negative	2.0	4.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3069.0	1.14	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.4	0.01	NA	BLL	3069.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	8.4
all_phase2_target_2018_pub	TARGET-10-PARBPX	TARGET-10-PARBPX-09	7.0	2268.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	47.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3383.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,t(7;12*;12;11)(p13;p13;q13;p11.2),+10,der(10)t(10;21)(q26;q21)x2,dic(14;22)(p11.2;p11.2),der(19)t(19;21)(p13.2;q22)[17]/46,XX[3]	Negative	NA	NA	NA	0.04	0.01	NA	NA	0.65	0.01	NA	BLL	3383.0	112.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.54
all_phase2_target_2018_pub	TARGET-10-PARBRK	TARGET-10-PARBRK-03	8.0	2636.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1124.0	99.0	1.163	Not Hispanic or Latino	Negative	Censored	NA	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	8	BLL	99.0	NA	1:DECEASED	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	0.266666666667	Negative	3.6
all_phase2_target_2018_pub	TARGET-10-PARBRK	TARGET-10-PARBRK-04	8.0	2636.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1124.0	99.0	1.163	Not Hispanic or Latino	Negative	Censored	0.4617	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	99.0	NA	1:DECEASED	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	NA	Negative	3.6
all_phase2_target_2018_pub	TARGET-10-PARBRK	TARGET-10-PARBRK-09	8.0	2636.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1124.0	99.0	1.163	Not Hispanic or Latino	Negative	Censored	0.2392	NA	Unknown	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	1	BLL	99.0	NA	1:DECEASED	No	AALL0331	Black or African American	3	Female	Matched	Unknown	No	NA	0.0333333333333	Negative	3.6
all_phase2_target_2018_pub	TARGET-10-PARBRM	TARGET-10-PARBRM-09	18.0	6350.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	73.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3114.0	1.24	Not Hispanic or Latino	Negative	None	NA	57,XX,+X,+4,+6,+8,+10,+11,+14,+17,+18,+21,+21[15]/47,XX[5]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.68	0.01	NA	BLL	3114.0	103.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	4.07
all_phase2_target_2018_pub	TARGET-10-PARBRV	TARGET-10-PARBRV-09	10.0	3297.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	3123.0	1	Hispanic or Latino	Positive	None	NA	45,XX,-13[5]/46,XX[14]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.02	0.01	NA	BLL	3123.0	103.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.5
all_phase2_target_2018_pub	TARGET-10-PARBRX	TARGET-10-PARBRX-09	7.0	2367.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	35.0	1	Hispanic or Latino	Negative	None	NA	47,XX,+21[3]/47,idem,del(6)(q21)[11]/46,XX[6]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.0	0.01	NA	BLL	35.0	2.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	48.6
all_phase2_target_2018_pub	TARGET-10-PARBSP	TARGET-10-PARBSP-09	4.0	1259.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3392.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,del(5)(q11.2q13),-8,del(12)(q22q24.3),+21,+mar[5]/46,XY[15]	Negative	NA	NA	NA	0.0014	0.0014	NA	NA	0.37	0.01	NA	BLL	3392.0	112.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	8.48
all_phase2_target_2018_pub	TARGET-10-PARBSW	TARGET-10-PARBSW-09	4.0	1187.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3197.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,t(7;12;21)(p22;p13;q22)[18]/46,idem,i(21)(q10)[4]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.0	0.01	NA	BLL	3197.0	106.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	7.6
all_phase2_target_2018_pub	TARGET-10-PARBTA	TARGET-10-PARBTA-09	8.0	2654.0	NA	NA	VALIDATION	Negative	3.0	3.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3065.0	1.152	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.07	0.01	NA	NA	0.0054	NA	NA	BLL	3065.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	4.4
all_phase2_target_2018_pub	TARGET-10-PARBVI	TARGET-10-PARBVI-04	14.0	4948.0	NA	NA	DISCOVERY	Negative	6.0	1.0	NA	52.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1172.0	958.0	1	Hispanic or Latino	Negative	Relapse	0.0559	46,XX[30]	Negative	None of the above	0.005	0.001	0.12	0.01	NA	NA	0.56	0.01	NA	BLL	1172.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	124.76
all_phase2_target_2018_pub	TARGET-10-PARBVI	TARGET-10-PARBVI-09	14.0	4948.0	NA	NA	DISCOVERY	Negative	6.0	1.0	NA	52.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1172.0	958.0	1	Hispanic or Latino	Negative	Relapse	0.0026	46,XX[30]	Negative	None of the above	0.005	0.001	0.12	0.01	NA	NA	0.56	0.01	5	BLL	1172.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.166666666667	Negative	124.76
all_phase2_target_2018_pub	TARGET-10-PARBWN	TARGET-10-PARBWN-09	15.0	5260.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3082.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(1;19)(q23;p13)[6]/46,idem,add(7)(p22)[8]/47,idem,+14[4]/46,XY[1]	Negative	NA	NA	0.1	0.13	0.01	NA	NA	0.063	0.001	NA	BLL	3082.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	11.9
all_phase2_target_2018_pub	TARGET-10-PARBXX	TARGET-10-PARBXX-09	6.0	2035.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	5.0	0.0	3.0	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3c	No	NA	849.0	1.075	Not Hispanic or Latino	Negative	None	NA	46,XY[21]	Negative	NA	NA	NA	2.4	0.01	NA	NA	27.1	0.01	NA	BLL	849.0	28.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	47.0
all_phase2_target_2018_pub	TARGET-10-PARBYS	TARGET-10-PARBYS-09	3.0	889.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	208.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,del(9)(p21),t(11;14)(p15;q11.2)[3]/45,idem,-X[2]/46,XX[15]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	208.0	7.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	6.6
all_phase2_target_2018_pub	TARGET-10-PARBYU	TARGET-10-PARBYU-09	5.0	1492.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3352.0	1.17	Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+6,+10,+14,+17,+18,+21,+21[15]/55,idem,dup(1)(q23q32)[2]/46,XX[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	2.3	0.01	NA	BLL	3352.0	111.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	15.3
all_phase2_target_2018_pub	TARGET-10-PARBZT	TARGET-10-PARBZT-09	11.0	3736.0	NA	NA	VALIDATION	Negative	3.0	1.0	0.0	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3144.0	1.08	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	0.027000000000000003	0.01	2.0	0.01	NA	NA	0.93	0.01	NA	BLL	3144.0	104.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PARCAX	TARGET-10-PARCAX-09	5.0	1538.0	NA	NA	VALIDATION	Negative	6.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3392.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3392.0	112.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	6.3
all_phase2_target_2018_pub	TARGET-10-PARCBE	TARGET-10-PARCBE-09	5.0	1823.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3022.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0023	0.01	NA	NA	0.11	0.01	NA	BLL	3022.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	9.5
all_phase2_target_2018_pub	TARGET-10-PARCBK	TARGET-10-PARCBK-04	17.0	6030.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	NA	37.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	628.0	580.0	1.05	Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;11)(q21;q23)[14]/46,idem,i(7)(q10)[4]/46,XY[2]	Positive	MLL-Rearranged	0.01	0.01	0.019	0.001	NA	NA	1.27	0.01	NA	BLL	628.0	21.0	1:DECEASED	No	AALL0232	Unknown	2	Male	Matched	Negative	No	No	NA	Negative	463.0
all_phase2_target_2018_pub	TARGET-10-PARCBK	TARGET-10-PARCBK-09	17.0	6030.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	NA	37.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	628.0	580.0	1.05	Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;11)(q21;q23)[14]/46,idem,i(7)(q10)[4]/46,XY[2]	Positive	MLL-Rearranged	0.01	0.01	0.019	0.001	NA	NA	1.27	0.01	NA	BLL	628.0	21.0	1:DECEASED	No	AALL0232	Unknown	2	Male	Matched	Negative	No	No	NA	Negative	463.0
all_phase2_target_2018_pub	TARGET-10-PARCCM	TARGET-10-PARCCM-09	8.0	2576.0	NA	NA	VALIDATION	Negative	10.0	2.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3081.0	1.24	Not Hispanic or Latino	Negative	None	NA	57,XY,+X,+Y,+4,+5,+6,+8,+10,+14,+18,+21,+21[16]/46,XY[4]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3081.0	102.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	44.7
all_phase2_target_2018_pub	TARGET-10-PARCDS	TARGET-10-PARCDS-09	14.0	4885.0	NA	NA	VALIDATION	Negative	0.0	2.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3051.0	1.04	Not Hispanic or Latino	Negative	None	NA	46,XX[32]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.97	0.01	NA	BLL	3051.0	101.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.0
all_phase2_target_2018_pub	TARGET-10-PARCDV	TARGET-10-PARCDV-09	5.0	1621.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	198.0	1	Hispanic or Latino	Negative	Death	NA	46,XY,der(19)t(1;19)(q23;p13.3)[2]/46,idem,-6,del(13)(q12q22),+mar[4]/46,XY[14]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.32	0.01	NA	BLL	198.0	7.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	171.4
all_phase2_target_2018_pub	TARGET-10-PARCDX	TARGET-10-PARCDX-09	5.0	1476.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3188.0	1	Not Hispanic or Latino	Negative	None	NA	47,XX,+X,idic(17)(p11.2)[6]/46,XX[24]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3188.0	105.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	28.0
all_phase2_target_2018_pub	TARGET-10-PARCDZ	TARGET-10-PARCDZ-09	6.0	1967.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3234.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0031	0.0031	NA	NA	0.066	0.001	NA	BLL	3234.0	107.0	0:LIVING	No	AALL0331	Asian	1	Female	Matched	Unknown	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARCFM	TARGET-10-PARCFM-09	15.0	5160.0	NA	NA	VALIDATION	Negative	0.0	NA	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	NA	1	Hispanic or Latino	Negative	NA	NA	45,XY,der(7)t(7;17)(p22;q12),-9,-17,+mar1[9]/45,idem,-mar1,+mar2[5]/46,XY[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	NA	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	28.6
all_phase2_target_2018_pub	TARGET-10-PARCGU	TARGET-10-PARCGU-09	3.0	841.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3220.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(1)(p34),del(2)(p11.2p25),dic(9;9)(p21;p21),der(12)t(1;12)(p34;q24.1),add(14)(q32),+mar[9]/46,XY[11]	Negative	NA	NA	NA	0.002	0.001	NA	NA	0.3	0.01	NA	BLL	3220.0	106.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	160.0
all_phase2_target_2018_pub	TARGET-10-PARCHB	TARGET-10-PARCHB-03	3.0	787.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	60.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	801.0	1.06	Not Hispanic or Latino	Negative	Relapse	NA	50,XY,+X,del(16)(q11.2),+21,+21,+mar[10]/46,XY[55]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	12.1	0.01	1	BLL	3047.0	NA	0:LIVING	No	AALL0331	White	2	Male	Matched	Negative	No	No	0.0333333333333	Negative	23.5
all_phase2_target_2018_pub	TARGET-10-PARCHB	TARGET-10-PARCHB-09	3.0	787.0	NA	NA	DISCOVERY	Negative	3.0	0.0	NA	60.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	801.0	1.06	Not Hispanic or Latino	Negative	Relapse	0.0814	50,XY,+X,del(16)(q11.2),+21,+21,+mar[10]/46,XY[55]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	12.1	0.01	NA	BLL	3047.0	NA	0:LIVING	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	23.5
all_phase2_target_2018_pub	TARGET-10-PARCHU	TARGET-10-PARCHU-09	3.0	941.0	CHEMOTHERAPY	NA	VALIDATION	Negative	4.0	1.0	NA	90.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2569.0	1.19	Unknown	Negative	None	NA	54,XY,+X,dup(1)(q23q32),+4,+6,+10,+14,+17,+21,+21[8]/46,XY[12]	Negative	NA	NA	NA	0.002	0.001	NA	NA	1.9	0.01	NA	BLL	2569.0	85.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	34.4
all_phase2_target_2018_pub	TARGET-10-PARCHY	TARGET-10-PARCHY-09	3.0	1064.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3267.0	1.22	Not Hispanic or Latino	Negative	None	NA	56,XY,+X,+4,+6,+10,+14,+17,+18,+19,+21,+21[cp2]/46,XY[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.05	0.01	NA	BLL	3267.0	108.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	1.2
all_phase2_target_2018_pub	TARGET-10-PARCKD	TARGET-10-PARCKD-09	3.0	928.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3041.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[22]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.03	0.01	NA	BLL	3041.0	100.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	45.0
all_phase2_target_2018_pub	TARGET-10-PARCKJ	TARGET-10-PARCKJ-03	3.0	829.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2941.0	1.19	Not Hispanic or Latino	Negative	None	NA	54,XX,+4,+8,+10,+14,+17,+18,+21,+21[cp4]/46,XX[5]	Negative	NA	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	2941.0	97.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	27.0
all_phase2_target_2018_pub	TARGET-10-PARCKV	TARGET-10-PARCKV-09	5.0	1563.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	35.0	1.22	Not Hispanic or Latino	Negative	Censored	NA	57,XY,+X,+4,+6,+8,+9,+10,+11,+14,+18,der(19)t(17;19)(q21;p13.3),+21,+21[17]/46,XY[3]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.3	0.01	NA	BLL	35.0	2.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	31.7
all_phase2_target_2018_pub	TARGET-10-PARCLU	TARGET-10-PARCLU-09	17.0	6051.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	57.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3052.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,der(9*)t(9*;9)(p13;q22),der(9)t(9*;9)(p13;q22)add(9)(p13)[6]/46,XX[14]	Negative	NA	NA	NA	0.07	0.01	NA	NA	0.7	0.01	NA	BLL	3052.0	101.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	12.62
all_phase2_target_2018_pub	TARGET-10-PARCLW	TARGET-10-PARCLW-09	4.0	1200.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3012.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.02	0.01	NA	BLL	3012.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	11.2
all_phase2_target_2018_pub	TARGET-10-PARCMD	TARGET-10-PARCMD-03	2.0	617.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	48.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3187.0	1.17	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3187.0	105.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	16.6
all_phase2_target_2018_pub	TARGET-10-PARCMG	TARGET-10-PARCMG-03	5.0	1476.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	53.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3381.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3381.0	112.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	55.1
all_phase2_target_2018_pub	TARGET-10-PARCSH	TARGET-10-PARCSH-09	11.0	3872.0	CHEMOTHERAPY; Transplant	NA	VALIDATION	Positive	1.0	2.0	NA	76.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3184.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(9;22)(q34;q11.2)[20]	Negative	NA	NA	NA	0.5	0.01	NA	NA	2.7	0.01	NA	BLL	3184.0	105.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	10.3
all_phase2_target_2018_pub	TARGET-10-PARCTN	TARGET-10-PARCTN-09	11.0	3908.0	NA	NA	VALIDATION	Negative	NA	1.0	1.0	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3268.0	1.04	Not Hispanic or Latino	Negative	None	NA	46,XX,del(13)(q12q14),der(15)t(1;15)(q12;p11.2),der(19)t(1;19)(q23;p13.3)[3]/47,XX,+1,i(1)(q10),del(6)(q13q25),der(19)t(1;19)(q23;p13.3)[6]/46,XX[21]	Negative	NA	0.0	NA	0.11	0.01	NA	NA	NA	NA	NA	BLL	3268.0	108.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	7.9
all_phase2_target_2018_pub	TARGET-10-PARCUM	TARGET-10-PARCUM-09	12.0	4056.0	CHEMOTHERAPY	NA	VALIDATION	Negative	10.0	3.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	222.0	1	Hispanic or Latino	Negative	Death	NA	NA	Negative	NA	0.0	NA	0.003	0.001	NA	NA	0.0	0.01	NA	BLL	222.0	8.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	8.6
all_phase2_target_2018_pub	TARGET-10-PARCUW	TARGET-10-PARCUW-09	4.0	1341.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3284.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,add(6)(q21)[4]/46,XX[10]	Negative	NA	NA	0.01	0.25	0.01	NA	NA	2.6	0.01	NA	BLL	3284.0	108.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	13.9
all_phase2_target_2018_pub	TARGET-10-PARCVB	TARGET-10-PARCVB-09	3.0	979.0	CHEMOTHERAPY	NA	VALIDATION	Negative	2.0	1.0	NA	53.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3189.0	1	Unknown	Negative	None	NA	46,XX[30]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.73	0.01	NA	BLL	3189.0	105.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Unknown	No	NA	NA	Negative	45.1
all_phase2_target_2018_pub	TARGET-10-PARCVM	TARGET-10-PARCVM-03	4.0	1459.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	24.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2424.0	1	Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q12q22)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2424.0	80.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	255.0
all_phase2_target_2018_pub	TARGET-10-PARCVT	TARGET-10-PARCVT-09	15.0	5419.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	67.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	99.0	0.53	Not Hispanic or Latino	Negative	Relapse	NA	26,X,+X,+14,+21[14]/46,XX[6]	Negative	NA	NA	NA	0.8	0.01	NA	NA	7.83	0.01	NA	BLL	237.0	8.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	121.1
all_phase2_target_2018_pub	TARGET-10-PARCWB	TARGET-10-PARCWB-09	5.0	1632.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	2992.0	1	Hispanic or Latino	Negative	None	NA	45,XY,dic(7;12)(p11.2;p11.2)[7]/46,XY[13]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.06	0.01	NA	BLL	2992.0	99.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	8.1
all_phase2_target_2018_pub	TARGET-10-PARCZY	TARGET-10-PARCZY-09	2.0	624.0	NA	NA	VALIDATION	Negative	1.0	4.0	NA	68.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3045.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.23	0.01	NA	BLL	3045.0	101.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	76.3
all_phase2_target_2018_pub	TARGET-10-PARDAK	TARGET-10-PARDAK-09	9.0	3093.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3374.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(4;11)(q21;q23)[19]/46,XY[1]	Positive	NA	0.0	NA	0.002	0.001	NA	NA	NA	NA	NA	BLL	3374.0	111.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	144.0
all_phase2_target_2018_pub	TARGET-10-PARDBN	TARGET-10-PARDBN-09	16.0	5810.0	SURGERY	Left total hip arthroplasty	VALIDATION	Negative	0.0	4.0	NA	62.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2732.0	1	Hispanic or Latino	Negative	None	NA	46,XY[26]	Negative	NA	0.002	0.002	0.5	0.01	NA	NA	6.3	0.01	NA	BLL	2732.0	90.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	21.0
all_phase2_target_2018_pub	TARGET-10-PARDBT	TARGET-10-PARDBT-09	5.0	1537.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3181.0	1	Not Hispanic or Latino	Positive	None	NA	45,X,-X,t(2;12)(q11.2;p11.2)[6]/46,XX[26]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3181.0	105.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	89.0
all_phase2_target_2018_pub	TARGET-10-PARDCJ	TARGET-10-PARDCJ-09	17.0	5868.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2791.0	1	Hispanic or Latino	Negative	None	NA	46,XX,del(9)(p13p22)[19]/46,XX[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	3.0	0.01	NA	BLL	2791.0	92.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	2.21
all_phase2_target_2018_pub	TARGET-10-PARDCR	TARGET-10-PARDCR-09	5.0	1660.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2985.0	1	Hispanic or Latino	Positive	None	NA	46,XY,der(3)add(3)(p21)add(3)(q27),der(5)t(3;5)(p21;q21),del(12)(p11.2p13)[6]/46,XY[5]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.06	0.01	NA	BLL	2985.0	99.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	32.0
all_phase2_target_2018_pub	TARGET-10-PARDCY	TARGET-10-PARDCY-09	16.0	5493.0	NA	NA	VALIDATION	Negative	NA	0.0	0.0	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1885.0	1.21	Not Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+6,add(7)(p11.2),+10,+14,+17,+18,+21,+21[2]/46,XX[18]	Negative	NA	0.0	NA	2.2	0.01	NA	NA	0.72	0.01	NA	BLL	1885.0	62.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	2.7
all_phase2_target_2018_pub	TARGET-10-PARDDM	TARGET-10-PARDDM-09	5.0	1751.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3033.0	1.173	Not Hispanic or Latino	Negative	None	NA	54,XY,+4,+6,+8,+10,+17,+18,+21,+21[2]/46,XY[14]	Negative	NA	NA	NA	0.0066	0.0066	NA	NA	NA	NA	NA	BLL	3033.0	100.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	17.0
all_phase2_target_2018_pub	TARGET-10-PARDDV	TARGET-10-PARDDV-09	4.0	1193.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3176.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,del(12)(p11.2p12),+21[7]/46,XY[13]	Negative	NA	NA	NA	0.017	0.1	NA	NA	0.0	0.01	NA	BLL	3176.0	105.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	21.61
all_phase2_target_2018_pub	TARGET-10-PARDDW	TARGET-10-PARDDW-09	5.0	1626.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3350.0	1.05	Not Hispanic or Latino	Negative	None	NA	50,XY,+X,+Y,+21,+21[19]/46,XY[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	30.4	0.01	NA	BLL	3350.0	111.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	14.8
all_phase2_target_2018_pub	TARGET-10-PARDEG	TARGET-10-PARDEG-09	14.0	4757.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	1526.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,del(9)(p22)[2]/47,idem,+21[6]/46.XX[9]	Negative	NA	NA	NA	0.005	0.01	NA	NA	0.13	0.01	NA	BLL	1526.0	51.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	49.7
all_phase2_target_2018_pub	TARGET-10-PARDEJ	TARGET-10-PARDEJ-09	4.0	1245.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3076.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3076.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	67.4
all_phase2_target_2018_pub	TARGET-10-PARDEP	TARGET-10-PARDEP-09	13.0	4673.0	NA	NA	VALIDATION	Negative	NA	3.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2333.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[22]	Negative	NA	NA	NA	0.064	0.001	NA	NA	0.032	0.001	NA	BLL	2333.0	77.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	22.9
all_phase2_target_2018_pub	TARGET-10-PARDEY	TARGET-10-PARDEY-09	6.0	2059.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3038.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,del(12)(p13)[cp2]/46,XX[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.006	0.001	NA	BLL	3038.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	4.81
all_phase2_target_2018_pub	TARGET-10-PARDFB	TARGET-10-PARDFB-09	4.0	1138.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	2.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	2190.0	1.09	Hispanic or Latino	Negative	Relapse	NA	50,XY,+3,del(3)(q23),-8,+10,+15,+16,+18[cp7]/46,XY[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.01	0.01	NA	BLL	3044.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	51.5
all_phase2_target_2018_pub	TARGET-10-PARDFH	TARGET-10-PARDFH-09	5.0	1518.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3014.0	1	Hispanic or Latino	Positive	None	NA	46,XX,add(12)(p13)[4]/46,XX[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.04	0.01	NA	BLL	3014.0	100.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	24.31
all_phase2_target_2018_pub	TARGET-10-PARDFI	TARGET-10-PARDFI-09	4.0	1136.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3080.0	NA	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.001	0.001	NA	NA	0.27	0.01	NA	BLL	3080.0	102.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	18.1
all_phase2_target_2018_pub	TARGET-10-PARDFN	TARGET-10-PARDFN-09	11.0	3981.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3158.0	1.12	Not Hispanic or Latino	Negative	None	NA	52,XY,+X,del(8)(p22),+10,add(12)(p11.2),+14,+18,-20,+21,+21,+mar[cp12]/46,XY[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.29	0.01	NA	BLL	3158.0	104.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	11.9
all_phase2_target_2018_pub	TARGET-10-PARDHK	TARGET-10-PARDHK-09	2.0	641.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3345.0	1	Hispanic or Latino	Positive	None	NA	46,XX,add(12)(p13)[6]/46,XX[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	3345.0	110.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	22.4
all_phase2_target_2018_pub	TARGET-10-PARDHW	TARGET-10-PARDHW-09	2.0	494.0	CHEMOTHERAPY	NA	VALIDATION	Negative	2.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3171.0	1.27	Hispanic or Latino	Negative	None	NA	62,XX,+X,+4,+5,+6,+9,+10,+11,+12,+14,+15,+17,+18,+21,+21,+2mar[4]/46,XX[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.025	0.001	NA	BLL	3171.0	105.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	5.0
all_phase2_target_2018_pub	TARGET-10-PARDIN	TARGET-10-PARDIN-09	4.0	1223.0	NA	NA	VALIDATION	Negative	1.0	2.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3350.0	1.4	Not Hispanic or Latino	Negative	None	NA	66,XY,+X,+Y,+3,+4,+5,+8,+9,del(9)(p22p24),+10,+10,+11,+12,+14,+14,+17,+18,+21,+21,+22,+2mar[7]/46,XY[13]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3350.0	111.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	37.6
all_phase2_target_2018_pub	TARGET-10-PARDKG	TARGET-10-PARDKG-09	10.0	3592.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	2129.0	1	Hispanic or Latino	Negative	Death	NA	45,XY,-18,der(20)t(18;20)(q11.2;q11.2)[13]/46,XY[12]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2129.0	70.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	218.7
all_phase2_target_2018_pub	TARGET-10-PARDLJ	TARGET-10-PARDLJ-09	15.0	5446.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Unknown	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1306.0	1	Not Hispanic or Latino	Unknown	SMN	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	0.03	0.01	NA	BLL	1555.0	52.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	48.8
all_phase2_target_2018_pub	TARGET-10-PARDLP	TARGET-10-PARDLP-09	5.0	1621.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3026.0	1.21	Hispanic or Latino	Negative	None	NA	56,XX,+X,+4,+6,+8,+10,+14,+17,+18,+21,+21[6]	Negative	NA	NA	NA	0.0	0.001	NA	NA	1.19	0.01	NA	BLL	3026.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	10.7
all_phase2_target_2018_pub	TARGET-10-PARDLR	TARGET-10-PARDLR-09	9.0	3042.0	CHEMOTHERAPY; Transplant	NA	VALIDATION;DISCOVERY	Negative	1.0	0.0	NA	33.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	409.0	1.11	Not Hispanic or Latino	Negative	Relapse	NA	51,XX,+5,+6,,add(9)(p21),+11,add(14)(q32),+18,+20,add(21)(p11.2)[3]/51,idem,der(6)t(1;6)(q21;q25)[8]/51,idem,der(19)t(1;19)(q21;q13.4)[4]	Negative	None of the above	NA	NA	0.033	0.001	NA	NA	2.6	0.01	NA	BLL	1766.0	59.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	18.57
all_phase2_target_2018_pub	TARGET-10-PARDLZ	TARGET-10-PARDLZ-09	12.0	4199.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2040.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,add(5)(q31),del(6)(q21),add(17)(p13),+21[5]/47,idem,del(12)(p12),add(12)(p12)[11]/46,XY[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2040.0	68.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	5.7
all_phase2_target_2018_pub	TARGET-10-PARDMI	TARGET-10-PARDMI-09	5.0	1529.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3110.0	1	Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.012	0.001	NA	BLL	3110.0	103.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	2.2
all_phase2_target_2018_pub	TARGET-10-PARDNF	TARGET-10-PARDNF-09	11.0	3916.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	1.0	0.0	NA	40.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	212.0	136.0	1.1	Hispanic or Latino	Negative	Relapse	NA	48,XY,+X,t(4;11)(q21;q23),+8,add(21)(p11.2)[7]/46,XY[4]	Positive	MLL-Rearranged	NA	NA	0.02	0.01	NA	NA	5.8	0.01	NA	BLL	212.0	7.0	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	126.6
all_phase2_target_2018_pub	TARGET-10-PARDRI	TARGET-10-PARDRI-09	10.0	3624.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3315.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	2.1	0.01	NA	BLL	3315.0	109.0	0:LIVING	No	AALL0331	Asian	1	Male	Matched	Unknown	No	No	NA	Negative	38.4
all_phase2_target_2018_pub	TARGET-10-PARDRS	TARGET-10-PARDRS-09	9.0	3193.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	34.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3121.0	NA	Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+8,+10,+14,+17,+20,+21,+21[12]/46,XX[8]	Negative	NA	NA	NA	0.0	0.001	NA	NA	1.59	0.01	NA	BLL	3121.0	103.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	1.17
all_phase2_target_2018_pub	TARGET-10-PARDSN	TARGET-10-PARDSN-09	7.0	2244.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	54.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3351.0	1.251	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+4,+6,+10,+14,+17,+18,+21,+21,[5]/55,idem,add(1)(q42)[6]/46,XY[10]	Negative	NA	NA	NA	0.0015	0.0015	NA	NA	0.38	0.01	NA	BLL	3351.0	111.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	2.28
all_phase2_target_2018_pub	TARGET-10-PARDSP	TARGET-10-PARDSP-09	6.0	2165.0	NA	NA	VALIDATION	Negative	4.0	3.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3006.0	1.16	Hispanic or Latino	Negative	None	NA	55,XX,+4,+5,+10,+14,+17,+18,+21,+21,+mar[cp4]/46,XX[21]	Negative	NA	NA	NA	0.0	0.01	NA	NA	1.83	0.01	NA	BLL	3006.0	99.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	1.9
all_phase2_target_2018_pub	TARGET-10-PARDST	TARGET-10-PARDST-09	6.0	2011.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3038.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,t(12;21)(p12;q22)[5]/46,XY[15]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.64	0.01	NA	BLL	3038.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	69.4
all_phase2_target_2018_pub	TARGET-10-PARDUM	TARGET-10-PARDUM-09	6.0	2104.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3062.0	1.14	Not Hispanic or Latino	Negative	None	NA	53,XX,+X,+4,+6,+14,+17,+18,+21[15]/46,XX[5]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3062.0	101.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	24.5
all_phase2_target_2018_pub	TARGET-10-PARDVD	TARGET-10-PARDVD-09	12.0	4187.0	NA	NA	VALIDATION	Negative	3.0	2.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3273.0	1	Not Hispanic or Latino	Positive	None	NA	48,XX,-14,t(12;21)(p12;q22),+21,+der(21)t(12;21),+mar[cp4]/46,XX[16]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.099	0.001	NA	BLL	3273.0	108.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	15.0
all_phase2_target_2018_pub	TARGET-10-PARDWE	TARGET-10-PARDWE-03	19.0	6685.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	NA	3.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	504.0	369.0	1	Unknown	Unknown	Relapse	NA	46,XY,add(8)(q24)[11]/46,XY,add(1)(q32),del(6)(q13),del(6)(q13q23)[8]/46,XY[1]	Negative	None of the above	NA	NA	0.009000000000000001	0.001	NA	NA	0.5	0.01	7	BLL	504.0	17.0	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Negative	No	No	0.233333333333	Negative	47.6
all_phase2_target_2018_pub	TARGET-10-PARDWE	TARGET-10-PARDWE-04	19.0	6685.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	NA	3.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	504.0	369.0	1	Unknown	Unknown	Relapse	0.1279	46,XY,add(8)(q24)[11]/46,XY,add(1)(q32),del(6)(q13),del(6)(q13q23)[8]/46,XY[1]	Negative	None of the above	NA	NA	0.009000000000000001	0.001	NA	NA	0.5	0.01	NA	BLL	504.0	17.0	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	47.6
all_phase2_target_2018_pub	TARGET-10-PARDWE	TARGET-10-PARDWE-40	19.0	6685.0	CHEMOTHERAPY	NA	DISCOVERY	Negative	NA	3.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	504.0	369.0	1	Unknown	Unknown	Relapse	NA	46,XY,add(8)(q24)[11]/46,XY,add(1)(q32),del(6)(q13),del(6)(q13q23)[8]/46,XY[1]	Negative	None of the above	NA	NA	0.009000000000000001	0.001	NA	NA	0.5	0.01	NA	BLL	504.0	17.0	1:DECEASED	No	AALL0232	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	47.6
all_phase2_target_2018_pub	TARGET-10-PARDWM	TARGET-10-PARDWM-09	16.0	5641.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	4.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3300.0	1.092	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.052000000000000005	0.001	NA	NA	0.12	0.01	NA	BLL	3300.0	109.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	7.76
all_phase2_target_2018_pub	TARGET-10-PARDXG	TARGET-10-PARDXG-09	13.0	4705.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3040.0	1.72	Not Hispanic or Latino	Positive	None	NA	79,XX,+X,+1,+2,+2,+3,+3,+4,+5,+5,+6,r(6)(p25q13,+7,+8,+9,+10,+10,+11,+12,+13,+14,+14,+16,+16,+17,+17,+18,+18,+19,+19,+20,+21,+21,+22,+22[7]/80,idem,+21[2]/46,XX[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.18	0.01	NA	BLL	3040.0	100.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Positive	32.51
all_phase2_target_2018_pub	TARGET-10-PARDXI	TARGET-10-PARDXI-03	11.0	3801.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3011.0	1.25	Unknown	Negative	None	NA	57,XY,+X,+1,del(1)(q42),add(1)(p13),+3,+4,+6,+7,del(7)(q22),+10,-12,+14,+14,i(17)(q10),+21,+21,+mar[15]/46,XY[5]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.006999999999999999	0.001	NA	BLL	3011.0	99.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	24.5
all_phase2_target_2018_pub	TARGET-10-PARDXS	TARGET-10-PARDXS-09	4.0	1347.0	NA	NA	VALIDATION	Negative	27.0	1.0	NA	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3a	No	NA	2807.0	1.19	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+6,+10,add(12)(p13),+14,+18,+21,+21,+mar[cp12]/46,XY[8]	Negative	NA	NA	0.01	0.081	0.001	NA	NA	0.83	0.01	NA	BLL	2807.0	93.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	149.0
all_phase2_target_2018_pub	TARGET-10-PAREAA	TARGET-10-PAREAA-09	6.0	1869.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	671.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,t(1;4)(p22;q31.1),del(9)(p21)[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	3.4	0.01	NA	BLL	3078.0	102.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	145.3
all_phase2_target_2018_pub	TARGET-10-PAREAL	TARGET-10-PAREAL-09	10.0	3385.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3073.0	1.05	Hispanic or Latino	Negative	None	NA	48,XX,+X,der(19)t(1;19)(q23;p13.3),+21[2]/46,XX[18]	Negative	NA	NA	NA	0.0065	0.0065	NA	NA	3.4	0.01	NA	BLL	3073.0	102.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Positive	No	NA	NA	Negative	22.0
all_phase2_target_2018_pub	TARGET-10-PAREBA	TARGET-10-PAREBA-09	3.0	1066.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	487.0	1.18	Hispanic or Latino	Negative	None	NA	56,XY,+X,+4,+6,+10,+14,+17,+18,+21,+21,+22[16]/57,idem,+8[2]/46,XY[2]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.09699999999999999	0.001	NA	BLL	487.0	17.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	23.1
all_phase2_target_2018_pub	TARGET-10-PAREBH	TARGET-10-PAREBH-09	19.0	6768.0	CHEMOTHERAPY	NA	VALIDATION	Negative	6.0	1.0	1.0	81.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	Yes	NA	110.0	1	Not Hispanic or Latino	Negative	Death	NA	47,XY,+21c[20]	Negative	NA	NA	NA	3.0	0.01	2.2	NA	12.4	0.01	NA	BLL	110.0	4.0	1:DECEASED	No	AALL0232	American Indian or Alaska Native	1	Male	Matched	Negative	No	No	NA	Negative	171.2
all_phase2_target_2018_pub	TARGET-10-PAREDS	TARGET-10-PAREDS-03	2.0	548.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3335.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	6.3	0.01	NA	BLL	3335.0	110.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	38.5
all_phase2_target_2018_pub	TARGET-10-PAREEE	TARGET-10-PAREEE-09	5.0	1747.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3059.0	1.146	Not Hispanic or Latino	Negative	None	NA	53,XY,+X,+4,+6,+9,+14,+21,+21[9]/46,XY[18]	Negative	NA	NA	0.01	0.27	0.01	NA	NA	0.11	0.01	NA	BLL	3059.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	6.4
all_phase2_target_2018_pub	TARGET-10-PAREEX	TARGET-10-PAREEX-09	8.0	2798.0	NA	NA	VALIDATION	Negative	18.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3046.0	1.21	Hispanic or Latino	Negative	None	NA	56,XX,+X,+4,+6,+8,+10,+14,+14,+17,+18,+21[16]/46,XX[4]	Negative	NA	NA	NA	0.0	0.001	NA	NA	1.02	0.01	NA	BLL	3046.0	101.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	24.59
all_phase2_target_2018_pub	TARGET-10-PAREGC	TARGET-10-PAREGC-03	6.0	1983.0	NA	NA	VALIDATION	Negative	NA	NA	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Negative	NA	NA	46,XX,der(16)t(1;16)(q11;q13),der(17)t(17;18)(p13;q11.2),der(18)t(10;18)(q11.2;p11.2)[15]/46,XX[5]	Negative	NA	NA	NA	0.037000000000000005	0.001	NA	NA	7.3	0.01	NA	BLL	NA	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	80.0
all_phase2_target_2018_pub	TARGET-10-PAREGE	TARGET-10-PAREGE-09	7.0	2459.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2968.0	1.08	Hispanic or Latino	Negative	None	NA	50,X,-Y,+X,+10,+14,+21,+21[3]/46,XY[17]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.04	0.01	NA	BLL	2968.0	98.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PAREGZ	TARGET-10-PAREGZ-09	9.0	3128.0	NA	NA	VALIDATION	Negative	8.0	1.0	NA	45.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3087.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,del(13)(q12q22)[20]	Negative	NA	NA	NA	0.49	0.01	NA	NA	NA	NA	NA	BLL	3087.0	102.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	203.88
all_phase2_target_2018_pub	TARGET-10-PAREHN	TARGET-10-PAREHN-09	16.0	5674.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	363.0	1	Hispanic or Latino	Negative	None	NA	46,XY[22]	Negative	NA	NA	NA	0.23	0.01	NA	NA	NA	NA	NA	BLL	363.0	12.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	127.7
all_phase2_target_2018_pub	TARGET-10-PAREIE	TARGET-10-PAREIE-09	13.0	4451.0	CHEMOTHERAPY; Transplant	NA	VALIDATION	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	537.0	0.78	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	NA	NA	NA	0.64	0.01	NA	NA	0.7	0.01	NA	BLL	608.0	20.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	6.59
all_phase2_target_2018_pub	TARGET-10-PAREIN	TARGET-10-PAREIN-09	4.0	1300.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1435.0	1	Not Hispanic or Latino	Positive	Relapse	NA	46,XY,del(11)(q23q23),der(12)del(12)(p11.2)t(12;15)(p11.2;q15),der(15)t(12;15)(p11.2;q15)[5]/47,idem,+10[7]/46,XY[6]	Negative	NA	NA	NA	0.0072	0.0072	NA	NA	0.077	0.001	NA	BLL	3106.0	103.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	23.79
all_phase2_target_2018_pub	TARGET-10-PAREIV	TARGET-10-PAREIV-09	4.0	1107.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	76.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3046.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.035	0.001	NA	NA	NA	NA	NA	BLL	3046.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	7.8
all_phase2_target_2018_pub	TARGET-10-PAREJA	TARGET-10-PAREJA-09	8.0	2593.0	CHEMOTHERAPY	NA	VALIDATION	Negative	4.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1971.0	1.18	Not Hispanic or Latino	Unknown	None	NA	54,XX,+X,+4,+8,+10,+13,+18,+21,+mar[13]/46,XX[7]	Negative	NA	NA	NA	0.03	0.01	NA	NA	1.19	0.01	NA	BLL	1971.0	65.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	3.7
all_phase2_target_2018_pub	TARGET-10-PAREJZ	TARGET-10-PAREJZ-09	17.0	5901.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1714.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+5,add(9)(p13),del(12)(p11.2p13)[10]/47,idem,del(13)(q12q22)[cp2]/46,XY[8]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.07	0.01	NA	BLL	1714.0	57.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	39.4
all_phase2_target_2018_pub	TARGET-10-PAREKG	TARGET-10-PAREKG-09	9.0	2954.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3016.0	1	Not Hispanic or Latino	Negative	None	NA	47,XX,+X,del(20)(q13.1q13.3),r(21)amp(AML1)[7]/46,XX[13]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.39	0.01	NA	BLL	3016.0	100.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	4.3
all_phase2_target_2018_pub	TARGET-10-PAREKH	TARGET-10-PAREKH-09	6.0	1930.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2702.0	1.25	Hispanic or Latino	Negative	None	NA	58,XY,+X,+4,+5,+6,+8,+10,+14,+16,+17,+18,+21,+21[11]/46,XY[10]	Negative	NA	NA	NA	0.0	0.001	NA	NA	11.3	0.01	NA	BLL	2702.0	89.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Positive	17.2
all_phase2_target_2018_pub	TARGET-10-PAREKM	TARGET-10-PAREKM-09	5.0	1583.0	NA	NA	VALIDATION	Negative	15.0	3.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3228.0	1.16	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+4,+6,+14,+17,+21,+21,+mar[8]/46,XY[12]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3228.0	107.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARELH	TARGET-10-PARELH-03	12.0	4348.0	Chemotherapy; Radiation (NOS)	NA	DISCOVERY	Positive	51.0	35.0	NA	83.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	48.0	1	Unknown	Negative	Induction failure	NA	45,XY,-7,t(9;22)(q34;q11.2)[18]/46,XY[2]	Negative	BCR-ABL1	NA	NA	13.5	0.01	NA	NA	49.6	0.01	NA	BLL	486.0	NA	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	57.6
all_phase2_target_2018_pub	TARGET-10-PARENT	TARGET-10-PARENT-09	3.0	1009.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3124.0	1.21	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3124.0	103.0	0:LIVING	No	AALL0331	Asian	1	Male	Matched	Unknown	No	No	NA	Negative	28.2
all_phase2_target_2018_pub	TARGET-10-PARENU	TARGET-10-PARENU-09	2.0	703.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3329.0	1.18	Hispanic or Latino	Negative	None	NA	55,XX,+X,+4,+6,+10,+14,+17,+18,+21,+21[13]/46,XX[7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.03	0.01	NA	BLL	3329.0	110.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	15.9
all_phase2_target_2018_pub	TARGET-10-PARENW	TARGET-10-PARENW-09	18.0	6376.0	CHEMOTHERAPY; Transplant; OTHER THERAPY	; PLAT CAR-T cell infusion	VALIDATION	Negative	3.0	1.0	NA	40.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1680.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	NA	NA	NA	0.046	0.001	NA	NA	0.067	0.001	NA	BLL	3139.0	104.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	1.2
all_phase2_target_2018_pub	TARGET-10-PAREPB	TARGET-10-PAREPB-09	4.0	1254.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2630.0	1.217	Not Hispanic or Latino	Negative	None	NA	58,XXYc,+4,+6,+8,+10,+11,+12,+14,+18,+19,add(19)(p13.3),+21,+21[cp13]/47,XXYc[cp13]	Negative	NA	NA	NA	0.0029	0.01	NA	NA	NA	NA	NA	BLL	2630.0	87.0	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	15.74
all_phase2_target_2018_pub	TARGET-10-PAREPF	TARGET-10-PAREPF-09	6.0	2018.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	3000.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,i(21)(q10)[cp5]/47,idem,+i(21)(q10)[7]/46,XY[8]	Negative	NA	NA	NA	0.006999999999999999	0.01	NA	NA	NA	NA	NA	BLL	3000.0	99.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	4.9
all_phase2_target_2018_pub	TARGET-10-PARERM	TARGET-10-PARERM-09	4.0	1289.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	1.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2741.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	48,XX,+X,-15,-20,+21,+2mar[20]/46,XX[1]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.086	0.001	NA	BLL	3105.0	103.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	91.5
all_phase2_target_2018_pub	TARGET-10-PARERS	TARGET-10-PARERS-09	4.0	1458.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3024.0	1.22	Not Hispanic or Latino	Negative	None	NA	56,XX,+X,+4,+6,+8,+10,+14,+17,+18,+21,+22[11]/46,XX[9]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3024.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	24.0
all_phase2_target_2018_pub	TARGET-10-PARESP	TARGET-10-PARESP-09	2.0	600.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	85.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	975.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XY,t(7;12)(p13;p13),+18[12]/46,XY[8]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.48	0.01	NA	BLL	3265.0	108.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	No	NA	Negative	268.7
all_phase2_target_2018_pub	TARGET-10-PAREST	TARGET-10-PAREST-09	4.0	1371.0	NA	NA	VALIDATION	Negative	1.0	4.0	NA	57.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2562.0	1.18	Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	0.001	NA	NA	37.3	0.01	NA	BLL	2562.0	85.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	6.3
all_phase2_target_2018_pub	TARGET-10-PARETC	TARGET-10-PARETC-09	6.0	2052.0	NA	NA	VALIDATION	Negative	15.0	0.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3023.0	1.1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	0.0	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3023.0	100.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	1.8
all_phase2_target_2018_pub	TARGET-10-PARETH	TARGET-10-PARETH-09	8.0	2686.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3051.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+17[30]	Negative	NA	0.0	NA	0.14	0.01	NA	NA	0.5	0.01	NA	BLL	3051.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	56.9
all_phase2_target_2018_pub	TARGET-10-PARETV	TARGET-10-PARETV-09	9.0	2933.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3008.0	1.2	Not Hispanic or Latino	Negative	None	NA	54,XX,+X,dup(1)(q12q32),+4,+6,+10,+14,+17,+18,+21[cp19]	Negative	NA	NA	NA	0.012	0.001	NA	NA	1.24	0.01	NA	BLL	3008.0	99.0	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	28.3
all_phase2_target_2018_pub	TARGET-10-PAREUH	TARGET-10-PAREUH-09	8.0	2712.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2331.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.02	0.01	NA	NA	0.006999999999999999	0.001	NA	BLL	2331.0	77.0	0:LIVING	No	AALL0331	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Negative	2.89
all_phase2_target_2018_pub	TARGET-10-PAREWE	TARGET-10-PAREWE-09	4.0	1106.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3073.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,t(3;10()q25;q21.2),add(12)(p13),+21[12]/46,XY[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.091	0.001	NA	BLL	3073.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	64.5
all_phase2_target_2018_pub	TARGET-10-PAREWM	TARGET-10-PAREWM-09	7.0	2471.0	NA	NA	VALIDATION	Negative	2.0	2.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3052.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	2.7	0.01	NA	BLL	3052.0	101.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	1.1
all_phase2_target_2018_pub	TARGET-10-PAREWZ	TARGET-10-PAREWZ-09	13.0	4692.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3198.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,inv(12)(q12q23)c,+8[18]/46,XY,inv(12)(q12q23)c[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3198.0	106.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	15.7
all_phase2_target_2018_pub	TARGET-10-PAREYJ	TARGET-10-PAREYJ-09	5.0	1764.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	231.0	1	Hispanic or Latino	Positive	None	NA	46,XY,t(2;12)(p13;p13)[17]/46,XY[3]	Negative	NA	NA	NA	0.0056	0.01	NA	NA	0.77	0.01	NA	BLL	231.0	8.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	16.9
all_phase2_target_2018_pub	TARGET-10-PAREYW	TARGET-10-PAREYW-09	18.0	6267.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	83.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3021.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p21)[18]/46,XY[5]	Negative	NA	NA	NA	0.011000000000000001	0.01	NA	NA	21.6	0.01	NA	BLL	3021.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	121.0
all_phase2_target_2018_pub	TARGET-10-PAREZM	TARGET-10-PAREZM-09	4.0	1130.0	NA	NA	VALIDATION	Negative	10.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	2811.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	0.0	NA	0.092	0.001	NA	BLL	2811.0	93.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	299.2
all_phase2_target_2018_pub	TARGET-10-PARFAP	TARGET-10-PARFAP-09	6.0	2040.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3020.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.026000000000000002	0.001	NA	NA	0.29	0.01	NA	BLL	3020.0	100.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PARFDB	TARGET-10-PARFDB-09	15.0	5416.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3207.0	1.11	Not Hispanic or Latino	Negative	None	NA	46,XY,der(1)t(1;5;?)(p13;q22q35;?),der(5)t(5;12)(q22;p11.2),del(10)(q22q24),del(12)(q12q22),der(12)t(1;12)(p13;p11.2),dup(17)(q23q25)[cp8]/46,XY[12]	Negative	NA	NA	NA	0.012	0.001	NA	NA	0.06	0.01	NA	BLL	3207.0	106.0	0:LIVING	No	AALL0232	Asian	1	Male	Matched	Negative	No	Yes	NA	Negative	16.7
all_phase2_target_2018_pub	TARGET-10-PARFDG	TARGET-10-PARFDG-09	8.0	2765.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	2.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2357.0	1.15	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+Y,+8,+10,+14,+17,+18,+21,+21[11]/56,idem,+18[9]	Negative	NA	NA	NA	0.004	0.001	NA	NA	0.94	0.01	NA	BLL	2357.0	78.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	3.7
all_phase2_target_2018_pub	TARGET-10-PARFDL	TARGET-10-PARFDL-09	21.0	7491.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	22.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3075.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(1;8)(q25;p21),t(10;14)(q24;q11.2),del(22)(q11.2q13)[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3075.0	102.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	27.04
all_phase2_target_2018_pub	TARGET-10-PARFDW	TARGET-10-PARFDW-09	4.0	1338.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3002.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0064	0.01	NA	NA	NA	NA	NA	BLL	3002.0	99.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Unknown	No	No	NA	Negative	5.5
all_phase2_target_2018_pub	TARGET-10-PARFEH	TARGET-10-PARFEH-09	3.0	806.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	48.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2634.0	1.16	Hispanic or Latino	Negative	None	NA	54,XY,+4,der(4)t(4;17)(p16;q11.2),+6,+10,+14,+18,+21,+21[19]/46,XY[3]	Negative	NA	NA	NA	0.0	0.001	NA	NA	1.27	0.01	NA	BLL	2634.0	87.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	104.5
all_phase2_target_2018_pub	TARGET-10-PARFFC	TARGET-10-PARFFC-03	3.0	794.0	CHEMOTHERAPY; RADIATION (NOS)	; Treated on COG AALL0031 protocol	VALIDATION	Positive	1.0	1.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3238.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,t(9;22)(q34;q11.2),+mar[1]/48,idem,+21,+der(22)t(9;22)[1]/46,XY[18]	Negative	NA	NA	NA	0.0076	0.0076	NA	NA	NA	NA	NA	BLL	3238.0	107.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	17.37
all_phase2_target_2018_pub	TARGET-10-PARFHH	TARGET-10-PARFHH-09	6.0	2073.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	1.0	1.0	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3216.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	0.01	0.14	0.01	NA	NA	7.8	0.01	NA	BLL	3216.0	106.0	0:LIVING	No	AALL0331	Black or African American	1	Male	Matched	Unknown	No	No	NA	Negative	7.58
all_phase2_target_2018_pub	TARGET-10-PARFIH	TARGET-10-PARFIH-09	6.0	1925.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1099.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q13q22)[11]/46,idem,+1,dic(1;13)(p12;p11.2)[4]/46,XY[5]	Negative	NA	NA	NA	0.027999999999999997	0.001	NA	NA	NA	NA	NA	BLL	1099.0	37.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	102.1
all_phase2_target_2018_pub	TARGET-10-PARFIZ	TARGET-10-PARFIZ-09	8.0	2621.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3118.0	1.163	Hispanic or Latino	Negative	None	NA	53,XX,+X,+6,+10,+10,+18,+21,+21[8]/46,XX[12]	Negative	NA	NA	NA	0.068	0.001	NA	NA	NA	NA	NA	BLL	3118.0	103.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	7.2
all_phase2_target_2018_pub	TARGET-10-PARFJK	TARGET-10-PARFJK-09	4.0	1249.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3081.0	1.16	Unknown	Negative	None	NA	54,XX,+X,dup(1)(q21q32),+4,+6,+10,+14,+17,+18,+21,[7]/46,XX[13]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.053	0.001	NA	BLL	3081.0	102.0	0:LIVING	No	AALL0331	Unknown	1	Female	Matched	Negative	No	NA	NA	Positive	22.6
all_phase2_target_2018_pub	TARGET-10-PARFJM	TARGET-10-PARFJM-09	4.0	1293.0	NA	NA	VALIDATION	Negative	13.0	0.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3176.0	1.16	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,dup(1)(q23q32),+4,+6,+14,+17,+18,+21,+21[15]/46,XY[7]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	3.7	0.01	NA	BLL	3176.0	105.0	0:LIVING	No	AALL0331	White	1	Male	Matched	Negative	No	No	NA	Negative	18.1
all_phase2_target_2018_pub	TARGET-10-PARFKD	TARGET-10-PARFKD-09	12.0	4064.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	Yes	NA	2837.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+21c[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2837.0	94.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	4.9
all_phase2_target_2018_pub	TARGET-10-PARFLV	TARGET-10-PARFLV-04	17.0	5906.0	NA	NA	DISCOVERY	Negative	10.0	1.0	NA	48.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	334.0	293.0	1.08	Hispanic or Latino	Negative	Relapse	0.0017	NA	Negative	None of the above	0.0	0.01	0.57	0.01	NA	NA	2.4	0.01	NA	BLL	334.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	214.5
all_phase2_target_2018_pub	TARGET-10-PARFLV	TARGET-10-PARFLV-09	17.0	5906.0	NA	NA	DISCOVERY	Negative	10.0	1.0	NA	48.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	334.0	293.0	1.08	Hispanic or Latino	Negative	Relapse	0.0138	NA	Negative	None of the above	0.0	0.01	0.57	0.01	NA	NA	2.4	0.01	2	BLL	334.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	0.1	Negative	214.5
all_phase2_target_2018_pub	TARGET-10-PARFPJ	TARGET-10-PARFPJ-09	4.0	1348.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2946.0	1	Unknown	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	2946.0	97.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	145.7
all_phase2_target_2018_pub	TARGET-10-PARFSF	TARGET-10-PARFSF-09	3.0	919.0	NA	NA	VALIDATION	Negative	0.0	3.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3176.0	1.17	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+4,+6,+9,+10,+13,+18,+21[3]/46,XY[17]	Negative	NA	0.0	NA	0.22	0.01	NA	NA	1.0	0.01	NA	BLL	3176.0	105.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	84.0
all_phase2_target_2018_pub	TARGET-10-PARFTR	TARGET-10-PARFTR-03	6.0	2127.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	465.0	284.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(1;19)(q23;p13.3)[16]/46,XY[4]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	10.3	0.01	3	BLL	465.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Positive	No	No	0.1	Negative	9.5
all_phase2_target_2018_pub	TARGET-10-PARFTR	TARGET-10-PARFTR-04	6.0	2127.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	465.0	284.0	1	Not Hispanic or Latino	Negative	Relapse	0.0020	46,XY,t(1;19)(q23;p13.3)[16]/46,XY[4]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	10.3	0.01	NA	BLL	465.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Positive	No	No	NA	Negative	9.5
all_phase2_target_2018_pub	TARGET-10-PARFTR	TARGET-10-PARFTR-09	6.0	2127.0	NA	NA	DISCOVERY	Negative	0.0	1.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	465.0	284.0	1	Not Hispanic or Latino	Negative	Relapse	0.0008	46,XY,t(1;19)(q23;p13.3)[16]/46,XY[4]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	10.3	0.01	4	BLL	465.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Positive	No	No	0.133333333333	Negative	9.5
all_phase2_target_2018_pub	TARGET-10-PARFVZ	TARGET-10-PARFVZ-04	9.0	3034.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	952.0	1	Hispanic or Latino	Positive	Relapse	NA	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2983.0	NA	0:LIVING	No	AALL0331	Unknown	2	Male	Matched	Unknown	No	No	NA	Negative	0.7
all_phase2_target_2018_pub	TARGET-10-PARFVZ	TARGET-10-PARFVZ-09	9.0	3034.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	952.0	1	Hispanic or Latino	Positive	Relapse	NA	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2983.0	NA	0:LIVING	No	AALL0331	Unknown	2	Male	Matched	Unknown	No	No	NA	Negative	0.7
all_phase2_target_2018_pub	TARGET-10-PARFXJ	TARGET-10-PARFXJ-09	12.0	4245.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2988.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,der(5)t(5;12)(p15.3;q13),inv(7)(p15q32),i(9)(q10)[11]/46,XY[5]	Negative	NA	NA	NA	0.025	0.001	NA	NA	NA	NA	NA	BLL	2988.0	99.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PARGBK	TARGET-10-PARGBK-09	14.0	4850.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 1	No	NA	957.0	1.29	Not Hispanic or Latino	Unknown	Relapse	NA	58,XY,+X,+2,+4,+5,+6,+8,+10,+11,+14,+16,der(16)t(1;16)(q21;q12.1),+17,+21[19]/46,XY[1]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.015	0.001	NA	BLL	957.0	32.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	29.6
all_phase2_target_2018_pub	TARGET-10-PARGBR	TARGET-10-PARGBR-09	18.0	6412.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	21.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3213.0	1	Hispanic or Latino	Negative	None	NA	47,XY,+mar[3]/46,XY[17]	Negative	NA	NA	NA	0.12	0.01	NA	NA	3.69	0.01	NA	BLL	3213.0	106.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	92.72
all_phase2_target_2018_pub	TARGET-10-PARGBT	TARGET-10-PARGBT-09	11.0	3851.0	NA	NA	VALIDATION	Negative	0.0	4.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3120.0	1	Not Hispanic or Latino	Negative	None	NA	45,XX,-16[12]/46,XX[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.31	0.01	NA	BLL	3120.0	103.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	6.6
all_phase2_target_2018_pub	TARGET-10-PARGFL	TARGET-10-PARGFL-04	5.0	1499.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	3.0	0.0	NA	29.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3a	No	NA	1079.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	52,XY,+6,+9,+11,+13,+19,+22[11]/46,XY[8]	Negative	NA	NA	NA	0.14	0.01	NA	NA	NA	NA	NA	BLL	1893.0	63.0	1:DECEASED	No	AALL0434	White	2	Male	Matched	Negative	No	No	NA	Negative	148.6
all_phase2_target_2018_pub	TARGET-10-PARGFL	TARGET-10-PARGFL-09	5.0	1499.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	3.0	0.0	NA	29.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3a	No	NA	1079.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	52,XY,+6,+9,+11,+13,+19,+22[11]/46,XY[8]	Negative	NA	NA	NA	0.14	0.01	NA	NA	NA	NA	NA	BLL	1893.0	63.0	1:DECEASED	No	AALL0434	White	2	Male	Matched	Negative	No	No	NA	Negative	148.6
all_phase2_target_2018_pub	TARGET-10-PARGFV	TARGET-10-PARGFV-03	3.0	1033.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	970.0	1.308	Hispanic or Latino	Negative	Relapse	NA	62,XY,+X,+3,+4,+5,+6,+8,+10,+11,+12,add(12)(p12),+14,+16,+17,+18,+20,+21,+21[cp11]/46,XY[9]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.001	NA	NA	0.32	0.01	2	BLL	3311.0	NA	0:LIVING	No	AALL0331	White	3	Male	Matched	Negative	No	No	0.0666666666667	Positive	21.9
all_phase2_target_2018_pub	TARGET-10-PARGFV	TARGET-10-PARGFV-04	3.0	1033.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	970.0	1.308	Hispanic or Latino	Negative	Relapse	0.4563	62,XY,+X,+3,+4,+5,+6,+8,+10,+11,+12,add(12)(p12),+14,+16,+17,+18,+20,+21,+21[cp11]/46,XY[9]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.001	NA	NA	0.32	0.01	NA	BLL	3311.0	NA	0:LIVING	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Positive	21.9
all_phase2_target_2018_pub	TARGET-10-PARGFV	TARGET-10-PARGFV-09	3.0	1033.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	970.0	1.308	Hispanic or Latino	Negative	Relapse	0.2617	62,XY,+X,+3,+4,+5,+6,+8,+10,+11,+12,add(12)(p12),+14,+16,+17,+18,+20,+21,+21[cp11]/46,XY[9]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.001	NA	NA	0.32	0.01	NA	BLL	3311.0	NA	0:LIVING	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Positive	21.9
all_phase2_target_2018_pub	TARGET-10-PARGFX	TARGET-10-PARGFX-03	4.0	1156.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3a	No	NA	3106.0	1	Not Hispanic or Latino	Positive	None	NA	46,XX,del(12)(p13),der(12)t(12;15)(p13;q13),del(15)(q13)[22]/45,XX,der(12)t(12;14)(p13;q11.2),der(12)t(12;15)(p13;q13),-14,del(15)(q13)[7]/46,XX[1]	Negative	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3106.0	103.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	205.2
all_phase2_target_2018_pub	TARGET-10-PARGGI	TARGET-10-PARGGI-09	11.0	3708.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2958.0	1.081	Not Hispanic or Latino	Negative	None	NA	46,XX,del(11)(q23q25),del(13)(q12q14),t(14;18)(q11.2;q21.1)[5]/46,XX[35].ish t(14;18)(BCL2+,IGH-;BCL2-,IGH+)	Negative	NA	NA	NA	0.013999999999999999	0.001	NA	NA	0.45	0.01	NA	BLL	2958.0	98.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	12.0
all_phase2_target_2018_pub	TARGET-10-PARGHW	TARGET-10-PARGHW-03	19.0	6842.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	482.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;10)(q11;p11.1)[20]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	0.0	0.01	13	BLL	1467.0	NA	0:LIVING	No	AALL0232	White	3	Male	Matched	Unknown	No	No	0.466666666667	Negative	28.0
all_phase2_target_2018_pub	TARGET-10-PARGHW	TARGET-10-PARGHW-04	19.0	6842.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	482.0	1	Hispanic or Latino	Negative	Relapse	0.0021	46,XY,t(4;10)(q11;p11.1)[20]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	0.0	0.01	NA	BLL	1467.0	NA	0:LIVING	No	AALL0232	White	3	Male	Matched	Unknown	No	No	NA	Negative	28.0
all_phase2_target_2018_pub	TARGET-10-PARGHW	TARGET-10-PARGHW-09	19.0	6842.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	482.0	1	Hispanic or Latino	Negative	Relapse	0.0015	46,XY,t(4;10)(q11;p11.1)[20]	Negative	None of the above	NA	NA	0.0	0.001	NA	NA	0.0	0.01	2	BLL	1467.0	NA	0:LIVING	No	AALL0232	White	3	Male	Matched	Unknown	No	No	0.0666666666667	Negative	28.0
all_phase2_target_2018_pub	TARGET-10-PARGJH	TARGET-10-PARGJH-09	2.0	552.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3048.0	1.119	Not Hispanic or Latino	Negative	None	NA	45,XY,dic(9;20)(p13;q11.2)[28]/46,XY[15]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.07	0.01	NA	BLL	3048.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	60.9
all_phase2_target_2018_pub	TARGET-10-PARGJY	TARGET-10-PARGJY-09	18.0	6501.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3268.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	0.4	0.01	NA	BLL	3268.0	108.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	3.9
all_phase2_target_2018_pub	TARGET-10-PARGKD	TARGET-10-PARGKD-09	5.0	1521.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3194.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0056	0.0056	NA	NA	NA	NA	NA	BLL	3194.0	106.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	54.9
all_phase2_target_2018_pub	TARGET-10-PARGLE	TARGET-10-PARGLE-09	12.0	4183.0	CHEMOTHERAPY	NA	VALIDATION	Positive	0.0	1.0	NA	27.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	750.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(9;22)(q34;q11.2)[7]/45midem,del(3)(q21q25),-7[10]/46,XY[3]	Negative	NA	NA	NA	0.26	0.01	NA	NA	8.67	0.01	NA	BLL	3209.0	106.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	35.4
all_phase2_target_2018_pub	TARGET-10-PARGLI	TARGET-10-PARGLI-09	13.0	4578.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2c	No	NA	729.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[25]	Negative	NA	NA	NA	0.019	0.001	NA	NA	0.47	0.01	NA	BLL	2574.0	85.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	300.0
all_phase2_target_2018_pub	TARGET-10-PARGLW	TARGET-10-PARGLW-09	11.0	3744.0	NA	NA	VALIDATION	Negative	1.0	2.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3206.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[30]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.15	0.01	NA	BLL	3206.0	106.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	0.6
all_phase2_target_2018_pub	TARGET-10-PARGML	TARGET-10-PARGML-03	3.0	789.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	187.0	116.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,t(1;19)(q23;p13.3)[3]/48,idem,+8,+mar[3]/46,XX[18]	Negative	TCF3-PBX1	NA	NA	0.0	0.1	NA	NA	1.2	0.01	1	BLL	187.0	NA	1:DECEASED	No	AALL0331	White	3	Female	Matched	Positive	No	NA	0.0333333333333	Negative	45.2
all_phase2_target_2018_pub	TARGET-10-PARGML	TARGET-10-PARGML-04	3.0	789.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	187.0	116.0	1	Hispanic or Latino	Negative	Relapse	0.0499	46,XX,t(1;19)(q23;p13.3)[3]/48,idem,+8,+mar[3]/46,XX[18]	Negative	TCF3-PBX1	NA	NA	0.0	0.1	NA	NA	1.2	0.01	NA	BLL	187.0	NA	1:DECEASED	No	AALL0331	White	3	Female	Matched	Positive	No	NA	NA	Negative	45.2
all_phase2_target_2018_pub	TARGET-10-PARGML	TARGET-10-PARGML-09	3.0	789.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	187.0	116.0	1	Hispanic or Latino	Negative	Relapse	0.0004	46,XX,t(1;19)(q23;p13.3)[3]/48,idem,+8,+mar[3]/46,XX[18]	Negative	TCF3-PBX1	NA	NA	0.0	0.1	NA	NA	1.2	0.01	NA	BLL	187.0	NA	1:DECEASED	No	AALL0331	White	3	Female	Matched	Positive	No	NA	NA	Negative	45.2
all_phase2_target_2018_pub	TARGET-10-PARGMW	TARGET-10-PARGMW-09	3.0	923.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3065.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.006	0.001	NA	NA	0.12	0.01	NA	BLL	3065.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	166.5
all_phase2_target_2018_pub	TARGET-10-PARGUZ	TARGET-10-PARGUZ-09	16.0	5806.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1380.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,-9,t(12;21)(p12;q22),+21,der(21)add(21)(p11.2)t(12;21)[2]/46,XX[18]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.01	0.01	NA	BLL	1380.0	46.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	1.83
all_phase2_target_2018_pub	TARGET-10-PARGVZ	TARGET-10-PARGVZ-03	10.0	3571.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	989.0	1.156	Not Hispanic or Latino	Negative	Relapse	NA	53,XX,+X,+4,+6,+18,add(18)(p11.1),+21,+21,+mar[cp7]/46,XX[9]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	0.034	0.001	5	BLL	3152.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Negative	No	NA	0.166666666667	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PARGVZ	TARGET-10-PARGVZ-04	10.0	3571.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	989.0	1.156	Not Hispanic or Latino	Negative	Relapse	0.1748	53,XX,+X,+4,+6,+18,add(18)(p11.1),+21,+21,+mar[cp7]/46,XX[9]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	0.034	0.001	NA	BLL	3152.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PARGVZ	TARGET-10-PARGVZ-09	10.0	3571.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	989.0	1.156	Not Hispanic or Latino	Negative	Relapse	0.2460	53,XX,+X,+4,+6,+18,add(18)(p11.1),+21,+21,+mar[cp7]/46,XX[9]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	0.034	0.001	NA	BLL	3152.0	NA	0:LIVING	No	AALL0331	White	3	Female	Matched	Negative	No	NA	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PARGYV	TARGET-10-PARGYV-09	5.0	1541.0	CHEMOTHERAPY; Transplant	NA	VALIDATION	Positive	2.0	1.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	412.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,add(2)(q31),der(5)t(2;5)(q31;q31),der(9)add(9)(p13)t(9;22)(q34;q11.2),der(22)t(9;22)(q34;q11.2)[10]/50,idem,+X,+6,+14,+21[6]/46,XY[4]	Negative	NA	NA	NA	0.048	0.001	NA	NA	2.07	0.01	NA	BLL	704.0	24.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	333.5
all_phase2_target_2018_pub	TARGET-10-PARHAN	TARGET-10-PARHAN-09	15.0	5458.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1594.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.04	0.01	NA	BLL	1594.0	53.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	23.4
all_phase2_target_2018_pub	TARGET-10-PARHBI	TARGET-10-PARHBI-09	8.0	2883.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3010.0	1	Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3010.0	99.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	9.6
all_phase2_target_2018_pub	TARGET-10-PARHBT	TARGET-10-PARHBT-09	18.0	6213.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2956.0	1.162	Not Hispanic or Latino	Unknown	None	NA	48,XY,+8,+mar[4]/46,XY[16]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2956.0	98.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	254.7
all_phase2_target_2018_pub	TARGET-10-PARHEA	TARGET-10-PARHEA-09	11.0	3873.0	CHEMOTHERAPY; Transplant; OTHER THERAPY	; Gleevac	VALIDATION	Positive	9.0	2.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	582.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	NA	NA	NA	1.6	0.01	NA	NA	1.19	0.01	NA	BLL	3083.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	4.8
all_phase2_target_2018_pub	TARGET-10-PARHES	TARGET-10-PARHES-09	5.0	1698.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	12.0	2.0	NA	55.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	31.0	1	Not Hispanic or Latino	Unknown	Progression	NA	NA	Negative	NA	NA	NA	2.7	0.01	NA	NA	NA	NA	NA	BLL	2940.0	97.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	711.6
all_phase2_target_2018_pub	TARGET-10-PARHFF	TARGET-10-PARHFF-09	11.0	3711.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2841.0	1.172	Not Hispanic or Latino	Negative	None	NA	54,XX,+X,+4,+6,+14,+17,+18,+21,+22[12]/56,idem,+1[10]/53,idem,del(6)(q16),-22[2]/46,XX[8]	Negative	NA	NA	NA	0.0052	0.0052	NA	NA	0.3	0.01	NA	BLL	2841.0	94.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PARHLM	TARGET-10-PARHLM-09	3.0	797.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3279.0	1.091	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0023	0.01	NA	NA	2.5	0.01	NA	BLL	3279.0	108.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	55.5
all_phase2_target_2018_pub	TARGET-10-PARHMT	TARGET-10-PARHMT-09	15.0	5443.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	1.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3117.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(12)(p11.2)[8]/46,XY[14]	Negative	NA	NA	NA	0.27	0.01	NA	NA	9.4	0.01	NA	BLL	3117.0	103.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	185.8
all_phase2_target_2018_pub	TARGET-10-PARHSD	TARGET-10-PARHSD-09	4.0	1425.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3002.0	1.256	Hispanic or Latino	Negative	None	NA	56,XX,+X,dup(1)(q23q42),+3,+6,+10,+10,+14,+18,+21,+21,+22[18]/46,XX[2]	Negative	NA	NA	NA	0.0	0.001	NA	NA	5.5	0.01	NA	BLL	3002.0	99.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	94.8
all_phase2_target_2018_pub	TARGET-10-PARHUM	TARGET-10-PARHUM-09	19.0	6907.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1164.0	876.0	1	Hispanic or Latino	Negative	Relapse	0.0536	46,XX,del(9)(p21),-13,del(20)(q11.2),+mar[10]/46,XX[10]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.08800000000000001	0.001	NA	BLL	1164.0	NA	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	24.17
all_phase2_target_2018_pub	TARGET-10-PARIAD	TARGET-10-PARIAD-03	2.0	596.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	510.0	339.0	1.105	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(1;19)(q23;p13.3)[14]/46,XY[6]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.41	0.01	5	BLL	510.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Male	Matched	Positive	No	No	0.166666666667	Negative	67.8
all_phase2_target_2018_pub	TARGET-10-PARIAD	TARGET-10-PARIAD-04	2.0	596.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	510.0	339.0	1.105	Not Hispanic or Latino	Negative	Relapse	0.0160	46,XY,t(1;19)(q23;p13.3)[14]/46,XY[6]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.41	0.01	NA	BLL	510.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Male	Matched	Positive	No	No	NA	Negative	67.8
all_phase2_target_2018_pub	TARGET-10-PARIAD	TARGET-10-PARIAD-09	2.0	596.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	510.0	339.0	1.105	Not Hispanic or Latino	Negative	Relapse	0.0008	46,XY,t(1;19)(q23;p13.3)[14]/46,XY[6]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.41	0.01	NA	BLL	510.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Male	Matched	Positive	No	No	NA	Negative	67.8
all_phase2_target_2018_pub	TARGET-10-PARIBB	TARGET-10-PARIBB-09	12.0	4268.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1253.0	1.435	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0019	0.0019	NA	NA	0.86	0.01	NA	BLL	1253.0	42.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Positive	4.2
all_phase2_target_2018_pub	TARGET-10-PARIIA	TARGET-10-PARIIA-09	14.0	4801.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1349.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.44	0.01	NA	BLL	1349.0	45.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Negative	4.9
all_phase2_target_2018_pub	TARGET-10-PARIKN	TARGET-10-PARIKN-60.1	9.0	3246.0	NA	NA	XENOGRAFT	Negative	10.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(13)(q14q22)[5]/46,XY[15]	Negative	NA	0.0	0.0	1.1	0.01	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	White	6	Male	Matched	Negative	No	No	NA	Negative	66.1
all_phase2_target_2018_pub	TARGET-10-PARIKN	TARGET-10-PARIKN-60.2	9.0	3246.0	NA	NA	XENOGRAFT	Negative	10.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(13)(q14q22)[5]/46,XY[15]	Negative	NA	0.0	0.0	1.1	0.01	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	White	6	Male	Matched	Negative	No	No	NA	Negative	66.1
all_phase2_target_2018_pub	TARGET-10-PARIKN	TARGET-10-PARIKN-60.3	9.0	3246.0	NA	NA	XENOGRAFT	Negative	10.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(13)(q14q22)[5]/46,XY[15]	Negative	NA	0.0	0.0	1.1	0.01	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	White	6	Male	Matched	Negative	No	No	NA	Negative	66.1
all_phase2_target_2018_pub	TARGET-10-PARIKN	TARGET-10-PARIKN-60.4	9.0	3246.0	NA	NA	XENOGRAFT	Negative	10.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(13)(q14q22)[5]/46,XY[15]	Negative	NA	0.0	0.0	1.1	0.01	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	White	6	Male	Matched	Negative	No	No	NA	Negative	66.1
all_phase2_target_2018_pub	TARGET-10-PARIKN	TARGET-10-PARIKN-60.5	9.0	3246.0	NA	NA	XENOGRAFT	Negative	10.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(13)(q14q22)[5]/46,XY[15]	Negative	NA	0.0	0.0	1.1	0.01	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	White	6	Male	Matched	Negative	No	No	NA	Negative	66.1
all_phase2_target_2018_pub	TARGET-10-PARIKN	TARGET-10-PARIKN-60.7	9.0	3246.0	NA	NA	XENOGRAFT	Negative	10.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(13)(q14q22)[5]/46,XY[15]	Negative	NA	0.0	0.0	1.1	0.01	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	White	6	Male	Matched	Negative	No	No	NA	Negative	66.1
all_phase2_target_2018_pub	TARGET-10-PARILG	TARGET-10-PARILG-09	12.0	4134.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	44.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2402.0	1	Unknown	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2402.0	79.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	2.0
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.11	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.13	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.16	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.17	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.21	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.23	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.3	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.5	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.7	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIPA	TARGET-10-PARIPA-60.9	3.0	968.0	Transplant	NA	XENOGRAFT	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3115.0	0.525	Not Hispanic or Latino	Negative	None	NA	25,X,+14,+21[6]/50,idem,x2[7]/46,XX[7]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.2	0.01	NA	BLL	3115.0	103.0	0:LIVING	No	AALL0331	White	10	Female	Matched	Negative	No	NA	NA	Negative	32.5
all_phase2_target_2018_pub	TARGET-10-PARIYD	TARGET-10-PARIYD-09	9.0	3278.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3108.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[30]	Negative	NA	NA	NA	0.22	0.01	NA	NA	NA	NA	NA	BLL	3108.0	103.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	65.9
all_phase2_target_2018_pub	TARGET-10-PARIZN	TARGET-10-PARIZN-09	11.0	3724.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	0.0	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 3b	No	NA	537.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY[30]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	673.0	23.0	1:DECEASED	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	202.0
all_phase2_target_2018_pub	TARGET-10-PARJAY	TARGET-10-PARJAY-09	16.0	5652.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2889.0	1	Hispanic or Latino	Negative	None	NA	46,XX,add(9)(p13),del(9)(p13p22)[10]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2889.0	95.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	14.05
all_phase2_target_2018_pub	TARGET-10-PARJBB	TARGET-10-PARJBB-09	3.0	814.0	CHEMOTHERAPY	NA	VALIDATION	Negative	4.0	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3041.0	1	Not Hispanic or Latino	Negative	None	NA	43,X,-Y,dic(9;17)(p13;p11.2),der(12)t(12;21)(p11.2;q11.2),-21[8]/46,XY[17]	Negative	NA	NA	NA	0.006999999999999999	0.001	NA	NA	NA	NA	NA	BLL	3041.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	185.0
all_phase2_target_2018_pub	TARGET-10-PARJBZ	TARGET-10-PARJBZ-03	14.0	5095.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	1992.0	1.259	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.71	0.01	NA	BLL	1992.0	66.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Positive	18.7
all_phase2_target_2018_pub	TARGET-10-PARJJP	TARGET-10-PARJJP-09	13.0	4666.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3199.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.28	0.01	NA	BLL	3199.0	106.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	8.9
all_phase2_target_2018_pub	TARGET-10-PARJLF	TARGET-10-PARJLF-09	11.0	3938.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2459.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	0.0	NA	0.11	0.01	NA	NA	33.7	0.01	NA	BLL	2459.0	81.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	5.5
all_phase2_target_2018_pub	TARGET-10-PARJMY	TARGET-10-PARJMY-09	13.0	4717.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	4.0	4.0	NA	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1147.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,del(12)(p13),del(16)(q23)[12]/48,XX,del(14)(p12),del(12)(p13),+2mar[2]/46,XX[6]	Negative	NA	NA	NA	0.03	0.01	NA	NA	20.6	0.01	NA	BLL	3114.0	103.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	150.6
all_phase2_target_2018_pub	TARGET-10-PARJNL	TARGET-10-PARJNL-09	11.0	3655.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	81.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1119.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	NA	NA	NA	0.15	0.01	NA	NA	1.0	0.01	NA	BLL	3069.0	101.0	1:DECEASED	Yes	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Negative	301.0
all_phase2_target_2018_pub	TARGET-10-PARJNR	TARGET-10-PARJNR-09	11.0	4000.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3095.0	1	Hispanic or Latino	Negative	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.0	0.01	NA	BLL	3095.0	102.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Negative	7.27
all_phase2_target_2018_pub	TARGET-10-PARJNX	TARGET-10-PARJNX-09	4.0	1131.0	Chemotherapy; Chemotherapy; XRT	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	3006.0	1	Unknown	Negative	None	NA	46,XX,t(11;14)(p13;q11.2)[18]/46,XX[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3006.0	99.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	130.32
all_phase2_target_2018_pub	TARGET-10-PARJPL	TARGET-10-PARJPL-09	4.0	1374.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3158.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,+3,der(3)t(3;9)(q12;q13),del(8)(p11.1),-9[18]/46,XY[2]	Negative	NA	NA	NA	0.0	0.1	NA	NA	NA	NA	NA	BLL	3158.0	104.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	244.5
all_phase2_target_2018_pub	TARGET-10-PARJRT	TARGET-10-PARJRT-09	3.0	877.0	NA	NA	VALIDATION	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3050.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(1;12)(q12;q13),der(9)add(9)(p13)add(9)(q13)[9]/46,XX,t(1;12)(q21;q13),del(9)(p13p22),t(9;15)(p24;q15)[3]/46,XX[3]	Negative	NA	NA	NA	0.0018	0.0018	NA	NA	0.29	0.01	NA	BLL	3050.0	101.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	118.2
all_phase2_target_2018_pub	TARGET-10-PARJSR	TARGET-10-PARJSR-04	12.0	4093.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	853.0	588.0	1.238	Not Hispanic or Latino	Negative	Relapse	0.3398	55,XY,+5,+6,+8,+10,+11,+17,+18,+18,+21[17]/46,XY[2]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.001	NA	NA	0.09699999999999999	0.001	NA	BLL	853.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	13.3
all_phase2_target_2018_pub	TARGET-10-PARJSR	TARGET-10-PARJSR-09	12.0	4093.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	853.0	588.0	1.238	Not Hispanic or Latino	Negative	Relapse	0.3156	55,XY,+5,+6,+8,+10,+11,+17,+18,+18,+21[17]/46,XY[2]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.001	NA	NA	0.09699999999999999	0.001	48	BLL	853.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	1.56666666667	Negative	13.3
all_phase2_target_2018_pub	TARGET-10-PARJWB	TARGET-10-PARJWB-09	14.0	4945.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	478.0	1	Hispanic or Latino	Negative	None	NA	49,XX,+X,+6,+21[12]/46,XX[8]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.32	0.01	NA	BLL	478.0	16.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	146.3
all_phase2_target_2018_pub	TARGET-10-PARJXW	TARGET-10-PARJXW-09	15.0	5413.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	35.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(1;14)(p32;q11.2),del(9)(p13)[24]/46,XY[1]	Negative	NA	NA	NA	0.026000000000000002	0.001	NA	NA	NA	NA	NA	BLL	35.0	2.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	183.7
all_phase2_target_2018_pub	TARGET-10-PARJYV	TARGET-10-PARJYV-09	12.0	4333.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3100.0	1	Hispanic or Latino	Negative	None	NA	46,X,-Y,t(4;17)(q21;p11.2),+r[2]/46,XY[18]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.035	0.001	NA	BLL	3100.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	23.0
all_phase2_target_2018_pub	TARGET-10-PARJZZ	TARGET-10-PARJZZ-03	5.0	1538.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	993.0	795.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+8[5]/46,XY[15]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	1	BLL	993.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	0.0333333333333	Negative	21.5
all_phase2_target_2018_pub	TARGET-10-PARJZZ	TARGET-10-PARJZZ-04	5.0	1538.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	993.0	795.0	1	Hispanic or Latino	Negative	Relapse	0.0509	47,XY,+8[5]/46,XY[15]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	993.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	NA	Negative	21.5
all_phase2_target_2018_pub	TARGET-10-PARJZZ	TARGET-10-PARJZZ-09	5.0	1538.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	993.0	795.0	1	Hispanic or Latino	Negative	Relapse	0.0220	47,XY,+8[5]/46,XY[15]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	7	BLL	993.0	NA	1:DECEASED	No	AALL0331	White	3	Male	Matched	Negative	No	No	0.266666666667	Negative	21.5
all_phase2_target_2018_pub	TARGET-10-PARKBT	TARGET-10-PARKBT-09	16.0	5740.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	34.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3143.0	1.177	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+4,+6,+14,+15,+17,+21,+21,i(22)(q10)[8]/46,XY[12]	Negative	NA	NA	NA	0.81	0.01	NA	NA	0.58	0.01	NA	BLL	3143.0	104.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	5.1
all_phase2_target_2018_pub	TARGET-10-PARKEN	TARGET-10-PARKEN-03	2.0	608.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3064.0	1.2	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+4,+6,+8,+10,+14,+17,+18,+21[11]/57,idem,+7,+12[3]/46,XY[6]	Negative	NA	NA	NA	0.05	0.01	NA	NA	0.0	0.01	NA	BLL	3064.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	57.48
all_phase2_target_2018_pub	TARGET-10-PARKEU	TARGET-10-PARKEU-09	6.0	2065.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2016.0	1.102	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+4,+6,+7,+10,+14,+17,+21,+21[4]/46,XY[2]	Negative	NA	NA	NA	0.027000000000000003	0.001	NA	NA	0.031	0.001	NA	BLL	2016.0	67.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	3.1
all_phase2_target_2018_pub	TARGET-10-PARKFN	TARGET-10-PARKFN-09	4.0	1099.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	484.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,del(12)(p12p13),t(12;22)(p13;q12)[12]/46,XX[8]	Negative	NA	NA	NA	0.0069	0.0069	NA	NA	1.0	0.01	NA	BLL	484.0	16.0	0:LIVING	No	AALL0232	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	78.1
all_phase2_target_2018_pub	TARGET-10-PARKFU	TARGET-10-PARKFU-09	16.0	5519.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3078.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[21]	Negative	NA	NA	NA	0.005	0.001	NA	NA	0.02	0.01	NA	BLL	3078.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	1.3
all_phase2_target_2018_pub	TARGET-10-PARKLK	TARGET-10-PARKLK-09	2.0	662.0	NA	NA	VALIDATION	Negative	NA	3.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	29.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.084	0.001	NA	NA	NA	NA	NA	BLL	29.0	1.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	132.8
all_phase2_target_2018_pub	TARGET-10-PARKLL	TARGET-10-PARKLL-09	14.0	4868.0	NA	NA	VALIDATION	Negative	1.0	2.0	0.0	28.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	47.0	1	Not Hispanic or Latino	Negative	Progression	NA	46,XX,del(13)(q14q22)[10]/46,XX[17]	Negative	NA	NA	NA	2.5	0.01	NA	NA	NA	NA	NA	BLL	2837.0	94.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	117.8
all_phase2_target_2018_pub	TARGET-10-PARKNJ	TARGET-10-PARKNJ-09	3.0	732.0	Chemotherapy	NA	DISCOVERY	Negative	6.0	4.0	NA	61.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	464.0	440.0	1	Unknown	Negative	Relapse	NA	46,XY,t(4;11)(q21;q23)[3]/46,XY[26]/	Positive	MLL-Rearranged	NA	NA	0.84	0.01	NA	NA	26.6	0.01	NA	BLL	464.0	NA	1:DECEASED	No	AALL0331	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	32.0
all_phase2_target_2018_pub	TARGET-10-PARKZX	TARGET-10-PARKZX-09	13.0	4739.0	CHEMOTHERAPY; OTHER THERAPY	Maintenance therapy was extended 6 months from initial end of therapy in January of 2010. Patient has now completed therapy, off study, as of June 8th, 2010.; Cart-T cell therapy	VALIDATION	Negative	1.0	2.0	NA	30.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1371.0	1.243	Hispanic or Latino	Negative	Relapse	NA	56,XX,+X,+4,+6,+8,+10,+11,+14,+14,+21,+21[20]	Negative	NA	NA	NA	0.0025	0.0025	NA	NA	0.6	0.01	NA	BLL	3087.0	102.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	74.7
all_phase2_target_2018_pub	TARGET-10-PARLAF	TARGET-10-PARLAF-04	4.0	1449.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	618.0	1	Unknown	Positive	Relapse	0.1470	89~91,XXYY,der(3)t(3;12)(p11;q11),r(3)(p12q12,r(3)(p26q29),-9,-14,-14,-15,-15,der(17)t(3;17)(p11;p11)x2,-19,-19,+4~6mar[11]/46,XY[12]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.06	0.01	NA	BLL	2939.0	NA	0:LIVING	No	AALL0331	Black or African American	2	Male	Matched	Negative	No	No	NA	Positive	8.36
all_phase2_target_2018_pub	TARGET-10-PARLAF	TARGET-10-PARLAF-09	4.0	1449.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	618.0	1	Unknown	Positive	Relapse	0.0007	89~91,XXYY,der(3)t(3;12)(p11;q11),r(3)(p12q12,r(3)(p26q29),-9,-14,-14,-15,-15,der(17)t(3;17)(p11;p11)x2,-19,-19,+4~6mar[11]/46,XY[12]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.06	0.01	1	BLL	2939.0	NA	0:LIVING	No	AALL0331	Black or African American	2	Male	Matched	Negative	No	No	0.0333333333333	Positive	8.36
all_phase2_target_2018_pub	TARGET-10-PARLBP	TARGET-10-PARLBP-09	11.0	3662.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2030.0	1.111	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2030.0	67.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	62.1
all_phase2_target_2018_pub	TARGET-10-PARLDF	TARGET-10-PARLDF-09	5.0	1512.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	19.0	3.0	NA	36.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1686.0	1	Not Hispanic or Latino	Positive	Relapse	NA	46,XY,t(4;12)(p16;q13)[1]/46,idem,add(12)(p12),del(15)(q13q15)[5]/46,idem,del(6)(q15q25),add(12)(p11.2),del(15)(q13q15)[4]/46,XY[9]	Negative	NA	NA	NA	0.0049	0.0049	NA	NA	NA	NA	NA	BLL	3071.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	79.2
all_phase2_target_2018_pub	TARGET-10-PARLEK	TARGET-10-PARLEK-03	9.0	3215.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	1.0	1.0	NA	76.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	799.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(4;11)(q21;q23)[14]/46,XX[4]	Positive	MLL-Rearranged	NA	NA	2.0	0.01	NA	NA	3.7	0.01	2	BLL	2900.0	NA	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.0666666666667	Negative	406.9
all_phase2_target_2018_pub	TARGET-10-PARLEK	TARGET-10-PARLEK-09	9.0	3215.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	1.0	1.0	NA	76.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	799.0	1	Not Hispanic or Latino	Negative	Relapse	0.0022	46,XX,t(4;11)(q21;q23)[14]/46,XX[4]	Positive	MLL-Rearranged	NA	NA	2.0	0.01	NA	NA	3.7	0.01	NA	BLL	2900.0	NA	0:LIVING	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	406.9
all_phase2_target_2018_pub	TARGET-10-PARLFI	TARGET-10-PARLFI-09	14.0	5102.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3075.0	1	Hispanic or Latino	Negative	None	NA	46,XY,t(4;11)(q21;q23)[12]/46,XY[8]	Positive	NA	NA	NA	0.0	0.001	NA	NA	NA	NA	NA	BLL	3075.0	102.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	374.7
all_phase2_target_2018_pub	TARGET-10-PARLHD	TARGET-10-PARLHD-04	NA	NA	NA	NA	VALIDATION	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	1	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-PARLJA	TARGET-10-PARLJA-09	9.0	3151.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2932.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(2;14)(p11.1;q32)[16]/46,idem,add(16)(q24)[2]/46,XY[2]	Negative	NA	NA	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	2932.0	97.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	130.0
all_phase2_target_2018_pub	TARGET-10-PARLMI	TARGET-10-PARLMI-09	2.0	485.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3016.0	1.191	Not Hispanic or Latino	Negative	None	NA	53,XX,+X,+6,+8,+14,+17,+21,+21[7]/46,XX[13]	Negative	NA	NA	NA	0.0038	0.0038	NA	NA	0.0038	NA	NA	BLL	3016.0	100.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	135.8
all_phase2_target_2018_pub	TARGET-10-PARLPA	TARGET-10-PARLPA-09	17.0	6040.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1202.0	1.221	Not Hispanic or Latino	Negative	Censored	NA	NA	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.0	0.01	NA	BLL	1202.0	40.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Positive	1.9
all_phase2_target_2018_pub	TARGET-10-PARLPB	TARGET-10-PARLPB-09	15.0	5252.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3032.0	1	Unknown	Negative	None	NA	46,XY[25]	Negative	NA	NA	NA	0.0	0.001	NA	NA	0.27	0.01	NA	BLL	3032.0	100.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	2.8
all_phase2_target_2018_pub	TARGET-10-PARLST	TARGET-10-PARLST-09	10.0	3448.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	3058.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	0.0	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	3058.0	101.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	689.1
all_phase2_target_2018_pub	TARGET-10-PARLSU	TARGET-10-PARLSU-09	22.0	7816.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	258.0	1	Unknown	Negative	Death	NA	46,XX,t(4;11)(q25;q23)[28]/46,XX[16]	Positive	NA	NA	NA	1.1	0.01	NA	NA	0.78	0.01	NA	BLL	258.0	9.0	1:DECEASED	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	9.6
all_phase2_target_2018_pub	TARGET-10-PARLTU	TARGET-10-PARLTU-09	17.0	5854.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3205.0	1.059	Not Hispanic or Latino	Negative	None	NA	47,XY,+8,i(9)(q10),i(17)(q10[6]/46,XY[14]	Negative	NA	NA	NA	0.012	0.001	NA	NA	0.1	0.01	NA	BLL	3205.0	106.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	1.0
all_phase2_target_2018_pub	TARGET-10-PARLTX	TARGET-10-PARLTX-09	2.0	576.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	35.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1121.0	1.128	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+6,+14,+15,+17,+21,+21,+21[cp5]/46,XY[19]	Negative	NA	NA	0.01	0.13	0.01	NA	NA	8.4	0.01	NA	BLL	1121.0	37.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	126.36
all_phase2_target_2018_pub	TARGET-10-PARLZG	TARGET-10-PARLZG-03	12.0	4093.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1003.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,add(1)(q21),t(1;19)(q23;p13.3)[6]/46,XX,t(1;19)(q23;p13.3),-15,+mar[4]/46,XX[10]	Negative	TCF3-PBX1	0.0	0.1	0.45	0.01	NA	NA	0.06	0.01	NA	BLL	1546.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Positive	No	NA	NA	Negative	12.9
all_phase2_target_2018_pub	TARGET-10-PARLZG	TARGET-10-PARLZG-04	12.0	4093.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1003.0	1	Not Hispanic or Latino	Negative	Relapse	0.0013	46,XX,add(1)(q21),t(1;19)(q23;p13.3)[6]/46,XX,t(1;19)(q23;p13.3),-15,+mar[4]/46,XX[10]	Negative	TCF3-PBX1	0.0	0.1	0.45	0.01	NA	NA	0.06	0.01	NA	BLL	1546.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Positive	No	NA	NA	Negative	12.9
all_phase2_target_2018_pub	TARGET-10-PARLZG	TARGET-10-PARLZG-09	12.0	4093.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1003.0	1	Not Hispanic or Latino	Negative	Relapse	0.0159	46,XX,add(1)(q21),t(1;19)(q23;p13.3)[6]/46,XX,t(1;19)(q23;p13.3),-15,+mar[4]/46,XX[10]	Negative	TCF3-PBX1	0.0	0.1	0.45	0.01	NA	NA	0.06	0.01	NA	BLL	1546.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Positive	No	NA	NA	Negative	12.9
all_phase2_target_2018_pub	TARGET-10-PARMEG	TARGET-10-PARMEG-09	11.0	3687.0	NA	NA	VALIDATION	Negative	13.0	1.0	NA	7.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3037.0	1	Hispanic or Latino	Positive	None	NA	48,XX,+10,+mar1[10]/47,XX,add(14)(p11.2),+mar2[4]/46,XX[6]	Negative	NA	0.0	NA	0.0	0.01	NA	NA	0.35	0.01	NA	BLL	3037.0	100.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	49.76
all_phase2_target_2018_pub	TARGET-10-PARMFF	TARGET-10-PARMFF-09	9.0	3039.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3189.0	1	Not Hispanic or Latino	Negative	None	NA	44,X,-Y,dic(9;21)(p13;p11.2)[13]/46,XY[7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3189.0	105.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	27.5
all_phase2_target_2018_pub	TARGET-10-PARMIH	TARGET-10-PARMIH-09	13.0	4537.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2856.0	1	Hispanic or Latino	Unknown	SMN	NA	46,XY,t(9;9)(p10;p10),t(11;14)(p13;q11.2)[13]/46,XY[7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2953.0	98.0	1:DECEASED	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	375.9
all_phase2_target_2018_pub	TARGET-10-PARMKK	TARGET-10-PARMKK-09	4.0	1222.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	3003.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;14)(p13;q11.2)[5]/46,idem,inv(14)(q11.2q32)[13]/46,XY[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3003.0	99.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	477.8
all_phase2_target_2018_pub	TARGET-10-PARMKM	TARGET-10-PARMKM-03	2.0	581.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2995.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(8;14)(q24.1;q11.2)[20]	Negative	NA	NA	NA	0.19	0.01	NA	NA	NA	NA	NA	BLL	2995.0	99.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	446.1
all_phase2_target_2018_pub	TARGET-10-PARMMA	TARGET-10-PARMMA-09	6.0	1866.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2594.0	1	Not Hispanic or Latino	Positive	Relapse	NA	47,XX,+16[7]/47,idem,del(12)(p11)[12]/46,XX[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.64	0.01	NA	BLL	2959.0	98.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	66.3
all_phase2_target_2018_pub	TARGET-10-PARMMV	TARGET-10-PARMMV-09	7.0	2322.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3052.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3052.0	101.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	77.0
all_phase2_target_2018_pub	TARGET-10-PARMRF	TARGET-10-PARMRF-09	6.0	2186.0	NA	NA	VALIDATION	Negative	2.0	3.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	.	No	NA	2989.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[21]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2989.0	99.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	446.0
all_phase2_target_2018_pub	TARGET-10-PARMSB	TARGET-10-PARMSB-09	14.0	5059.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2654.0	1	Hispanic or Latino	Negative	None	NA	47,XX,+21[18]/46,XX[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2654.0	88.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	15.7
all_phase2_target_2018_pub	TARGET-10-PARMSP	TARGET-10-PARMSP-04	18.0	6555.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	NA	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	584.0	441.0	1.077	Not Hispanic or Latino	Negative	Relapse	0.3723	53,XY,+X,+1,?add(2)(p13),+5,-7,+11,add(16)(q22),idic(17)(p11.2),+21,?add(21)(q22)x2,+22,+mar1,+mar2[16]/46,XY[4]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.2	0.01	NA	NA	61.2	0.01	NA	BLL	584.0	20.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	9.9
all_phase2_target_2018_pub	TARGET-10-PARMSP	TARGET-10-PARMSP-09	18.0	6555.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	NA	73.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	584.0	441.0	1.077	Not Hispanic or Latino	Negative	Relapse	0.1197	53,XY,+X,+1,?add(2)(p13),+5,-7,+11,add(16)(q22),idic(17)(p11.2),+21,?add(21)(q22)x2,+22,+mar1,+mar2[16]/46,XY[4]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.2	0.01	NA	NA	61.2	0.01	2	BLL	584.0	20.0	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.0666666666667	Negative	9.9
all_phase2_target_2018_pub	TARGET-10-PARMUC	TARGET-10-PARMUC-03	3.0	968.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2995.0	1	Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.12	0.01	NA	NA	NA	NA	NA	BLL	2995.0	99.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	145.0
all_phase2_target_2018_pub	TARGET-10-PARMWH	TARGET-10-PARMWH-09	21.0	7513.0	NA	NA	VALIDATION	Negative	6.0	0.0	NA	51.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3089.0	1.096	Unknown	Negative	None	NA	47,XX,t(2;5)(q31;q33),der(13)t(1;13)(q12;p12),+mar[20]	Negative	NA	NA	NA	0.12	0.01	NA	NA	NA	NA	NA	BLL	3089.0	102.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	75.1
all_phase2_target_2018_pub	TARGET-10-PARMWZ	TARGET-10-PARMWZ-09	11.0	3700.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	21.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	36.0	0.607	Not Hispanic or Latino	Negative	None	NA	28,X,+Y,+6,+10,+18,+21[3]/56,idemx2[17]	Negative	NA	NA	NA	0.0011	0.01	NA	NA	2.1	0.01	NA	BLL	36.0	2.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	19.6
all_phase2_target_2018_pub	TARGET-10-PARMXF	TARGET-10-PARMXF-03	5.0	1464.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	951.0	640.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	None of the above	NA	NA	0.024	0.001	NA	NA	0.42	0.01	NA	BLL	951.0	NA	1:DECEASED	Yes	AALL0331	White	4	Female	Matched	Unknown	No	NA	NA	Negative	14.7
all_phase2_target_2018_pub	TARGET-10-PARMXF	TARGET-10-PARMXF-04	5.0	1464.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	951.0	640.0	1	Hispanic or Latino	Negative	Relapse	0.0003	46,XX[20]	Negative	None of the above	NA	NA	0.024	0.001	NA	NA	0.42	0.01	NA	BLL	951.0	NA	1:DECEASED	Yes	AALL0331	White	4	Female	Matched	Unknown	No	NA	NA	Negative	14.7
all_phase2_target_2018_pub	TARGET-10-PARMXF	TARGET-10-PARMXF-09	5.0	1464.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	951.0	640.0	1	Hispanic or Latino	Negative	Relapse	0.0014	46,XX[20]	Negative	None of the above	NA	NA	0.024	0.001	NA	NA	0.42	0.01	3	BLL	951.0	NA	1:DECEASED	Yes	AALL0331	White	4	Female	Matched	Unknown	No	NA	0.1	Negative	14.7
all_phase2_target_2018_pub	TARGET-10-PARMXF	TARGET-10-PARMXF-40	5.0	1464.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	7.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	951.0	640.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	None of the above	NA	NA	0.024	0.001	NA	NA	0.42	0.01	NA	BLL	951.0	NA	1:DECEASED	Yes	AALL0331	White	4	Female	Matched	Unknown	No	NA	NA	Negative	14.7
all_phase2_target_2018_pub	TARGET-10-PARMYP	TARGET-10-PARMYP-09	6.0	2076.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	59.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3089.0	1.348	Not Hispanic or Latino	Negative	None	NA	63,XY,+X,+3,+4,+6,+8,+9,+10,+11,+14,+14,+16,+17,+18,+21,+21,+22,+mar[18]/46,XY[32]	Negative	NA	NA	NA	0.0	0.01	NA	NA	11.0	0.01	NA	BLL	3089.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	59.0
all_phase2_target_2018_pub	TARGET-10-PARNAF	TARGET-10-PARNAF-03	5.0	1678.0	CHEMOTHERAPY; OTHER THERAPY	; CTL019 therapy at CHOP	VALIDATION	Negative	2.0	1.0	NA	39.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1148.0	1	Not Hispanic or Latino	Positive	Relapse	NA	NA	Negative	NA	NA	NA	0.05	0.01	NA	NA	0.5	0.01	NA	BLL	2201.0	73.0	1:DECEASED	No	AALL0232	Unknown	1	Female	Matched	Unknown	No	NA	NA	Negative	106.5
all_phase2_target_2018_pub	TARGET-10-PARNBN	TARGET-10-PARNBN-09	11.0	3674.0	NA	NA	VALIDATION	Negative	6.0	0.0	NA	54.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1687.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;14)(p13;q11.2)[19]/46,idem,del(6)(q21q24)[3]/46,XY[9]	Negative	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	1687.0	56.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	300.0
all_phase2_target_2018_pub	TARGET-10-PARNDB	TARGET-10-PARNDB-09	11.0	3701.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2805.0	1	Hispanic or Latino	Negative	None	NA	46,XX,t(1;19)(q23;p13.3)[3]/46,idem,der(14)t(1;14)(q25;p11.2)[2]/46,XX[15]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.004	0.001	NA	BLL	2805.0	93.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	33.4
all_phase2_target_2018_pub	TARGET-10-PARNDR	TARGET-10-PARNDR-09	18.0	6243.0	NA	NA	DISCOVERY	Unknown	0.0	2.0	NA	13.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	439.0	202.0	1	Hispanic or Latino	Unknown	Relapse	NA	46,XY[29]	Unknown	None of the above	NA	NA	0.03	0.01	NA	NA	0.17	0.01	NA	BLL	439.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Unknown	1.07
all_phase2_target_2018_pub	TARGET-10-PARNDY	TARGET-10-PARNDY-09	10.0	3338.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3b	No	NA	3049.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,t(3;7)(p21;q32),del(6)(q15q21),del(12)(p11.2p13)[16]/46,XY[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.03	0.01	NA	BLL	3049.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	53.4
all_phase2_target_2018_pub	TARGET-10-PARNEH	TARGET-10-PARNEH-09	5.0	1463.0	Chemotherapy	NA	VALIDATION	Negative	4.0	0.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	524.0	1.0497	Not Hispanic or Latino	Negative	Death	NA	46,XY,del(6)(q2?3q2?6),del(9)(p21)[8]/46,XY[12]	Negative	NA	NA	NA	3.0	0.01	NA	NA	NA	NA	NA	BLL	524.0	18.0	1:DECEASED	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	24.3
all_phase2_target_2018_pub	TARGET-10-PARNFY	TARGET-10-PARNFY-04	12.0	4350.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	2801.0	1	Not Hispanic or Latino	Negative	None	NA	45,X,-X,t(1;19)(q23;p13),del(6)(q21),i(9)(q10)[5]/46,XX[15]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2801.0	NA	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	12.8
all_phase2_target_2018_pub	TARGET-10-PARNGI	TARGET-10-PARNGI-09	3.0	988.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	1264.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	NA	NA	NA	0.006999999999999999	0.001	NA	NA	NA	NA	NA	BLL	1410.0	47.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	265.0
all_phase2_target_2018_pub	TARGET-10-PARNIZ	TARGET-10-PARNIZ-09	2.0	615.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2919.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(2;14)(p11.2;q11.2),t(7;12;9)(p13;p13;p13)[10]/47,idem,+21[1]/46,XY[12]	Negative	NA	NA	NA	0.08199999999999999	0.001	NA	NA	0.61	0.01	NA	BLL	2919.0	96.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	161.1
all_phase2_target_2018_pub	TARGET-10-PARNJB	TARGET-10-PARNJB-09	23.0	8232.0	NA	NA	VALIDATION	Negative	73.0	1.0	NA	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3148.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(4;11)(p10;p10)[15]/46,XX[5]	Negative	NA	NA	NA	1.5	0.01	NA	NA	NA	NA	NA	BLL	3148.0	104.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	35.4
all_phase2_target_2018_pub	TARGET-10-PARNLW	TARGET-10-PARNLW-09	16.0	5493.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	16.0	3.0	NA	32.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2870.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(4;11)(q21;q23)[4]/46,XX[16]	Positive	NA	NA	NA	3.3	0.01	NA	NA	0.02	0.01	NA	BLL	2870.0	95.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	149.2
all_phase2_target_2018_pub	TARGET-10-PARNMF	TARGET-10-PARNMF-03	3.0	1024.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	1022.0	1	Not Hispanic or Latino	Positive	Relapse	NA	NA	Negative	ETV6-RUNX1	NA	NA	0.012	0.001	NA	NA	6.9	0.01	9	BLL	3157.0	NA	0:LIVING	No	AALL0331	White	4	Female	Matched	Unknown	No	NA	0.3	Negative	47.7
all_phase2_target_2018_pub	TARGET-10-PARNMF	TARGET-10-PARNMF-04	3.0	1024.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	1022.0	1	Not Hispanic or Latino	Positive	Relapse	0.0165	NA	Negative	ETV6-RUNX1	NA	NA	0.012	0.001	NA	NA	6.9	0.01	NA	BLL	3157.0	NA	0:LIVING	No	AALL0331	White	4	Female	Matched	Unknown	No	NA	NA	Negative	47.7
all_phase2_target_2018_pub	TARGET-10-PARNMF	TARGET-10-PARNMF-09	3.0	1024.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	1022.0	1	Not Hispanic or Latino	Positive	Relapse	0.0036	NA	Negative	ETV6-RUNX1	NA	NA	0.012	0.001	NA	NA	6.9	0.01	NA	BLL	3157.0	NA	0:LIVING	No	AALL0331	White	4	Female	Matched	Unknown	No	NA	NA	Negative	47.7
all_phase2_target_2018_pub	TARGET-10-PARNMF	TARGET-10-PARNMF-40	3.0	1024.0	NA	NA	DISCOVERY	Negative	4.0	1.0	NA	23.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	1022.0	1	Not Hispanic or Latino	Positive	Relapse	NA	NA	Negative	ETV6-RUNX1	NA	NA	0.012	0.001	NA	NA	6.9	0.01	NA	BLL	3157.0	NA	0:LIVING	No	AALL0331	White	4	Female	Matched	Unknown	No	NA	NA	Negative	47.7
all_phase2_target_2018_pub	TARGET-10-PARNMV	TARGET-10-PARNMV-09	10.0	3481.0	Chemotherapy	NA	VALIDATION	Negative	6.0	0.0	NA	78.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2905.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q13q23)[8]/46,XY[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2905.0	96.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	250.7
all_phase2_target_2018_pub	TARGET-10-PARNSH	TARGET-10-PARNSH-03	18.0	6419.0	NA	NA	DISCOVERY	Negative	13.0	0.0	NA	58.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1022.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,add(9)(p13)[2]/46,XX[18]	Negative	TCF3-PBX1	0.0	0.01	0.11	0.01	NA	NA	10.7	0.01	3	BLL	2029.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Positive	No	NA	0.133333333333	Negative	23.5
all_phase2_target_2018_pub	TARGET-10-PARNSH	TARGET-10-PARNSH-04	18.0	6419.0	NA	NA	DISCOVERY	Negative	13.0	0.0	NA	58.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1022.0	1	Not Hispanic or Latino	Negative	Relapse	0.0006	46,XX,add(9)(p13)[2]/46,XX[18]	Negative	TCF3-PBX1	0.0	0.01	0.11	0.01	NA	NA	10.7	0.01	NA	BLL	2029.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Positive	No	NA	NA	Negative	23.5
all_phase2_target_2018_pub	TARGET-10-PARNSH	TARGET-10-PARNSH-09	18.0	6419.0	NA	NA	DISCOVERY	Negative	13.0	0.0	NA	58.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	1022.0	1	Not Hispanic or Latino	Negative	Relapse	0.0109	46,XX,add(9)(p13)[2]/46,XX[18]	Negative	TCF3-PBX1	0.0	0.01	0.11	0.01	NA	NA	10.7	0.01	NA	BLL	2029.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Positive	No	NA	NA	Negative	23.5
all_phase2_target_2018_pub	TARGET-10-PARNSP	TARGET-10-PARNSP-09	7.0	2206.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3086.0	1	Not Hispanic or Latino	Negative	None	NA	47,XYY?c,der(9)t(9;16)(p13;q13),del(12)(p12)[15]/47,XYY?c[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3086.0	102.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	28.7
all_phase2_target_2018_pub	TARGET-10-PARNSW	TARGET-10-PARNSW-09	14.0	5015.0	CHEMOTHERAPY	NA	VALIDATION	Positive	3.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2224.0	1.2152	Not Hispanic or Latino	Negative	None	NA	56,XY,+4,+5,+6,+8,t(9;22)(q34;q11.2),+10,del(10)(q22),+17,+21,+21,+21,+mar[cp4]/46,XY[3]	Negative	NA	NA	NA	0.011000000000000001	0.001	NA	NA	0.43	0.01	NA	BLL	2224.0	74.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	5.0
all_phase2_target_2018_pub	TARGET-10-PARNTW	TARGET-10-PARNTW-09	4.0	1111.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 1	No	NA	957.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,add(7)(p11.2),add(12)(p11.2),-17,+mar[13]/46,XX[6]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.14	0.01	NA	BLL	2937.0	NA	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.1
all_phase2_target_2018_pub	TARGET-10-PARNXJ	TARGET-10-PARNXJ-09	5.0	1760.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	1.0	2.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	110.0	1	Hispanic or Latino	Unknown	Relapse	NA	46,XY,inv(14)(q11.2q34)[4]/45,XY,-19[3]/46,XY[8]	Negative	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2840.0	94.0	0:LIVING	Yes	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	181.6
all_phase2_target_2018_pub	TARGET-10-PARPCA	TARGET-10-PARPCA-09	6.0	2176.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	477.0	251.0	1	Not Hispanic or Latino	Negative	Relapse	0.0151	46,XX[20]	Negative	None of the above	NA	NA	0.37	0.01	NA	NA	0.009000000000000001	0.001	NA	BLL	477.0	NA	1:DECEASED	No	AALL0331	White	1	Female	Matched	Unknown	No	NA	NA	Negative	10.7
all_phase2_target_2018_pub	TARGET-10-PARPDP	TARGET-10-PARPDP-09	17.0	6184.0	Transplant	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	602.0	1	Not Hispanic or Latino	Negative	Death	NA	46,XY,t(3;4;11)(p14;q21;q23)[9]/46,XY[10]	Positive	NA	NA	NA	0.5	0.01	NA	NA	0.67	0.01	NA	BLL	602.0	20.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	243.9
all_phase2_target_2018_pub	TARGET-10-PARPET	TARGET-10-PARPET-09	5.0	1811.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1939.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1939.0	64.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Negative	191.9
all_phase2_target_2018_pub	TARGET-10-PARPFF	TARGET-10-PARPFF-09	16.0	5645.0	CHEMOTHERAPY; Transplant	NA	VALIDATION	Negative	4.0	5.0	3.0	56.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1554.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	NA	0.0	NA	1.3	0.01	0.0	NA	3.5	0.01	NA	BLL	1850.0	61.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	96.3
all_phase2_target_2018_pub	TARGET-10-PARPGJ	TARGET-10-PARPGJ-09	12.0	4131.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1216.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0074	0.0074	NA	NA	NA	NA	NA	BLL	1216.0	40.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	22.11
all_phase2_target_2018_pub	TARGET-10-PARPGL	TARGET-10-PARPGL-09	14.0	4759.0	NA	NA	VALIDATION	Negative	1.0	2.0	NA	24.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2854.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0044	0.0044	NA	NA	1.1	0.01	NA	BLL	2854.0	94.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	202.5
all_phase2_target_2018_pub	TARGET-10-PARPGW	TARGET-10-PARPGW-09	5.0	1620.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	2910.0	1	Not Hispanic or Latino	Positive	None	NA	46~48,XX,del(8)(q13q22),der(11)t(11;15)(q23;q22),der(12)t(12;14)(p13;q24),der(12)(12pter->12p13::21q22->21q11.2::12p11.2->12qter),-15,+21,+21,del(21)(q21)x2,i(21)(q10)[cp18]/46,XX[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	2.9	0.01	NA	BLL	2910.0	96.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	67.6
all_phase2_target_2018_pub	TARGET-10-PARPHB	TARGET-10-PARPHB-09	2.0	400.0	NA	NA	VALIDATION	Negative	5.0	1.0	NA	79.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3b	No	NA	2960.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q13q23)[3]/46,XY[17]	Negative	NA	NA	NA	0.038	0.001	NA	NA	NA	NA	NA	BLL	2960.0	98.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	313.0
all_phase2_target_2018_pub	TARGET-10-PARPIF	TARGET-10-PARPIF-09	14.0	4900.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3055.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[36]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3055.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	21.84
all_phase2_target_2018_pub	TARGET-10-PARPNM	TARGET-10-PARPNM-03	14.0	4941.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	233.0	116.0	1.1865	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,dup(1)(q24q31),i(7)(q10),del(9)(p21p24),add(18)(q21)[8]/46,XX,dup(1)(q24q31),add(9)(p22),del(9)(p21p24),del(10)(p13p14)[7]/46,XX[4]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	1.3	0.01	5	BLL	233.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Negative	No	NA	0.166666666667	Negative	82.7
all_phase2_target_2018_pub	TARGET-10-PARPNM	TARGET-10-PARPNM-04	14.0	4941.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	233.0	116.0	1.1865	Not Hispanic or Latino	Negative	Relapse	0.0018	46,XX,dup(1)(q24q31),i(7)(q10),del(9)(p21p24),add(18)(q21)[8]/46,XX,dup(1)(q24q31),add(9)(p22),del(9)(p21p24),del(10)(p13p14)[7]/46,XX[4]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	1.3	0.01	NA	BLL	233.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Negative	No	NA	NA	Negative	82.7
all_phase2_target_2018_pub	TARGET-10-PARPNM	TARGET-10-PARPNM-09	14.0	4941.0	NA	NA	DISCOVERY	Negative	4.0	2.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	233.0	116.0	1.1865	Not Hispanic or Latino	Negative	Relapse	0.0172	46,XX,dup(1)(q24q31),i(7)(q10),del(9)(p21p24),add(18)(q21)[8]/46,XX,dup(1)(q24q31),add(9)(p22),del(9)(p21p24),del(10)(p13p14)[7]/46,XX[4]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	1.3	0.01	7	BLL	233.0	NA	1:DECEASED	No	AALL0232	Black or African American	3	Female	Matched	Negative	No	NA	0.233333333333	Negative	82.7
all_phase2_target_2018_pub	TARGET-10-PARPPV	TARGET-10-PARPPV-09	15.0	5143.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3008.0	1.0824	Hispanic or Latino	Negative	None	NA	46,XY,idic(9)(p13),der(19)t(1;19)(q23;p13.3)[17]/46,XY[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	3008.0	99.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	17.82
all_phase2_target_2018_pub	TARGET-10-PARPRD	TARGET-10-PARPRD-04	11.0	3889.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	944.0	743.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	0.001	0.001	0.13	0.01	NA	NA	0.03	0.01	NA	BLL	944.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	900.0
all_phase2_target_2018_pub	TARGET-10-PARPRD	TARGET-10-PARPRD-09	11.0	3889.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	944.0	743.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	0.001	0.001	0.13	0.01	NA	NA	0.03	0.01	NA	BLL	944.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	900.0
all_phase2_target_2018_pub	TARGET-10-PARPRW	TARGET-10-PARPRW-03	16.0	5479.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	0.0	0.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	442.0	377.0	1	Hispanic or Latino	Negative	Relapse	NA	48,XX,+4,t(17;19)(q22;p13.3),+22[7]/46,XX[13]	Negative	TCF3-HLF	NA	NA	0.0	0.01	NA	NA	NA	NA	10	BLL	442.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Female	Matched	Negative	No	NA	0.333333333333	Negative	13.6
all_phase2_target_2018_pub	TARGET-10-PARPRW	TARGET-10-PARPRW-04	16.0	5479.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	0.0	0.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	442.0	377.0	1	Hispanic or Latino	Negative	Relapse	0.0987	48,XX,+4,t(17;19)(q22;p13.3),+22[7]/46,XX[13]	Negative	TCF3-HLF	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	442.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Female	Matched	Negative	No	NA	NA	Negative	13.6
all_phase2_target_2018_pub	TARGET-10-PARPRW	TARGET-10-PARPRW-09	16.0	5479.0	Chemotherapy; Radiation (NOS); Transplant	NA	DISCOVERY	Negative	0.0	0.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	442.0	377.0	1	Hispanic or Latino	Negative	Relapse	0.0847	48,XX,+4,t(17;19)(q22;p13.3),+22[7]/46,XX[13]	Negative	TCF3-HLF	NA	NA	0.0	0.01	NA	NA	NA	NA	2	BLL	442.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Female	Matched	Negative	No	NA	0.0666666666667	Negative	13.6
all_phase2_target_2018_pub	TARGET-10-PARPUL	TARGET-10-PARPUL-09	3.0	820.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2825.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,der(9)t(9;9)(p13;q34)[11]/46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2825.0	93.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	60.2
all_phase2_target_2018_pub	TARGET-10-PARPVU	TARGET-10-PARPVU-04	2.0	537.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	NA	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	484.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,add(11)(q23)[4]	Positive	MLL-Rearranged	0.0	0.01	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2881.0	NA	0:LIVING	Yes	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	77.7
all_phase2_target_2018_pub	TARGET-10-PARPVU	TARGET-10-PARPVU-09	2.0	537.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	NA	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	484.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,add(11)(q23)[4]	Positive	MLL-Rearranged	0.0	0.01	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2881.0	NA	0:LIVING	Yes	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	77.7
all_phase2_target_2018_pub	TARGET-10-PARPXV	TARGET-10-PARPXV-09	5.0	1600.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2b	No	NA	1789.0	1	Not Hispanic or Latino	Positive	None	NA	47,XY,+10[10]/46,XY[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.09	0.01	NA	BLL	1789.0	59.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	166.9
all_phase2_target_2018_pub	TARGET-10-PARPYH	TARGET-10-PARPYH-09	6.0	2105.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2925.0	1	Hispanic or Latino	Positive	None	NA	46,XY,del(11)(q23)[2]/46,XY[19]	Negative	NA	NA	NA	0.043	0.001	NA	NA	0.0	0.01	NA	BLL	2925.0	97.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	71.8
all_phase2_target_2018_pub	TARGET-10-PARPYJ	TARGET-10-PARPYJ-09	8.0	2719.0	NA	NA	VALIDATION	Negative	75.0	4.0	NA	85.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2759.0	1.0259	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(5;7)(q33;q11.2)[3]/46,XX[17]	Negative	NA	0.0	NA	1.7	0.01	NA	NA	NA	NA	NA	BLL	2759.0	91.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	162.8
all_phase2_target_2018_pub	TARGET-10-PARPYS	TARGET-10-PARPYS-09	15.0	5372.0	CHEMOTHERAPY	NA	VALIDATION;DISCOVERY	Negative	0.0	0.0	0.0	71.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	472.0	371.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,add(22)(q13.3)[2]/46,XY[18]	Negative	None of the above	NA	NA	4.7	0.01	1.3	NA	3.6	0.01	NA	BLL	472.0	16.0	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	106.7
all_phase2_target_2018_pub	TARGET-10-PARPZI	TARGET-10-PARPZI-09	7.0	2316.0	CHEMOTHERAPY	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1663.0	1.0951	Not Hispanic or Latino	Negative	Relapse	NA	47,XY,add(2)(p23),+mar[5]/46,XY[15]	Negative	NA	NA	NA	0.012	0.001	NA	NA	0.0051	NA	NA	BLL	3067.0	101.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	Yes	No	NA	Negative	162.3
all_phase2_target_2018_pub	TARGET-10-PARPZJ	TARGET-10-PARPZJ-03	2.0	648.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	419.0	1.1096	Not Hispanic or Latino	Positive	Relapse	NA	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.0033	NA	3	BLL	2419.0	NA	0:LIVING	No	AALL0331	White	3	Male	Matched	Unknown	No	No	0.1	Negative	16.41
all_phase2_target_2018_pub	TARGET-10-PARPZJ	TARGET-10-PARPZJ-04	2.0	648.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	419.0	1.1096	Not Hispanic or Latino	Positive	Relapse	0.0569	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.0033	NA	NA	BLL	2419.0	NA	0:LIVING	No	AALL0331	White	3	Male	Matched	Unknown	No	No	NA	Negative	16.41
all_phase2_target_2018_pub	TARGET-10-PARPZJ	TARGET-10-PARPZJ-09	2.0	648.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	4.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	419.0	1.1096	Not Hispanic or Latino	Positive	Relapse	0.0006	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	0.0033	NA	NA	BLL	2419.0	NA	0:LIVING	No	AALL0331	White	3	Male	Matched	Unknown	No	No	NA	Negative	16.41
all_phase2_target_2018_pub	TARGET-10-PARPZR	TARGET-10-PARPZR-09	2.0	490.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	VALIDATION	Negative	7.0	2.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2788.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Positive	NA	NA	NA	1.7	0.01	NA	NA	5.3	0.01	NA	BLL	2788.0	92.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	56.4
all_phase2_target_2018_pub	TARGET-10-PARRAF	TARGET-10-PARRAF-03	9.0	3021.0	NA	NA	DISCOVERY	Positive	76.0	63.0	NA	95.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1	Hispanic or Latino	Unknown	Induction failure	NA	46,XY,add(6)(p25),-7,-9,t(9;22)(q34;q11.2),+14,+der(22)t(9;22)(q34;q11.2)[5]/46,XY[15]	Negative	BCR-ABL1	NA	NA	43.0	0.01	NA	NA	NA	NA	NA	BLL	275.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	96.2
all_phase2_target_2018_pub	TARGET-10-PARRJV	TARGET-10-PARRJV-09	2.0	711.0	NA	NA	VALIDATION	Negative	NA	7.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	NA	1.1441	Not Hispanic or Latino	Negative	NA	NA	46,XY,add(9)(p12),add(9)(p13)[10]/46,XY[10]	Negative	NA	NA	NA	0.11	0.01	0.0	NA	0.03	0.01	NA	BLL	NA	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	152.0
all_phase2_target_2018_pub	TARGET-10-PARRKG	TARGET-10-PARRKG-03	8.0	2620.0	CHEMOTHERAPY	NA	VALIDATION	Negative	0.0	0.0	NA	85.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	397.0	1	Not Hispanic or Latino	Negative	Censored	NA	46,XY[20]	Negative	NA	NA	NA	0.14	0.01	NA	NA	17.3	0.01	NA	BLL	397.0	14.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	75.0
all_phase2_target_2018_pub	TARGET-10-PARRKK	TARGET-10-PARRKK-09	9.0	3244.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2752.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(1;7)(p34;p13),del(6)(q21q25)[17]/46,XY[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2752.0	91.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	183.9
all_phase2_target_2018_pub	TARGET-10-PARRKW	TARGET-10-PARRKW-04	7.0	2505.0	NA	NA	DISCOVERY	Negative	2.0	3.0	NA	59.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1053.0	705.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,add(21)(q22)[6]/46,XX[3]	Negative	None of the above	0.09	0.01	0.11	0.01	NA	NA	0.72	0.01	NA	BLL	1053.0	NA	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	4.3
all_phase2_target_2018_pub	TARGET-10-PARRKW	TARGET-10-PARRKW-09	7.0	2505.0	NA	NA	DISCOVERY	Negative	2.0	3.0	NA	59.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1053.0	705.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,add(21)(q22)[6]/46,XX[3]	Negative	None of the above	0.09	0.01	0.11	0.01	NA	NA	0.72	0.01	NA	BLL	1053.0	NA	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	4.3
all_phase2_target_2018_pub	TARGET-10-PARRMU	TARGET-10-PARRMU-09	15.0	5168.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2931.0	1.1855	Unknown	Negative	None	NA	56,XX,+X,+4,+6,+9,+10,+14,+17,+18,+21,+21[8]/46,XX[12]	Negative	NA	NA	NA	0.004	0.001	NA	NA	2.28	0.01	NA	BLL	2931.0	97.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Positive	11.91
all_phase2_target_2018_pub	TARGET-10-PARRPA	TARGET-10-PARRPA-09	22.0	7899.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	43.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3028.0	1.2278	Not Hispanic or Latino	Negative	None	NA	60,XY,+X,+4,+8,+10,+11,+12,+14,+14,+17,+19,+21,+3mar[3]/46,XY[22]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.19	0.01	NA	BLL	3028.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	1.6
all_phase2_target_2018_pub	TARGET-10-PARRPK	TARGET-10-PARRPK-60.1	25.0	8898.0	CHEMOTHERAPY; RADIATION (NOS); Transplant	NA	XENOGRAFT	Negative	22.0	0.0	0.0	87.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	2587.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,add(1)(q42)[3]/46,idem,del(9)(p21),add(14)(p11.2)[14]/46,XY[2]	Negative	NA	0.0	0.0	1.1	0.01	0.24	NA	32.5	0.01	NA	BLL	2817.0	93.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	172.0
all_phase2_target_2018_pub	TARGET-10-PARRSR	TARGET-10-PARRSR-09	14.0	5018.0	Transplant	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2684.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,del(6)(q15q21),del(9)(p21),add(19)(p13.3)[11]/46,XX[9]	Negative	NA	NA	NA	0.018000000000000002	0.001	NA	NA	0.02	0.01	NA	BLL	2684.0	89.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	18.0
all_phase2_target_2018_pub	TARGET-10-PARRVI	TARGET-10-PARRVI-09	14.0	4889.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	84.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1224.0	1.2135	Not Hispanic or Latino	Negative	Relapse	NA	55,XX,+X,+X,dup(1)(q25q44),+4,+6,+10,+14,+17,+18,+21[9]/46,XX[11]	Negative	NA	NA	NA	0.008	0.001	NA	NA	2.4	0.01	NA	BLL	1336.0	44.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	2.5
all_phase2_target_2018_pub	TARGET-10-PARRVK	TARGET-10-PARRVK-09	18.0	6433.0	NA	NA	VALIDATION	Negative	3.0	3.0	1.0	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	212.0	1	Hispanic or Latino	Negative	Death	NA	47,XX,+X,add(20)(q13.3)[5]/46,XX[8]	Negative	NA	NA	NA	1.5	0.01	0.0	NA	1.6	0.01	NA	BLL	212.0	7.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	215.9
all_phase2_target_2018_pub	TARGET-10-PARRYW	TARGET-10-PARRYW-09	12.0	4347.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	61.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3087.0	1.18	Not Hispanic or Latino	Negative	None	NA	55,XY,+X,+4,+6,+10,+14,+17,+18,+21,+21[13]/56,idem,+9[4]/46,XY[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	14.5	0.01	NA	BLL	3087.0	102.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Positive	8.5
all_phase2_target_2018_pub	TARGET-10-PARSET	TARGET-10-PARSET-09	11.0	3986.0	Chemotherapy; XRT	NA	VALIDATION	Negative	2.0	1.0	NA	75.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	356.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	356.0	12.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	520.0
all_phase2_target_2018_pub	TARGET-10-PARSGC	TARGET-10-PARSGC-03	4.0	1133.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	932.0	1.1439	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	2829.0	NA	0:LIVING	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	0.1	Negative	14.3
all_phase2_target_2018_pub	TARGET-10-PARSGM	TARGET-10-PARSGM-09	14.0	4849.0	NA	NA	VALIDATION	Negative	8.0	0.0	NA	45.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	219.0	1.1823	Not Hispanic or Latino	Negative	None	NA	54,XY,+X,+4,+6,+9,+14,+17,+18,+21[3]/55,idem,+21[17]	Negative	NA	0.006	0.006	0.14	0.01	NA	NA	24.1	0.01	NA	BLL	219.0	8.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.1
all_phase2_target_2018_pub	TARGET-10-PARSHV	TARGET-10-PARSHV-09	14.0	5080.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2700.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(2;7)(p11.2;q22)[5]/46,XY[1]	Negative	NA	NA	NA	0.008	0.001	NA	NA	0.0	0.01	NA	BLL	2700.0	89.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	13.2
all_phase2_target_2018_pub	TARGET-10-PARSJG	TARGET-10-PARSJG-09	12.0	4371.0	Chemotherapy	NA	VALIDATION	Negative	1.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1300.0	1.1093	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,del(6)(q15q21)[[9]/46,XY[11]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2737.0	90.0	0:LIVING	Yes	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	523.6
all_phase2_target_2018_pub	TARGET-10-PARSJH	TARGET-10-PARSJH-09	17.0	6089.0	CHEMOTHERAPY	NA	VALIDATION	Positive	12.0	1.0	NA	79.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2695.0	1	Not Hispanic or Latino	Negative	None	NA	45,XY,-7,t(9;22)(q34;q11.2)[12]/46,XY[9]	Negative	NA	NA	NA	2.9	0.01	NA	NA	0.057999999999999996	0.001	NA	BLL	2695.0	89.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	40.3
all_phase2_target_2018_pub	TARGET-10-PARSKH	TARGET-10-PARSKH-09	15.0	5436.0	CHEMOTHERAPY	NA	VALIDATION	Negative	1.0	0.0	NA	96.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	213.0	0.6306	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	NA	NA	NA	0.024	0.001	NA	NA	5.7	0.01	NA	BLL	276.0	10.0	1:DECEASED	Yes	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	10.2
all_phase2_target_2018_pub	TARGET-10-PARSKV	TARGET-10-PARSKV-09	8.0	2563.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	2959.0	1.1361	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2959.0	98.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	214.71
all_phase2_target_2018_pub	TARGET-10-PARSKY	TARGET-10-PARSKY-09	4.0	1255.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3a	No	NA	1545.0	1.3676	Not Hispanic or Latino	Negative	None	NA	64,XY,+X,inv(2)(p21q23)c,+3,+4,+5,+6,+9,+10,+10,+11,+12,der(12)t(1;12)(q21;p13),+14,+14,+16,der(16)t(16;21)(p13;q21),+17,+18,+20,+21,+22[cp33]/46,XY,inv(2)(p21q23)c[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1545.0	51.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Positive	135.6
all_phase2_target_2018_pub	TARGET-10-PARSNX	TARGET-10-PARSNX-09	14.0	4915.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2077.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q21q25)[7]/46,XY[23]	Negative	NA	NA	NA	0.07	0.01	NA	NA	NA	NA	NA	BLL	2077.0	69.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	12.1
all_phase2_target_2018_pub	TARGET-10-PARSRH	TARGET-10-PARSRH-04	10.0	3532.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	500.0	297.0	1.0692	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;11)(11;18)(q21;q23q13;q21)[20]	Positive	MLL-Rearranged	0.0	0.01	0.03	0.01	NA	NA	NA	NA	NA	BLL	500.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	25.0
all_phase2_target_2018_pub	TARGET-10-PARSRH	TARGET-10-PARSRH-09	10.0	3532.0	NA	NA	DISCOVERY	Negative	NA	3.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	500.0	297.0	1.0692	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,t(4;11)(11;18)(q21;q23q13;q21)[20]	Positive	MLL-Rearranged	0.0	0.01	0.03	0.01	NA	NA	NA	NA	NA	BLL	500.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	25.0
all_phase2_target_2018_pub	TARGET-10-PARSRI	TARGET-10-PARSRI-09	16.0	5649.0	Transplant	NA	VALIDATION	Negative	0.0	1.0	NA	12.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2512.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	NA	NA	NA	0.032	0.001	NA	NA	0.11	0.01	NA	BLL	2707.0	89.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Negative	213.2
all_phase2_target_2018_pub	TARGET-10-PARSSV	TARGET-10-PARSSV-09	7.0	2471.0	NA	NA	VALIDATION	Negative	10.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2896.0	1	Hispanic or Latino	Negative	None	NA	46,XX,add(5)(p13),inv(12)(p13q15)[20]	Negative	NA	0.008	0.008	0.5	0.01	NA	NA	15.3	0.01	NA	BLL	2896.0	96.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	293.88
all_phase2_target_2018_pub	TARGET-10-PARSTB	TARGET-10-PARSTB-09	16.0	5638.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	11.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2542.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(1)(q21),add(12)(p11.2)[3]/46,idem,-3,add(6)(q25),add(9)(p13),add(9)(p13),-add(12),-16,+r,+mar1,+mar2[16]/46,XY[2]	Negative	NA	NA	NA	0.0058	0.0058	NA	NA	1.4	0.01	NA	BLL	2542.0	84.0	0:LIVING	No	AALL0232	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	13.7
all_phase2_target_2018_pub	TARGET-10-PARSUV	TARGET-10-PARSUV-09	19.0	6714.0	CHEMOTHERAPY; OTHER THERAPY	T cell apheresis as part of adult Moffitt clinical trial	VALIDATION	Negative	0.0	0.0	NA	72.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2770.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,X,t(Y;14)(p11.2;q32)[3]/46,idem,del(9)(p13p22)[3]/46,XY[18]	Negative	NA	NA	0.01	0.18	0.01	NA	NA	0.7	0.01	NA	BLL	3016.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	227.0
all_phase2_target_2018_pub	TARGET-10-PARSZH	TARGET-10-PARSZH-04	13.0	4719.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1001.0	1	Not Hispanic or Latino	Negative	Relapse	0.0765	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2400.0	NA	0:LIVING	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	NA	Negative	1.1
all_phase2_target_2018_pub	TARGET-10-PARSZH	TARGET-10-PARSZH-09	13.0	4719.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1001.0	1	Not Hispanic or Latino	Negative	Relapse	0.0250	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	NA	NA	3	BLL	2400.0	NA	0:LIVING	No	AALL0232	White	2	Female	Matched	Unknown	No	NA	0.1	Negative	1.1
all_phase2_target_2018_pub	TARGET-10-PARTAK	TARGET-10-PARTAK-09	11.0	3901.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	48.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1207.0	1	Hispanic or Latino	Negative	Censored	NA	46,XY[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	1.2	0.01	NA	BLL	1207.0	40.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	16.8
all_phase2_target_2018_pub	TARGET-10-PARTAY	TARGET-10-PARTAY-09	8.0	2568.0	NA	NA	VALIDATION	Positive	34.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	NA	1.0759	Not Hispanic or Latino	Negative	NA	NA	46,XX,der(9)del(9)(p13)t(9;22)(q34;q11.2),der(22)t(9;22)(q34;q11.2)[5]/45,XX,der(9;14)(q10;q10)t(9;22)(q34;q11.2),der(22)t(9;22)(q34;q11.2)[3]/46,XX[7]	Negative	NA	NA	NA	0.79	0.01	NA	NA	0.72	0.01	NA	BLL	NA	NA	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	105.44
all_phase2_target_2018_pub	TARGET-10-PARTBP	TARGET-10-PARTBP-09	6.0	2057.0	Chemotherapy	NA	VALIDATION	Negative	1.0	1.0	NA	70.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3083.0	1	Hispanic or Latino	Unknown	None	NA	46,XY,t(10;14)(q24;q11.2)[14]/46,XY[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	3083.0	102.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	94.1
all_phase2_target_2018_pub	TARGET-10-PARTEF	TARGET-10-PARTEF-09	4.0	1123.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	3015.0	1	Unknown	Positive	None	NA	45,X,-X,t(12;21;22)(p13;q22;q13)[9]/46,XX[11]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.059000000000000004	0.001	NA	BLL	3015.0	100.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	146.0
all_phase2_target_2018_pub	TARGET-10-PARTGB	TARGET-10-PARTGB-09	19.0	6782.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	173.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.005	0.001	NA	NA	3.7	0.01	NA	BLL	173.0	6.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	88.5
all_phase2_target_2018_pub	TARGET-10-PARTGW	TARGET-10-PARTGW-09	6.0	1850.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	37.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2a	No	NA	1995.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,i(9)(q10),der(19)t(1;19)(q23;p13.3)[2]/46,idem,del(6)(q15q21)[9]/46,XX[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.65	0.01	NA	BLL	1995.0	66.0	0:LIVING	No	AALL0232	Black or African American	1	Female	Matched	Positive	No	NA	NA	Negative	52.6
all_phase2_target_2018_pub	TARGET-10-PARTID	TARGET-10-PARTID-09	15.0	5315.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2647.0	1	Not Hispanic or Latino	Negative	None	NA	45,XX,add(8)([11.2),add(9)(p21),-13[21]	Negative	NA	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	2647.0	88.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	3.66
all_phase2_target_2018_pub	TARGET-10-PARTIK	TARGET-10-PARTIK-09	4.0	1402.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2174.0	1	Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.011000000000000001	0.001	NA	NA	9.8	0.01	NA	BLL	2174.0	72.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	108.8
all_phase2_target_2018_pub	TARGET-10-PARTJJ	TARGET-10-PARTJJ-09	4.0	1170.0	NA	NA	VALIDATION	Negative	NA	NA	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2928.0	1	Not Hispanic or Latino	Positive	None	NA	45,XY,add(2)(p21),dic(12;17)(p11.2;p11.2)[18]/46,XY[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.18	0.01	NA	BLL	2928.0	97.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	66.7
all_phase2_target_2018_pub	TARGET-10-PARTJL	TARGET-10-PARTJL-04	3.0	1060.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	0.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	509.0	1.1412	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	8.3	0.01	NA	BLL	968.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Unknown	No	NA	NA	Negative	34.7
all_phase2_target_2018_pub	TARGET-10-PARTJL	TARGET-10-PARTJL-09	3.0	1060.0	Chemotherapy	NA	DISCOVERY	Negative	3.0	0.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	509.0	1.1412	Not Hispanic or Latino	Negative	Relapse	0.0222	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	8.3	0.01	NA	BLL	968.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Unknown	No	NA	NA	Negative	34.7
all_phase2_target_2018_pub	TARGET-10-PARTKL	TARGET-10-PARTKL-04	3.0	1089.0	NA	NA	DISCOVERY	Negative	7.0	1.0	NA	60.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	900.0	805.0	1.1347	Not Hispanic or Latino	Negative	Relapse	0.1676	51,XX,+X,+6,add(13)(p11.2),+14,+21,+21[21]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.12	0.01	NA	NA	8.2	0.01	NA	BLL	900.0	NA	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	10.7
all_phase2_target_2018_pub	TARGET-10-PARTKL	TARGET-10-PARTKL-09	3.0	1089.0	NA	NA	DISCOVERY	Negative	7.0	1.0	NA	60.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	900.0	805.0	1.1347	Not Hispanic or Latino	Negative	Relapse	0.0236	51,XX,+X,+6,add(13)(p11.2),+14,+21,+21[21]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.12	0.01	NA	NA	8.2	0.01	3	BLL	900.0	NA	1:DECEASED	No	AALL0331	White	2	Female	Matched	Negative	No	NA	0.1	Negative	10.7
all_phase2_target_2018_pub	TARGET-10-PARTLY	TARGET-10-PARTLY-09	13.0	4492.0	Chemotherapy	NA	VALIDATION	Negative	3.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	3058.0	1.1282	Not Hispanic or Latino	Unknown	None	NA	49,XY,del(13)(q12q32),+18,add(18)(q21),+mar1,+mar2[18]/46,XY[2]	Negative	NA	NA	NA	0.2	0.01	NA	NA	NA	NA	NA	BLL	3058.0	101.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	4.2
all_phase2_target_2018_pub	TARGET-10-PARTPW	TARGET-10-PARTPW-09	16.0	5483.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2750.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+mar[4]/46,XY[6]	Negative	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2750.0	91.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Negative	No	No	NA	Negative	15.3
all_phase2_target_2018_pub	TARGET-10-PARTRW	TARGET-10-PARTRW-04	6.0	2062.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	675.0	1	Not Hispanic or Latino	Negative	Relapse	0.1869	46,X,t(Y;9)(q12;p21),+X,-8[13]/46,XY[7]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.22	0.01	NA	BLL	1619.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	6.91
all_phase2_target_2018_pub	TARGET-10-PARTRW	TARGET-10-PARTRW-09	6.0	2062.0	Chemotherapy	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	Yes	CNS 2	No	NA	675.0	1	Not Hispanic or Latino	Negative	Relapse	0.0538	46,X,t(Y;9)(q12;p21),+X,-8[13]/46,XY[7]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.22	0.01	NA	BLL	1619.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	6.91
all_phase2_target_2018_pub	TARGET-10-PARTSC	TARGET-10-PARTSC-09	9.0	3035.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2919.0	1	Not Hispanic or Latino	Positive	None	NA	46,XY,t(5;8;12)(q13;q13;p13),der(9)t(9;12)(q34;p13)t(12;21)(p13;q22)[16]/46,XY[4]	Negative	NA	NA	NA	0.0015	0.01	NA	NA	NA	NA	NA	BLL	2919.0	96.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	88.0
all_phase2_target_2018_pub	TARGET-10-PARTWH	TARGET-10-PARTWH-09	12.0	4270.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	3013.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(6;12)(q13;q24.1),del(12)(p13)[18]/46,XY[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	3013.0	100.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	5.23
all_phase2_target_2018_pub	TARGET-10-PARTXF	TARGET-10-PARTXF-04	3.0	1090.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1001.0	686.0	1.1672	Hispanic or Latino	Negative	Relapse	NA	55,X,-Y,+X,dup(1)(q32q12),+4,+6,+10,+14,+17,+18,+21,+21,+22[6]/46,XY[14]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.003	0.001	NA	NA	NA	NA	NA	BLL	1001.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Positive	10.2
all_phase2_target_2018_pub	TARGET-10-PARTXF	TARGET-10-PARTXF-09	3.0	1090.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	25.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	1001.0	686.0	1.1672	Hispanic or Latino	Negative	Relapse	NA	55,X,-Y,+X,dup(1)(q32q12),+4,+6,+10,+14,+17,+18,+21,+21,+22[6]/46,XY[14]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.003	0.001	NA	NA	NA	NA	NA	BLL	1001.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Positive	10.2
all_phase2_target_2018_pub	TARGET-10-PARTYT	TARGET-10-PARTYT-04	3.0	847.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	257.0	1	Hispanic or Latino	Negative	Relapse	0.0015	47,XY,+5,t(9;15)(q32;q12)[4]/46,XY[17]	Negative	None of the above	0.0	0.1	0.3	0.01	NA	NA	0.0	0.01	NA	BLL	3003.0	NA	0:LIVING	No	AALL0331	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	25.7
all_phase2_target_2018_pub	TARGET-10-PARTYT	TARGET-10-PARTYT-09	3.0	847.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	257.0	1	Hispanic or Latino	Negative	Relapse	0.0640	47,XY,+5,t(9;15)(q32;q12)[4]/46,XY[17]	Negative	None of the above	0.0	0.1	0.3	0.01	NA	NA	0.0	0.01	NA	BLL	3003.0	NA	0:LIVING	No	AALL0331	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	25.7
all_phase2_target_2018_pub	TARGET-10-PARTYT	TARGET-10-PARTYT-40	3.0	847.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	257.0	1	Hispanic or Latino	Negative	Relapse	NA	47,XY,+5,t(9;15)(q32;q12)[4]/46,XY[17]	Negative	None of the above	0.0	0.1	0.3	0.01	NA	NA	0.0	0.01	NA	BLL	3003.0	NA	0:LIVING	No	AALL0331	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	25.7
all_phase2_target_2018_pub	TARGET-10-PARTZE	TARGET-10-PARTZE-09	13.0	4551.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2a	No	NA	632.0	1	Not Hispanic or Latino	Negative	Relapse	NA	47,XY,t(1;19)(q23;p13),+6,der(13)t(1;13)(q23;q14)[4]/47,XY,t(1;19)(q23;p13),+6,der(13)t(1;13)(q23;q22)[11]/46,XY,t(1;19)(q23;p13),+der(6)t(1;6)(q23;q26)[2]/46,XY[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	859.0	29.0	1:DECEASED	No	AALL0232	White	1	Male	Matched	Positive	No	No	NA	Negative	3.3
all_phase2_target_2018_pub	TARGET-10-PARTZJ	TARGET-10-PARTZJ-09	3.0	1062.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	29.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1615.0	1	Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.46	0.01	NA	BLL	1615.0	54.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	57.6
all_phase2_target_2018_pub	TARGET-10-PARUBK	TARGET-10-PARUBK-03	13.0	4601.0	Chemotherapy	NA	DISCOVERY	Negative	23.0	4.0	NA	36.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	560.0	399.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(4;11)(q21;q23)[20]	Positive	MLL-Rearranged	NA	NA	0.79	NA	NA	NA	9.9	0.01	NA	BLL	560.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	1148.5
all_phase2_target_2018_pub	TARGET-10-PARUBK	TARGET-10-PARUBK-09	13.0	4601.0	Chemotherapy	NA	DISCOVERY	Negative	23.0	4.0	NA	36.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	560.0	399.0	1	Not Hispanic or Latino	Negative	Relapse	0.0019	46,XX,t(4;11)(q21;q23)[20]	Positive	MLL-Rearranged	NA	NA	0.79	NA	NA	NA	9.9	0.01	NA	BLL	560.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	1148.5
all_phase2_target_2018_pub	TARGET-10-PARUBN	TARGET-10-PARUBN-09	13.0	4586.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	43.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1280.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,der(17)t(1;17)(q21;q25),add(21)(q22)[9]/46,idem,add(19)(p13.3)[7]/46,XX[4]	Negative	NA	2.6	0.01	0.62	0.01	NA	NA	1.8	0.01	NA	BLL	2525.0	84.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	5.2
all_phase2_target_2018_pub	TARGET-10-PARUBU	TARGET-10-PARUBU-09	4.0	1134.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	17.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1387.0	1	Not Hispanic or Latino	Positive	Relapse	NA	46,XY,del(1)(q42),del(11)(q21q23),del(12)(p13)[5]/46,XY,del(1)(q42),del(6)(q13q21),del(12)(p13),del(13)(q14q22)[9]/46,XY[16]	Negative	NA	NA	NA	0.005	0.001	NA	NA	0.37	0.01	NA	BLL	2959.0	98.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	77.1
all_phase2_target_2018_pub	TARGET-10-PARUBX	TARGET-10-PARUBX-09	11.0	3771.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	519.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(4)(q12),der(11)ins(11;?)(q13;?)t(4;11)(q1?2;q23),del(12)(q13),der(21)add(q22)[6]/46,XY[5]	Negative	NA	NA	NA	0.0011	0.0011	NA	NA	0.006999999999999999	0.001	NA	BLL	519.0	18.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	2.25
all_phase2_target_2018_pub	TARGET-10-PARUCI	TARGET-10-PARUCI-09	4.0	1187.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2141.0	1.0749	Hispanic or Latino	Negative	None	NA	51,XX,+14,+17,+21,+21,+mar[3]/46,XX[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	7.1	0.01	NA	BLL	2141.0	71.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	116.0
all_phase2_target_2018_pub	TARGET-10-PARUCT	TARGET-10-PARUCT-09	15.0	5358.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	82.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 3a	No	NA	3037.0	1	Unknown	Positive	None	NA	46,XY,add(12)(p13),add(18)(q11.2)[8]/46,idem,add(X)(p11.2)[5]/46,XY[2]	Negative	NA	NA	NA	0.006999999999999999	0.001	NA	NA	8.9	0.01	NA	BLL	3037.0	100.0	0:LIVING	No	AALL0232	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	132.2
all_phase2_target_2018_pub	TARGET-10-PARUEU	TARGET-10-PARUEU-09	6.0	2036.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2247.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(2)(q34)[11]/46,XY[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2247.0	74.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	314.0
all_phase2_target_2018_pub	TARGET-10-PARUGP	TARGET-10-PARUGP-09	3.0	759.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	16.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	289.0	223.0	1.2262	Unknown	Negative	Relapse	0.0947	NA	Negative	TCF3-PBX1	0.0	0.1	0.14	0.01	NA	NA	0.49	0.01	3	BLL	289.0	NA	1:DECEASED	No	AALL0331	White	1	Male	Matched	Positive	No	No	0.1	Negative	12.6
all_phase2_target_2018_pub	TARGET-10-PARUGV	TARGET-10-PARUGV-09	2.0	571.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2878.0	1	Not Hispanic or Latino	Positive	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2878.0	95.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	73.3
all_phase2_target_2018_pub	TARGET-10-PARUIT	TARGET-10-PARUIT-09	2.0	395.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2816.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,t(4;11)(q21;q23),+der(4)t(4;11)[13]/48,idem,+Y[5]/46,XY[2]	Positive	NA	NA	NA	0.075	0.001	NA	NA	NA	NA	NA	BLL	2816.0	93.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	129.7
all_phase2_target_2018_pub	TARGET-10-PARUIW	TARGET-10-PARUIW-03	5.0	1777.0	NA	NA	DISCOVERY	Negative	3.0	1.0	NA	83.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	945.0	1	Hispanic or Latino	Positive	Relapse	NA	47,XX,add(4)(q22),del(7)(q32q36),del(9)(q22q34.3),add(17)(p12),+21[12]/46,XX[8]	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	15.3	0.01	NA	BLL	2791.0	NA	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	9.6
all_phase2_target_2018_pub	TARGET-10-PARUKK	TARGET-10-PARUKK-09	16.0	5647.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1420.0	1	Hispanic or Latino	Negative	None	NA	46,XY,dup(10)(q11.2q23)[4]/46,XY[16]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.07	0.01	NA	BLL	1420.0	47.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	38.9
all_phase2_target_2018_pub	TARGET-10-PARUKW	TARGET-10-PARUKW-09	10.0	3576.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2701.0	1	Hispanic or Latino	Negative	None	NA	46,XX,t(10;12)(p11.2;q12)[4]/46,XX[17]	Negative	NA	NA	NA	0.65	0.01	NA	NA	NA	NA	NA	BLL	2701.0	89.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	32.3
all_phase2_target_2018_pub	TARGET-10-PARURK	TARGET-10-PARURK-09	14.0	4912.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2184.0	1.2136	Not Hispanic or Latino	Negative	None	NA	57,XX,+X,+4,+6,+8,+10,+12,+14,+17,+21,+21,+21[9]/46,XX[11]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2184.0	72.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Positive	3.3
all_phase2_target_2018_pub	TARGET-10-PARUYE	TARGET-10-PARUYE-03	2.0	616.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2900.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX[69]	Negative	NA	NA	NA	0.011000000000000001	0.001	NA	NA	0.25	0.01	NA	BLL	2900.0	96.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Unknown	No	NA	NA	Negative	231.1
all_phase2_target_2018_pub	TARGET-10-PARUYH	TARGET-10-PARUYH-09	4.0	1216.0	NA	NA	VALIDATION	Negative	4.0	2.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 2c	No	NA	2725.0	1.0902	Not Hispanic or Latino	Positive	None	NA	46,XX,t(12;21)(p13;q22)[1]/46,XX[20]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.02	0.01	NA	BLL	2725.0	90.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	251.5
all_phase2_target_2018_pub	TARGET-10-PARUYU	TARGET-10-PARUYU-09	12.0	4024.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2477.0	1.1268	Not Hispanic or Latino	Negative	None	NA	45,XY,dic(9;12)(p13;p13)[18]/46,XY[2]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.05	0.01	NA	BLL	2477.0	82.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	42.6
all_phase2_target_2018_pub	TARGET-10-PARVAK	TARGET-10-PARVAK-09	7.0	2198.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2933.0	1	Hispanic or Latino	Negative	None	NA	46,XX,der(19)t(1;19)(q23;p13.3)[4]/46,XX[16]	Negative	NA	NA	NA	0.004	0.001	NA	NA	0.03	0.01	NA	BLL	2933.0	97.0	0:LIVING	No	AALL0232	White	1	Female	Matched	Positive	No	NA	NA	Negative	83.3
all_phase2_target_2018_pub	TARGET-10-PARVBL	TARGET-10-PARVBL-09	12.0	4106.0	NA	NA	VALIDATION	Negative	NA	4.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2788.0	1.0695	Hispanic or Latino	Negative	None	NA	46,XX,der(12)t(6;12)(q12;p12)[14]/46,XX[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	0.0	0.01	NA	BLL	2788.0	92.0	0:LIVING	No	AALL0232	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	13.8
all_phase2_target_2018_pub	TARGET-10-PARVBS	TARGET-10-PARVBS-03	17.0	5947.0	NA	NA	DISCOVERY	Negative	70.0	72.0	NA	80.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	34.0	1	Hispanic or Latino	Negative	Induction failure	NA	46,XY,t(1;9)(p22;p13)[7]/46,XY[15]	Negative	None of the above	NA	NA	86.2	0.01	NA	NA	1.0	0.01	NA	BLL	52.0	NA	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	7.0
all_phase2_target_2018_pub	TARGET-10-PARVBY	TARGET-10-PARVBY-09	3.0	970.0	NA	NA	VALIDATION	Negative	0.0	2.0	NA	41.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	2425.0	1.2038	Hispanic or Latino	Unknown	None	NA	56,XY,+X,+4,+6,+9,+10,+14,+18,+21,+21[5]/46,XY[17]	Negative	NA	NA	0.01	0.0085	0.0085	NA	NA	2.4	0.01	NA	BLL	2425.0	80.0	0:LIVING	No	AALL0232	White	1	Male	Matched	Negative	No	Yes	NA	Positive	15.9
all_phase2_target_2018_pub	TARGET-10-PARVCG	TARGET-10-PARVCG-09	11.0	3659.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	46.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	Yes	CNS 2b	No	NA	1305.0	1	Not Hispanic or Latino	Positive	Relapse	NA	46,X,-X,del(13)(q12q32),+16[3]/46,XX[14]	Negative	NA	NA	NA	0.0077	0.0077	NA	NA	0.13	0.01	NA	BLL	1339.0	45.0	1:DECEASED	No	AALL0232	White	1	Female	Matched	Negative	No	NA	NA	Negative	93.4
all_phase2_target_2018_pub	TARGET-10-PARVEI	TARGET-10-PARVEI-09	4.0	1253.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2769.0	1.1228	Not Hispanic or Latino	Negative	None	NA	46,XX,del(11)(q21q23.1),del(13)(q12q21)[19]/46,XX[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2769.0	92.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	108.7
all_phase2_target_2018_pub	TARGET-10-PARVHA	TARGET-10-PARVHA-03	18.0	6228.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	520.0	380.0	1.3844	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	520.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	8.7
all_phase2_target_2018_pub	TARGET-10-PARVHY	TARGET-10-PARVHY-09	16.0	5718.0	NA	NA	VALIDATION	Negative	2.0	2.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2948.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.6	0.01	NA	NA	NA	NA	NA	BLL	2948.0	97.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	57.7
all_phase2_target_2018_pub	TARGET-10-PARVMR	TARGET-10-PARVMR-09	5.0	1811.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2841.0	1	Unknown	Unknown	None	NA	46,XY,del(6)(q13q21)[7]/46,XY[14]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2841.0	94.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	79.1
all_phase2_target_2018_pub	TARGET-10-PARVWD	TARGET-10-PARVWD-09	18.0	6375.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	255.0	252.0	1	Not Hispanic or Latino	Negative	Relapse	0.0729	45,XY,del(4)(q21),t(5;8;12)(q34;p21;q21),der(7)t(7;8)(p22;q13),-8,del(10)(q24),del(12)(p13)[18]/46,XY[2]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.15	0.01	4	BLL	255.0	NA	1:DECEASED	No	AALL0232	Black or African American	1	Male	Matched	Negative	No	No	0.133333333333	Negative	3.8
all_phase2_target_2018_pub	TARGET-10-PARWDM	TARGET-10-PARWDM-09	16.0	5814.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	821.0	1.1216	Not Hispanic or Latino	Unknown	None	NA	46,XX,del(9)(p21)[13]/46,XX[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	821.0	27.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	88.39
all_phase2_target_2018_pub	TARGET-10-PARWID	TARGET-10-PARWID-09	20.0	7053.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2648.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2648.0	88.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Negative	114.9
all_phase2_target_2018_pub	TARGET-10-PARWLP	TARGET-10-PARWLP-09	8.0	2884.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	58.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2884.0	1.132	Not Hispanic or Latino	Unknown	None	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2884.0	95.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	145.0
all_phase2_target_2018_pub	TARGET-10-PARWMF	TARGET-10-PARWMF-09	12.0	4275.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2668.0	1.1243	Not Hispanic or Latino	Negative	None	NA	46,Y,t(X;2)(q13;p13)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2668.0	88.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	25.4
all_phase2_target_2018_pub	TARGET-10-PARWNW	TARGET-10-PARWNW-09	12.0	4366.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2324.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(9)(p22),add(18)(q23)[cp11]/46,XY[29]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2324.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	Yes	NA	Negative	61.3
all_phase2_target_2018_pub	TARGET-10-PARWVN	TARGET-10-PARWVN-03	3.0	845.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1040.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	45,XX,-9,der(19)t(1;19)(q23;p13.3)[2]/46,XX[21]	Negative	TCF3-PBX1	NA	NA	0.0045	NA	NA	NA	0.047	0.001	NA	BLL	2817.0	NA	0:LIVING	No	AALL0232	Unknown	3	Female	Matched	Positive	No	NA	NA	Negative	125.0
all_phase2_target_2018_pub	TARGET-10-PARWVN	TARGET-10-PARWVN-04	3.0	845.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1040.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	45,XX,-9,der(19)t(1;19)(q23;p13.3)[2]/46,XX[21]	Negative	TCF3-PBX1	NA	NA	0.0045	NA	NA	NA	0.047	0.001	NA	BLL	2817.0	NA	0:LIVING	No	AALL0232	Unknown	3	Female	Matched	Positive	No	NA	NA	Negative	125.0
all_phase2_target_2018_pub	TARGET-10-PARWVN	TARGET-10-PARWVN-09	3.0	845.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	1040.0	1	Not Hispanic or Latino	Unknown	Relapse	0.0470	45,XX,-9,der(19)t(1;19)(q23;p13.3)[2]/46,XX[21]	Negative	TCF3-PBX1	NA	NA	0.0045	NA	NA	NA	0.047	0.001	NA	BLL	2817.0	NA	0:LIVING	No	AALL0232	Unknown	3	Female	Matched	Positive	No	NA	NA	Negative	125.0
all_phase2_target_2018_pub	TARGET-10-PARXHT	TARGET-10-PARXHT-03	14.0	5106.0	Chemotherapy; XRT	NA	VALIDATION	Negative	2.0	1.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2652.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,del(6)(q21q23)[17]/46,XX[3]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2652.0	88.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	205.7
all_phase2_target_2018_pub	TARGET-10-PARXLS	TARGET-10-PARXLS-09	5.0	1601.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2756.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(7;10)(q32;q24),ins(13;9)(q14;q22qter)[19]/46,XY[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2756.0	91.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	13.5
all_phase2_target_2018_pub	TARGET-10-PARXMC	TARGET-10-PARXMC-04	7.0	2526.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	21.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	672.0	1	Hispanic or Latino	Positive	Relapse	0.0623	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	1.07	0.01	NA	BLL	2818.0	NA	0:LIVING	No	AALL0331	Unknown	2	Female	Matched	Unknown	No	NA	NA	Negative	20.5
all_phase2_target_2018_pub	TARGET-10-PARXMC	TARGET-10-PARXMC-09	7.0	2526.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	21.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	672.0	1	Hispanic or Latino	Positive	Relapse	0.0602	NA	Negative	ETV6-RUNX1	NA	NA	0.0	0.01	NA	NA	1.07	0.01	5	BLL	2818.0	NA	0:LIVING	No	AALL0331	Unknown	2	Female	Matched	Unknown	No	NA	0.166666666667	Negative	20.5
all_phase2_target_2018_pub	TARGET-10-PARXMV	TARGET-10-PARXMV-03	13.0	4523.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2441.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(7;10)(q34;q24)[11]/46,idem,del(5)(q11.2q15)[9]/46,XY[3]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2441.0	81.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	121.0
all_phase2_target_2018_pub	TARGET-10-PARXVS	TARGET-10-PARXVS-09	12.0	4292.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	0.0	2.0	NA	75.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	2055.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,del(6)(q21)[4]/46,XY[12]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2291.0	76.0	1:DECEASED	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	273.0
all_phase2_target_2018_pub	TARGET-10-PARYGI	TARGET-10-PARYGI-03	6.0	1854.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2755.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2755.0	91.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	61.1
all_phase2_target_2018_pub	TARGET-10-PARYMD	TARGET-10-PARYMD-04	NA	NA	NA	NA	VALIDATION	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	1	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-PASCIU	TARGET-10-PASCIU-03	3.0	795.0	NA	NA	DISCOVERY	Negative	11.0	0.0	NA	3.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	977.0	735.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY[20]	Negative	None of the above	0.0	0.01	0.0	0.01	NA	NA	2.1	0.01	2	BLL	977.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	0.0666666666667	Negative	95.1
all_phase2_target_2018_pub	TARGET-10-PASDYK	TARGET-10-PASDYK-03	4.0	1310.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	736.0	520.0	1.1723	Not Hispanic or Latino	Negative	Relapse	NA	52,XX,+X,+4,+6,+17,+21,+21[19]/46,XX[1]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.04	0.01	NA	NA	2.5	0.01	NA	BLL	736.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	67.7
all_phase2_target_2018_pub	TARGET-10-PASDYK	TARGET-10-PASDYK-09	4.0	1310.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	8.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	736.0	520.0	1.1723	Not Hispanic or Latino	Negative	Relapse	0.2478	52,XX,+X,+4,+6,+17,+21,+21[19]/46,XX[1]	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.04	0.01	NA	NA	2.5	0.01	3	BLL	736.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	0.1	Negative	67.7
all_phase2_target_2018_pub	TARGET-10-PASEVJ	TARGET-10-PASEVJ-04	12.0	4086.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	892.0	678.0	1	Hispanic or Latino	Negative	Relapse	0.0015	46,XX[20]	Negative	None of the above	NA	NA	0.032	0.001	NA	NA	0.9	0.01	NA	BLL	892.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Female	Matched	Unknown	No	NA	NA	Negative	39.8
all_phase2_target_2018_pub	TARGET-10-PASEVJ	TARGET-10-PASEVJ-09	12.0	4086.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	892.0	678.0	1	Hispanic or Latino	Negative	Relapse	0.0014	46,XX[20]	Negative	None of the above	NA	NA	0.032	0.001	NA	NA	0.9	0.01	7	BLL	892.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Female	Matched	Unknown	No	NA	0.233333333333	Negative	39.8
all_phase2_target_2018_pub	TARGET-10-PASEVJ	TARGET-10-PASEVJ-40	12.0	4086.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	15.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	892.0	678.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	None of the above	NA	NA	0.032	0.001	NA	NA	0.9	0.01	NA	BLL	892.0	NA	1:DECEASED	No	AALL0232	Unknown	3	Female	Matched	Unknown	No	NA	NA	Negative	39.8
all_phase2_target_2018_pub	TARGET-10-PASFGA	TARGET-10-PASFGA-60.1	15.0	5176.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1482.0	0.694	Not Hispanic or Latino	Negative	Death	NA	31,X,+Y,+5,+9,add(9)(p13),der(10)t(9;10)(p13;p15),+11,+14,+19,+21[6]/62,idemx2,-5,-add(9)(p13),-add(9)(p13),+der(9)t(9;13)(p13;q22)inv(9)(q13q34)x2,+10,+10,-der(10)t(9;10),-der(10)t(9;10),-11,-14,+18[5]/72,(33,X,+Y,+5,+8,+9,der(9)t(9;13)(p13;q22)inv(9)(q	Negative	NA	NA	NA	0.0081	0.01	NA	NA	0.2	0.01	NA	BLL	1482.0	49.0	1:DECEASED	No	AALL0232	White	6	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PASFGA	TARGET-10-PASFGA-60.11	15.0	5176.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1482.0	0.694	Not Hispanic or Latino	Negative	Death	NA	31,X,+Y,+5,+9,add(9)(p13),der(10)t(9;10)(p13;p15),+11,+14,+19,+21[6]/62,idemx2,-5,-add(9)(p13),-add(9)(p13),+der(9)t(9;13)(p13;q22)inv(9)(q13q34)x2,+10,+10,-der(10)t(9;10),-der(10)t(9;10),-11,-14,+18[5]/72,(33,X,+Y,+5,+8,+9,der(9)t(9;13)(p13;q22)inv(9)(q	Negative	NA	NA	NA	0.0081	0.01	NA	NA	0.2	0.01	NA	BLL	1482.0	49.0	1:DECEASED	No	AALL0232	White	6	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PASFGA	TARGET-10-PASFGA-60.3	15.0	5176.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1482.0	0.694	Not Hispanic or Latino	Negative	Death	NA	31,X,+Y,+5,+9,add(9)(p13),der(10)t(9;10)(p13;p15),+11,+14,+19,+21[6]/62,idemx2,-5,-add(9)(p13),-add(9)(p13),+der(9)t(9;13)(p13;q22)inv(9)(q13q34)x2,+10,+10,-der(10)t(9;10),-der(10)t(9;10),-11,-14,+18[5]/72,(33,X,+Y,+5,+8,+9,der(9)t(9;13)(p13;q22)inv(9)(q	Negative	NA	NA	NA	0.0081	0.01	NA	NA	0.2	0.01	NA	BLL	1482.0	49.0	1:DECEASED	No	AALL0232	White	6	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PASFGA	TARGET-10-PASFGA-60.5	15.0	5176.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1482.0	0.694	Not Hispanic or Latino	Negative	Death	NA	31,X,+Y,+5,+9,add(9)(p13),der(10)t(9;10)(p13;p15),+11,+14,+19,+21[6]/62,idemx2,-5,-add(9)(p13),-add(9)(p13),+der(9)t(9;13)(p13;q22)inv(9)(q13q34)x2,+10,+10,-der(10)t(9;10),-der(10)t(9;10),-11,-14,+18[5]/72,(33,X,+Y,+5,+8,+9,der(9)t(9;13)(p13;q22)inv(9)(q	Negative	NA	NA	NA	0.0081	0.01	NA	NA	0.2	0.01	NA	BLL	1482.0	49.0	1:DECEASED	No	AALL0232	White	6	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PASFGA	TARGET-10-PASFGA-60.7	15.0	5176.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1482.0	0.694	Not Hispanic or Latino	Negative	Death	NA	31,X,+Y,+5,+9,add(9)(p13),der(10)t(9;10)(p13;p15),+11,+14,+19,+21[6]/62,idemx2,-5,-add(9)(p13),-add(9)(p13),+der(9)t(9;13)(p13;q22)inv(9)(q13q34)x2,+10,+10,-der(10)t(9;10),-der(10)t(9;10),-11,-14,+18[5]/72,(33,X,+Y,+5,+8,+9,der(9)t(9;13)(p13;q22)inv(9)(q	Negative	NA	NA	NA	0.0081	0.01	NA	NA	0.2	0.01	NA	BLL	1482.0	49.0	1:DECEASED	No	AALL0232	White	6	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PASFGA	TARGET-10-PASFGA-60.9	15.0	5176.0	CHEMOTHERAPY; Transplant	NA	XENOGRAFT	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	No	CNS 1	No	NA	1482.0	0.694	Not Hispanic or Latino	Negative	Death	NA	31,X,+Y,+5,+9,add(9)(p13),der(10)t(9;10)(p13;p15),+11,+14,+19,+21[6]/62,idemx2,-5,-add(9)(p13),-add(9)(p13),+der(9)t(9;13)(p13;q22)inv(9)(q13q34)x2,+10,+10,-der(10)t(9;10),-der(10)t(9;10),-11,-14,+18[5]/72,(33,X,+Y,+5,+8,+9,der(9)t(9;13)(p13;q22)inv(9)(q	Negative	NA	NA	NA	0.0081	0.01	NA	NA	0.2	0.01	NA	BLL	1482.0	49.0	1:DECEASED	No	AALL0232	White	6	Male	Matched	Negative	No	No	NA	Negative	3.1
all_phase2_target_2018_pub	TARGET-10-PASFHR	TARGET-10-PASFHR-09	15.0	5323.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	65.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2633.0	1	Unknown	Unknown	None	NA	46,XY[19]	Unknown	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2633.0	87.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	52.6
all_phase2_target_2018_pub	TARGET-10-PASFKA	TARGET-10-PASFKA-09	13.0	4666.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2609.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	1.2	0.01	NA	NA	NA	NA	NA	BLL	2609.0	86.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	141.6
all_phase2_target_2018_pub	TARGET-10-PASFLK	TARGET-10-PASFLK-09	13.0	4390.0	NA	NA	VALIDATION	Negative	5.0	0.0	NA	59.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2675.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	2675.0	88.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	519.0
all_phase2_target_2018_pub	TARGET-10-PASFPU	TARGET-10-PASFPU-09	15.0	5208.0	Chemotherapy	NA	DISCOVERY	Negative	0.0	0.0	NA	9.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	410.0	186.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	0.16	0.01	NA	BLL	410.0	NA	1:DECEASED	No	AALL0232	Asian	1	Female	Matched	Unknown	No	NA	NA	Negative	4.6
all_phase2_target_2018_pub	TARGET-10-PASFTL	TARGET-10-PASFTL-09	5.0	1483.0	NA	NA	DISCOVERY	Negative	25.0	35.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1.1454	Not Hispanic or Latino	Negative	Induction failure	NA	54,XX,+X,+4,+8,+9,+14,+17,+18,+21[3]/46,XX[18]	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	43.0	0.01	NA	NA	0.6	0.01	NA	BLL	2481.0	NA	0:LIVING	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Positive	7.9
all_phase2_target_2018_pub	TARGET-10-PASFXA	TARGET-10-PASFXA-03	7.0	2374.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	645.0	455.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(1;19)(q21;p13.3),i(9)(q10)[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	5	BLL	645.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Positive	No	NA	0.166666666667	Negative	260.0
all_phase2_target_2018_pub	TARGET-10-PASFXA	TARGET-10-PASFXA-04	7.0	2374.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	645.0	455.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(1;19)(q21;p13.3),i(9)(q10)[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	645.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Positive	No	NA	NA	Negative	260.0
all_phase2_target_2018_pub	TARGET-10-PASFXA	TARGET-10-PASFXA-09	7.0	2374.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	30.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	645.0	455.0	1	Not Hispanic or Latino	Negative	Relapse	0.0456	46,XX,t(1;19)(q21;p13.3),i(9)(q10)[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	645.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Positive	No	NA	NA	Negative	260.0
all_phase2_target_2018_pub	TARGET-10-PASGBD	TARGET-10-PASGBD-40	NA	NA	NA	NA	VALIDATION	NA	NA	NA	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	NA	NA	NA	1	NA	Matched	NA	NA	NA	NA	NA	NA
all_phase2_target_2018_pub	TARGET-10-PASGFH	TARGET-10-PASGFH-09	18.0	6488.0	NA	NA	VALIDATION	Negative	24.0	2.0	NA	40.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1206.0	1	Not Hispanic or Latino	Unknown	Censored	NA	NA	Unknown	NA	0.0	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	1206.0	40.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	7.77
all_phase2_target_2018_pub	TARGET-10-PASHDV	TARGET-10-PASHDV-09	12.0	4257.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2671.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,inv(7)(p15q34),del(12)(p12)[17]/46,XY[10]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2671.0	88.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	123.0
all_phase2_target_2018_pub	TARGET-10-PASHNK	TARGET-10-PASHNK-09	7.0	2416.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2578.0	1	Unknown	Negative	None	NA	46,XY[22]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2578.0	85.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	52.3
all_phase2_target_2018_pub	TARGET-10-PASHUI	TARGET-10-PASHUI-04	6.0	1865.0	NA	NA	DISCOVERY	Negative	13.0	1.0	NA	46.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	605.0	574.0	1.1791	Not Hispanic or Latino	Negative	Relapse	0.0118	NA	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	6.48	0.01	NA	BLL	605.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Unknown	Yes	No	NA	Negative	15.3
all_phase2_target_2018_pub	TARGET-10-PASHUI	TARGET-10-PASHUI-09	6.0	1865.0	NA	NA	DISCOVERY	Negative	13.0	1.0	NA	46.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	605.0	574.0	1.1791	Not Hispanic or Latino	Negative	Relapse	0.0115	NA	Negative	Hyperdiploidy without trisomy of both chromsomes 4 and 10	NA	NA	0.0	0.01	NA	NA	6.48	0.01	2	BLL	605.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Unknown	Yes	No	0.0666666666667	Negative	15.3
all_phase2_target_2018_pub	TARGET-10-PASHUP	TARGET-10-PASHUP-09	10.0	3534.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2443.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(9)(p21),del(9)(p21),t(16;22)(p13.3;q11.2)[18]	Negative	NA	NA	NA	0.06	0.01	NA	NA	NA	NA	NA	BLL	2443.0	81.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	452.5
all_phase2_target_2018_pub	TARGET-10-PASHXL	TARGET-10-PASHXL-09	14.0	4942.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2491.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2491.0	82.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	134.9
all_phase2_target_2018_pub	TARGET-10-PASIIK	TARGET-10-PASIIK-03	4.0	1415.0	NA	NA	DISCOVERY	Negative	8.0	0.0	82.0	91.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	47.0	1.0884	Hispanic or Latino	Negative	Relapse	NA	47,XX,+8,t(14;18)(q32;q21)[19]/46,XX[1]	Negative	None of the above	NA	NA	2.4	0.01	84.8	NA	13.2	0.01	NA	BLL	168.0	NA	1:DECEASED	No	AALL0331	White	1	Female	Matched	Negative	No	NA	NA	Negative	10.67
all_phase2_target_2018_pub	TARGET-10-PASIIY	TARGET-10-PASIIY-09	6.0	2171.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1370.0	1	Unknown	Unknown	None	NA	46,XY[27]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1370.0	46.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	54.5
all_phase2_target_2018_pub	TARGET-10-PASILW	TARGET-10-PASILW-09	13.0	4535.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 2a	No	NA	149.0	1.0328	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(7;11)(q35;p13)[6]/46,XX[24]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	1664.0	55.0	1:DECEASED	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	141.51
all_phase2_target_2018_pub	TARGET-10-PASINX	TARGET-10-PASINX-09	12.0	4148.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2516.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;14)(p13;q11.2)[4]/46,XY[16]`	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2516.0	83.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	729.0
all_phase2_target_2018_pub	TARGET-10-PASJJR	TARGET-10-PASJJR-09	15.0	5216.0	Chemotherapy	NA	VALIDATION	Negative	1.0	0.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2503.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(5;6)(q13;p23),add(9)(p24)[6]/46,XY[7]	Negative	NA	NA	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	2503.0	83.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	3.5
all_phase2_target_2018_pub	TARGET-10-PASJLN	TARGET-10-PASJLN-09	11.0	3991.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2662.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,add(1)(p36.3[12]/46,XY[8]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2662.0	88.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	147.76
all_phase2_target_2018_pub	TARGET-10-PASJMK	TARGET-10-PASJMK-09	7.0	2300.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2646.0	NA	Hispanic or Latino	Unknown	None	NA	46,XX[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2646.0	87.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	16.54
all_phase2_target_2018_pub	TARGET-10-PASJYI	TARGET-10-PASJYI-09	15.0	5228.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	31.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2439.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	0.0	NA	1.2	0.01	NA	NA	NA	NA	NA	BLL	2439.0	81.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	435.32
all_phase2_target_2018_pub	TARGET-10-PASKAD	TARGET-10-PASKAD-09	11.0	3809.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3b	No	NA	2536.0	1.0993	Not Hispanic or Latino	Unknown	None	NA	46,XX,del(9)(p13)[4]/46,idem,del(6)(q13q21)[4]/50,idem,+8,+9,+20,+mar[cp3]/46,XX[9]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2536.0	84.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	223.3
all_phase2_target_2018_pub	TARGET-10-PASKAY	TARGET-10-PASKAY-03	2.0	585.0	Chemotherapy	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	487.0	312.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	0.11	0.01	3	BLL	487.0	NA	1:DECEASED	No	AALL0331	Black or African American	3	Male	Matched	Unknown	No	No	0.1	Positive	20.4
all_phase2_target_2018_pub	TARGET-10-PASKAY	TARGET-10-PASKAY-04	2.0	585.0	Chemotherapy	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	487.0	312.0	1	Not Hispanic or Latino	Negative	Relapse	0.0429	NA	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	0.11	0.01	NA	BLL	487.0	NA	1:DECEASED	No	AALL0331	Black or African American	3	Male	Matched	Unknown	No	No	NA	Positive	20.4
all_phase2_target_2018_pub	TARGET-10-PASKAY	TARGET-10-PASKAY-09	2.0	585.0	Chemotherapy	NA	DISCOVERY	Negative	NA	2.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	487.0	312.0	1	Not Hispanic or Latino	Negative	Relapse	0.0298	NA	Negative	Trisomy of both chromosomes 4 and 10	NA	NA	0.0	0.01	NA	NA	0.11	0.01	NA	BLL	487.0	NA	1:DECEASED	No	AALL0331	Black or African American	3	Male	Matched	Unknown	No	No	NA	Positive	20.4
all_phase2_target_2018_pub	TARGET-10-PASKCL	TARGET-10-PASKCL-09	13.0	4631.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2539.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2539.0	84.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	46.9
all_phase2_target_2018_pub	TARGET-10-PASKGG	TARGET-10-PASKGG-09	16.0	5682.0	Chemotherapy; XRT	NA	VALIDATION	Negative	2.0	1.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	33.0	1.068	Hispanic or Latino	Negative	Censored	NA	46,XY,del(6)(q13q23)[cp4]/46,XY[17]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	33.0	2.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	509.1
all_phase2_target_2018_pub	TARGET-10-PASKHT	TARGET-10-PASKHT-03	13.0	4562.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	716.0	550.0	1	Unknown	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.006999999999999999	0.001	NA	NA	0.18	0.01	3	BLL	716.0	NA	1:DECEASED	No	AALL0232	Black or African American	2	Male	Matched	Unknown	No	No	0.1	Negative	13.66
all_phase2_target_2018_pub	TARGET-10-PASKHT	TARGET-10-PASKHT-04	13.0	4562.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	716.0	550.0	1	Unknown	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.006999999999999999	0.001	NA	NA	0.18	0.01	NA	BLL	716.0	NA	1:DECEASED	No	AALL0232	Black or African American	2	Male	Matched	Unknown	No	No	NA	Negative	13.66
all_phase2_target_2018_pub	TARGET-10-PASKIC	TARGET-10-PASKIC-09	12.0	4092.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2710.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2710.0	90.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	44.4
all_phase2_target_2018_pub	TARGET-10-PASKRN	TARGET-10-PASKRN-03	6.0	1895.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2480.0	1	Hispanic or Latino	Unknown	None	NA	46mXY,del(9)(p12),t(11;14)(p13;q11.2)[2]/46,XY[1]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2480.0	82.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	44.1
all_phase2_target_2018_pub	TARGET-10-PASKSY	TARGET-10-PASKSY-09	10.0	3552.0	Chemotherapy	NA	VALIDATION	Negative	4.0	1.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2367.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(5)(q31),ins(5;1)(q22;q12q25),del(12)(p12p13)[3]/46,idem,del(17)(p11.2)[2]/47,idem,+10[8]/47,idem,+10,del(17)(p11.2)[2]/47,idem,+10,der(17)t(1;17)(q25;p13)[2]/46,XY[3]	Negative	NA	NA	NA	0.09	0.01	NA	NA	NA	NA	NA	BLL	2367.0	78.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	34.7
all_phase2_target_2018_pub	TARGET-10-PASKTG	TARGET-10-PASKTG-09	6.0	2130.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2128.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2128.0	70.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	66.6
all_phase2_target_2018_pub	TARGET-10-PASKXN	TARGET-10-PASKXN-09	10.0	3440.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	579.0	NA	Not Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q21q24)[7]/46,XY[13]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	579.0	20.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	33.7
all_phase2_target_2018_pub	TARGET-10-PASLAB	TARGET-10-PASLAB-09	5.0	1757.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2517.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,del(1)(p32p32)/46,XX	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2517.0	83.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	335.5
all_phase2_target_2018_pub	TARGET-10-PASLBB	TARGET-10-PASLBB-09	8.0	2874.0	Chemotherapy; XRT	NA	VALIDATION	Negative	23.0	0.0	NA	81.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2478.0	1.1203	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	1.0	0.01	NA	NA	NA	NA	NA	BLL	2478.0	82.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	321.6
all_phase2_target_2018_pub	TARGET-10-PASLZM	TARGET-10-PASLZM-03	7.0	2496.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	407.0	258.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,t(1;19)(q23;p13),i(7)(q10)[9]/46,XX[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.11	0.01	1	BLL	407.0	NA	1:DECEASED	No	AALL0331	White	4	Female	Matched	Positive	No	NA	0.0333333333333	Negative	11.2
all_phase2_target_2018_pub	TARGET-10-PASLZM	TARGET-10-PASLZM-04	7.0	2496.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	407.0	258.0	1	Hispanic or Latino	Negative	Relapse	0.0561	46,XX,t(1;19)(q23;p13),i(7)(q10)[9]/46,XX[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.11	0.01	NA	BLL	407.0	NA	1:DECEASED	No	AALL0331	White	4	Female	Matched	Positive	No	NA	NA	Negative	11.2
all_phase2_target_2018_pub	TARGET-10-PASLZM	TARGET-10-PASLZM-09	7.0	2496.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	407.0	258.0	1	Hispanic or Latino	Negative	Relapse	0.0006	46,XX,t(1;19)(q23;p13),i(7)(q10)[9]/46,XX[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.11	0.01	NA	BLL	407.0	NA	1:DECEASED	No	AALL0331	White	4	Female	Matched	Positive	No	NA	NA	Negative	11.2
all_phase2_target_2018_pub	TARGET-10-PASLZM	TARGET-10-PASLZM-40	7.0	2496.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	407.0	258.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,t(1;19)(q23;p13),i(7)(q10)[9]/46,XX[11]	Negative	TCF3-PBX1	NA	NA	0.0	0.01	NA	NA	0.11	0.01	NA	BLL	407.0	NA	1:DECEASED	No	AALL0331	White	4	Female	Matched	Positive	No	NA	NA	Negative	11.2
all_phase2_target_2018_pub	TARGET-10-PASMHF	TARGET-10-PASMHF-09	13.0	4410.0	NA	NA	VALIDATION	Negative	3.0	3.0	NA	17.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3a	No	NA	2531.0	1	Hispanic or Latino	Negative	None	NA	46,XX,t(8;14)(q24.1;q11.2)[2]/46,XX[7]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2531.0	84.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	411.0
all_phase2_target_2018_pub	TARGET-10-PASMIC	TARGET-10-PASMIC-09	14.0	4916.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2500.0	1.0724	Hispanic or Latino	Unknown	None	NA	46,XX,del(6)(q21q23),del(9)(p13p22)[14]/46,XX[6]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2500.0	83.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	81.0
all_phase2_target_2018_pub	TARGET-10-PASMNV	TARGET-10-PASMNV-09	13.0	4662.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2495.0	1	Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	2495.0	83.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	28.3
all_phase2_target_2018_pub	TARGET-10-PASMVF	TARGET-10-PASMVF-04	4.0	1163.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	6.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	671.0	1	Not Hispanic or Latino	Positive	Relapse	0.0137	45,X,-X,add(3)(p21),t(7;10)(q11.2;q24)[3]/46,XX[17]	Negative	ETV6-RUNX1	NA	NA	0.016	0.001	NA	NA	0.09	0.01	NA	BLL	1892.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PASMVF	TARGET-10-PASMVF-09	4.0	1163.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	6.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	671.0	1	Not Hispanic or Latino	Positive	Relapse	0.0275	45,X,-X,add(3)(p21),t(7;10)(q11.2;q24)[3]/46,XX[17]	Negative	ETV6-RUNX1	NA	NA	0.016	0.001	NA	NA	0.09	0.01	NA	BLL	1892.0	NA	0:LIVING	No	AALL0331	White	2	Female	Matched	Negative	No	NA	NA	Negative	4.0
all_phase2_target_2018_pub	TARGET-10-PASNEH	TARGET-10-PASNEH-09	6.0	2167.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2579.0	1	Not Hispanic or Latino	Unknown	None	NA	45,XY,-3,add(9)(p13)[16]/46,XY[4]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2579.0	85.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	46.3
all_phase2_target_2018_pub	TARGET-10-PASNTZ	TARGET-10-PASNTZ-09	8.0	2627.0	NA	NA	VALIDATION	Negative	12.0	0.0	NA	53.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2486.0	1	Unknown	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.76	0.01	NA	NA	NA	NA	NA	BLL	2486.0	82.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	24.8
all_phase2_target_2018_pub	TARGET-10-PASPBU	TARGET-10-PASPBU-09	16.0	5673.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2347.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,i(9)(q10),add(11)(p15)[6]/46,XY[15]	Negative	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2347.0	78.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	68.6
all_phase2_target_2018_pub	TARGET-10-PASPDS	TARGET-10-PASPDS-09	11.0	3990.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2626.0	1	Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	0.01	NA	NA	NA	NA	NA	BLL	2626.0	87.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	Yes	NA	Unknown	190.1
all_phase2_target_2018_pub	TARGET-10-PASPPN	TARGET-10-PASPPN-09	13.0	4593.0	Chemotherapy	NA	VALIDATION	Negative	0.0	0.0	NA	9.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	188.0	1	Unknown	Negative	Relapse	NA	46,XY,del(7)(p13p21)[7]/45,XY,dic(7;8)(p13;p11.2),del(10)(q22)[6]/46,XY[7]	Negative	NA	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	252.0	9.0	1:DECEASED	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	300.8
all_phase2_target_2018_pub	TARGET-10-PASRCV	TARGET-10-PASRCV-09	4.0	1241.0	Stem Cell Transplant; Chemotherapy	NA	VALIDATION	Negative	30.0	4.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2451.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX[20]	Negative	NA	NA	NA	3.2	0.01	NA	NA	NA	NA	NA	BLL	2451.0	81.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	321.53
all_phase2_target_2018_pub	TARGET-10-PASRMM	TARGET-10-PASRMM-09	5.0	1595.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2485.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(9)(p21)[5]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2485.0	82.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	143.7
all_phase2_target_2018_pub	TARGET-10-PASRXC	TARGET-10-PASRXC-09	3.0	919.0	NA	NA	DISCOVERY	Negative	NA	1.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	NA	650.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.24	NA	NA	NA	0.02	0.01	NA	BLL	1009.0	NA	1:DECEASED	No	AALL0331	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	21.9
all_phase2_target_2018_pub	TARGET-10-PASSEF	TARGET-10-PASSEF-09	5.0	1806.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2487.0	1	Hispanic or Latino	Unknown	None	NA	46,XX,t(1;14)(p34;q11.2),t(11;14)(p13;q11.2)[12]/46,XX[8]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2487.0	82.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	127.1
all_phase2_target_2018_pub	TARGET-10-PASSHC	TARGET-10-PASSHC-09	16.0	5570.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	28.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2483.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p13),t(10;14)(q24;q11.2),add(12)(p13)[14]/46,XY[6]	Negative	NA	NA	NA	0.24	0.01	NA	NA	NA	NA	NA	BLL	2483.0	82.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	425.9
all_phase2_target_2018_pub	TARGET-10-PASSPP	TARGET-10-PASSPP-09	10.0	3642.0	Chemotherapy	NA	VALIDATION	Negative	3.0	0.0	NA	47.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2386.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;19)(q23;p13.3)[20]/46,XY[3]	Positive	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2386.0	79.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	139.1
all_phase2_target_2018_pub	TARGET-10-PASSRP	TARGET-10-PASSRP-09	5.0	1643.0	NA	NA	VALIDATION	Negative	15.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1231.0	1	Not Hispanic or Latino	Unknown	Censored	NA	NA	Negative	NA	NA	NA	1.7	0.01	NA	NA	NA	NA	NA	BLL	1231.0	41.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	546.0
all_phase2_target_2018_pub	TARGET-10-PASSSR	TARGET-10-PASSSR-09	8.0	2878.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2463.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[42]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2463.0	81.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	94.6
all_phase2_target_2018_pub	TARGET-10-PASSUP	TARGET-10-PASSUP-03	8.0	2856.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	798.0	669.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,del(5)(q13),der(9)t(5;9)(9qter->9q33::9p21->9q33::5q13->5qter),del(9)(p21)[18]/46,XY[2]	Negative	None of the above	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	798.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Negative	No	No	NA	Negative	115.0
all_phase2_target_2018_pub	TARGET-10-PASSXJ	TARGET-10-PASSXJ-03	4.0	1329.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	552.0	323.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,add(6)(q23)[7]/47,idem,+13[4]/47,idem,+5,del(7)(q22)[13]/46,XY[15]	Negative	None of the above	NA	NA	0.0064	NA	NA	NA	1.1	0.01	NA	BLL	552.0	NA	1:DECEASED	No	AALL0331	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PASSXJ	TARGET-10-PASSXJ-04	4.0	1329.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	552.0	323.0	1	Hispanic or Latino	Negative	Relapse	0.0843	46,XY,add(6)(q23)[7]/47,idem,+13[4]/47,idem,+5,del(7)(q22)[13]/46,XY[15]	Negative	None of the above	NA	NA	0.0064	NA	NA	NA	1.1	0.01	NA	BLL	552.0	NA	1:DECEASED	No	AALL0331	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PASSXJ	TARGET-10-PASSXJ-09	4.0	1329.0	NA	NA	DISCOVERY	Negative	1.0	1.0	NA	14.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	552.0	323.0	1	Hispanic or Latino	Negative	Relapse	0.0115	46,XY,add(6)(q23)[7]/47,idem,+13[4]/47,idem,+5,del(7)(q22)[13]/46,XY[15]	Negative	None of the above	NA	NA	0.0064	NA	NA	NA	1.1	0.01	NA	BLL	552.0	NA	1:DECEASED	No	AALL0331	Unknown	3	Male	Matched	Negative	No	No	NA	Negative	16.2
all_phase2_target_2018_pub	TARGET-10-PASSZA	TARGET-10-PASSZA-09	15.0	5416.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2496.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p21.3)[10]/46,XY[10]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2496.0	83.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	119.2
all_phase2_target_2018_pub	TARGET-10-PASTDU	TARGET-10-PASTDU-09	9.0	3236.0	NA	NA	VALIDATION	Negative	42.0	0.0	NA	87.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2507.0	1	Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	1.2	0.01	NA	NA	NA	NA	NA	BLL	2507.0	83.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	43.57
all_phase2_target_2018_pub	TARGET-10-PASTHE	TARGET-10-PASTHE-09	7.0	2327.0	NA	NA	VALIDATION	Negative	NA	3.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2543.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XX,+19[9]/46,XX[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2543.0	84.0	0:LIVING	No	AALL0434	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	37.8
all_phase2_target_2018_pub	TARGET-10-PASTLP	TARGET-10-PASTLP-09	10.0	3420.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2240.0	1	Hispanic or Latino	Unknown	None	NA	46,XY,t(5;14)(q35;q32)[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2240.0	74.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	181.43
all_phase2_target_2018_pub	TARGET-10-PASTPT	TARGET-10-PASTPT-09	5.0	1774.0	Chemotherapy	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2490.0	1	Not Hispanic or Latino	Negative	None	NA	49,XX,der(5)t(5;14)(q31;q22),+10,+21,+21[5]/46,XX[15]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2490.0	82.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	35.0
all_phase2_target_2018_pub	TARGET-10-PASTXU	TARGET-10-PASTXU-09	13.0	4711.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2002.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2002.0	66.0	0:LIVING	No	AALL0434	Native Hawaiian or other Pacific Islander	1	Female	Matched	Unknown	No	NA	NA	Unknown	198.5
all_phase2_target_2018_pub	TARGET-10-PASUBW	TARGET-10-PASUBW-04	14.0	5098.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	474.0	336.0	1	Not Hispanic or Latino	Negative	Relapse	0.0849	48,XY,add(3)(q11.2),+8,del(8)(p11.1),add(12)(p11.2),+mar[11]/93,idemx2,-8,-8,-21,+mar[6]/46,XY[2]	Negative	None of the above	NA	NA	0.036000000000000004	0.001	NA	NA	0.0037	NA	NA	BLL	474.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	NA	Negative	7.4
all_phase2_target_2018_pub	TARGET-10-PASUBW	TARGET-10-PASUBW-09	14.0	5098.0	NA	NA	DISCOVERY	Negative	NA	2.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	474.0	336.0	1	Not Hispanic or Latino	Negative	Relapse	0.0732	48,XY,add(3)(q11.2),+8,del(8)(p11.1),add(12)(p11.2),+mar[11]/93,idemx2,-8,-8,-21,+mar[6]/46,XY[2]	Negative	None of the above	NA	NA	0.036000000000000004	0.001	NA	NA	0.0037	NA	1	BLL	474.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Negative	No	No	0.0333333333333	Negative	7.4
all_phase2_target_2018_pub	TARGET-10-PASUGC	TARGET-10-PASUGC-09	10.0	3515.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2411.0	1	Hispanic or Latino	Unknown	None	NA	46,XY,inv(5)(p15.1q31)[6]/46,idem,del(13)(q14q22)[1]/46,idem,del(6)(q15q21),del(13)(q14q22)[3]/46,XY[17]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2411.0	80.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	214.5
all_phase2_target_2018_pub	TARGET-10-PASUIN	TARGET-10-PASUIN-09	14.0	5004.0	Chemotherapy	NA	VALIDATION	Negative	4.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2243.0	1	Not Hispanic or Latino	Unknown	SMN	NA	46,XY,t(3;14)(p14;q32),del(9)(p12)[6]/46,XY[15]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2564.0	85.0	0:LIVING	No	AALL0434	Native Hawaiian or other Pacific Islander	1	Male	Matched	Negative	No	No	NA	Negative	194.6
all_phase2_target_2018_pub	TARGET-10-PASUSV	TARGET-10-PASUSV-09	9.0	3127.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2552.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,der(15)t(9;15)(p13~21;q15~22),del(15)(q15~22)[5]/46,XY[15]	Negative	NA	NA	NA	0.5	0.01	NA	NA	NA	NA	NA	BLL	2552.0	84.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	373.4
all_phase2_target_2018_pub	TARGET-10-PASVIN	TARGET-10-PASVIN-09	8.0	2619.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2428.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(9)(p13),t(11;14)(p13;q11.2)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2428.0	80.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	74.08
all_phase2_target_2018_pub	TARGET-10-PASVPZ	TARGET-10-PASVPZ-09	4.0	1333.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2432.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2432.0	80.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	213.68
all_phase2_target_2018_pub	TARGET-10-PASVUW	TARGET-10-PASVUW-03	9.0	2953.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	77.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	420.0	310.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,del(7)(q31)[3]/46,XY,del(4)(q21q27)[2]/46,XY[15]	Negative	None of the above	NA	NA	0.02	NA	NA	NA	0.94	0.01	NA	BLL	420.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	13.61
all_phase2_target_2018_pub	TARGET-10-PASVUW	TARGET-10-PASVUW-04	9.0	2953.0	NA	NA	DISCOVERY	Negative	0.0	0.0	NA	77.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	420.0	310.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XY,del(7)(q31)[3]/46,XY,del(4)(q21q27)[2]/46,XY[15]	Negative	None of the above	NA	NA	0.02	NA	NA	NA	0.94	0.01	NA	BLL	420.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Negative	No	No	NA	Negative	13.61
all_phase2_target_2018_pub	TARGET-10-PASWFN	TARGET-10-PASWFN-09	12.0	4136.0	NA	NA	VALIDATION	Negative	26.0	2.0	NA	24.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2395.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[23]	Negative	NA	NA	NA	2.5	0.01	NA	NA	NA	NA	NA	BLL	2395.0	79.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Negative	5.8
all_phase2_target_2018_pub	TARGET-10-PASWNU	TARGET-10-PASWNU-09	16.0	5580.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2070.0	1	Unknown	Unknown	None	NA	46,XX,del(9)(p13),t(10;11)(p12;q21)[cp5]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2070.0	69.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	52.9
all_phase2_target_2018_pub	TARGET-10-PASWSR	TARGET-10-PASWSR-09	4.0	1249.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2316.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(11;14)(p13;q11.2)[10]/46,XX[10]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2316.0	77.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	83.4
all_phase2_target_2018_pub	TARGET-10-PASWUH	TARGET-10-PASWUH-03	10.0	3524.0	NA	NA	DISCOVERY	Negative	60.0	70.0	NA	65.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	33.0	1	Not Hispanic or Latino	Negative	Induction failure	NA	46,XX[20]	Negative	None of the above	NA	NA	77.2	NA	NA	NA	7.7	0.01	NA	BLL	2072.0	NA	0:LIVING	No	AALL0331	Asian	1	Female	Matched	Unknown	No	NA	NA	Negative	42.5
all_phase2_target_2018_pub	TARGET-10-PASWXB	TARGET-10-PASWXB-09	10.0	3526.0	Chemotherapy	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3c	No	NA	2288.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2288.0	76.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	50.08
all_phase2_target_2018_pub	TARGET-10-PASWXZ	TARGET-10-PASWXZ-09	8.0	2759.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2440.0	1	Hispanic or Latino	Negative	None	NA	46,XX,add(1)(q42),i(9)(q10),t(10;13)(p11.1;q14),t(11;19)(19;4)(q23;p13.3p13.3;q27),del(12)(p11.2)[16]/46,XX[4]	Positive	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2440.0	81.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	482.1
all_phase2_target_2018_pub	TARGET-10-PASWZJ	TARGET-10-PASWZJ-09	6.0	1908.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2403.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2403.0	80.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Unknown	167.4
all_phase2_target_2018_pub	TARGET-10-PASXIL	TARGET-10-PASXIL-09	9.0	3222.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3a	No	NA	2493.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;14)(q31;q32)[12]/46,XY[13]	Negative	NA	NA	NA	0.01	0.01	NA	NA	NA	NA	NA	BLL	2493.0	82.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	63.25
all_phase2_target_2018_pub	TARGET-10-PASXLT	TARGET-10-PASXLT-09	5.0	1491.0	NA	NA	VALIDATION	Negative	5.0	0.0	NA	50.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2419.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(9)(p21.3p21.3)[4]/46,XT[38]	Negative	NA	NA	NA	0.2	0.01	NA	NA	NA	NA	NA	BLL	2419.0	80.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	93.8
all_phase2_target_2018_pub	TARGET-10-PASXLZ	TARGET-10-PASXLZ-09	6.0	1910.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2312.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[21]	Unknown	NA	NA	NA	0.06	0.01	NA	NA	NA	NA	NA	BLL	2312.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	20.9
all_phase2_target_2018_pub	TARGET-10-PASXMF	TARGET-10-PASXMF-09	11.0	3815.0	NA	NA	VALIDATION	Negative	0.0	3.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2359.0	1.1583	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2359.0	78.0	0:LIVING	No	AALL0434	Native Hawaiian or other Pacific Islander	1	Male	Matched	Unknown	No	No	NA	Unknown	291.0
all_phase2_target_2018_pub	TARGET-10-PASXSI	TARGET-10-PASXSI-09	9.0	3272.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3b	No	NA	2420.0	1	Hispanic or Latino	Unknown	None	NA	46,XY,t(11;14)(p13;q11.2)[18]/46,XY[2]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2420.0	80.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	403.8
all_phase2_target_2018_pub	TARGET-10-PASXUC	TARGET-10-PASXUC-09	7.0	2490.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2238.0	1.8989	Not Hispanic or Latino	Unknown	None	NA	89<4n>,XXX,-X,-2,-3,+6,-7,-9,+10,-11,i(17)(q10)[6]/46,XX[15]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2238.0	74.0	0:LIVING	No	AALL0434	Asian	1	Female	Matched	Negative	No	NA	NA	Positive	30.07
all_phase2_target_2018_pub	TARGET-10-PASXUU	TARGET-10-PASXUU-09	8.0	2562.0	Chemotherapy	NA	VALIDATION	Negative	2.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2306.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q13q21),del(9)(p13)[4]/46,idem,-10,+mar[4]/46,idem,del(9)(p13),add(11)(p15)[4]/46,XY[8]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2306.0	76.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	167.2
all_phase2_target_2018_pub	TARGET-10-PASYAJ	TARGET-10-PASYAJ-09	4.0	1113.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2426.0	1.0509	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(9;9)(p10;p10)[2]/46,idem,t(5;14)(q33;q32.1)[9]/46,idem,add(X)(p22),t(4;5)(q12;q35),+add(9)(q10),-der(9)t(9;9)(p10;p10),-10,+mar[4]/46,XY[10]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2426.0	80.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	113.2
all_phase2_target_2018_pub	TARGET-10-PASYCN	TARGET-10-PASYCN-09	11.0	4009.0	Chemotherapy; XRT	NA	VALIDATION	Negative	2.0	1.0	NA	21.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2313.0	1.0996	Not Hispanic or Latino	Negative	None	NA	50,XY,+X,+6,+19,+21[13]/46,XY[7]	Negative	NA	NA	NA	0.27	0.01	NA	NA	NA	NA	NA	BLL	2313.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	45.6
all_phase2_target_2018_pub	TARGET-10-PASYGM	TARGET-10-PASYGM-03	8.0	2750.0	NA	NA	DISCOVERY	Negative	NA	0.0	NA	2.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	429.0	314.0	1	Hispanic or Latino	Negative	Relapse	NA	46,XX,der(19)t(1;19)(q23;p13.3)[8]/46,XX[12]	Negative	TCF3-PBX1	NA	NA	0.0	NA	NA	NA	0.05	0.01	4	BLL	429.0	NA	1:DECEASED	No	AALL0331	White	1	Female	Matched	Positive	No	NA	0.133333333333	Negative	14.1
all_phase2_target_2018_pub	TARGET-10-PASYHN	TARGET-10-PASYHN-09	18.0	6367.0	Chemotherapy	NA	VALIDATION	Negative	39.0	2.0	NA	65.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1023.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q13q21)[18]/46,XY[2]	Negative	NA	NA	NA	1.1	0.01	NA	NA	NA	NA	NA	BLL	1023.0	34.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	107.7
all_phase2_target_2018_pub	TARGET-10-PASYIS	TARGET-10-PASYIS-09	9.0	2937.0	NA	NA	VALIDATION	Negative	5.0	0.0	NA	33.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2288.0	1	Not Hispanic or Latino	Negative	None	NA	45,X,-X,add(1)(p36)[6]/46,XX[14]	Negative	NA	NA	NA	0.5	0.01	NA	NA	NA	NA	NA	BLL	2288.0	76.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	97.0
all_phase2_target_2018_pub	TARGET-10-PASYRH	TARGET-10-PASYRH-03	16.0	5836.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	0.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	576.0	453.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[31]	Negative	None of the above	NA	NA	0.01	NA	NA	NA	NA	NA	NA	BLL	576.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	148.52
all_phase2_target_2018_pub	TARGET-10-PASYRH	TARGET-10-PASYRH-04	16.0	5836.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	0.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	576.0	453.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY[31]	Negative	None of the above	NA	NA	0.01	NA	NA	NA	NA	NA	NA	BLL	576.0	NA	1:DECEASED	No	AALL0232	White	2	Male	Matched	Unknown	No	No	NA	Negative	148.52
all_phase2_target_2018_pub	TARGET-10-PASYSJ	TARGET-10-PASYSJ-09	15.0	5379.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3a	No	NA	2126.0	1.1722	Not Hispanic or Latino	Negative	None	NA	46,XY,t(11;14)(p13;q11.2)[12]/47,idem,+20[2]/46,XY[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2126.0	70.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	104.7
all_phase2_target_2018_pub	TARGET-10-PASYWF	TARGET-10-PASYWF-03	6.0	2022.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3c	No	NA	2321.0	1.0736	Not Hispanic or Latino	Negative	None	NA	NA	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2321.0	77.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	616.0
all_phase2_target_2018_pub	TARGET-10-PASZEW	TARGET-10-PASZEW-09	8.0	2681.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2314.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(9;19)(q12;p13.3)[9]/46,XX[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2314.0	77.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	15.6
all_phase2_target_2018_pub	TARGET-10-PASZIY	TARGET-10-PASZIY-09	15.0	5234.0	NA	NA	VALIDATION	Negative	11.0	0.0	NA	92.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2369.0	1.0766	Hispanic or Latino	Negative	None	NA	50,XY,+7,+18,+19,+20[11]/46,XY[1]	Negative	NA	NA	NA	3.8	0.01	NA	NA	NA	NA	NA	BLL	2369.0	78.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	12.0
all_phase2_target_2018_pub	TARGET-10-PASZJW	TARGET-10-PASZJW-03	30.0	10946.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2325.0	1	Not Hispanic or Latino	Negative	None	NA	46,Y,ins(X;11)(q28;q23q23),add(1)(q42),add(6)(q21)[12]/46,XY[8]	Positive	NA	NA	NA	0.17	0.01	NA	NA	NA	NA	NA	BLL	2325.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	130.1
all_phase2_target_2018_pub	TARGET-10-PATALJ	TARGET-10-PATALJ-09	13.0	4669.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1902.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(10;11)(p13;q21)[14]/46,XY[6]	Negative	NA	NA	NA	0.69	0.01	NA	NA	NA	NA	NA	BLL	1902.0	63.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	4.7
all_phase2_target_2018_pub	TARGET-10-PATAXS	TARGET-10-PATAXS-09	2.0	367.0	NA	NA	VALIDATION	Negative	4.0	2.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2252.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2252.0	75.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Unknown	No	No	NA	Negative	6.1
all_phase2_target_2018_pub	TARGET-10-PATAYT	TARGET-10-PATAYT-09	6.0	2158.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2370.0	1	Hispanic or Latino	Unknown	None	NA	46,X,add(X)(q13),del(1)(p36.1),add(6)(q25),del(9)(p13),-10,del(12)(p11.2),+mar[13]/46,XX[7]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2370.0	78.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	26.8
all_phase2_target_2018_pub	TARGET-10-PATBDJ	TARGET-10-PATBDJ-09	16.0	5803.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2344.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;19)(q23;p13.3)[10]/46,XY[10]	Positive	NA	NA	NA	0.06	0.01	NA	NA	NA	NA	NA	BLL	2344.0	78.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	43.0
all_phase2_target_2018_pub	TARGET-10-PATBDK	TARGET-10-PATBDK-09	8.0	2901.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2312.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[26]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2312.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	226.2
all_phase2_target_2018_pub	TARGET-10-PATBGC	TARGET-10-PATBGC-09	11.0	3946.0	NA	NA	VALIDATION	Negative	21.0	2.0	NA	64.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1841.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(4;12;9)(q13;p13q34)[20]	Negative	NA	NA	NA	0.8	0.01	NA	NA	NA	NA	NA	BLL	1841.0	61.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	353.4
all_phase2_target_2018_pub	TARGET-10-PATBNT	TARGET-10-PATBNT-09	14.0	4938.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2156.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(11;19)(q23;p13.3)[10]/46,XY[10]	Positive	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2156.0	71.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	11.7
all_phase2_target_2018_pub	TARGET-10-PATBRV	TARGET-10-PATBRV-09	9.0	3054.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	213.0	1	Not Hispanic or Latino	Unknown	Death	NA	46,XX,t(10;11)(p13;q21)[12]/46,XX[7]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	213.0	8.0	1:DECEASED	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	579.0
all_phase2_target_2018_pub	TARGET-10-PATBTX	TARGET-10-PATBTX-09	4.0	1152.0	Chemotherapy	NA	VALIDATION	Negative	1.0	3.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2185.0	1	Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.06	0.01	NA	NA	NA	NA	NA	BLL	2185.0	72.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	25.4
all_phase2_target_2018_pub	TARGET-10-PATBYK	TARGET-10-PATBYK-09	17.0	6000.0	Chemotherapy	pallative chemotherapy	VALIDATION	Negative	1.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	387.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	743.0	25.0	1:DECEASED	No	AALL0434	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Negative	554.0
all_phase2_target_2018_pub	TARGET-10-PATCDM	TARGET-10-PATCDM-09	4.0	1192.0	Stem Cell Transplant	NA	VALIDATION	Negative	0.0	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 3b	No	NA	357.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,del(6)(q13q21)[4]/46,XY[26]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	949.0	32.0	1:DECEASED	No	AALL0434	White	2	Male	Matched	Negative	No	No	NA	Negative	748.0
all_phase2_target_2018_pub	TARGET-10-PATCDM	TARGET-10-PATCDM-40	4.0	1192.0	Stem Cell Transplant	NA	VALIDATION	Negative	0.0	0.0	NA	27.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 3b	No	NA	357.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XY,del(6)(q13q21)[4]/46,XY[26]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	949.0	32.0	1:DECEASED	No	AALL0434	White	2	Male	Matched	Negative	No	No	NA	Negative	748.0
all_phase2_target_2018_pub	TARGET-10-PATCDZ	TARGET-10-PATCDZ-09	14.0	4837.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	NA	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	NA	1	Hispanic or Latino	Unknown	NA	NA	46,XY,t(5;14)(q35;q32)/46,XY	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	NA	NA	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	15.7
all_phase2_target_2018_pub	TARGET-10-PATCKV	TARGET-10-PATCKV-09	15.0	5266.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	42.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2406.0	1.0941	Hispanic or Latino	Unknown	None	NA	50,XY,+8,+10,+13,+19[17]/46,XY[3]	Negative	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2406.0	80.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	2.33
all_phase2_target_2018_pub	TARGET-10-PATCNI	TARGET-10-PATCNI-09	5.0	1682.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	28.0	2.0	NA	81.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2400.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(11;19)(q23;p13.3)[cp20]	Positive	NA	NA	NA	2.2	0.01	NA	NA	NA	NA	NA	BLL	2400.0	79.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	369.0
all_phase2_target_2018_pub	TARGET-10-PATCTI	TARGET-10-PATCTI-04	7.0	2414.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	482.0	363.0	1	Not Hispanic or Latino	Negative	Relapse	0.1609	46,XY,der(9)inv(9)(p13q34)add(9)(q22),der(19)t(1;19)(q23;p13.3)[3]/46,idem,add(13)(q12)[6]/46,idem,t(15;15)(q12;q26)[2]/46,XY[9]	Negative	TCF3-PBX1	0.0	0.01	0.18	NA	NA	NA	0.15	0.01	NA	BLL	482.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Positive	No	No	NA	Negative	11.1
all_phase2_target_2018_pub	TARGET-10-PATCTI	TARGET-10-PATCTI-09	7.0	2414.0	NA	NA	DISCOVERY	Negative	0.0	2.0	NA	10.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	482.0	363.0	1	Not Hispanic or Latino	Negative	Relapse	0.0548	46,XY,der(9)inv(9)(p13q34)add(9)(q22),der(19)t(1;19)(q23;p13.3)[3]/46,idem,add(13)(q12)[6]/46,idem,t(15;15)(q12;q26)[2]/46,XY[9]	Negative	TCF3-PBX1	0.0	0.01	0.18	NA	NA	NA	0.15	0.01	NA	BLL	482.0	NA	1:DECEASED	No	AALL0331	White	2	Male	Matched	Positive	No	No	NA	Negative	11.1
all_phase2_target_2018_pub	TARGET-10-PATCUK	TARGET-10-PATCUK-09	13.0	4397.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2244.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(1;4)(p32;q11.2),add(7)(q34),del(9)(p21.3),del(11)(p15)[18]/46,XY[2].ish t(1;14)(1p36-;IGH+;1p36+,IGH-),del(9)(p16-)	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2244.0	74.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	203.5
all_phase2_target_2018_pub	TARGET-10-PATCZN	TARGET-10-PATCZN-09	5.0	1806.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2302.0	1	Hispanic or Latino	Unknown	None	NA	46,XX[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2302.0	76.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	292.2
all_phase2_target_2018_pub	TARGET-10-PATDBU	TARGET-10-PATDBU-09	10.0	3551.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	54.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2334.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;14)(p13;q11.2)[5]/46,idem,del(6)(q13q21)[2]/46,XY[23]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2334.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	49.0
all_phase2_target_2018_pub	TARGET-10-PATDDZ	TARGET-10-PATDDZ-09	13.0	4600.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	14.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2183.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q21q25)[5]/46,XY[14]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2183.0	72.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	96.1
all_phase2_target_2018_pub	TARGET-10-PATDFE	TARGET-10-PATDFE-09	6.0	1835.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	1166.0	1	Hispanic or Latino	Unknown	Relapse	NA	46,XX[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2365.0	78.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	13.2
all_phase2_target_2018_pub	TARGET-10-PATDGZ	TARGET-10-PATDGZ-09	3.0	937.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2324.0	1.922	Not Hispanic or Latino	Negative	None	NA	46,XY,add(9)(p13)/92,idemx2[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2324.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	28.7
all_phase2_target_2018_pub	TARGET-10-PATDKT	TARGET-10-PATDKT-09	23.0	8169.0	NA	NA	VALIDATION	Negative	4.0	2.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2305.0	1	Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2305.0	76.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	88.5
all_phase2_target_2018_pub	TARGET-10-PATDLG	TARGET-10-PATDLG-09	12.0	4306.0	NA	NA	VALIDATION	Negative	4.0	1.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2351.0	1.071	Not Hispanic or Latino	Negative	None	NA	46,XY,t(10;14)(q24;q11.2)[5]/46,XY[46]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2351.0	78.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	21.2
all_phase2_target_2018_pub	TARGET-10-PATDMN	TARGET-10-PATDMN-09	7.0	2526.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	39.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2323.0	1	Hispanic or Latino	Unknown	None	NA	46,XY[21]	Unknown	NA	NA	NA	0.26	0.01	NA	NA	NA	NA	NA	BLL	2323.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	167.8
all_phase2_target_2018_pub	TARGET-10-PATDRC	TARGET-10-PATDRC-03	7.0	2463.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	59.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1262.0	1	Not Hispanic or Latino	Unknown	Censored	NA	46,XY[20]	Unknown	NA	NA	NA	1.3	0.01	NA	NA	NA	NA	NA	BLL	1262.0	42.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	71.7
all_phase2_target_2018_pub	TARGET-10-PATEAK	TARGET-10-PATEAK-09	18.0	6551.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2340.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XY,+6,del(6)(q21)[10]/47,idem,add(19)(q13)[2]/46,XY[8]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2340.0	77.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Negative	No	No	NA	Negative	211.8
all_phase2_target_2018_pub	TARGET-10-PATEEN	TARGET-10-PATEEN-03	24.0	8568.0	NA	NA	DISCOVERY	Negative	2.0	1.0	NA	18.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	516.0	418.0	1	Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.2	0.01	NA	NA	6.9	0.01	NA	BLL	516.0	NA	1:DECEASED	No	AALL0232	White	1	Male	Matched	Unknown	No	No	NA	Negative	337.0
all_phase2_target_2018_pub	TARGET-10-PATEFF	TARGET-10-PATEFF-09	7.0	2366.0	Chemotherapy; XRT; Other	Bone marrow transplant	VALIDATION	Negative	2.0	0.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 3c	No	NA	124.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,t(1;1)(p32;q25)[43]/46,XY[21]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2114.0	70.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	35.3
all_phase2_target_2018_pub	TARGET-10-PATEHZ	TARGET-10-PATEHZ-03	9.0	3198.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	NA	0.0	NA	1.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	545.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,del(6)(q13)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1707.0	57.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	18.85
all_phase2_target_2018_pub	TARGET-10-PATEIT	TARGET-10-PATEIT-09	10.0	3485.0	Chemotherapy	NA	VALIDATION	Negative	10.0	0.0	NA	92.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 2a	No	NA	440.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,del(9)(p21.3)[7]/46,idem,del(6)(q12q21)[9]/46,idem,del(6)(q12q21),t(8;14)(q24;q11.2)[7]	Negative	NA	NA	NA	3.3	0.01	NA	NA	NA	NA	NA	BLL	605.0	20.0	1:DECEASED	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	472.0
all_phase2_target_2018_pub	TARGET-10-PATEMI	TARGET-10-PATEMI-09	18.0	6491.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2172.0	1	Hispanic or Latino	Unknown	None	NA	46,XX,t(3;11)(q11.2;p15)[20]	Negative	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2172.0	72.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	5.4
all_phase2_target_2018_pub	TARGET-10-PATENL	TARGET-10-PATENL-04	4.0	1345.0	Chemotherapy	NA	VALIDATION	Negative	3.0	2.0	NA	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	425.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,t(7;11)(q34;p15)[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	605.0	20.0	1:DECEASED	No	AALL0434	White	2	Male	Matched	Negative	No	No	NA	Negative	41.0
all_phase2_target_2018_pub	TARGET-10-PATENL	TARGET-10-PATENL-09	4.0	1345.0	Chemotherapy	NA	VALIDATION	Negative	3.0	2.0	NA	20.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	425.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XY,t(7;11)(q34;p15)[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	605.0	20.0	1:DECEASED	No	AALL0434	White	2	Male	Matched	Negative	No	No	NA	Negative	41.0
all_phase2_target_2018_pub	TARGET-10-PATEVL	TARGET-10-PATEVL-09	4.0	1228.0	NA	NA	VALIDATION	Negative	11.0	0.0	NA	95.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2339.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;14)(q35;q32)	Negative	NA	NA	NA	0.15	0.01	NA	NA	NA	NA	NA	BLL	2339.0	77.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	911.8
all_phase2_target_2018_pub	TARGET-10-PATEYS	TARGET-10-PATEYS-09	6.0	1912.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3b	No	NA	1932.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[21]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1932.0	64.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Negative	536.7
all_phase2_target_2018_pub	TARGET-10-PATFJD	TARGET-10-PATFJD-09	3.0	920.0	NA	NA	VALIDATION	Negative	3.0	2.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2295.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XX,add(3)(p11),+8,der(10)t(3;10)(p11;p11)add(10)(q21),add(16)(q22)[28]/46,XX[5]	Negative	NA	NA	NA	2.5	0.01	NA	NA	NA	NA	NA	BLL	2295.0	76.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	77.73
all_phase2_target_2018_pub	TARGET-10-PATFJP	TARGET-10-PATFJP-09	9.0	3249.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2025.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,+17[9]/46,XY[12]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2025.0	67.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	232.66
all_phase2_target_2018_pub	TARGET-10-PATFRM	TARGET-10-PATFRM-09	19.0	6696.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	79.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2203.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[30]	Unknown	NA	NA	NA	0.1	0.01	NA	NA	NA	NA	NA	BLL	2203.0	73.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	7.2
all_phase2_target_2018_pub	TARGET-10-PATFVG	TARGET-10-PATFVG-09	6.0	2130.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2191.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2191.0	73.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	225.0
all_phase2_target_2018_pub	TARGET-10-PATFWF	TARGET-10-PATFWF-09	18.0	6364.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	208.0	1	Unknown	Unknown	None	NA	46,XY,t(5;14)(q31;q32),del(12)(p11.2)-17,+add(19)(p13.3)	Negative	NA	NA	NA	4.9	0.01	NA	NA	NA	NA	NA	BLL	208.0	7.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	20.3
all_phase2_target_2018_pub	TARGET-10-PATFYZ	TARGET-10-PATFYZ-09	16.0	5624.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2317.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,der(10)t(10;14)(q24;q24),del(12)(p11.2p13),add(14)(q11.2)[8]/46,XY[13]	Negative	NA	NA	NA	0.07	0.01	NA	NA	NA	NA	NA	BLL	2317.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	136.9
all_phase2_target_2018_pub	TARGET-10-PATGBY	TARGET-10-PATGBY-09	22.0	7715.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2334.0	1	Unknown	Unknown	None	NA	46,XX[23]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2334.0	77.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	3.9
all_phase2_target_2018_pub	TARGET-10-PATGKE	TARGET-10-PATGKE-09	12.0	4202.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2006.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2006.0	66.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	37.3
all_phase2_target_2018_pub	TARGET-10-PATGLV	TARGET-10-PATGLV-09	7.0	2257.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	5.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2289.0	1	Hispanic or Latino	Negative	None	NA	46,XY,del(10)(q22q24),del(11)(q13q23)[24]/46,XY[16]	Negative	NA	NA	NA	0.2	0.01	NA	NA	NA	NA	NA	BLL	2289.0	76.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	224.7
all_phase2_target_2018_pub	TARGET-10-PATGMP	TARGET-10-PATGMP-09	11.0	3924.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1907.0	1	Not Hispanic or Latino	Negative	SMN	NA	46,XY,t(1;14)(p32;q11.2)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2180.0	72.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	111.9
all_phase2_target_2018_pub	TARGET-10-PATGVX	TARGET-10-PATGVX-09	8.0	2668.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2305.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(7;19)(q22;p13),del(16)(q22)[cp3]/46,idem,der(18)t(1;18)(q12;q22)[2]/47,idem,+8,t(9;12)(p24;p12),del(16)(q22)[2]/46,XX[13]	Negative	NA	NA	NA	0.016	0.01	NA	NA	NA	NA	NA	BLL	2305.0	76.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	16.6
all_phase2_target_2018_pub	TARGET-10-PATGWP	TARGET-10-PATGWP-09	15.0	5192.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	26.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2203.0	1	Not Hispanic or Latino	Unknown	None	NA	45,XY,der(5)t(1;5)(q21;q13),t(7;14)(q15;q32),der(8;12)(q10;q10)[16]/46,XY[4]	Negative	NA	NA	NA	1.6	0.01	NA	NA	NA	NA	NA	BLL	2203.0	73.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	175.2
all_phase2_target_2018_pub	TARGET-10-PATGXS	TARGET-10-PATGXS-09	14.0	5075.0	NA	NA	VALIDATION	Negative	36.0	0.0	NA	76.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2136.0	1.085	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.7	0.01	NA	NA	NA	NA	NA	BLL	2136.0	71.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Negative	25.4
all_phase2_target_2018_pub	TARGET-10-PATGYH	TARGET-10-PATGYH-09	17.0	5959.0	NA	NA	VALIDATION	Negative	20.0	0.0	NA	55.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2154.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;19)(q23;p13.3)[20]	Positive	NA	NA	NA	2.9	0.01	NA	NA	NA	NA	NA	BLL	2154.0	71.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	99.3
all_phase2_target_2018_pub	TARGET-10-PATGZA	TARGET-10-PATGZA-09	15.0	5253.0	Chemotherapy; XRT	NA	VALIDATION	Negative	1.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2184.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XX,t(1;3)(p36.1;p21),+10,add(12)(p13)[cp8]/47,idem,del(6)(q23q25),del(14)(q24q32)[cp7]/46,XX[7]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2184.0	72.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	0.7
all_phase2_target_2018_pub	TARGET-10-PATHBG	TARGET-10-PATHBG-09	3.0	1081.0	NA	NA	VALIDATION	Negative	12.0	0.0	NA	68.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2176.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,t(4;11)(q21;p15),+20[27]/46,XX[3]	Negative	NA	NA	NA	0.85	0.01	NA	NA	NA	NA	NA	BLL	2176.0	72.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	53.6
all_phase2_target_2018_pub	TARGET-10-PATHFE	TARGET-10-PATHFE-09	12.0	4081.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2178.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q15q23),i(9)(p13)[11]/46,XY[9]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2178.0	72.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	20.8
all_phase2_target_2018_pub	TARGET-10-PATHGY	TARGET-10-PATHGY-09	4.0	1319.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2125.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(1)(p36.1),-11,+19,der(19)t(11;19)(q13;q13.3)[20]/46,XY[2]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2125.0	70.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	193.0
all_phase2_target_2018_pub	TARGET-10-PATHJF	TARGET-10-PATHJF-09	11.0	3743.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2039.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2039.0	68.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Negative	43.6
all_phase2_target_2018_pub	TARGET-10-PATHRF	TARGET-10-PATHRF-09	6.0	1889.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2289.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2289.0	76.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	107.7
all_phase2_target_2018_pub	TARGET-10-PATHWV	TARGET-10-PATHWV-09	9.0	3127.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	2253.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q13q21)[7]/46,XY[4]	Negative	NA	NA	NA	0.09	0.01	NA	NA	NA	NA	NA	BLL	2253.0	75.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	224.0
all_phase2_target_2018_pub	TARGET-10-PATIBE	TARGET-10-PATIBE-09	12.0	4106.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2124.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XX,+8,t(11;19)(q23;p13.3)[20]	Positive	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2124.0	70.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	315.0
all_phase2_target_2018_pub	TARGET-10-PATIKN	TARGET-10-PATIKN-03	2.0	699.0	Chemotherapy; XRT	NA	VALIDATION	Negative	1.0	0.0	NA	79.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2139.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(11;14)(p13;q11)[17]/46,XY[3]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2139.0	71.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	148.2
all_phase2_target_2018_pub	TARGET-10-PATISC	TARGET-10-PATISC-04	9.0	3131.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	408.0	302.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	2.6	0.01	NA	BLL	408.0	NA	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Unknown	No	No	NA	Negative	14.8
all_phase2_target_2018_pub	TARGET-10-PATISC	TARGET-10-PATISC-09	9.0	3131.0	NA	NA	DISCOVERY	Negative	1.0	0.0	NA	5.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	408.0	302.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	2.6	0.01	NA	BLL	408.0	NA	1:DECEASED	No	AALL0331	Black or African American	2	Male	Matched	Unknown	No	No	NA	Negative	14.8
all_phase2_target_2018_pub	TARGET-10-PATITB	TARGET-10-PATITB-09	16.0	5514.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2191.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2191.0	73.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Unknown	No	No	NA	Negative	343.9
all_phase2_target_2018_pub	TARGET-10-PATITY	TARGET-10-PATITY-09	9.0	3125.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	19.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2156.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,del(6)(q15q23),i(9)(q10),t(10;14)(q24;q11.2)[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2156.0	71.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	50.9
all_phase2_target_2018_pub	TARGET-10-PATJBC	TARGET-10-PATJBC-09	6.0	1948.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	16.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2203.0	1	Hispanic or Latino	Unknown	None	NA	47,XY,+8[20]	Negative	NA	NA	NA	1.4	0.01	NA	NA	NA	NA	NA	BLL	2203.0	73.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	36.2
all_phase2_target_2018_pub	TARGET-10-PATJLT	TARGET-10-PATJLT-09	13.0	4416.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	28.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3a	No	NA	2201.0	1	Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q13q23),t(7;9)(q34;q32)[21]/46,XY[2]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2201.0	73.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	252.0
all_phase2_target_2018_pub	TARGET-10-PATJZK	TARGET-10-PATJZK-09	19.0	6843.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	469.0	1	Not Hispanic or Latino	Negative	Relapse	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1335.0	44.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	9.7
all_phase2_target_2018_pub	TARGET-10-PATKGP	TARGET-10-PATKGP-09	11.0	3861.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3c	No	NA	2167.0	1	Hispanic or Latino	Negative	None	NA	46,XX[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2167.0	72.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Negative	6.3
all_phase2_target_2018_pub	TARGET-10-PATKVD	TARGET-10-PATKVD-09	3.0	904.0	Chemotherapy; Stem Cell Transplant	Immunotherapy - Gengraft (anti-GVHD)	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 1	No	NA	191.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2151.0	71.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	180.57
all_phase2_target_2018_pub	TARGET-10-PATKWU	TARGET-10-PATKWU-09	14.0	4834.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2083.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(3)(q11.2),inv(14)(q11.2q32)[8]/47,idem,+14[12]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2083.0	69.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	22.9
all_phase2_target_2018_pub	TARGET-10-PATKYI	TARGET-10-PATKYI-09	21.0	7614.0	NA	NA	VALIDATION	Negative	5.0	1.0	NA	20.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2009.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p13p22)[7]/46,XY[20]	Negative	NA	NA	NA	0.7	0.01	NA	NA	NA	NA	NA	BLL	2009.0	67.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	1.8
all_phase2_target_2018_pub	TARGET-10-PATLGU	TARGET-10-PATLGU-09	8.0	2578.0	Chemotherapy; XRT	NA	VALIDATION	Negative	3.0	0.0	NA	13.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2b	No	NA	2183.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2183.0	72.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Unknown	No	No	NA	Unknown	263.0
all_phase2_target_2018_pub	TARGET-10-PATLHH	TARGET-10-PATLHH-09	8.0	2830.0	NA	NA	VALIDATION	Negative	14.0	5.0	NA	49.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2162.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(2;11)(q33;q23),t(11;17)(q23;q21),del(12)(p11.2)[5]/47,idem,+7[5]/46,XY[13]	Positive	NA	NA	NA	4.9	0.01	NA	NA	NA	NA	NA	BLL	2162.0	72.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	34.0
all_phase2_target_2018_pub	TARGET-10-PATLHS	TARGET-10-PATLHS-09	11.0	4004.0	NA	NA	VALIDATION	Negative	3.0	1.0	NA	25.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1553.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1553.0	52.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	Yes	NA	Unknown	38.8
all_phase2_target_2018_pub	TARGET-10-PATLMA	TARGET-10-PATLMA-03	9.0	3115.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	87.0	1	Not Hispanic or Latino	Negative	None	NA	47,XX,+9,del(9)(p13),t(10;11)(p13;q21),del(12)(p11.2)[cp5]/46,XX[25]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	87.0	3.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	22.8
all_phase2_target_2018_pub	TARGET-10-PATLNS	TARGET-10-PATLNS-09	3.0	823.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	18.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2086.0	1	Unknown	Unknown	None	NA	46,X,add(X)(p22),der(1)t(1;?)(p36.1;?)t(?;20)(?;p11.2),del(1)(q32),del(6)(13q23),t(6;7)(q23;q34)(WCP6,WCP7;WCP7,WCP6),del(11)(q13),add(20)(p11.2)[17]/46,XX[3]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2086.0	69.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Negative	No	NA	NA	Negative	18.4
all_phase2_target_2018_pub	TARGET-10-PATLNZ	TARGET-10-PATLNZ-09	10.0	3601.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1221.0	1	Unknown	Unknown	None	NA	46,XY,t(1;14)(p32;q11.2)[12]/47,idem,+8[4]/46,XY[4]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1221.0	41.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	3.4
all_phase2_target_2018_pub	TARGET-10-PATLPN	TARGET-10-PATLPN-03	3.0	945.0	Chemotherapy; XRT	NA	VALIDATION	Negative	1.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2055.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2057.0	68.0	0:LIVING	Yes	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	674.0
all_phase2_target_2018_pub	TARGET-10-PATLRZ	TARGET-10-PATLRZ-09	14.0	5105.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2025.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,add(9)(p21),add(9)(p21)	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2025.0	67.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	102.4
all_phase2_target_2018_pub	TARGET-10-PATMAF	TARGET-10-PATMAF-09	17.0	6011.0	NA	NA	VALIDATION	Negative	3.0	0.0	NA	64.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1469.0	1	Not Hispanic or Latino	Negative	None	NA	47,XY,der(1)t(1;1)(p36.1;q12),+19[10]/46,XY[10]	Negative	NA	NA	NA	4.2	0.01	NA	NA	NA	NA	NA	BLL	1469.0	49.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	12.5
all_phase2_target_2018_pub	TARGET-10-PATMRE	TARGET-10-PATMRE-09	7.0	2472.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	38.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2099.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,+5,del(5)(q13q33),der(5)t(5;11)(q13;q13),-11[15]/46,XY[5]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2099.0	70.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	312.8
all_phase2_target_2018_pub	TARGET-10-PATMTV	TARGET-10-PATMTV-09	12.0	4045.0	NA	NA	VALIDATION	Negative	10.0	0.0	NA	30.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2179.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(6;11)(q27;q23)[20]	Positive	NA	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	2179.0	72.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	188.3
all_phase2_target_2018_pub	TARGET-10-PATMVH	TARGET-10-PATMVH-09	19.0	6724.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2079.0	1	Not Hispanic or Latino	Unknown	None	NA	45,XY,dic(4;9)(p11;p11),del(6)(q23),t(11;14)(p13;q11.2)[4]/46,XY[16]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2079.0	69.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	35.2
all_phase2_target_2018_pub	TARGET-10-PATMXN	TARGET-10-PATMXN-09	15.0	5450.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	23.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1191.0	1	Not Hispanic or Latino	Negative	Censored	NA	46,XY,add(3)(p21),add(5)(q22)[5]/46,XY[13]	Negative	NA	NA	NA	4.6	0.01	NA	NA	NA	NA	NA	BLL	1191.0	40.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	6.6
all_phase2_target_2018_pub	TARGET-10-PATMYZ	TARGET-10-PATMYZ-09	13.0	4421.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	28.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2108.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;7)(q35;q22)[2]/46,XY[18]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2108.0	70.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	4.9
all_phase2_target_2018_pub	TARGET-10-PATNAM	TARGET-10-PATNAM-09	3.0	814.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2156.0	1	Hispanic or Latino	Unknown	None	NA	46,XX,del(6)(q21)[20]	Negative	NA	NA	NA	2.8	0.01	NA	NA	NA	NA	NA	BLL	2156.0	71.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Negative	No	NA	NA	Negative	607.4
all_phase2_target_2018_pub	TARGET-10-PATNIA	TARGET-10-PATNIA-09	7.0	2401.0	NA	NA	VALIDATION	Negative	0.0	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2153.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,del(1)(p13p31),del(7)(q32q36)[16]/46,XX[4]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2153.0	71.0	0:LIVING	No	AALL0434	Asian	1	Female	Matched	Negative	No	NA	NA	Negative	143.9
all_phase2_target_2018_pub	TARGET-10-PATPDA	TARGET-10-PATPDA-09	3.0	747.0	Chemotherapy; XRT	NA	VALIDATION	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	1815.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(8;11)(q24;p11.2)[8]/46,XY[12]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1815.0	60.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	605.0
all_phase2_target_2018_pub	TARGET-10-PATPGE	TARGET-10-PATPGE-09	20.0	7204.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	75.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2009.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2009.0	67.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	150.0
all_phase2_target_2018_pub	TARGET-10-PATPWF	TARGET-10-PATPWF-03	2.0	661.0	Chemotherapy	NA	VALIDATION	Negative	3.0	0.0	NA	10.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1925.0	1	Unknown	Unknown	None	NA	46,XY,del(6)(q13q25),del(9)(p13)[16]/46,XY[4]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1925.0	64.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	272.0
all_phase2_target_2018_pub	TARGET-10-PATRAB	TARGET-10-PATRAB-09	5.0	1707.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2146.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,del(9)(p13p22)[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2146.0	71.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	427.9
all_phase2_target_2018_pub	TARGET-10-PATRGV	TARGET-10-PATRGV-09	2.0	577.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	NA	0.0	NA	0.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 3a	No	NA	128.0	1	Not Hispanic or Latino	Unknown	Relapse	NA	46,XX,t(1;11)(p36.1;p11.2)[18]/46,XX[2]	Negative	NA	NA	NA	0.61	0.01	NA	NA	NA	NA	NA	BLL	1679.0	56.0	1:DECEASED	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	59.2
all_phase2_target_2018_pub	TARGET-10-PATRHL	TARGET-10-PATRHL-09	7.0	2299.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2043.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(7;10)(q34;q24),del(9)(p13)[9]/46,XY[11]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2043.0	68.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	22.7
all_phase2_target_2018_pub	TARGET-10-PATRIC	TARGET-10-PATRIC-03	22.0	7678.0	NA	NA	DISCOVERY	Negative	90.0	89.0	NA	93.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	28.0	1	Not Hispanic or Latino	Negative	Induction failure	NA	46,XY[25]	Negative	None of the above	NA	NA	80.3	0.01	NA	NA	84.6	0.01	NA	BLL	202.0	NA	1:DECEASED	No	AALL0232	Unknown	1	Male	Matched	Unknown	No	No	NA	Negative	145.1
all_phase2_target_2018_pub	TARGET-10-PATRNA	TARGET-10-PATRNA-09	3.0	803.0	NA	NA	VALIDATION	Negative	0.0	0.0	NA	8.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	2079.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(7;9)(q34;q34),del(12)(p12)[3]/46,XY[29]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2079.0	69.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	397.0
all_phase2_target_2018_pub	TARGET-10-PATRUN	TARGET-10-PATRUN-09	5.0	1763.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	101.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,add(9)(p21)[6]/46,XY[14]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	101.0	4.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	18.1
all_phase2_target_2018_pub	TARGET-10-PATRXL	TARGET-10-PATRXL-09	5.0	1767.0	Chemotherapy	NA	VALIDATION	Negative	2.0	0.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	1795.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[21]	Negative	NA	NA	NA	0.19	0.01	NA	NA	NA	NA	NA	BLL	1795.0	60.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	133.1
all_phase2_target_2018_pub	TARGET-10-PATSAH	TARGET-10-PATSAH-04	18.0	6424.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	1.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	138.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(9;9)(q12;p12)[9]/46,XX[11]	Negative	None of the above	NA	NA	0.0	NA	NA	NA	0.0	0.01	NA	BLL	711.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	15.8
all_phase2_target_2018_pub	TARGET-10-PATSAH	TARGET-10-PATSAH-09	18.0	6424.0	Chemotherapy	NA	DISCOVERY	Negative	1.0	1.0	NA	NA	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 1	No	NA	138.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,t(9;9)(q12;p12)[9]/46,XX[11]	Negative	None of the above	NA	NA	0.0	NA	NA	NA	0.0	0.01	NA	BLL	711.0	NA	1:DECEASED	No	AALL0232	White	2	Female	Matched	Negative	No	NA	NA	Negative	15.8
all_phase2_target_2018_pub	TARGET-10-PATSDS	TARGET-10-PATSDS-03	15.0	5428.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2055.0	1	Not Hispanic or Latino	Negative	None	NA	NA	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2055.0	68.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	190.8
all_phase2_target_2018_pub	TARGET-10-PATSIL	TARGET-10-PATSIL-09	16.0	5700.0	NA	NA	VALIDATION	Negative	2.0	1.0	NA	9.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2030.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q13q21)[18]/46,XY[1]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2030.0	67.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	23.8
all_phase2_target_2018_pub	TARGET-10-PATSIY	TARGET-10-PATSIY-09	10.0	3404.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	0.0	1.0	NA	77.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1721.0	1	Hispanic or Latino	Unknown	Relapse	NA	46,XY,del(7)(p13)[5]/46,XY[6]	Negative	NA	NA	NA	0.026000000000000002	0.01	NA	NA	NA	NA	NA	BLL	2090.0	69.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	145.0
all_phase2_target_2018_pub	TARGET-10-PATSLH	TARGET-10-PATSLH-09	3.0	824.0	Chemotherapy	NA	VALIDATION	Negative	6.0	0.0	NA	15.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1807.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,der(14)(14pter->14q32::14q11.2->14q11.2::14q24->14q11.2::14q32->14qter),del(14)(q11.2q32)[17]/46,XY[3]	Negative	NA	NA	NA	0.02	0.01	NA	NA	NA	NA	NA	BLL	1807.0	60.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	102.3
all_phase2_target_2018_pub	TARGET-10-PATTEE	TARGET-10-PATTEE-03	14.0	5021.0	NA	NA	DISCOVERY	Negative	12.0	0.0	NA	69.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	232.0	98.0	1	Not Hispanic or Latino	Negative	Relapse	NA	46,XX,add(9)(p13)[1]/46,idem,dup(1)(q12q42)[5]/46,XX[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	33.0	0.01	1	BLL	232.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Negative	No	NA	0.0666666666667	Negative	107.0
all_phase2_target_2018_pub	TARGET-10-PATTEE	TARGET-10-PATTEE-04	14.0	5021.0	NA	NA	DISCOVERY	Negative	12.0	0.0	NA	69.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	232.0	98.0	1	Not Hispanic or Latino	Negative	Relapse	0.0325	46,XX,add(9)(p13)[1]/46,idem,dup(1)(q12q42)[5]/46,XX[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	33.0	0.01	NA	BLL	232.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Negative	No	NA	NA	Negative	107.0
all_phase2_target_2018_pub	TARGET-10-PATTEE	TARGET-10-PATTEE-09	14.0	5021.0	NA	NA	DISCOVERY	Negative	12.0	0.0	NA	69.0	Yes	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B-Precursor	No	CNS 2	No	232.0	98.0	1	Not Hispanic or Latino	Negative	Relapse	0.0356	46,XX,add(9)(p13)[1]/46,idem,dup(1)(q12q42)[5]/46,XX[14]	Negative	None of the above	NA	NA	0.0	0.01	NA	NA	33.0	0.01	NA	BLL	232.0	NA	1:DECEASED	No	AALL0232	White	3	Female	Matched	Negative	No	NA	NA	Negative	107.0
all_phase2_target_2018_pub	TARGET-10-PATTHR	TARGET-10-PATTHR-09	17.0	5917.0	NA	NA	VALIDATION	Negative	41.0	3.0	NA	49.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2041.0	1	Not Hispanic or Latino	Unknown	None	NA	45,XY,add(1)(p34),add(2)(p11.2),t(3;9)(p11;p13),add(12)(p11.2),del(14)(q24q32),-18[17]/46,XY[4]	Negative	NA	NA	NA	3.6	0.01	NA	NA	NA	NA	NA	BLL	2041.0	68.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Negative	No	No	NA	Negative	15.2
all_phase2_target_2018_pub	TARGET-10-PATVDA	TARGET-10-PATVDA-03	3.0	780.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	42.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX[20]	Unknown	NA	NA	NA	0.12	0.01	NA	NA	NA	NA	NA	BLL	42.0	2.0	0:LIVING	No	AALL0434	Asian	1	Female	Matched	Unknown	No	NA	NA	Unknown	8.6
all_phase2_target_2018_pub	TARGET-10-PATWHB	TARGET-10-PATWHB-09	11.0	3904.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 3c	No	NA	1914.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XX,t(5;14)(q35;q32)	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1914.0	63.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	751.8
all_phase2_target_2018_pub	TARGET-10-PATWIJ	TARGET-10-PATWIJ-09	15.0	5187.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1941.0	1	Hispanic or Latino	Unknown	None	NA	92,XXYY[2]/46,XY[18]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1941.0	64.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Positive	118.3
all_phase2_target_2018_pub	TARGET-10-PATWJU	TARGET-10-PATWJU-09	6.0	2127.0	NA	NA	VALIDATION	Negative	NA	2.0	NA	4.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	2013.0	1	Unknown	Unknown	None	NA	47,XY,t(6;7)(q23;q34),+8[10]/46,XY[10]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	2013.0	67.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	9.2
all_phase2_target_2018_pub	TARGET-10-PATWNL	TARGET-10-PATWNL-09	2.0	633.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Unknown	NA	NA	45,XX,add(7)(q32),-14[18]/46,XX[12]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	42.8
all_phase2_target_2018_pub	TARGET-10-PATWXC	TARGET-10-PATWXC-09	16.0	5488.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1839.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(11;14)(p13;q11.2)[8]/46,XY[12]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1839.0	61.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	88.6
all_phase2_target_2018_pub	TARGET-10-PATWYL	TARGET-10-PATWYL-09	16.0	5586.0	NA	NA	VALIDATION	Negative	4.0	0.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	1838.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(6)(q12q16.1)[11]/47,idem,+mar[5]/46,XY[4]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1838.0	61.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	40.4
all_phase2_target_2018_pub	TARGET-10-PATWYZ	TARGET-10-PATWYZ-09	4.0	1385.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1973.0	1	Not Hispanic or Latino	Unknown	None	NA	47,XY,del(9)(p13),+21[11]/47,idem,t(2;13)(p21;q14)[2]/48,idem,t(2;13)(q21;q14),+4,del(6)(q13q23)[5]/46,XY[8]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1973.0	65.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	37.04
all_phase2_target_2018_pub	TARGET-10-PATXAL	TARGET-10-PATXAL-09	16.0	5626.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	235.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,add(9)(p13)[13]/46,XY[3]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	235.0	8.0	0:LIVING	No	AALL0434	Black or African American	1	Male	Matched	Negative	No	No	NA	Negative	158.8
all_phase2_target_2018_pub	TARGET-10-PATXKW	TARGET-10-PATXKW-03	19.0	6640.0	Chemotherapy	NA	VALIDATION	Negative	0.0	0.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	1374.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,-16,+mar[15]/47,idem,+4[5]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1374.0	46.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	56.5
all_phase2_target_2018_pub	TARGET-10-PATXNK	TARGET-10-PATXNK-09	10.0	3428.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1865.0	1	Not Hispanic or Latino	Unknown	None	NA	45,XY,del(6)(q13q23),dic(9;22)(p21;p11.1)[13]/46,XY[7]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1865.0	62.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	402.59
all_phase2_target_2018_pub	TARGET-10-PATXNR	TARGET-10-PATXNR-09	18.0	6258.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1869.0	NA	Not Hispanic or Latino	Negative	None	NA	46,X,-X,del(3)(q21q25),add(9)(p21),del(9)p21p21),+10[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1869.0	62.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	152.0
all_phase2_target_2018_pub	TARGET-10-PATXSK	TARGET-10-PATXSK-09	7.0	2279.0	NA	NA	VALIDATION	Negative	2.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	1991.0	1	Not Hispanic or Latino	Unknown	None	NA	48,XY,t(3;10)(p21;q24),+12,+21[5]/46,XY[2]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1991.0	66.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	91.6
all_phase2_target_2018_pub	TARGET-10-PATYCH	TARGET-10-PATYCH-09	4.0	1432.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1854.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[20]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1854.0	61.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Negative	15.8
all_phase2_target_2018_pub	TARGET-10-PATYJK	TARGET-10-PATYJK-09	13.0	4451.0	Chemotherapy	NA	VALIDATION	Negative	8.0	0.0	NA	61.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1955.0	1.1333	Not Hispanic or Latino	Unknown	None	NA	51,XY,+8,+10,t(10;11)(p11.2;p13),+11,+13,del(13)(q12q14)[16]/46,XY[4]	Negative	NA	NA	NA	1.0	0.01	NA	NA	NA	NA	NA	BLL	1955.0	65.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	2.4
all_phase2_target_2018_pub	TARGET-10-PATYMP	TARGET-10-PATYMP-09	19.0	6742.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1759.0	1	Unknown	Unknown	None	NA	47,XY,+Y?c[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1759.0	58.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	20.04
all_phase2_target_2018_pub	TARGET-10-PATYWV	TARGET-10-PATYWV-09	8.0	2799.0	Chemotherapy; Stem Cell Transplant	NA	VALIDATION	Negative	NA	0.0	NA	2.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	741.0	1	Not Hispanic or Latino	Unknown	SMN	NA	46,XY,del(6)(q15q23)[11]/46,XY[9]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1649.0	55.0	1:DECEASED	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	135.1
all_phase2_target_2018_pub	TARGET-10-PATZFF	TARGET-10-PATZFF-09	11.0	3906.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1832.0	1	Unknown	Unknown	None	NA	46,XX,del(9)(p13)[5]/46,XX[15]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1832.0	61.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Negative	No	NA	NA	Negative	97.7
all_phase2_target_2018_pub	TARGET-10-PATZSL	TARGET-10-PATZSL-09	11.0	3663.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1897.0	1	Not Hispanic or Latino	Negative	None	NA	46,XX,-9,t(11;14)(p13;q11.2),-15,+mar1,+mar2[cp17]/90,idemx2,-mar2,-mar2[cp2]/46,XX[1]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1897.0	63.0	0:LIVING	No	AALL0434	Asian	1	Female	Matched	Negative	No	NA	NA	Positive	35.7
all_phase2_target_2018_pub	TARGET-10-PATZVD	TARGET-10-PATZVD-09	5.0	1518.0	Chemotherapy	NA	VALIDATION	Negative	NA	1.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1908.0	1	Unknown	Unknown	None	NA	46,XY[20]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1908.0	63.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Unknown	No	No	NA	Unknown	2.22
all_phase2_target_2018_pub	TARGET-10-PATZWA	TARGET-10-PATZWA-03	11.0	3686.0	Chemotherapy; XRT	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1863.0	1	Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1863.0	62.0	0:LIVING	No	AALL0434	White	1	Female	Matched	Unknown	No	NA	NA	Unknown	43.1
all_phase2_target_2018_pub	TARGET-10-PATZYC	TARGET-10-PATZYC-09	4.0	1350.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	3.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1882.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,i(9)(q10),add(10)(q22),del(11)(q23),add(12)(p11.2)[cp6]/46,XY[19]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1882.0	62.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	745.36
all_phase2_target_2018_pub	TARGET-10-PATZYR	TARGET-10-PATZYR-03	9.0	3256.0	NA	NA	VALIDATION	Negative	1.0	1.0	NA	40.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1903.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,del(9)(p12)[15]/46,XY[3]	Negative	NA	NA	NA	0.03	0.01	NA	NA	NA	NA	NA	BLL	1903.0	63.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	188.4
all_phase2_target_2018_pub	TARGET-10-PAUACG	TARGET-10-PAUACG-09	5.0	1807.0	NA	NA	VALIDATION	Negative	22.0	0.0	NA	61.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1777.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,t(2;10)(p13;p11.2),del(9)(p13)[10]	Negative	NA	NA	NA	1.0	0.01	NA	NA	NA	NA	NA	BLL	1777.0	59.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	90.91
all_phase2_target_2018_pub	TARGET-10-PAUAFN	TARGET-10-PAUAFN-09	4.0	1437.0	NA	NA	VALIDATION	Negative	NA	1.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2a	No	NA	1854.0	1	Unknown	Unknown	None	NA	46,XY,del(9)(p21),t(11;14)(p13;q11.2)[4]/46,XY[16]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1854.0	61.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	769.32
all_phase2_target_2018_pub	TARGET-10-PAUAJA	TARGET-10-PAUAJA-09	12.0	4343.0	NA	NA	VALIDATION	Negative	16.0	0.0	NA	48.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1875.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY,ins(19;11)(p13.3;q23q23),del(12)(p13)[14]/46,XY[7]	Positive	NA	NA	NA	2.1	0.01	NA	NA	NA	NA	NA	BLL	1875.0	62.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	156.8
all_phase2_target_2018_pub	TARGET-10-PAUAYB	TARGET-10-PAUAYB-09	19.0	6682.0	Chemotherapy; XRT	NA	VALIDATION	Negative	5.0	3.0	NA	60.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 2c	No	NA	1834.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,t(5;14)(q35;q32)[20]	Negative	NA	NA	NA	0.68	0.01	NA	NA	NA	NA	NA	BLL	1834.0	61.0	0:LIVING	No	AALL0434	Asian	1	Male	Matched	Negative	No	No	NA	Negative	197.3
all_phase2_target_2018_pub	TARGET-10-PAUAZV	TARGET-10-PAUAZV-09	9.0	3039.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1807.0	1	Hispanic or Latino	Unknown	None	NA	46,XY[19]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1807.0	60.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	14.1
all_phase2_target_2018_pub	TARGET-10-PAUBCB	TARGET-10-PAUBCB-09	16.0	5623.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	6.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1870.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY[40]	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1870.0	62.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Unknown	No	No	NA	Unknown	213.9
all_phase2_target_2018_pub	TARGET-10-PAUBCT	TARGET-10-PAUBCT-09	14.0	4757.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1845.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,dup(9)(q11q12)inv(9)(p11q12),del(12)(p11.2)[6]/46,XY[14]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1845.0	61.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	75.9
all_phase2_target_2018_pub	TARGET-10-PAUBLL	TARGET-10-PAUBLL-09	8.0	2617.0	NA	NA	VALIDATION	Negative	NA	0.0	NA	0.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1914.0	1	Not Hispanic or Latino	Unknown	None	NA	NA	Unknown	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1914.0	63.0	0:LIVING	No	AALL0434	Black or African American	1	Female	Matched	Unknown	No	NA	NA	Unknown	7.04
all_phase2_target_2018_pub	TARGET-10-PAUBPY	TARGET-10-PAUBPY-09	12.0	4219.0	Chemotherapy	NA	VALIDATION	Negative	8.0	10.0	NA	53.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1837.0	1	Hispanic or Latino	Negative	None	NA	46,XY,add(7)(p22)[3]/46,XY[2]	Negative	NA	NA	NA	0.04	0.01	NA	NA	NA	NA	NA	BLL	1837.0	61.0	0:LIVING	No	AALL0434	Unknown	1	Male	Matched	Negative	No	No	NA	Negative	50.9
all_phase2_target_2018_pub	TARGET-10-PAUBRD	TARGET-10-PAUBRD-09	5.0	1755.0	Chemotherapy	NA	VALIDATION	Negative	NA	0.0	NA	1.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Unknown	NA	NA	46,XY,add(3)(q21)[4]/46,XY[16]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	NA	NA	NA	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	73.0
all_phase2_target_2018_pub	TARGET-10-PAUBTC	TARGET-10-PAUBTC-09	2.0	667.0	Chemotherapy; Stem Cell Transplant; XRT	NA	VALIDATION	Negative	4.0	0.0	NA	NA	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	Yes	CNS 3a	No	NA	119.0	1.114	Not Hispanic or Latino	Unknown	Relapse	NA	NA	Negative	NA	NA	NA	0.37	0.01	NA	NA	NA	NA	NA	BLL	1833.0	61.0	0:LIVING	No	AALL0434	Unknown	1	Female	Matched	Unknown	No	NA	NA	Unknown	888.0
all_phase2_target_2018_pub	TARGET-10-PAUBXP	TARGET-10-PAUBXP-09	9.0	3035.0	NA	NA	VALIDATION	Negative	1.0	0.0	NA	12.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1747.0	1	Not Hispanic or Latino	Negative	None	NA	45,XY,der(6;15)(p10;q10),add(9)(p22)[11]/46,XY[19]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1747.0	58.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	93.0
all_phase2_target_2018_pub	TARGET-10-PAUCDC	TARGET-10-PAUCDC-09	17.0	6151.0	Chemotherapy	NA	VALIDATION	Negative	6.0	1.0	NA	72.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1867.0	1	Not Hispanic or Latino	Unknown	None	NA	46,XY,der(4)t(4;13)(p15;q14),del(6)(q13q21)[17]/46,XY[3]	Negative	NA	NA	NA	0.0	NA	NA	NA	NA	NA	NA	BLL	1867.0	62.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	628.8
all_phase2_target_2018_pub	TARGET-10-PAUCDY	TARGET-10-PAUCDY-09	10.0	3632.0	NA	NA	VALIDATION	Negative	7.0	4.0	NA	73.0	No	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	T Cell ALL	No	CNS 1	No	NA	1793.0	1	Not Hispanic or Latino	Negative	None	NA	46,XY[25]	Negative	NA	NA	NA	4.8	0.01	NA	NA	NA	NA	NA	BLL	1793.0	59.0	0:LIVING	No	AALL0434	White	1	Male	Matched	Negative	No	No	NA	Negative	2.2
all_phase2_target_2018_pub	TARGET-10-PAUXZX	TARGET-10-PAUXZX-60.1	6.0	1828.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	NA	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Positive	NA	NA	46,XX,t(9;12)(q34;p13)[18]/46,XX[2]	Negative	NA	NA	NA	0.06	0.01	NA	NA	1.4	0.01	NA	BLL	NA	NA	NA	NA	AALL1131	White	3	Female	Matched	Negative	NA	NA	NA	Negative	322.2
all_phase2_target_2018_pub	TARGET-10-PAUXZX	TARGET-10-PAUXZX-60.2	6.0	1828.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	NA	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Positive	NA	NA	46,XX,t(9;12)(q34;p13)[18]/46,XX[2]	Negative	NA	NA	NA	0.06	0.01	NA	NA	1.4	0.01	NA	BLL	NA	NA	NA	NA	AALL1131	White	3	Female	Matched	Negative	NA	NA	NA	Negative	322.2
all_phase2_target_2018_pub	TARGET-10-PAUXZX	TARGET-10-PAUXZX-60.3	6.0	1828.0	NA	NA	XENOGRAFT	Negative	NA	0.0	NA	NA	NA	B-Lymphoblastic Leukemia/Lymphoma	B-Lymphoblastic Leukemia/Lymphoma	B Cell ALL	NA	CNS 1	No	NA	NA	1	Not Hispanic or Latino	Positive	NA	NA	46,XX,t(9;12)(q34;p13)[18]/46,XX[2]	Negative	NA	NA	NA	0.06	0.01	NA	NA	1.4	0.01	NA	BLL	NA	NA	NA	NA	AALL1131	White	3	Female	Matched	Negative	NA	NA	NA	Negative	322.2